Seed	Sign	Gene_target	Ensembl	Repeated	N_repeated	Repeated2	N_repeated2	P-value	Ortholist2	Orthologs	TRRUST(+)	Phenotype	GO	GOterm	Keyword	Reactome	Reactome_terms
PDSS1	positive	NOP16	ENSG00000048162	PDSS1	1	PDSS1	1	0.000415974425998722	WBGene00013958				GO:0043231;GO:0005634;GO:0005730;GO:0003723;GO:0042273	intracellular membrane-bounded organelle;nucleoplasm;nucleolus;RNA binding;nucleus;ribosomal large subunit biogenesis	Acetylation;Alternative splicing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation		
PDSS1	positive	TIPIN	ENSG00000075131	PDSS1	1	PDSS1	1	0.000446159983276906	WBGene00017738	WBGene00017738(0)			GO:0005634;GO:0005737;GO:0043231;GO:0051301;GO:0005515;GO:0006974;GO:0007049;GO:0003677;GO:0005654;GO:0000076;GO:0048478;GO:0006260;GO:0008284;GO:0044770;GO:0031298;GO:0043111;GO:0000077;GO:0009411;GO:0031573;GO:0033262;GO:0000790	nucleus;cellular response to DNA damage stimulus;replication fork protection;DNA replication checkpoint;cytoplasm;cell division;protein binding;cell cycle;DNA binding;nucleoplasm;DNA replication;positive regulation of cell population proliferation;cell cycle phase transition;replication fork protection complex;replication fork arrest;DNA damage checkpoint;response to UV;intra-S DNA damage checkpoint;regulation of nuclear cell cycle DNA replication;nuclear chromatin	Cell cycle;Cell division;Cytoplasm;DNA damage;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-5693607	DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Processing of DNA double-strand break ends
PDSS1	positive	CKS2	ENSG00000123975	PDSS1	1	PDSS1	1	0.000588353184545865	WBGene00001051;WBGene00022162				GO:0051301;GO:0005515;GO:0007049;GO:0000079;GO:0042393;GO:0016538;GO:0019901;GO:0043130;GO:0045737;GO:0019005;GO:0061575;GO:0000307;GO:0007346;GO:0003682;GO:0006357;GO:0007127;GO:0008283;GO:0044772	cyclin-dependent protein serine/threonine kinase regulator activity;cell division;protein binding;cell cycle;histone binding;protein kinase binding;ubiquitin binding;SCF ubiquitin ligase complex;regulation of mitotic cell cycle;cyclin-dependent protein serine/threonine kinase activator activity;cyclin-dependent protein kinase holoenzyme complex;chromatin binding;regulation of transcription by RNA polymerase II;meiosis I;cell population proliferation;mitotic cell cycle phase transition;positive regulation of cyclin-dependent protein serine/threonine kinase activity	3D-structure;Acetylation;Cell cycle;Cell division;Reference proteome		
PDSS1	positive	EZH2	ENSG00000106462	PDSS1	1	PDSS1	1	0.000674192615960356	WBGene00003220	WBGene00019584(0);WBGene00018023(0);WBGene00008527(0);WBGene00019690(0);WBGene00020919(0);WBGene00016603(0);WBGene00021282(0);WBGene00022431(0);WBGene00008062(0);WBGene00008206(0);WBGene00020006(0)	AXL;CCND1;CCNE1;KPNB1;MMP2;PCNA;RPLP0	Weaver syndrome;WEAVER SYNDROME 2;Weaver syndrome	GO:0018024;GO:0034968;GO:0008284;GO:0005634;GO:0016740;GO:0008168;GO:0032259;GO:0031490;GO:0006325;GO:0000790;GO:0005515;GO:0048511;GO:0000122;GO:0000981;GO:0043547;GO:0005654;GO:0071902;GO:0048387;GO:0003682;GO:0035098;GO:0003677;GO:0045892;GO:0070317;GO:0010718;GO:0000978;GO:0042752;GO:0006355;GO:0045814;GO:0042054;GO:1990841;GO:0046976;GO:0043406;GO:1902808;GO:0016571;GO:0016279;GO:0006348;GO:0070734;GO:0000781;GO:0000979;GO:0003714;GO:0003723;GO:0043021;GO:0043565;GO:0044212;GO:0070878;GO:0001932;GO:0006306;GO:0006357;GO:0010468;GO:0010629;GO:0014013;GO:0014834;GO:0014898;GO:0021695;GO:0021766;GO:0032355;GO:0034244;GO:0035984;GO:0036333;GO:0042127;GO:0043433;GO:0045605;GO:0050767;GO:0051154;GO:0070301;GO:0070314;GO:0071168;GO:0097421;GO:0098532;GO:1900006;GO:1904772;GO:2000134;GO:0005737;GO:0045120	histone-lysine N-methyltransferase activity;histone lysine methylation;protein binding;positive regulation of cell population proliferation;nucleus;transferase activity;methyltransferase activity;methylation;chromatin DNA binding;chromatin organization;nuclear chromatin;rhythmic process;negative regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;positive regulation of GTPase activity;nucleoplasm;positive regulation of protein serine/threonine kinase activity;chromatin binding;ESC/E(Z) complex;DNA binding;negative regulation of transcription, DNA-templated;negative regulation of G0 to G1 transition;RNA polymerase II cis-regulatory region sequence-specific DNA binding;positive regulation of epithelial to mesenchymal transition;regulation of circadian rhythm;regulation of transcription, DNA-templated;negative regulation of gene expression, epigenetic;histone methyltransferase activity;promoter-specific chromatin binding;histone methyltransferase activity (H3-K27 specific);positive regulation of MAP kinase activity;positive regulation of cell cycle G1/S phase transition;histone methylation;protein-lysine N-methyltransferase activity;chromatin silencing at telomere;histone H3-K27 methylation;chromosome, telomeric region;RNA polymerase II core promoter sequence-specific DNA binding;transcription corepressor activity;RNA binding;ribonucleoprotein complex binding;sequence-specific DNA binding;transcription regulatory region DNA binding;primary miRNA binding;regulation of protein phosphorylation;DNA methylation;regulation of transcription by RNA polymerase II;regulation of gene expression;negative regulation of gene expression;regulation of gliogenesis;skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration;cardiac muscle hypertrophy in response to stress;cerebellar cortex development;hippocampus development;response to estradiol;negative regulation of transcription elongation from RNA polymerase II promoter;cellular response to trichostatin A;hepatocyte homeostasis;regulation of cell population proliferation;negative regulation of DNA-binding transcription factor activity;negative regulation of epidermal cell differentiation;regulation of neurogenesis;negative regulation of striated muscle cell differentiation;cellular response to hydrogen peroxide;G1 to G0 transition;protein localization to chromatin;liver regeneration;histone H3-K27 trimethylation;positive regulation of dendrite development;response to tetrachloromethane;negative regulation of G1/S transition of mitotic cell cycle;cytoplasm;pronucleus	3D-structure;Alternative splicing;Biological rhythms;Chromatin regulator;Disease mutation;Glycoprotein;Isopeptide bond;Methyltransferase;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation	R-HSA-1266738;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1257604;R-HSA-2262752;R-HSA-6807070;R-HSA-8953897;R-HSA-9006925;R-HSA-2559580;R-HSA-2559583;R-HSA-8943724;R-HSA-8953750;R-HSA-212165;R-HSA-3247509;R-HSA-4839726;R-HSA-5617472;R-HSA-5619507;R-HSA-3214841;R-HSA-212300	Developmental Biology;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;PIP3 activates AKT signaling;Cellular responses to stress;PTEN Regulation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Oxidative Stress Induced Senescence;Cellular Senescence;Regulation of PTEN gene transcription;Transcriptional Regulation by E2F6;Epigenetic regulation of gene expression;Chromatin modifying enzymes;Chromatin organization;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;PKMTs methylate histone lysines;PRC2 methylates histones and DNA
PDSS1	positive	CCNB1	ENSG00000134057	PDSS1	1	PDSS1	1	0.000721315516950094	WBGene00000865;WBGene00000866;WBGene00000867;WBGene00000863	WBGene00000867(0);WBGene00000866(0);WBGene00000865(0);WBGene00000871(0);WBGene00000870(0);WBGene00014069(0);WBGene00021040(0);WBGene00000863(0);WBGene00000864(0);WBGene00017259(0)			GO:0005737;GO:0005634;GO:0005829;GO:0051301;GO:0005856;GO:0005515;GO:0007049;GO:0005813;GO:0005815;GO:0005759;GO:0006977;GO:0005654;GO:0019901;GO:0031145;GO:1901990;GO:0000086;GO:0045737;GO:0006367;GO:0044389;GO:0045931;GO:0000942;GO:0007052;GO:0004672;GO:0016538;GO:0000079;GO:0007077;GO:0044772;GO:0051726;GO:0000307;GO:0010971;GO:1905448;GO:0097125;GO:0005113;GO:0016301;GO:0035173;GO:0061575;GO:0000278;GO:0001556;GO:0001701;GO:0001933;GO:0006468;GO:0007080;GO:0007283;GO:0009612;GO:0009636;GO:0010629;GO:0031442;GO:0033129;GO:0042246;GO:0042493;GO:0045787;GO:0046680;GO:0048146;GO:0048565;GO:0051987;GO:0055015;GO:0060045;GO:0060623;GO:0065003;GO:0071283;GO:0071398;GO:0071407;GO:0071456;GO:0090266;GO:2000775;GO:0000922;GO:0016020	nucleus;cytoplasm;cell;cytosol;cytoskeleton;cell division;protein binding;cell cycle;centrosome;microtubule organizing center;mitochondrial matrix;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;nucleoplasm;protein kinase binding;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;G2/M transition of mitotic cell cycle;positive regulation of cyclin-dependent protein serine/threonine kinase activity;transcription initiation from RNA polymerase II promoter;ubiquitin-like protein ligase binding;positive regulation of mitotic cell cycle;condensed nuclear chromosome outer kinetochore;mitotic spindle organization;protein kinase activity;cyclin-dependent protein serine/threonine kinase regulator activity;regulation of cyclin-dependent protein serine/threonine kinase activity;mitotic nuclear envelope disassembly;mitotic cell cycle phase transition;regulation of cell cycle;cyclin-dependent protein kinase holoenzyme complex;positive regulation of G2/M transition of mitotic cell cycle;positive regulation of mitochondrial ATP synthesis coupled electron transport;cyclin B1-CDK1 complex;patched binding;histone kinase activity;cyclin-dependent protein serine/threonine kinase activator activity;mitotic cell cycle;oocyte maturation;in utero embryonic development;negative regulation of protein phosphorylation;protein phosphorylation;mitotic metaphase plate congression;spermatogenesis;response to mechanical stimulus;response to toxic substance;negative regulation of gene expression;positive regulation of mRNA 3'-end processing;positive regulation of histone phosphorylation;tissue regeneration;response to drug;positive regulation of cell cycle;response to DDT;positive regulation of fibroblast proliferation;digestive tract development;positive regulation of attachment of spindle microtubules to kinetochore;ventricular cardiac muscle cell development;positive regulation of cardiac muscle cell proliferation;regulation of chromosome condensation;protein-containing complex assembly;cellular response to iron(III) ion;cellular response to fatty acid;cellular response to organic cyclic compound;cellular response to hypoxia;regulation of mitotic cell cycle spindle assembly checkpoint;histone H3-S10 phosphorylation involved in chromosome condensation;spindle pole;membrane	3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Cyclin;Cytoplasm;Cytoskeleton;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-174143;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-453274;R-HSA-453276;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-69481;R-HSA-69620;R-HSA-8852276;R-HSA-8878166;R-HSA-2500257;R-HSA-68877;R-HSA-2980766;R-HSA-3301854;R-HSA-68875;R-HSA-2565942;R-HSA-453279;R-HSA-69206;R-HSA-174048;R-HSA-176412;R-HSA-69473;R-HSA-75035;R-HSA-6804114;R-HSA-69273;R-HSA-2465910;R-HSA-113507;R-HSA-113510;R-HSA-162658;R-HSA-2299718;R-HSA-156711;R-HSA-2514853;R-HSA-2980767;R-HSA-69478;R-HSA-4419969;R-HSA-176417	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;APC/C-mediated degradation of cell cycle proteins;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;M Phase;G2/M Transition;Cell Cycle, Mitotic;G2/M Checkpoints;Cell Cycle Checkpoints;The role of GTSE1 in G2/M progression after G2 checkpoint;Transcriptional regulation by RUNX2;Resolution of Sister Chromatid Cohesion;Mitotic Prometaphase;Nuclear Envelope Breakdown;Nuclear Pore Complex (NPC) Disassembly;Mitotic Prophase;Regulation of PLK1 Activity at G2/M Transition;Mitotic G1 phase and G1/S transition;G1/S Transition;APC/C:Cdc20 mediated degradation of Cyclin B;Phosphorylation of the APC/C;G2/M DNA damage checkpoint;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Cyclin A/B1/B2 associated events during G2/M transition;MASTL Facilitates Mitotic Progression;E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Golgi Cisternae Pericentriolar Stack Reorganization;Condensation of Prophase Chromosomes;Polo-like kinase mediated events;Condensation of Prometaphase Chromosomes;Activation of NIMA Kinases NEK9, NEK6, NEK7;G2/M DNA replication checkpoint;Depolymerisation of the Nuclear Lamina;Phosphorylation of Emi1
PDSS1	positive	CHEK1	ENSG00000149554	PDSS1	1	PDSS1	1	0.000721315516950094	WBGene00000498;WBGene00019817;WBGene00012792;WBGene00017083;WBGene00019814;WBGene00019815				GO:0043231;GO:0004672;GO:0005524;GO:0006468;GO:0005654;GO:0035402;GO:0000077;GO:0000086;GO:0001833;GO:0006281;GO:0006974;GO:0006997;GO:0007093;GO:0010468;GO:0010767;GO:0035407;GO:0042127;GO:0048096;GO:1902742;GO:2000615;GO:0000785;GO:0005634;GO:0005657;GO:0005737;GO:0000166;GO:0004674;GO:0016301;GO:0016740;GO:0016310;GO:0005615;GO:0005856;GO:0005515;GO:0007049;GO:0006915;GO:0005813;GO:0005815;GO:0035556;GO:0005829;GO:0071260;GO:0010569;GO:1901796;GO:0032991;GO:0019904;GO:0006260;GO:0070317;GO:0090399;GO:0000781;GO:0006975;GO:0018107;GO:0045787;GO:0045839;GO:0046602;GO:0072425;GO:0000794	ATP binding;protein phosphorylation;protein kinase activity;intracellular membrane-bounded organelle;nucleoplasm;histone kinase activity (H3-T11 specific);DNA damage checkpoint;G2/M transition of mitotic cell cycle;inner cell mass cell proliferation;DNA repair;cellular response to DNA damage stimulus;nucleus organization;mitotic cell cycle checkpoint;regulation of gene expression;regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage;histone H3-T11 phosphorylation;regulation of cell population proliferation;chromatin-mediated maintenance of transcription;apoptotic process involved in development;regulation of histone H3-K9 acetylation;chromatin;nucleus;replication fork;protein serine/threonine kinase activity;cytoplasm;nucleotide binding;kinase activity;transferase activity;phosphorylation;cytoskeleton;extracellular space;protein binding;cell cycle;apoptotic process;centrosome;microtubule organizing center;intracellular signal transduction;cytosol;cellular response to mechanical stimulus;regulation of double-strand break repair via homologous recombination;regulation of signal transduction by p53 class mediator;protein-containing complex;protein domain specific binding;DNA replication;negative regulation of G0 to G1 transition;replicative senescence;chromosome, telomeric region;DNA damage induced protein phosphorylation;peptidyl-threonine phosphorylation;positive regulation of cell cycle;negative regulation of mitotic nuclear division;regulation of mitotic centrosome separation;signal transduction involved in G2 DNA damage checkpoint;condensed nuclear chromosome	3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;Isopeptide bond;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69481;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-6796648;R-HSA-9006934;R-HSA-5633007;R-HSA-6804756;R-HSA-176187;R-HSA-8953750;R-HSA-1433557;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-75035	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;G2/M Checkpoints;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;TP53 Regulates Transcription of DNA Repair Genes;Signaling by Receptor Tyrosine Kinases;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Activation of ATR in response to replication stress;Transcriptional Regulation by E2F6;Signaling by SCF-KIT;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
PDSS1	positive	POLE2	ENSG00000100479	PDSS1	1	PDSS1	1	0.000771457914633289	WBGene00017237	WBGene00017237(1)			GO:0005634;GO:0043231;GO:0016740;GO:0005654;GO:0003677;GO:0005515;GO:0016604;GO:0006260;GO:0016779;GO:0003887;GO:0008622;GO:0006261;GO:0000082;GO:0006281;GO:0042276;GO:0006270;GO:0032201	DNA binding;DNA replication;DNA-directed DNA polymerase activity;DNA-dependent DNA replication;epsilon DNA polymerase complex;nucleus;intracellular membrane-bounded organelle;nucleoplasm;protein binding;nuclear body;G1/S transition of mitotic cell cycle;DNA repair;error-prone translesion synthesis;DNA replication initiation;telomere maintenance via semi-conservative replication	3D-structure;Alternative splicing;DNA replication;DNA-binding;Nucleus;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69002;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-73886;R-HSA-453279;R-HSA-69206;R-HSA-68962;R-HSA-157579;R-HSA-180786;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174417;R-HSA-174430;R-HSA-68952;R-HSA-5696397	Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;DNA Replication Pre-Initiation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Chromosome Maintenance;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of the pre-replicative complex;Telomere Maintenance;Extension of Telomeres;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Telomere C-strand (Lagging Strand) Synthesis;Telomere C-strand synthesis initiation;DNA replication initiation;Gap-filling DNA repair synthesis and ligation in GG-NER
PDSS1	positive	PTTG1	ENSG00000164611	PDSS1	1	PDSS1	1	0.000771457914633289			CCNB1;CDC42;CDK1;DOCK1;ID3;KDR;LGALS1;MYC;PTTG1IP;RAC1;RHOA;S100A4;VEGFA		GO:0005634;GO:0005737;GO:0051301;GO:0010951;GO:0051276;GO:0006281;GO:0006974;GO:0007049;GO:0006355;GO:0006357;GO:0007059;GO:0045143;GO:0005515;GO:0005829;GO:0031145;GO:0017124;GO:0006366;GO:0003700;GO:0007283;GO:0006511;GO:0004869;GO:0000981;GO:2000816	nucleus;cytoplasm;chromosome organization;cell division;negative regulation of endopeptidase activity;DNA repair;cellular response to DNA damage stimulus;cell cycle;regulation of transcription, DNA-templated;protein binding;regulation of transcription by RNA polymerase II;chromosome segregation;homologous chromosome segregation;cytosol;anaphase-promoting complex-dependent catabolic process;SH3 domain binding;transcription by RNA polymerase II;DNA-binding transcription factor activity;spermatogenesis;ubiquitin-dependent protein catabolic process;cysteine-type endopeptidase inhibitor activity;DNA-binding transcription factor activity, RNA polymerase II-specific;negative regulation of mitotic sister chromatid separation	Acetylation;Cell cycle;Cell division;Chromosome partition;Cytoplasm;DNA damage;DNA repair;Mitosis;Nucleus;Phosphoprotein;Proto-oncogene;Reference proteome;Repeat;SH3-binding;Ubl conjugation	R-HSA-1640170;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-176409;R-HSA-176814;R-HSA-2467813;R-HSA-2555396;R-HSA-453276;R-HSA-68882;R-HSA-68886;R-HSA-69278	Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic
PDSS1	positive	PCNA	ENSG00000132646	PDSS1	1	PDSS1	1	0.000824793016608649	WBGene00003955	WBGene00003955(0)		PCNA-related progressive neurodegenerative photosensitivity syndrome;Ataxia-telangiectasia-like disorder 2	GO:0005634;GO:0005654;GO:0003677;GO:0006275;GO:0005515;GO:0006281;GO:0006974;GO:0016604;GO:0006260;GO:0042802;GO:0016567;GO:0006977;GO:0070062;GO:0003682;GO:0000784;GO:0045739;GO:0016032;GO:0000785;GO:0030855;GO:0030971;GO:0070182;GO:0019899;GO:0019985;GO:0045740;GO:0005813;GO:0034644;GO:0006283;GO:0003684;GO:0043596;GO:0042276;GO:0000083;GO:0006298;GO:0042769;GO:0035035;GO:0006296;GO:0033683;GO:0006272;GO:0032201;GO:0006297;GO:0070987;GO:0000701;GO:0030337;GO:0032139;GO:0032405;GO:0000723;GO:0031297;GO:0032077;GO:1902990;GO:0005657;GO:0030894;GO:0043626;GO:0070557;GO:0030331;GO:0000122;GO:0006287;GO:0006979;GO:0007507;GO:0032355;GO:0033993;GO:0044849;GO:0046686;GO:0070301;GO:0071466;GO:0071548;GO:0097421;GO:1902065;GO:0000307;GO:0005652	DNA binding;DNA polymerase processivity factor activity;regulation of DNA replication;nucleus;nucleoplasm;protein binding;DNA repair;cellular response to DNA damage stimulus;nuclear body;DNA replication;identical protein binding;protein ubiquitination;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;extracellular exosome;chromatin binding;nuclear chromosome, telomeric region;positive regulation of DNA repair;viral process;protein C-terminus binding;chromatin;epithelial cell differentiation;receptor tyrosine kinase binding;protein-containing complex binding;DNA polymerase binding;enzyme binding;translesion synthesis;positive regulation of DNA replication;centrosome;cellular response to UV;transcription-coupled nucleotide-excision repair;damaged DNA binding;nuclear replication fork;error-prone translesion synthesis;regulation of transcription involved in G1/S transition of mitotic cell cycle;mismatch repair;DNA damage response, detection of DNA damage;histone acetyltransferase binding;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;leading strand elongation;telomere maintenance via semi-conservative replication;positive regulation of DNA-directed DNA polymerase activity;nucleotide-excision repair, DNA gap filling;error-free translesion synthesis;purine-specific mismatch base pair DNA N-glycosylase activity;dinucleotide insertion or deletion binding;MutLalpha complex binding;telomere maintenance;replication fork processing;positive regulation of deoxyribonuclease activity;mitotic telomere maintenance via semi-conservative replication;replication fork;replisome;PCNA complex;PCNA-p21 complex;estrogen receptor binding;negative regulation of transcription by RNA polymerase II;base-excision repair, gap-filling;response to oxidative stress;heart development;response to estradiol;response to lipid;estrous cycle;response to cadmium ion;cellular response to hydrogen peroxide;cellular response to xenobiotic stimulus;response to dexamethasone;liver regeneration;response to L-glutamate;cyclin-dependent protein kinase holoenzyme complex;nuclear lamina	3D-structure;Acetylation;DNA damage;DNA repair;DNA replication;DNA-binding;Deafness;Direct protein sequencing;Disease mutation;Dwarfism;Host-virus interaction;Isopeptide bond;Methylation;Neurodegeneration;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866654;R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-2990846;R-HSA-3108232;R-HSA-4615885;R-HSA-73886;R-HSA-453279;R-HSA-69206;R-HSA-157579;R-HSA-180786;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-6804114;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-110312;R-HSA-5655862;R-HSA-5656121;R-HSA-69190;R-HSA-69205;R-HSA-5696399;R-HSA-110314;R-HSA-1538133;R-HSA-1362277;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174411;R-HSA-174417;R-HSA-69091;R-HSA-69109;R-HSA-69166;R-HSA-69183;R-HSA-69186;R-HSA-110320;R-HSA-5696397;R-HSA-174414;R-HSA-174437;R-HSA-5358508;R-HSA-5358565;R-HSA-5358606	Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of DNA replication proteins;Chromosome Maintenance;Mitotic G1 phase and G1/S transition;G1/S Transition;Telomere Maintenance;Extension of Telomeres;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);Translesion synthesis by REV1;Translesion synthesis by POLK;Translesion synthesis by POLI;DNA strand elongation;G1/S-Specific Transcription;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;G0 and Early G1;Transcription of E2F targets under negative control by DREAM complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;Translesion Synthesis by POLH;Gap-filling DNA repair synthesis and ligation in GG-NER;Processive synthesis on the C-strand of the telomere;Removal of the Flap Intermediate from the C-strand;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
PDSS1	positive	LMNB1	ENSG00000113368	PDSS1	1	PDSS1	1	0.000881502555644342	WBGene00003052;WBGene00002050;WBGene00002051;WBGene00002052;WBGene00003485;WBGene00002053;WBGene00002054			Adult-onset autosomal dominant leukodystrophy;LEUKODYSTROPHY DEMYELINATING ADULT-ONSET AUTOSOMAL DOMINANT	GO:0005882;GO:0005634;GO:0016020;GO:0031965;GO:0005515;GO:0005654;GO:0005637;GO:0005635;GO:0035722;GO:0005198;GO:0003690;GO:0043274;GO:1990837;GO:0005638;GO:0016363	intermediate filament;nucleus;membrane;nuclear membrane;protein binding;nucleoplasm;nuclear inner membrane;nuclear envelope;interleukin-12-mediated signaling pathway;structural molecule activity;double-stranded DNA binding;phospholipase binding;sequence-specific double-stranded DNA binding;lamin filament;nuclear matrix	3D-structure;Acetylation;Chromosomal rearrangement;Coiled coil;Direct protein sequencing;Disulfide bond;Intermediate filament;Isopeptide bond;Leukodystrophy;Lipoprotein;Membrane;Methylation;Nucleus;Phosphoprotein;Polymorphism;Prenylation;Reference proteome;Ubl conjugation	R-HSA-168256;R-HSA-109581;R-HSA-5357801;R-HSA-1221632;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-1643685;R-HSA-1280215;R-HSA-2262752;R-HSA-2555396;R-HSA-449147;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-8953897;R-HSA-2980766;R-HSA-68875;R-HSA-447115;R-HSA-8950505;R-HSA-9020591;R-HSA-2559583;R-HSA-75153;R-HSA-8862803;R-HSA-8863678;R-HSA-111465;R-HSA-2559586;R-HSA-2995383;R-HSA-2995410;R-HSA-4419969;R-HSA-2559584;R-HSA-352238	Immune System;Apoptosis;Programmed Cell Death;Meiotic synapsis;Reproduction;Meiosis;Cell Cycle;Disease;Cytokine Signaling in Immune system;Cellular responses to stress;Mitotic Metaphase and Anaphase;Signaling by Interleukins;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cellular responses to external stimuli;Nuclear Envelope Breakdown;Mitotic Prophase;Interleukin-12 family signaling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;Cellular Senescence;Apoptotic execution phase;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Apoptotic cleavage of cellular proteins;DNA Damage/Telomere Stress Induced Senescence;Initiation of Nuclear Envelope Reformation;Nuclear Envelope Reassembly;Depolymerisation of the Nuclear Lamina;Formation of Senescence-Associated Heterochromatin Foci (SAHF);Breakdown of the nuclear lamina
PDSS1	positive	MCM2	ENSG00000073111	PDSS1	1	PDSS1	1	0.00094177711707033	WBGene00003154	WBGene00003154(1)		Autosomal dominant non-syndromic sensorineural deafness type DFNA;DEAFNESS AUTOSOMAL DOMINANT 70	GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0005524;GO:0005654;GO:0016787;GO:0003677;GO:0015630;GO:0005515;GO:0006270;GO:0007049;GO:0006915;GO:0006260;GO:0003678;GO:0004386;GO:0042555;GO:0000784;GO:0003697;GO:1905775;GO:0000785;GO:0000082;GO:0000727;GO:0003688;GO:0043138;GO:0006268;GO:1902975;GO:0006267;GO:0017116;GO:0019899;GO:0042393;GO:0006334;GO:0071353;GO:0090102;GO:0005664;GO:0032508	DNA binding;nucleus;ATP binding;DNA replication;DNA replication initiation;negative regulation of DNA helicase activity;MCM complex;cytoplasm;metal ion binding;nucleotide binding;nucleoplasm;hydrolase activity;microtubule cytoskeleton;protein binding;cell cycle;apoptotic process;DNA helicase activity;helicase activity;nuclear chromosome, telomeric region;chromatin;G1/S transition of mitotic cell cycle;double-strand break repair via break-induced replication;single-stranded DNA binding;DNA replication origin binding;3'-5' DNA helicase activity;DNA unwinding involved in DNA replication;mitotic DNA replication initiation;pre-replicative complex assembly involved in nuclear cell cycle DNA replication;enzyme binding;histone binding;nucleosome assembly;cellular response to interleukin-4;cochlea development;nuclear origin of replication recognition complex;DNA duplex unwinding	3D-structure;ATP-binding;Acetylation;Cell cycle;DNA replication;DNA-binding;Deafness;Disease mutation;Helicase;Hydrolase;Isopeptide bond;Metal-binding;Non-syndromic deafness;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	R-HSA-1640170;R-HSA-68867;R-HSA-68949;R-HSA-69002;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-453279;R-HSA-69206;R-HSA-176187;R-HSA-68962;R-HSA-176974;R-HSA-69190	Cell Cycle;Assembly of the pre-replicative complex;Orc1 removal from chromatin;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;Unwinding of DNA;DNA strand elongation
PDSS1	positive	HELLS	ENSG00000119969	PDSS1	1	PDSS1	1	0.00094177711707033				ICF syndrome;IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4	GO:0005634;GO:0000166;GO:0005524;GO:0016787;GO:0051301;GO:0005515;GO:0007049;GO:0007275;GO:0004386;GO:0000775;GO:0005721;GO:0010216;GO:0046651;GO:0031508;GO:0006346;GO:0003682;GO:0001655;GO:0006306;GO:0006342;GO:0043066;GO:1990830;GO:2001243	ATP binding;nucleus;nucleotide binding;hydrolase activity;cell division;protein binding;cell cycle;multicellular organism development;helicase activity;chromosome, centromeric region;pericentric heterochromatin;maintenance of DNA methylation;lymphocyte proliferation;pericentric heterochromatin assembly;methylation-dependent chromatin silencing;chromatin binding;urogenital system development;DNA methylation;chromatin silencing;negative regulation of apoptotic process;cellular response to leukemia inhibitory factor;negative regulation of intrinsic apoptotic signaling pathway	ATP-binding;Alternative splicing;Cell cycle;Cell division;Coiled coil;Developmental protein;Disease mutation;Helicase;Hydrolase;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation		
PDSS1	positive	CTPS1	ENSG00000171793	PDSS1	1	PDSS1	1	0.00094177711707033	WBGene00012316	WBGene00012316(1)		Severe combined immunodeficiency due to CTPS1 deficiency;IMMUNODEFICIENCY 24	GO:0016020;GO:0000166;GO:0005524;GO:0016874;GO:0005515;GO:0006241;GO:0002376;GO:0003883;GO:0006221;GO:0006541;GO:0044210;GO:0042802;GO:0005737;GO:0005829;GO:0006139;GO:0015949;GO:0042098;GO:0042493;GO:0042100;GO:0019856;GO:0097268	CTP biosynthetic process;CTP synthase activity;pyrimidine nucleotide biosynthetic process;membrane;nucleotide binding;ATP binding;ligase activity;protein binding;immune system process;glutamine metabolic process;'de novo' CTP biosynthetic process;identical protein binding;cytoplasm;cytosol;nucleobase-containing compound metabolic process;nucleobase-containing small molecule interconversion;T cell proliferation;response to drug;B cell proliferation;pyrimidine nucleobase biosynthetic process;cytoophidium	3D-structure;ATP-binding;Acetylation;Alternative splicing;Glutamine amidotransferase;Immunity;Ligase;Nucleotide-binding;Phosphoprotein;Polymorphism;Pyrimidine biosynthesis;Reference proteome	R-HSA-1430728;R-HSA-15869;R-HSA-499943	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
PDSS1	positive	DTL	ENSG00000143476	PDSS1	1	PDSS1	1	0.00100581647300813	WBGene00011318	WBGene00011318(0)			GO:0005634;GO:0005737;GO:0016020;GO:0005730;GO:0005829;GO:0016567;GO:0005694;GO:0005856;GO:0005515;GO:0004842;GO:0006974;GO:0048511;GO:0006511;GO:0006260;GO:0005813;GO:0005815;GO:0005654;GO:0043687;GO:0031965;GO:0051726;GO:0009411;GO:0010971;GO:0072425;GO:0000209;GO:0006513;GO:0045732;GO:0042769;GO:0019985;GO:0031464;GO:0080008;GO:0031465	protein binding;nucleus;cytoplasm;membrane;nucleoplasm;nucleolus;cytosol;protein ubiquitination;cytoskeleton;chromosome;ubiquitin-protein transferase activity;cellular response to DNA damage stimulus;rhythmic process;ubiquitin-dependent protein catabolic process;DNA replication;centrosome;microtubule organizing center;post-translational protein modification;nuclear membrane;regulation of cell cycle;response to UV;positive regulation of G2/M transition of mitotic cell cycle;signal transduction involved in G2 DNA damage checkpoint;protein polyubiquitination;protein monoubiquitination;positive regulation of protein catabolic process;DNA damage response, detection of DNA damage;translesion synthesis;Cul4A-RING E3 ubiquitin ligase complex;Cul4-RING E3 ubiquitin ligase complex;Cul4B-RING E3 ubiquitin ligase complex	3D-structure;Acetylation;Alternative splicing;Biological rhythms;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA replication;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation;Ubl conjugation pathway;WD repeat	R-HSA-392499;R-HSA-597592;R-HSA-73894;R-HSA-8951664;R-HSA-73893;R-HSA-110314	Metabolism of proteins;Post-translational protein modification;DNA Repair;Neddylation;DNA Damage Bypass;Recognition of DNA damage by PCNA-containing replication complex
PDSS1	positive	NAA15	ENSG00000164134	PDSS1	1	PDSS1	1	0.00100581647300813	WBGene00021754	WBGene00021754(0)		CONGENITAL HEART DISEASE and NEURODEVELOPMENTAL DISORDER;MENTAL RETARDATION AUTOSOMAL DOMINANT 50	GO:0003723;GO:0005634;GO:0005737;GO:0016020;GO:0043066;GO:0005829;GO:0005515;GO:0007275;GO:0030154;GO:0045893;GO:0043022;GO:0050821;GO:0001525;GO:0005667;GO:0016407;GO:0004596;GO:0006474;GO:0031415;GO:0017196	protein binding;RNA binding;nucleus;cytoplasm;membrane;negative regulation of apoptotic process;cytosol;multicellular organism development;cell differentiation;positive regulation of transcription, DNA-templated;protein stabilization;angiogenesis;ribosome binding;transcription factor complex;acetyltransferase activity;peptide alpha-N-acetyltransferase activity;N-terminal protein amino acid acetylation;NatA complex;N-terminal peptidyl-methionine acetylation	3D-structure;Acetylation;Alternative splicing;Angiogenesis;Cytoplasm;Developmental protein;Differentiation;Disease mutation;Mental retardation;Nucleus;Phosphoprotein;Reference proteome;Repeat;TPR repeat;Transcription;Transcription regulation		
PDSS1	positive	RFWD3	ENSG00000168411	PDSS1	1	PDSS1	1	0.00100581647300813				Fanconi anemia;FANCONI ANEMIA COMPLEMENTATION GROUP W	GO:0005634;GO:0005737;GO:0046872;GO:0016740;GO:0005654;GO:0016567;GO:0004842;GO:0005515;GO:0006281;GO:0006974;GO:0036297;GO:0035861;GO:0031297;GO:0016605;GO:0000724;GO:0002039;GO:0010212;GO:0090734;GO:0031571;GO:2000001;GO:0031052;GO:0097371	nucleus;protein binding;ubiquitin-protein transferase activity;interstrand cross-link repair;protein ubiquitination;cytoplasm;metal ion binding;transferase activity;nucleoplasm;DNA repair;cellular response to DNA damage stimulus;ubiquitin protein ligase activity;PML body;site of double-strand break;replication fork processing;double-strand break repair via homologous recombination;p53 binding;response to ionizing radiation;site of DNA damage;mitotic G1 DNA damage checkpoint;regulation of DNA damage checkpoint;chromosome breakage;MDM2/MDM4 family protein binding	3D-structure;Coiled coil;Cytoplasm;DNA damage;DNA repair;Disease mutation;Fanconi anemia;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transferase;Ubl conjugation pathway;WD repeat;Zinc;Zinc-finger		
PDSS1	positive	BLM	ENSG00000197299	PDSS1	1	PDSS1	1	0.00100581647300813	WBGene00001865;WBGene00004322;WBGene00006944;WBGene00019334	WBGene00001865(0)		Bloom syndrome;Bloom syndrome;Bloom syndrome	GO:0005634;GO:0003676;GO:0046872;GO:0000166;GO:0005524;GO:0005829;GO:0016787;GO:0008270;GO:0003677;GO:0003824;GO:0042803;GO:0006281;GO:0005515;GO:0006310;GO:0006974;GO:0004386;GO:0006260;GO:0003678;GO:0045893;GO:0005730;GO:0044237;GO:0005737;GO:0016818;GO:0000781;GO:0043138;GO:0005654;GO:0016887;GO:0051260;GO:0031297;GO:0000800;GO:0000733;GO:0016605;GO:0032508;GO:0000400;GO:0016363;GO:1901796;GO:0051259;GO:0007095;GO:0000724;GO:0002039;GO:0003697;GO:0008094;GO:0000228;GO:0071479;GO:0090656;GO:0000723;GO:0051782;GO:0000405;GO:0009378;GO:0036310;GO:0061821;GO:0006268;GO:0061820;GO:0005694;GO:0051880;GO:0044806;GO:0000079;GO:0072711;GO:0010165;GO:0000729;GO:0000403;GO:0061749;GO:0061849;GO:1905773;GO:0045910;GO:0048478;GO:0072757;GO:0090329;GO:0005657;GO:0005622	DNA binding;nucleus;ATP binding;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;catalytic activity;DNA repair;nucleic acid binding;cellular metabolic process;DNA replication;nucleotide binding;DNA recombination;helicase activity;3'-5' DNA helicase activity;metal ion binding;nucleoplasm;cytosol;hydrolase activity;zinc ion binding;protein homodimerization activity;protein binding;cellular response to DNA damage stimulus;identical protein binding;ATPase activity;DNA helicase activity;positive regulation of transcription, DNA-templated;nucleolus;cytoplasm;chromosome, telomeric region;PML body;protein-containing complex;protein homooligomerization;replication fork processing;lateral element;DNA strand renaturation;single-stranded DNA binding;replication fork protection;four-way junction DNA binding;nuclear matrix;regulation of signal transduction by p53 class mediator;mitotic G2 DNA damage checkpoint;protein complex oligomerization;double-strand break repair via homologous recombination;p53 binding;DNA-dependent ATPase activity;nuclear chromosome;cellular response to ionizing radiation;t-circle formation;telomere maintenance;DNA duplex unwinding;negative regulation of cell division;bubble DNA binding;four-way junction helicase activity;annealing helicase activity;telomeric D-loop binding;DNA unwinding involved in DNA replication;telomeric D-loop disassembly;chromosome;G-quadruplex DNA binding;G-quadruplex DNA unwinding;regulation of cyclin-dependent protein serine/threonine kinase activity;cellular response to hydroxyurea;response to X-ray;DNA double-strand break processing;Y-form DNA binding;forked DNA-dependent helicase activity;telomeric G-quadruplex DNA binding;8-hydroxy-2'-deoxyguanosine DNA binding;negative regulation of DNA recombination;cellular response to camptothecin;regulation of DNA-dependent DNA replication;replication fork	3D-structure;ATP-binding;Acetylation;DNA damage;DNA repair;DNA replication;DNA-binding;Disease mutation;Dwarfism;Helicase;Hydrolase;Isopeptide bond;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Zinc	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-69481;R-HSA-69620;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-5633007;R-HSA-6804756;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5693554;R-HSA-912446;R-HSA-5685938	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;G2/M Checkpoints;Cell Cycle Checkpoints;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Meiotic recombination;HDR through Single Strand Annealing (SSA)
PDSS1	positive	CDC20	ENSG00000117399	PDSS1	1	PDSS1	1	0.00107382992321303	WBGene00001511;WBGene00001510				GO:0005737;GO:0005634;GO:0005829;GO:0005654;GO:0016567;GO:0051301;GO:0005856;GO:0005515;GO:0007049;GO:0030154;GO:0000922;GO:0005815;GO:0007399;GO:0016579;GO:0031145;GO:1901990;GO:0008022;GO:0010997;GO:0097027;GO:1904668;GO:0019899;GO:0006511;GO:0005680;GO:0005819;GO:0090129;GO:0031915;GO:0007094;GO:0042826;GO:0007064;GO:0008284;GO:0040020;GO:0050773;GO:0090307;GO:0005813;GO:0032991;GO:0048471	protein binding;anaphase-promoting complex binding;ubiquitin-protein transferase activator activity;positive regulation of ubiquitin protein ligase activity;cytoplasm;nucleoplasm;cytosol;protein ubiquitination;cytoskeleton;cell division;cell cycle;cell differentiation;spindle pole;microtubule organizing center;nervous system development;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;protein C-terminus binding;enzyme binding;ubiquitin-dependent protein catabolic process;anaphase-promoting complex;spindle;positive regulation of synapse maturation;positive regulation of synaptic plasticity;mitotic spindle assembly checkpoint;histone deacetylase binding;mitotic sister chromatid cohesion;positive regulation of cell population proliferation;regulation of meiotic nuclear division;regulation of dendrite development;mitotic spindle assembly;centrosome;protein-containing complex;perinuclear region of cytoplasm	3D-structure;Acetylation;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Differentiation;Isopeptide bond;Mitosis;Neurogenesis;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation;Ubl conjugation pathway;WD repeat	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-983168;R-HSA-983169;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-2467813;R-HSA-2555396;R-HSA-453276;R-HSA-5688426;R-HSA-5689880;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618;R-HSA-141405;R-HSA-141430;R-HSA-174048;R-HSA-176407;R-HSA-179409;R-HSA-176417	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;Deubiquitination;Ub-specific processing proteases;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;APC/C:Cdc20 mediated degradation of Cyclin B;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;APC-Cdc20 mediated degradation of Nek2A;Phosphorylation of Emi1
PDSS1	positive	RFC3	ENSG00000133119	PDSS1	1	PDSS1	1	0.00107382992321303	WBGene00004339	WBGene00004339(0)			GO:0005634;GO:0003677;GO:0005515;GO:0032508;GO:0006260;GO:0006261;GO:0005654;GO:0016887;GO:1901796;GO:0019985;GO:0006283;GO:0042276;GO:0017116;GO:0003689;GO:0042769;GO:0046683;GO:0006296;GO:0033683;GO:0000731;GO:0032201;GO:1900264;GO:0031390;GO:0006297;GO:0070987;GO:0006271;GO:0005663	DNA binding;DNA replication;nucleus;protein binding;DNA duplex unwinding;ATPase activity;DNA-dependent DNA replication;DNA repair;nucleoplasm;regulation of signal transduction by p53 class mediator;translesion synthesis;transcription-coupled nucleotide-excision repair;error-prone translesion synthesis;single-stranded DNA helicase activity;DNA damage response, detection of DNA damage;response to organophosphorus;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;DNA synthesis involved in DNA repair;telomere maintenance via semi-conservative replication;DNA clamp loader activity;positive regulation of DNA-directed DNA polymerase activity;Ctf18 RFC-like complex;nucleotide-excision repair, DNA gap filling;error-free translesion synthesis;DNA strand elongation involved in DNA replication;DNA replication factor C complex	Acetylation;Alternative splicing;DNA replication;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-73886;R-HSA-5633007;R-HSA-6804756;R-HSA-176187;R-HSA-157579;R-HSA-180786;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-5685938;R-HSA-110312;R-HSA-5655862;R-HSA-5656121;R-HSA-69190;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174411;R-HSA-174417;R-HSA-69091;R-HSA-69109;R-HSA-69186;R-HSA-110320;R-HSA-5696397	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Chromosome Maintenance;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Activation of ATR in response to replication stress;Telomere Maintenance;Extension of Telomeres;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through Single Strand Annealing (SSA);Translesion synthesis by REV1;Translesion synthesis by POLK;Translesion synthesis by POLI;DNA strand elongation;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Polymerase switching;Leading Strand Synthesis;Lagging Strand Synthesis;Translesion Synthesis by POLH;Gap-filling DNA repair synthesis and ligation in GG-NER
PDSS1	positive	STIP1	ENSG00000168439	PDSS1	1	PDSS1	1	0.00107382992321303	WBGene00019983				GO:0003723;GO:0005634;GO:0005737;GO:0005515;GO:0005829;GO:0032991;GO:0005794;GO:0051879;GO:0008022;GO:0030544;GO:0051087;GO:0098761;GO:0101031	protein binding;RNA binding;nucleus;cytoplasm;cytosol;protein-containing complex;Golgi apparatus;Hsp90 protein binding;chaperone complex;protein C-terminus binding;Hsp70 protein binding;chaperone binding;cellular response to interleukin-7	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;TPR repeat;Ubl conjugation	R-HSA-2262752;R-HSA-8953897;R-HSA-3371497	Cellular responses to stress;Cellular responses to external stimuli;HSP90 chaperone cycle for steroid hormone receptors (SHR)
PDSS1	positive	VRK1	ENSG00000100749	PDSS1	1	PDSS1	1	0.00114603664227697	WBGene00017895	WBGene00008088(0);WBGene00010692(0);WBGene00008883(0);WBGene00017725(0);WBGene00013868(0);WBGene00008464(0);WBGene00010719(0);WBGene00013744(0);WBGene00020071(0);WBGene00018122(0);WBGene00009402(0);WBGene00010874(0);WBGene00012169(0);WBGene00016673(0);WBGene00022705(0);WBGene00022032(0);WBGene00022102(0);WBGene00017895(0);WBGene00013979(0);WBGene00013978(0);WBGene00016541(0);WBGene00012637(0);WBGene00007791(0);WBGene00019556(0);WBGene00016513(0);WBGene00016765(0);WBGene00022108(0);WBGene00007335(0);WBGene00017050(0);WBGene00021639(0);WBGene00008423(0);WBGene00014007(0);WBGene00007448(0);WBGene00016946(0);WBGene00020381(0);WBGene00008662(0);WBGene00018839(0);WBGene00016963(0);WBGene00018202(0);WBGene00018203(0);WBGene00017714(0);WBGene00010555(0);WBGene00019642(0);WBGene00015893(0);WBGene00016111(0);WBGene00019119(0);WBGene00020580(0);WBGene00007269(0);WBGene00019561(0);WBGene00019562(0);WBGene00011283(0);WBGene00022707(0);WBGene00017803(0);WBGene00018123(0);WBGene00020072(0);WBGene00012731(0);WBGene00018745(0);WBGene00007777(0);WBGene00007049(0);WBGene00019459(0);WBGene00019086(0);WBGene00020223(0);WBGene00016388(0);WBGene00018004(0);WBGene00007305(0);WBGene00009324(0);WBGene00021109(0);WBGene00019769(0)		Microcephaly-complex motor and sensory axonal neuropathy syndrome;Pontocerebellar hypoplasia type 1;Pontocerebellar hypoplasia type 1;PONTOCEREBELLAR HYPOPLASIA TYPE 1A	GO:0005634;GO:0005737;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005730;GO:0005829;GO:0005654;GO:0051301;GO:0005856;GO:0005515;GO:0007049;GO:0005795;GO:0005819;GO:0018105;GO:0046777;GO:0007084;GO:0043987;GO:0019901;GO:0007077;GO:0090166;GO:0072354;GO:0031493;GO:0035175;GO:0072355;GO:0016020;GO:0016021	ATP binding;protein phosphorylation;protein kinase activity;nucleus;cytoplasm;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleoplasm;nucleolus;cytosol;cytoskeleton;cell division;protein binding;cell cycle;Golgi stack;spindle;peptidyl-serine phosphorylation;protein autophosphorylation;Wnt signaling pathway;mitotic nuclear envelope reassembly;histone H3-S10 phosphorylation;protein kinase binding;mitotic nuclear envelope disassembly;Golgi disassembly;histone kinase activity (H3-T3 specific);nucleosomal histone binding;histone kinase activity (H3-S10 specific);histone H3-T3 phosphorylation;membrane;integral component of membrane	3D-structure;ATP-binding;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Isopeptide bond;Kinase;Mitosis;Neurodegeneration;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-1640170;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-2980766;R-HSA-68875;R-HSA-2995383;R-HSA-2995410	Cell Cycle;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Nuclear Envelope Breakdown;Mitotic Prophase;Initiation of Nuclear Envelope Reformation;Nuclear Envelope Reassembly
PDSS1	positive	TTF2	ENSG00000116830	PDSS1	1	PDSS1	1	0.00114603664227697	WBGene00010061;WBGene00020742		TPO		GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0008270;GO:0000166;GO:0005524;GO:0005829;GO:0016787;GO:0003677;GO:0005515;GO:0005681;GO:0004386;GO:0008023;GO:0006353;GO:0008094;GO:0006369	zinc ion binding;ATP binding;mRNA processing;RNA splicing;nucleus;cytoplasm;nucleotide binding;cytosol;hydrolase activity;DNA binding;protein binding;spliceosomal complex;helicase activity;transcription elongation factor complex;DNA-templated transcription, termination;DNA-dependent ATPase activity;termination of RNA polymerase II transcription	ATP-binding;Alternative splicing;Cytoplasm;DNA-binding;Helicase;Hydrolase;Isopeptide bond;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Spliceosome;Transcription;Transcription regulation;Transcription termination;Ubl conjugation;Zinc;Zinc-finger;mRNA processing;mRNA splicing		
PDSS1	positive	MAD2L1	ENSG00000164109	PDSS1	1	PDSS1	1	0.00114603664227697	WBGene00003161	WBGene00003161(1)			GO:0005634;GO:0005737;GO:0043066;GO:0005654;GO:0051301;GO:0005694;GO:0005829;GO:0042803;GO:0005856;GO:0005515;GO:0007049;GO:0048471;GO:0000922;GO:0042802;GO:0000775;GO:0000776;GO:0000777;GO:0031145;GO:1901990;GO:0008022;GO:0007094;GO:0072686;GO:0006511;GO:0042177;GO:0000132;GO:0090267;GO:0044615;GO:0007093;GO:0051660;GO:0045930;GO:0000070;GO:1904667	cell;nucleus;cytoplasm;negative regulation of apoptotic process;nucleoplasm;cytoskeleton;cell division;chromosome;cytosol;protein homodimerization activity;protein binding;cell cycle;perinuclear region of cytoplasm;spindle pole;identical protein binding;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;protein C-terminus binding;mitotic spindle assembly checkpoint;mitotic spindle;ubiquitin-dependent protein catabolic process;negative regulation of protein catabolic process;establishment of mitotic spindle orientation;positive regulation of mitotic cell cycle spindle assembly checkpoint;nuclear pore nuclear basket;mitotic cell cycle checkpoint;establishment of centrosome localization;negative regulation of mitotic cell cycle;mitotic sister chromatid segregation;negative regulation of ubiquitin protein ligase activity	3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-174143;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-2467813;R-HSA-2555396;R-HSA-453276;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618;R-HSA-141405;R-HSA-141430;R-HSA-179409	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;APC-Cdc20 mediated degradation of Nek2A
PDSS1	positive	TYMS	ENSG00000176890	PDSS1	1	PDSS1	1	0.00114603664227697	WBGene00022455	WBGene00022455(1)		5-@FLUOROURACIL TOXICITY	GO:0005634;GO:0005737;GO:0016020;GO:0016740;GO:0008168;GO:0032259;GO:0005743;GO:0005739;GO:0005759;GO:0005829;GO:0009165;GO:0015949;GO:0071897;GO:0000083;GO:0046683;GO:0000900;GO:0005542;GO:1990825;GO:0017148;GO:0000166;GO:0003729;GO:0004799;GO:0008144;GO:0042803;GO:0048037;GO:0006206;GO:0006231;GO:0006235;GO:0006417;GO:0007568;GO:0007623;GO:0009636;GO:0014070;GO:0019088;GO:0019860;GO:0032570;GO:0033189;GO:0034097;GO:0035999;GO:0042493;GO:0045471;GO:0046078;GO:0046653;GO:0048589;GO:0051216;GO:0051384;GO:0051593;GO:0060574;GO:0097421;GO:0005730	thymidylate synthase activity;dTMP biosynthetic process;nucleus;cytoplasm;membrane;transferase activity;methyltransferase activity;methylation;mitochondrial inner membrane;mitochondrion;mitochondrial matrix;cytosol;nucleotide biosynthetic process;nucleobase-containing small molecule interconversion;DNA biosynthetic process;regulation of transcription involved in G1/S transition of mitotic cell cycle;response to organophosphorus;translation repressor activity, mRNA regulatory element binding;folic acid binding;sequence-specific mRNA binding;negative regulation of translation;nucleotide binding;mRNA binding;drug binding;identical protein binding;cofactor binding;pyrimidine nucleobase metabolic process;dTTP biosynthetic process;regulation of translation;aging;circadian rhythm;response to toxic substance;response to organic cyclic compound;uracil metabolic process;response to progesterone;response to vitamin A;response to cytokine;tetrahydrofolate interconversion;response to drug;response to ethanol;dUMP metabolic process;tetrahydrofolate metabolic process;developmental growth;cartilage development;response to glucocorticoid;response to folic acid;intestinal epithelial cell maturation;liver regeneration;nucleolus	3D-structure;Alternative splicing;Cytoplasm;Direct protein sequencing;Isopeptide bond;Membrane;Methyltransferase;Mitochondrion;Mitochondrion inner membrane;Nucleotide biosynthesis;Nucleus;Phosphoprotein;Reference proteome;Transferase;Ubl conjugation	R-HSA-1430728;R-HSA-1640170;R-HSA-69278;R-HSA-15869;R-HSA-453279;R-HSA-69206;R-HSA-499943;R-HSA-69205	Metabolism;Cell Cycle;Cell Cycle, Mitotic;Metabolism of nucleotides;Mitotic G1 phase and G1/S transition;G1/S Transition;Interconversion of nucleotide di- and triphosphates;G1/S-Specific Transcription
PDSS1	positive	MRTO4	ENSG00000053372	PDSS1	1	PDSS1	1	0.00122266603290622	WBGene00017347				GO:0003723;GO:0005634;GO:0005737;GO:0005515;GO:0042254;GO:0000027;GO:0005730;GO:0030687;GO:0042273;GO:0006364;GO:0000956;GO:0005622	ribosome biogenesis;ribosomal large subunit assembly;RNA binding;nucleus;cytoplasm;protein binding;nucleolus;preribosome, large subunit precursor;ribosomal large subunit biogenesis;rRNA processing;nuclear-transcribed mRNA catabolic process	Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis		
PDSS1	positive	PSMD11	ENSG00000108671	PDSS1	1	PDSS1	1	0.00122266603290622	WBGene00004462;WBGene00010309				GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0005515;GO:0000502;GO:0006511;GO:0038095;GO:0005576;GO:0022624;GO:0043248;GO:0050852;GO:0005654;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043161;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0048863;GO:0043312;GO:0005198;GO:0005838;GO:0008541;GO:0034774;GO:1904813	protein binding;proteasome assembly;nucleus;cytoplasm;membrane;cytosol;proteasome complex;ubiquitin-dependent protein catabolic process;Fc-epsilon receptor signaling pathway;extracellular region;proteasome accessory complex;T cell receptor signaling pathway;nucleoplasm;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;stem cell differentiation;structural molecule activity;neutrophil degranulation;proteasome regulatory particle;proteasome regulatory particle, lid subcomplex;secretory granule lumen;ficolin-1-rich granule lumen	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Proteasome;Reference proteome;Ubl conjugation	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-6798695;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Neutrophil degranulation;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
PDSS1	positive	TPX2	ENSG00000088325	PDSS1	1	PDSS1	1	0.00130395808495998					GO:0005634;GO:0005737;GO:0005654;GO:0051301;GO:0045171;GO:0005856;GO:0005515;GO:0007049;GO:0006915;GO:0005815;GO:0005874;GO:0072686;GO:0000922;GO:0005819;GO:0005829;GO:0019901;GO:0010389;GO:0090307;GO:1901796;GO:0000278;GO:0032147;GO:0015630;GO:0060236;GO:0061676;GO:0043203	microtubule;activation of protein kinase activity;regulation of mitotic spindle organization;spindle;nucleus;cytoplasm;nucleoplasm;intercellular bridge;cytoskeleton;cell division;protein binding;cell cycle;apoptotic process;mitotic spindle;spindle pole;cytosol;protein kinase binding;regulation of G2/M transition of mitotic cell cycle;mitotic spindle assembly;regulation of signal transduction by p53 class mediator;mitotic cell cycle;negative regulation of microtubule depolymerization;microtubule cytoskeleton;importin-alpha family protein binding;axon hillock;microtubule nucleation	3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Isopeptide bond;Microtubule;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-453274;R-HSA-69275;R-HSA-69278;R-HSA-8854518;R-HSA-5633007;R-HSA-6804756	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic;AURKA Activation by TPX2;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation
PDSS1	positive	CDC6	ENSG00000094804	PDSS1	1	PDSS1	1	0.00130395808495998	WBGene00000382;WBGene00012650	WBGene00000382(0)		Ear-patella-short stature syndrome;Meier-Gorlin syndrome 5;Meier-Gorlin syndrome 5	GO:0005634;GO:0005737;GO:0000166;GO:0005524;GO:0051301;GO:0005515;GO:0006270;GO:0045737;GO:0048146;GO:1904117;GO:1904385;GO:0007049;GO:0006260;GO:0000278;GO:0005654;GO:0005829;GO:0000082;GO:0008285;GO:0003688;GO:0019900;GO:0000079;GO:0033314;GO:0000076;GO:0000083;GO:0000922;GO:0008156;GO:0030071;GO:0051233;GO:0007089;GO:0032467;GO:0051984	DNA replication initiation;cell division;nucleus;cytoplasm;nucleotide binding;ATP binding;protein binding;positive regulation of cyclin-dependent protein serine/threonine kinase activity;positive regulation of fibroblast proliferation;cellular response to vasopressin;cellular response to angiotensin;cell cycle;DNA replication;mitotic cell cycle;nucleoplasm;cytosol;G1/S transition of mitotic cell cycle;negative regulation of cell population proliferation;DNA replication origin binding;kinase binding;regulation of cyclin-dependent protein serine/threonine kinase activity;mitotic DNA replication checkpoint;DNA replication checkpoint;regulation of transcription involved in G1/S transition of mitotic cell cycle;spindle pole;negative regulation of DNA replication;regulation of mitotic metaphase/anaphase transition;spindle midzone;traversing start control point of mitotic cell cycle;positive regulation of cytokinesis;positive regulation of chromosome segregation	3D-structure;ATP-binding;Cell cycle;Cell division;Cytoplasm;DNA replication;Disease mutation;Dwarfism;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-68827;R-HSA-68867;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-453279;R-HSA-69206;R-HSA-176187;R-HSA-68962;R-HSA-68689;R-HSA-69205;R-HSA-1538133;R-HSA-1362277	Cell Cycle;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;CDC6 association with the ORC:origin complex;G1/S-Specific Transcription;G0 and Early G1;Transcription of E2F targets under negative control by DREAM complex
PDSS1	positive	CDC7	ENSG00000097046	PDSS1	1	PDSS1	1	0.00130395808495998	WBGene00016421	WBGene00016421(0)			GO:0005634;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005654;GO:0051301;GO:0045171;GO:0005515;GO:0007049;GO:0072686;GO:0005737;GO:0018105;GO:0000082;GO:0000727;GO:0006260;GO:0008284;GO:0010571;GO:0010971;GO:0044770;GO:0070317	ATP binding;protein phosphorylation;protein kinase activity;nucleus;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleoplasm;intercellular bridge;cell division;protein binding;cell cycle;mitotic spindle;cytoplasm;peptidyl-serine phosphorylation;G1/S transition of mitotic cell cycle;double-strand break repair via break-induced replication;DNA replication;positive regulation of cell population proliferation;positive regulation of nuclear cell cycle DNA replication;positive regulation of G2/M transition of mitotic cell cycle;cell cycle phase transition;negative regulation of G0 to G1 transition	3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Isopeptide bond;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-69002;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-453279;R-HSA-69206;R-HSA-176187;R-HSA-68962;R-HSA-8953750	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;DNA Replication Pre-Initiation;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;Transcriptional Regulation by E2F6
PDSS1	positive	NUP93	ENSG00000102900	PDSS1	1	PDSS1	1	0.00130395808495998	WBGene00003799	WBGene00003799(0)		Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;NEPHROTIC SYNDROME TYPE 12	GO:0051028;GO:0005634;GO:0016020;GO:0015031;GO:0017056;GO:0005643;GO:0005515;GO:0075733;GO:0043657;GO:0006110;GO:0006406;GO:0006409;GO:0006606;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0031965;GO:0060395;GO:0006998;GO:0016973;GO:0072001;GO:0034399;GO:0051292;GO:0060391;GO:0006913	structural constituent of nuclear pore;nuclear pore;mRNA transport;nucleus;membrane;protein transport;protein binding;intracellular transport of virus;host cell;SMAD protein signal transduction;regulation of glycolytic process;mRNA export from nucleus;tRNA export from nucleus;protein import into nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;nuclear membrane;nuclear envelope organization;poly(A)+ mRNA export from nucleus;nuclear periphery;nuclear pore complex assembly;positive regulation of SMAD protein signal transduction;nucleocytoplasmic transport	3D-structure;Alternative splicing;Disease mutation;Membrane;Nuclear pore complex;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Translocation;Transport;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-5619115;R-HSA-68886;R-HSA-69278;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Disorders of transmembrane transporters;M Phase;Cell Cycle, Mitotic;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling
PDSS1	positive	GMNN	ENSG00000112312	PDSS1	1	PDSS1	1	0.00130395808495998				Ear-patella-short stature syndrome;Autosomal-Dominant Primordial Dwarfism Associated with Meier-Gorlin syndrome;MEIER-GORLIN SYNDROME 6	GO:0005634;GO:0005737;GO:0005829;GO:0006275;GO:0008156;GO:0045786;GO:0005515;GO:0007049;GO:0005654;GO:0045892;GO:0000082;GO:0042826;GO:0003682;GO:0035563;GO:0071163;GO:2000104;GO:0003714;GO:0070491;GO:0009887;GO:0065003	regulation of DNA replication;negative regulation of cell cycle;negative regulation of DNA replication;nucleus;cytoplasm;nucleoplasm;cytosol;protein binding;cell cycle;negative regulation of transcription, DNA-templated;G1/S transition of mitotic cell cycle;histone deacetylase binding;chromatin binding;positive regulation of chromatin binding;DNA replication preinitiation complex assembly;negative regulation of DNA-dependent DNA replication;transcription corepressor activity;repressing transcription factor binding;animal organ morphogenesis;protein-containing complex assembly	3D-structure;Acetylation;Cell cycle;Coiled coil;Cytoplasm;DNA replication inhibitor;Disease mutation;Dwarfism;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-68827;R-HSA-68867;R-HSA-69002;R-HSA-69278;R-HSA-69306;R-HSA-453279;R-HSA-69206;R-HSA-68962	Cell Cycle;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;DNA Replication Pre-Initiation;Cell Cycle, Mitotic;DNA Replication;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of the pre-replicative complex
PDSS1	positive	SNRPF	ENSG00000139343	PDSS1	1	PDSS1	1	0.00130395808495998	WBGene00004918	WBGene00004918(0)			GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0005829;GO:0005515;GO:0005681;GO:0000398;GO:0000387;GO:0071013;GO:0005685;GO:0005732;GO:0005654;GO:0046540;GO:0005687;GO:0034709;GO:0051170;GO:0034719;GO:0071005;GO:0071007;GO:0006369;GO:0005689;GO:0008334;GO:0005683;GO:0034715;GO:0030532	spliceosomal snRNP assembly;mRNA splicing, via spliceosome;spliceosomal complex;small nucleolar ribonucleoprotein complex;RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;cytosol;protein binding;catalytic step 2 spliceosome;U1 snRNP;nucleoplasm;U4/U6 x U5 tri-snRNP complex;U4 snRNP;methylosome;import into nucleus;SMN-Sm protein complex;U2-type precatalytic spliceosome;U2-type catalytic step 2 spliceosome;termination of RNA polymerase II transcription;U12-type spliceosomal complex;histone mRNA metabolic process;U7 snRNP;pICln-Sm protein complex;small nuclear ribonucleoprotein complex	3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Nucleus;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-191859;R-HSA-194441;R-HSA-72203;R-HSA-73856;R-HSA-72163;R-HSA-72172;R-HSA-72165;R-HSA-75067;R-HSA-111367;R-HSA-77588	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;snRNP Assembly;Metabolism of non-coding RNA;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA Splicing - Minor Pathway;Processing of Capped Intronless Pre-mRNA;SLBP independent Processing of Histone Pre-mRNAs;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
PDSS1	positive	MRPL39	ENSG00000154719	PDSS1	1	PDSS1	1	0.00130395808495998	WBGene00006617;WBGene00044344	WBGene00044344(0)			GO:0003723;GO:0005739;GO:0005840;GO:0000166;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:0005761	nucleotide binding;RNA binding;mitochondrion;ribosome;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;mitochondrial ribosome	3D-structure;Acetylation;Alternative splicing;Mitochondrion;Polymorphism;Reference proteome;Ribonucleoprotein;Ribosomal protein	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
PDSS1	positive	HPRT1	ENSG00000165704	PDSS1	1	PDSS1	1	0.00130395808495998	WBGene00013690	WBGene00019890(0)		Hypoxanthine guanine phosphoribosyltransferase partial deficiency;LESCH-NYHAN SYNDROME;GOUT HPRT-RELATED;LESCH-NYHAN SYNDROME;KELLEY-SEEGMILLER SYNDROME;LESCH-NYHAN SYNDROME	GO:0005737;GO:0046872;GO:0000166;GO:0016740;GO:0005829;GO:0009116;GO:0016757;GO:0042803;GO:0005515;GO:0000287;GO:0006164;GO:0042802;GO:0006166;GO:0004422;GO:0052657;GO:0001913;GO:0001975;GO:0006168;GO:0006178;GO:0007625;GO:0007626;GO:0021756;GO:0021895;GO:0021954;GO:0032264;GO:0042417;GO:0046083;GO:0046100;GO:0046651;GO:0048813;GO:0070062;GO:0051289;GO:0043101;GO:0032263;GO:0043103;GO:0045964;GO:0046038;GO:0046040	nucleoside metabolic process;purine ribonucleoside salvage;hypoxanthine phosphoribosyltransferase activity;cytoplasm;metal ion binding;nucleotide binding;transferase activity;cytosol;transferase activity, transferring glycosyl groups;protein binding;identical protein binding;magnesium ion binding;purine nucleotide biosynthetic process;guanine phosphoribosyltransferase activity;T cell mediated cytotoxicity;response to amphetamine;adenine salvage;guanine salvage;grooming behavior;locomotory behavior;striatum development;cerebral cortex neuron differentiation;central nervous system neuron development;IMP salvage;dopamine metabolic process;adenine metabolic process;hypoxanthine metabolic process;lymphocyte proliferation;dendrite morphogenesis;extracellular exosome;protein homotetramerization;purine-containing compound salvage;GMP salvage;hypoxanthine salvage;positive regulation of dopamine metabolic process;GMP catabolic process;IMP metabolic process	3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Disease mutation;Glycosyltransferase;Gout;Isopeptide bond;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Purine salvage;Reference proteome;Transferase;Ubl conjugation	R-HSA-1430728;R-HSA-15869;R-HSA-8956321;R-HSA-74217	Metabolism;Metabolism of nucleotides;Nucleotide salvage;Purine salvage
PDSS1	positive	PSMC3	ENSG00000165916	PDSS1	1	PDSS1	1	0.00130395808495998	WBGene00004505	WBGene00004505(1)			GO:0005737;GO:0000166;GO:0005524;GO:0016787;GO:0030163;GO:0005634;GO:0016020;GO:0005515;GO:0000502;GO:0038095;GO:0005576;GO:0042802;GO:0022624;GO:0050852;GO:0000932;GO:0045944;GO:0005654;GO:0005829;GO:0016887;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043161;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0016032;GO:0043312;GO:0034774;GO:1904813;GO:0008540;GO:0043921;GO:0045899;GO:0001824	ATP binding;hydrolase activity;cytoplasm;protein catabolic process;nucleotide binding;nucleus;membrane;protein binding;proteasome complex;ATPase activity;Fc-epsilon receptor signaling pathway;extracellular region;identical protein binding;proteasome accessory complex;T cell receptor signaling pathway;P-body;positive regulation of transcription by RNA polymerase II;nucleoplasm;cytosol;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;viral process;neutrophil degranulation;secretory granule lumen;ficolin-1-rich granule lumen;modulation by host of viral transcription;positive regulation of RNA polymerase II transcriptional preinitiation complex assembly;proteasome regulatory particle, base subcomplex;blastocyst development	3D-structure;ATP-binding;Acetylation;Cytoplasm;Direct protein sequencing;Host-virus interaction;Nucleotide-binding;Nucleus;Phosphoprotein;Proteasome;Reference proteome;Ubl conjugation	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-6798695;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Neutrophil degranulation;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
PDSS1	positive	ZWILCH	ENSG00000174442	PDSS1	1	PDSS1	1	0.00130395808495998	WBGene00021460	WBGene00021460(0)			GO:0051301;GO:0005694;GO:0005515;GO:0007049;GO:0000775;GO:0000776;GO:0000777;GO:0007093;GO:0005829;GO:1990423	mitotic cell cycle checkpoint;RZZ complex;cell division;chromosome;protein binding;cell cycle;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cytosol	3D-structure;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Kinetochore;Mitosis;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	SPDL1	ENSG00000040275	PDSS1	1	PDSS1	1	0.00139016373990031					GO:0005634;GO:0005737;GO:0051301;GO:0005694;GO:0005856;GO:0005515;GO:0007049;GO:0000922;GO:0005815;GO:0000775;GO:0000776;GO:0000777;GO:0005829;GO:0007094;GO:0034501;GO:0019899;GO:0000132;GO:0007080;GO:0000940;GO:0043515	mitotic spindle assembly checkpoint;protein localization to kinetochore;cell;nucleus;cytoplasm;cytoskeleton;cell division;chromosome;protein binding;cell cycle;spindle pole;microtubule organizing center;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cytosol;enzyme binding;establishment of mitotic spindle orientation;mitotic metaphase plate congression;condensed chromosome outer kinetochore;kinetochore binding	Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	CDC25A	ENSG00000164045	PDSS1	1	PDSS1	1	0.00139016373990031	WBGene00000387;WBGene00000386;WBGene00000388;WBGene00000389	WBGene00000388(0);WBGene00000387(0)			GO:0016787;GO:0051301;GO:0004721;GO:0006470;GO:0005515;GO:0004725;GO:0035335;GO:0007049;GO:1902751;GO:0005634;GO:0005737;GO:0005654;GO:0005829;GO:0019901;GO:0016579;GO:0008283;GO:0000086;GO:0000082;GO:0051087;GO:0034644;GO:0009314;GO:0000079;GO:0051726;GO:0010971;GO:0045931;GO:0110032;GO:0005622	protein tyrosine phosphatase activity;protein dephosphorylation;positive regulation of cell cycle G2/M phase transition;hydrolase activity;cell division;phosphoprotein phosphatase activity;protein binding;peptidyl-tyrosine dephosphorylation;cell cycle;nucleus;cytoplasm;nucleoplasm;cytosol;protein kinase binding;protein deubiquitination;G2/M transition of mitotic cell cycle;G1/S transition of mitotic cell cycle;chaperone binding;cellular response to UV;response to radiation;cell population proliferation;regulation of cyclin-dependent protein serine/threonine kinase activity;regulation of cell cycle;positive regulation of G2/M transition of mitotic cell cycle;positive regulation of mitotic cell cycle;positive regulation of G2/MI transition of meiotic cell cycle	3D-structure;Alternative splicing;Cell cycle;Cell division;Hydrolase;Mitosis;Phosphoprotein;Polymorphism;Protein phosphatase;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-1640170;R-HSA-1643685;R-HSA-453274;R-HSA-5688426;R-HSA-5689880;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69481;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-176187;R-HSA-69273;R-HSA-8862803;R-HSA-8863678;R-HSA-156711;R-HSA-1538133;R-HSA-1362277	Metabolism of proteins;Post-translational protein modification;Cell Cycle;Disease;Mitotic G2-G2/M phases;Deubiquitination;Ub-specific processing proteases;S Phase;G2/M Transition;Cell Cycle, Mitotic;G2/M Checkpoints;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Activation of ATR in response to replication stress;Cyclin A/B1/B2 associated events during G2/M transition;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models;Neurodegenerative Diseases;Polo-like kinase mediated events;G0 and Early G1;Transcription of E2F targets under negative control by DREAM complex
PDSS1	positive	FEN1	ENSG00000168496	PDSS1	1	PDSS1	1	0.00139016373990031	WBGene00000794	WBGene00000794(0)			GO:0005634;GO:0016020;GO:0046872;GO:0005730;GO:0016787;GO:0003677;GO:0003824;GO:0005739;GO:0006281;GO:0090305;GO:0005515;GO:0006974;GO:0016788;GO:0004518;GO:0004519;GO:0090502;GO:0004527;GO:0000287;GO:0006260;GO:0005654;GO:0004523;GO:0000784;GO:0032991;GO:0006284;GO:0003684;GO:0006302;GO:0045876;GO:0000724;GO:0008409;GO:0030145;GO:0032201;GO:0003690;GO:0008309;GO:0017108;GO:0048256;GO:0007613;GO:0009650;GO:0043137	DNA binding;catalytic activity;DNA repair;hydrolase activity, acting on ester bonds;nuclease activity;nucleus;membrane;metal ion binding;nucleoplasm;nucleolus;hydrolase activity;mitochondrion;nucleic acid phosphodiester bond hydrolysis;protein binding;cellular response to DNA damage stimulus;exonuclease activity;endonuclease activity;DNA replication;RNA phosphodiester bond hydrolysis, endonucleolytic;magnesium ion binding;RNA-DNA hybrid ribonuclease activity;nuclear chromosome, telomeric region;protein-containing complex;base-excision repair;damaged DNA binding;double-strand break repair;positive regulation of sister chromatid cohesion;double-strand break repair via homologous recombination;5'-3' exonuclease activity;manganese ion binding;telomere maintenance via semi-conservative replication;double-stranded DNA binding;double-stranded DNA exodeoxyribonuclease activity;5'-flap endonuclease activity;flap endonuclease activity;memory;UV protection;DNA replication, removal of RNA primer	3D-structure;Acetylation;Alternative initiation;DNA damage;DNA repair;DNA replication;Direct protein sequencing;Endonuclease;Exonuclease;Hydrolase;Magnesium;Metal-binding;Methylation;Mitochondrion;Nuclease;Nucleus;Phosphoprotein;Reference proteome	R-HSA-1640170;R-HSA-1643685;R-HSA-5693532;R-HSA-5693538;R-HSA-73894;R-HSA-162587;R-HSA-162906;R-HSA-5663205;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-73886;R-HSA-157579;R-HSA-180786;R-HSA-73884;R-HSA-73933;R-HSA-5685939;R-HSA-69190;R-HSA-162594;R-HSA-110362;R-HSA-110373;R-HSA-5651801;R-HSA-174417;R-HSA-69166;R-HSA-69183;R-HSA-69186;R-HSA-174414;R-HSA-174437	Cell Cycle;Disease;DNA Double-Strand Break Repair;Homology Directed Repair;DNA Repair;HIV Life Cycle;HIV Infection;Infectious disease;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Chromosome Maintenance;Telomere Maintenance;Extension of Telomeres;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through MMEJ (alt-NHEJ);DNA strand elongation;Early Phase of HIV Life Cycle;POLB-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;Processive synthesis on the C-strand of the telomere;Removal of the Flap Intermediate from the C-strand
PDSS1	positive	RUVBL1	ENSG00000175792	PDSS1	1	PDSS1	1	0.00139016373990031	WBGene00007784;WBGene00020687	WBGene00007784(0)			GO:0005634;GO:0000166;GO:0005524;GO:0016787;GO:0031011;GO:0003678;GO:0032508;GO:0006281;GO:0006310;GO:0006974;GO:0035267;GO:0004386;GO:0043139;GO:0097255;GO:0005829;GO:0005654;GO:0005737;GO:0016020;GO:1903508;GO:0051301;GO:0006325;GO:0005856;GO:0005515;GO:0007049;GO:0003713;GO:0005815;GO:0006338;GO:0000812;GO:0006357;GO:0001094;GO:0043531;GO:0051117;GO:1990904;GO:0045296;GO:0070062;GO:0016887;GO:0040008;GO:0016579;GO:0034080;GO:0090263;GO:0043967;GO:1904837;GO:0016363;GO:0071339;GO:0007283;GO:1904874;GO:0043968;GO:0017025;GO:0016573;GO:0000492	nucleus;nucleotide binding;ATP binding;hydrolase activity;Ino80 complex;DNA helicase activity;DNA duplex unwinding;DNA repair;DNA recombination;cellular response to DNA damage stimulus;NuA4 histone acetyltransferase complex;helicase activity;5'-3' DNA helicase activity;R2TP complex;nucleoplasm;cytosol;cytoplasm;membrane;cytoskeleton;positive regulation of nucleic acid-templated transcription;cell division;chromatin organization;protein binding;cell cycle;ATPase activity;transcription coactivator activity;microtubule organizing center;chromatin remodeling;Swr1 complex;regulation of transcription by RNA polymerase II;TFIID-class transcription factor complex binding;ADP binding;ATPase binding;ribonucleoprotein complex;cadherin binding;extracellular exosome;regulation of growth;protein deubiquitination;CENP-A containing nucleosome assembly;positive regulation of canonical Wnt signaling pathway;histone H4 acetylation;beta-catenin-TCF complex assembly;nuclear matrix;MLL1 complex;spermatogenesis;positive regulation of telomerase RNA localization to Cajal body;histone H2A acetylation;TBP-class protein binding;histone acetylation;box C/D snoRNP assembly	3D-structure;ATP-binding;Acetylation;Activator;Alternative splicing;Cell cycle;Cell division;Chromatin regulator;Cytoplasm;Cytoskeleton;DNA damage;DNA recombination;DNA repair;Direct protein sequencing;Growth regulation;Helicase;Hydrolase;Isopeptide bond;Membrane;Mitosis;Nucleotide-binding;Nucleus;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-1640170;R-HSA-73894;R-HSA-195721;R-HSA-201681;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-606279;R-HSA-73886;R-HSA-774815;R-HSA-201722;R-HSA-3247509;R-HSA-4839726;R-HSA-157579;R-HSA-171319;R-HSA-180786;R-HSA-3214847;R-HSA-5696398;R-HSA-5696399;R-HSA-5696394	Metabolism of proteins;Post-translational protein modification;Signal Transduction;Cell Cycle;DNA Repair;Signaling by WNT;TCF dependent signaling in response to WNT;Deubiquitination;UCH proteinases;Ub-specific processing proteases;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly;Formation of the beta-catenin:TCF transactivating complex;Chromatin modifying enzymes;Chromatin organization;Telomere Maintenance;Telomere Extension By Telomerase;Extension of Telomeres;HATs acetylate histones;Nucleotide Excision Repair;Global Genome Nucleotide Excision Repair (GG-NER);DNA Damage Recognition in GG-NER
PDSS1	positive	MCM10	ENSG00000065328	PDSS1	1	PDSS1	1	0.00148154526027	WBGene00012935	WBGene00012935(0)			GO:0005634;GO:0046872;GO:0005730;GO:0003677;GO:0005515;GO:0006270;GO:0006974;GO:0006260;GO:0003697;GO:0003690;GO:0042802;GO:0005654;GO:0000082;GO:0003688;GO:0031298;GO:0019899;GO:0008283	nucleus;single-stranded DNA binding;DNA replication;DNA replication initiation;double-stranded DNA binding;metal ion binding;nucleoplasm;nucleolus;DNA binding;protein binding;cellular response to DNA damage stimulus;identical protein binding;G1/S transition of mitotic cell cycle;DNA replication origin binding;replication fork protection complex;enzyme binding;cell population proliferation	Alternative splicing;Coiled coil;DNA damage;DNA replication;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	R-HSA-1640170;R-HSA-69002;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-453279;R-HSA-69206;R-HSA-176187;R-HSA-68962	Cell Cycle;DNA Replication Pre-Initiation;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of ATR in response to replication stress;Activation of the pre-replicative complex
PDSS1	positive	PRMT1	ENSG00000126457	PDSS1	1	PDSS1	1	0.00148154526027	WBGene00013766				GO:0016740;GO:0008168;GO:0032259;GO:0006479;GO:0045648;GO:1900745;GO:0003723;GO:0005634;GO:0005737;GO:0005829;GO:0005515;GO:0044020;GO:0005654;GO:0042802;GO:0006977;GO:0051260;GO:0008284;GO:0019899;GO:0007166;GO:0031175;GO:0045652;GO:0008327;GO:0018216;GO:0043985;GO:0034709;GO:0042054;GO:0046985;GO:0016274;GO:0035246;GO:0048273;GO:0045653;GO:1904047;GO:0016571;GO:0008276;GO:0035242;GO:0019919;GO:0035241;GO:0008170;GO:0035247	methyltransferase activity;protein methylation;transferase activity;methylation;positive regulation of erythrocyte differentiation;positive regulation of p38MAPK cascade;RNA binding;nucleus;cytoplasm;cytosol;protein binding;identical protein binding;protein-arginine omega-N monomethyltransferase activity;histone methyltransferase activity (H4-R3 specific);peptidyl-arginine omega-N-methylation;nucleoplasm;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;protein homooligomerization;positive regulation of cell population proliferation;enzyme binding;cell surface receptor signaling pathway;neuron projection development;regulation of megakaryocyte differentiation;methyl-CpG binding;peptidyl-arginine methylation;histone H4-R3 methylation;methylosome;histone methyltransferase activity;positive regulation of hemoglobin biosynthetic process;protein-arginine N-methyltransferase activity;peptidyl-arginine N-methylation;mitogen-activated protein kinase p38 binding;negative regulation of megakaryocyte differentiation;S-adenosyl-L-methionine binding;protein-arginine omega-N asymmetric methyltransferase activity;histone methylation;peptidyl-arginine methylation, to asymmetrical-dimethyl arginine;protein methyltransferase activity;N-methyltransferase activity;in utero embryonic development	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Isopeptide bond;Methyltransferase;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;S-adenosyl-L-methionine;Transferase;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-8878171;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-3247509;R-HSA-4839726;R-HSA-9018519;R-HSA-3214858;R-HSA-8936459;R-HSA-6804114	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Transcriptional regulation by RUNX1;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Chromatin modifying enzymes;Chromatin organization;Estrogen-dependent gene expression;RMTs methylate histone arginines;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
PDSS1	positive	KIF2C	ENSG00000142945	PDSS1	1	PDSS1	1	0.00148154526027	WBGene00002219	WBGene00002219(1)			GO:0000166;GO:0005524;GO:0003774;GO:0003777;GO:0008017;GO:0007018;GO:0005634;GO:0005737;GO:0016020;GO:0051301;GO:0005694;GO:0005856;GO:0005515;GO:0007049;GO:0005874;GO:0007059;GO:0000775;GO:0000776;GO:0000777;GO:0016887;GO:0005829;GO:0006890;GO:0005813;GO:0007019;GO:0019886;GO:0005871;GO:0051310;GO:0051315;GO:0005881;GO:0019237;GO:0007080;GO:0051983;GO:0051010;GO:0015630;GO:0035371;GO:0030951	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;nucleotide binding;motor activity;cell;nucleus;cytoplasm;membrane;cytoskeleton;cell division;chromosome;protein binding;cell cycle;microtubule;chromosome segregation;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;ATPase activity;cytosol;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;centrosome;spindle;microtubule depolymerization;antigen processing and presentation of exogenous peptide antigen via MHC class II;kinesin complex;metaphase plate congression;attachment of mitotic spindle microtubules to kinetochore;cytoplasmic microtubule;centromeric DNA binding;mitotic metaphase plate congression;regulation of chromosome segregation;microtubule plus-end binding;microtubule cytoskeleton;microtubule plus-end;establishment or maintenance of microtubule cytoskeleton polarity	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Coiled coil;Cytoplasm;Cytoskeleton;Kinetochore;Microtubule;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2132295;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-983189;R-HSA-983231;R-HSA-141424;R-HSA-141444;R-HSA-69618	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;MHC class II antigen presentation;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Kinesins;Factors involved in megakaryocyte development and platelet production;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	LMNB2	ENSG00000176619	PDSS1	1	PDSS1	1	0.00148154526027	WBGene00002050;WBGene00002051;WBGene00002052;WBGene00003485;WBGene00002053;WBGene00002054;WBGene00003052;WBGene00002055;WBGene00002056;WBGene00002057;WBGene00002058;WBGene00002067;WBGene00017327			Acquired partial lipodystrophy;Progressive myoclonic epilepsy type 9;Epilepsy progressive myoclonic 9;LIPODYSTROPHY PARTIAL ACQUIRED SUSCEPTIBILITY TO	GO:0005634;GO:0016020;GO:0031965;GO:0005515;GO:0005882;GO:0003674;GO:0008150;GO:0005637;GO:0005635;GO:0005638	nucleus;membrane;nuclear membrane;protein binding;intermediate filament;molecular_function;biological_process;nuclear inner membrane;nuclear envelope;lamin filament	3D-structure;Acetylation;Coiled coil;Direct protein sequencing;Disease mutation;Epilepsy;Intermediate filament;Isopeptide bond;Lipoprotein;Membrane;Methylation;Nucleus;Phosphoprotein;Polymorphism;Prenylation;Reference proteome;Ubl conjugation		
PDSS1	positive	HMMR	ENSG00000072571	PDSS1	1	PDSS1	1	0.00157837660378102	WBGene00000464			Breast Cancer	GO:0005540;GO:0005737;GO:0016020;GO:0005813;GO:0005829;GO:0015630;GO:0005515;GO:0009986;GO:0005886;GO:0010389;GO:0030214	hyaluronic acid binding;cytoplasm;membrane;cytosol;centrosome;microtubule cytoskeleton;protein binding;cell surface;plasma membrane;regulation of G2/M transition of mitotic cell cycle;hyaluronan catabolic process	Alternative splicing;Cytoplasm;Glycoprotein;Hyaluronic acid;Phosphoprotein;Polymorphism;Reference proteome;Repeat	R-HSA-1430728;R-HSA-1640170;R-HSA-453274;R-HSA-69275;R-HSA-69278;R-HSA-71387;R-HSA-8854518;R-HSA-1630316;R-HSA-2142845;R-HSA-2160916	Metabolism;Cell Cycle;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic;Metabolism of carbohydrates;AURKA Activation by TPX2;Glycosaminoglycan metabolism;Hyaluronan metabolism;Hyaluronan uptake and degradation
PDSS1	positive	NUP37	ENSG00000075188	PDSS1	1	PDSS1	1	0.00157837660378102				Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;MICROCEPHALY 24 PRIMARY AUTOSOMAL RECESSIVE	GO:0051028;GO:0005634;GO:0015031;GO:0005654;GO:0051301;GO:0005694;GO:0007049;GO:0005643;GO:0007059;GO:0000775;GO:0000776;GO:0000777;GO:0005515;GO:0005829;GO:0075733;GO:0043657;GO:0006110;GO:0006406;GO:0006409;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0031080	protein binding;nuclear pore outer ring;mRNA transport;nucleus;protein transport;nucleoplasm;cell division;chromosome;cell cycle;nuclear pore;chromosome segregation;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cytosol;intracellular transport of virus;host cell;regulation of glycolytic process;mRNA export from nucleus;tRNA export from nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope	3D-structure;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Disease mutation;Kinetochore;Mitosis;Nuclear pore complex;Nucleus;Primary microcephaly;Protein transport;Reference proteome;Repeat;Translocation;Transport;WD repeat;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-5619115;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531;R-HSA-141424;R-HSA-141444;R-HSA-69618	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Disorders of transmembrane transporters;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	AURKA	ENSG00000087586	PDSS1	1	PDSS1	1	0.00157837660378102	WBGene00000099;WBGene00000098				GO:0048471;GO:0005634;GO:0005737;GO:0005813;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005829;GO:0051301;GO:0005856;GO:0042995;GO:0005515;GO:0007049;GO:0005874;GO:0007098;GO:0000226;GO:0000922;GO:0005815;GO:0005819;GO:0030496;GO:0000780;GO:0000278;GO:0051321;GO:0007052;GO:0005929;GO:0006977;GO:0005654;GO:0019901;GO:0030030;GO:0005814;GO:0010972;GO:0031145;GO:0007100;GO:0000086;GO:0010389;GO:0031647;GO:1901796;GO:0046777;GO:0097431;GO:0032465;GO:0006511;GO:0032091;GO:0045840;GO:0005876;GO:0004712;GO:0035174;GO:0046982;GO:0000212;GO:0007051;GO:0009611;GO:0035404;GO:0046605;GO:0097421;GO:0015630;GO:0031616;GO:0032133;GO:0051233;GO:0031625;GO:0007057;GO:0009948;GO:0032436;GO:0043066;GO:0051642;GO:0071539;GO:1900195;GO:1990138;GO:0042585;GO:0043203;GO:0045120;GO:0072686;GO:0072687	ATP binding;protein phosphorylation;protein kinase activity;microtubule cytoskeleton organization;mitotic cell cycle;meiotic cell cycle;centrosome cycle;mitotic spindle organization;meiotic spindle organization;mitotic centrosome separation;perinuclear region of cytoplasm;nucleus;cytoplasm;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleoplasm;cytosol;cytoskeleton;cell division;centrosome;cell projection;protein binding;cell cycle;microtubule;spindle pole;microtubule organizing center;spindle;midbody;condensed nuclear chromosome, centromeric region;cilium;neuron projection;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;protein kinase binding;cell projection organization;centriole;negative regulation of G2/M transition of mitotic cell cycle;anaphase-promoting complex-dependent catabolic process;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;regulation of protein stability;negative regulation of gene expression;regulation of signal transduction by p53 class mediator;protein autophosphorylation;mitotic spindle pole;regulation of cytokinesis;ubiquitin-dependent protein catabolic process;negative regulation of protein binding;peptidyl-serine phosphorylation;positive regulation of mitotic nuclear division;spindle microtubule;protein serine/threonine/tyrosine kinase activity;histone serine kinase activity;protein heterodimerization activity;spindle organization;response to wounding;histone-serine phosphorylation;regulation of centrosome cycle;liver regeneration;microtubule cytoskeleton;spindle pole centrosome;chromosome passenger complex;spindle midzone;ubiquitin protein ligase binding;spindle assembly involved in female meiosis I;anterior/posterior axis specification;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of apoptotic process;centrosome localization;protein localization to centrosome;positive regulation of oocyte maturation;neuron projection extension;germinal vesicle;axon hillock;pronucleus;mitotic spindle;meiotic spindle	3D-structure;ATP-binding;Cell cycle;Cell division;Cell projection;Cilium;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Isopeptide bond;Kinase;Microtubule;Mitosis;Nucleotide-binding;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-174143;R-HSA-174178;R-HSA-453274;R-HSA-453276;R-HSA-69275;R-HSA-69278;R-HSA-8854050;R-HSA-2990846;R-HSA-3108232;R-HSA-4615885;R-HSA-2565942;R-HSA-8854518;R-HSA-5633007;R-HSA-6804756;R-HSA-6804114;R-HSA-8854521	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;G2/M Transition;Cell Cycle, Mitotic;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of DNA replication proteins;Regulation of PLK1 Activity at G2/M Transition;AURKA Activation by TPX2;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Interaction between PHLDA1 and AURKA
PDSS1	positive	APOO	ENSG00000184831	PDSS1	1	PDSS1	1	0.00157837660378102		WBGene00019333(0)			GO:0005743;GO:0005739;GO:0061617;GO:0042407;GO:0005615;GO:0016020;GO:0016021;GO:0005829;GO:0005783;GO:0005789;GO:0005794;GO:0005576;GO:0031305;GO:0000139;GO:0006869;GO:0005515;GO:0034361;GO:0034364;GO:0034362	MICOS complex;cristae formation;mitochondrial inner membrane;mitochondrion;extracellular space;membrane;integral component of membrane;cytosol;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;extracellular region;integral component of mitochondrial inner membrane;lipid transport;Golgi membrane;protein binding;very-low-density lipoprotein particle;high-density lipoprotein particle;inner mitochondrial membrane organization;SAM complex;MIB complex;low-density lipoprotein particle	Alternative splicing;Endoplasmic reticulum;Glycoprotein;Golgi apparatus;HDL;LDL;Lipid transport;Membrane;Mitochondrion;Mitochondrion inner membrane;Proteoglycan;Reference proteome;Secreted;Signal;Transmembrane;Transmembrane helix;Transport;VLDL	R-HSA-1852241;R-HSA-1592230;R-HSA-8949613	Organelle biogenesis and maintenance;Mitochondrial biogenesis;Cristae formation
PDSS1	positive	HNRNPAB	ENSG00000197451	PDSS1	1	PDSS1	1	0.00157837660378102					GO:0003676;GO:0003723;GO:0005634;GO:0005737;GO:0005654;GO:0005515;GO:0043565;GO:0003700;GO:1990904;GO:0090575;GO:0045893;GO:1990837;GO:0003729;GO:0001837	nucleic acid binding;RNA binding;nucleus;cytoplasm;nucleoplasm;protein binding;sequence-specific DNA binding;DNA-binding transcription factor activity;regulation of RNA metabolic process;ribonucleoprotein complex;RNA polymerase II transcription factor complex;positive regulation of transcription, DNA-templated;sequence-specific double-stranded DNA binding;mRNA binding;epithelial to mesenchymal transition	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation		
PDSS1	positive	POP1	ENSG00000104356	PDSS1	1	PDSS1	1	0.00168094380155959	WBGene00015486	WBGene00015486(0)		Anauxetic dysplasia;ANAUXETIC DYSPLASIA 2	GO:0001682;GO:0000172;GO:0005655;GO:0003723;GO:0005634;GO:0005730;GO:0008033;GO:0016787;GO:0005615;GO:0005515;GO:0090501;GO:0090502;GO:0005654;GO:0004526;GO:0033204;GO:0030681;GO:0000171;GO:0016078	tRNA 5'-leader removal;ribonuclease MRP complex;nucleolar ribonuclease P complex;RNA binding;nucleus;nucleolus;tRNA processing;hydrolase activity;extracellular space;protein binding;nucleoplasm;ribonuclease P activity;RNA phosphodiester bond hydrolysis, endonucleolytic;ribonuclease P RNA binding;multimeric ribonuclease P complex;ribonuclease MRP activity;tRNA catabolic process	3D-structure;Disease mutation;Dwarfism;Hydrolase;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;tRNA processing	R-HSA-72306;R-HSA-8953854;R-HSA-6784531	tRNA processing;Metabolism of RNA;tRNA processing in the nucleus
PDSS1	positive	LRRC59	ENSG00000108829	PDSS1	1	PDSS1	1	0.00168094380155959	WBGene00010139				GO:0003723;GO:0005634;GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0031090;GO:0043231;GO:0045296;GO:0042645;GO:0005635;GO:0005515	protein binding;RNA binding;nucleus;membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle;cadherin binding;mitochondrial nucleoid;nuclear envelope	Acetylation;Coiled coil;Direct protein sequencing;Endoplasmic reticulum;Leucine-rich repeat;Membrane;Microsome;Nucleus;Phosphoprotein;Reference proteome;Repeat;Signal-anchor;Transmembrane;Transmembrane helix		
PDSS1	positive	SNRPB	ENSG00000125835	PDSS1	1	PDSS1	1	0.00168094380155959	WBGene00004915	WBGene00004915(0)		Cerebro-costo-mandibular syndrome;Cerebro-costo-mandibular syndrome;Cerebro-costo-mandibular syndrome	GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0005654;GO:0005829;GO:0005515;GO:0005681;GO:0000387;GO:0000398;GO:0071013;GO:0005685;GO:0046540;GO:0005686;GO:0005687;GO:0005682;GO:0034709;GO:0070034;GO:0005697;GO:0051170;GO:0034719;GO:0071005;GO:0071007;GO:0006369;GO:0071004;GO:0005689;GO:0030532;GO:0006479;GO:0008334;GO:0005683;GO:0071208;GO:1990446;GO:1990447;GO:0007420;GO:0071204	RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;nucleoplasm;cytosol;protein binding;spliceosomal complex;spliceosomal snRNP assembly;mRNA splicing, via spliceosome;catalytic step 2 spliceosome;U1 snRNP;U4/U6 x U5 tri-snRNP complex;U2 snRNP;U4 snRNP;U5 snRNP;methylosome;telomerase RNA binding;telomerase holoenzyme complex;import into nucleus;SMN-Sm protein complex;U2-type precatalytic spliceosome;U2-type catalytic step 2 spliceosome;termination of RNA polymerase II transcription;U2-type prespliceosome;U12-type spliceosomal complex;small nuclear ribonucleoprotein complex;protein methylation;histone mRNA metabolic process;U7 snRNP;histone pre-mRNA DCP binding;U1 snRNP binding;U2 snRNP binding;brain development;histone pre-mRNA 3'end processing complex	3D-structure;Alternative splicing;Cytoplasm;Direct protein sequencing;Disease mutation;Mental retardation;Methylation;Nucleus;Polymorphism;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-191859;R-HSA-194441;R-HSA-72203;R-HSA-73856;R-HSA-72163;R-HSA-72172;R-HSA-72165;R-HSA-75067;R-HSA-111367;R-HSA-77588	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;snRNP Assembly;Metabolism of non-coding RNA;Processing of Capped Intron-Containing Pre-mRNA;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA Splicing - Minor Pathway;Processing of Capped Intronless Pre-mRNA;SLBP independent Processing of Histone Pre-mRNAs;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
PDSS1	positive	DNA2	ENSG00000138346	PDSS1	1	PDSS1	1	0.00168094380155959	WBGene00001016	WBGene00014965(0);WBGene00016566(0);WBGene00016565(0)		DNA2-related mitochondrial DNA deletion syndrome;PRIMORDIAL DWARFISM SECKEL SYNDROME 8;Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant 6;Seckel syndrome 8	GO:0005634;GO:0005739;GO:0032508;GO:0017108;GO:0017116;GO:0033567;GO:0046872;GO:0000166;GO:0005524;GO:0016787;GO:0003677;GO:0003824;GO:0008152;GO:0006281;GO:0006974;GO:0004519;GO:0004518;GO:0051536;GO:0051539;GO:0006260;GO:0003678;GO:0004386;GO:0003723;GO:0005737;GO:0005515;GO:0005654;GO:0016887;GO:0000784;GO:0006284;GO:1901796;GO:0045740;GO:0090656;GO:0042645;GO:0000723;GO:0032201;GO:1902990;GO:0043139;GO:0044806;GO:0016890;GO:0043137;GO:0005760;GO:0000076;GO:0000729;GO:0006264;GO:0043504;GO:0071932;GO:0090305	5'-flap endonuclease activity;single-stranded DNA helicase activity;DNA replication, Okazaki fragment processing;nucleoplasm;mitochondrion;DNA duplex unwinding;nucleus;metal ion binding;nucleotide binding;ATP binding;hydrolase activity;DNA binding;catalytic activity;metabolic process;DNA repair;cellular response to DNA damage stimulus;nuclease activity;endonuclease activity;iron-sulfur cluster binding;4 iron, 4 sulfur cluster binding;DNA replication;ATPase activity;DNA helicase activity;helicase activity;protein binding;RNA binding;cytoplasm;nuclear chromosome, telomeric region;base-excision repair;DNA replication checkpoint;regulation of signal transduction by p53 class mediator;positive regulation of DNA replication;t-circle formation;mitochondrial nucleoid;telomere maintenance;telomere maintenance via semi-conservative replication;mitotic telomere maintenance via semi-conservative replication;5'-3' DNA helicase activity;G-quadruplex DNA unwinding;site-specific endodeoxyribonuclease activity, specific for altered base;DNA replication, removal of RNA primer;gamma DNA polymerase complex;DNA double-strand break processing;mitochondrial DNA replication;mitochondrial DNA repair;replication fork reversal;nucleic acid phosphodiester bond hydrolysis	3D-structure;4Fe-4S;ATP-binding;Acetylation;Alternative splicing;DNA damage;DNA repair;DNA replication;DNA-binding;Disease mutation;Dwarfism;Endonuclease;Helicase;Hydrolase;Iron;Iron-sulfur;Mental retardation;Metal-binding;Mitochondrion;Multifunctional enzyme;Nuclease;Nucleotide-binding;Nucleus;Primary mitochondrial disease;Progressive external ophthalmoplegia;Reference proteome	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-73886;R-HSA-5633007;R-HSA-6804756;R-HSA-157579;R-HSA-180786;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5693554;R-HSA-5685938;R-HSA-69190;R-HSA-174417;R-HSA-69166;R-HSA-69183;R-HSA-69186;R-HSA-174414;R-HSA-174437	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Chromosome Maintenance;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Telomere Maintenance;Extension of Telomeres;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Single Strand Annealing (SSA);DNA strand elongation;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;Processive synthesis on the C-strand of the telomere;Removal of the Flap Intermediate from the C-strand
PDSS1	positive	COA7	ENSG00000162377	PDSS1	1	PDSS1	1	0.00168094380155959	WBGene00013925	WBGene00013925(1)		SPINOCEREBELLAR ATAXIA AUTOSOMAL RECESSIVE WITH AXONAL NEUROPATHY 3	GO:0005634;GO:0005739;GO:0005515;GO:0005758	protein binding;nucleoplasm;mitochondrion;mitochondrial intermembrane space	Acetylation;Disease mutation;Mitochondrion;Neurodegeneration;Neuropathy;Polymorphism;Reference proteome;Repeat		
PDSS1	positive	DTYMK	ENSG00000168393	PDSS1	1	PDSS1	1	0.00168094380155959	WBGene00011272				GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005634;GO:0006165;GO:0005737;GO:0005739;GO:0005829;GO:0046940;GO:0009165;GO:0004798;GO:0006233;GO:0004550;GO:0015949;GO:0006235;GO:0009041;GO:0006227;GO:0043627;GO:0045445;GO:0046105;GO:0046686;GO:0071363;GO:0005758;GO:0005759	ATP binding;thymidylate kinase activity;dTDP biosynthetic process;nucleotide binding;kinase activity;transferase activity;phosphorylation;nucleus;cytosol;nucleoside diphosphate phosphorylation;cytoplasm;mitochondrion;nucleoside monophosphate phosphorylation;nucleotide biosynthetic process;nucleoside diphosphate kinase activity;nucleobase-containing small molecule interconversion;dTTP biosynthetic process;uridylate kinase activity;dUDP biosynthetic process;response to estrogen;myoblast differentiation;thymidine biosynthetic process;response to cadmium ion;cellular response to growth factor stimulus;mitochondrial intermembrane space;mitochondrial matrix	3D-structure;ATP-binding;Acetylation;Alternative splicing;Kinase;Nucleotide biosynthesis;Nucleotide-binding;Reference proteome;Transferase	R-HSA-1430728;R-HSA-15869;R-HSA-499943	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
PDSS1	positive	CDK1	ENSG00000170312	PDSS1	1	PDSS1	1	0.00168094380155959	WBGene00000405;WBGene00000407	WBGene00000405(1)			GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0006468;GO:0005634;GO:0005737;GO:0016020;GO:0016301;GO:0016740;GO:0016310;GO:0043066;GO:0005829;GO:0005739;GO:0051301;GO:0005856;GO:0005515;GO:0006281;GO:0007049;GO:0048511;GO:0006915;GO:0006260;GO:0046718;GO:0005813;GO:0005815;GO:0005819;GO:0030496;GO:0005789;GO:0006977;GO:0005654;GO:0070062;GO:0016477;GO:0016579;GO:0031145;GO:1901990;GO:0000784;GO:0000086;GO:0010389;GO:0097711;GO:0007098;GO:0072686;GO:0005876;GO:0006367;GO:0030855;GO:0000226;GO:0042752;GO:0018107;GO:0001618;GO:0030332;GO:0000187;GO:0018105;GO:0004693;GO:0007077;GO:0005759;GO:0003682;GO:0008353;GO:0030544;GO:0035173;GO:0097472;GO:0000278;GO:0007095;GO:0007344;GO:0007569;GO:0008283;GO:0009636;GO:0010243;GO:0010628;GO:0010971;GO:0014038;GO:0014070;GO:0014075;GO:0014823;GO:0016572;GO:0030261;GO:0031100;GO:0034501;GO:0042493;GO:0042542;GO:0044772;GO:0045471;GO:0045740;GO:0045931;GO:0045995;GO:0046686;GO:0046688;GO:0048678;GO:0055015;GO:0060045;GO:0065003;GO:0070301;GO:0090166;GO:1900182;GO:1905448;GO:0000307;GO:0097125	ATP binding;protein phosphorylation;protein kinase activity;nucleotide binding;protein serine/threonine kinase activity;nucleus;cytoplasm;membrane;kinase activity;transferase activity;phosphorylation;negative regulation of apoptotic process;nucleoplasm;cytosol;mitochondrion;cytoskeleton;cell division;protein binding;DNA repair;cell cycle;rhythmic process;apoptotic process;DNA replication;viral entry into host cell;centrosome;microtubule organizing center;spindle;midbody;endoplasmic reticulum membrane;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;extracellular exosome;cell migration;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;nuclear chromosome, telomeric region;viral process;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking;centrosome cycle;mitotic spindle;spindle microtubule;transcription initiation from RNA polymerase II promoter;epithelial cell differentiation;microtubule cytoskeleton organization;regulation of circadian rhythm;peptidyl-threonine phosphorylation;virus receptor activity;cyclin binding;activation of MAPK activity;peptidyl-serine phosphorylation;cyclin-dependent protein serine/threonine kinase activity;mitotic nuclear envelope disassembly;mitochondrial matrix;chromatin binding;RNA polymerase II CTD heptapeptide repeat kinase activity;Hsp70 protein binding;histone kinase activity;cyclin-dependent protein kinase activity;mitotic cell cycle;mitotic G2 DNA damage checkpoint;pronuclear fusion;cell aging;cell population proliferation;response to toxic substance;response to organonitrogen compound;positive regulation of gene expression;positive regulation of G2/M transition of mitotic cell cycle;regulation of Schwann cell differentiation;response to organic cyclic compound;response to amine;response to activity;histone phosphorylation;chromosome condensation;animal organ regeneration;protein localization to kinetochore;positive regulation of protein import into nucleus;response to drug;response to hydrogen peroxide;mitotic cell cycle phase transition;response to ethanol;positive regulation of DNA replication;positive regulation of mitotic cell cycle;regulation of embryonic development;response to cadmium ion;response to copper ion;response to axon injury;ventricular cardiac muscle cell development;positive regulation of cardiac muscle cell proliferation;protein-containing complex assembly;cellular response to hydrogen peroxide;Golgi disassembly;positive regulation of protein localization to nucleus;positive regulation of mitochondrial ATP synthesis coupled electron transport;cyclin-dependent protein kinase holoenzyme complex;cyclin B1-CDK1 complex	3D-structure;ATP-binding;Acetylation;Alternative splicing;Apoptosis;Biological rhythms;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Host cell receptor for virus entry;Host-virus interaction;Isopeptide bond;Kinase;Mitochondrion;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Receptor;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-1852241;R-HSA-5617833;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1640170;R-HSA-174143;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-453274;R-HSA-453276;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-69481;R-HSA-69620;R-HSA-8852276;R-HSA-8878166;R-HSA-2500257;R-HSA-380320;R-HSA-68877;R-HSA-2980766;R-HSA-3301854;R-HSA-68875;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518;R-HSA-5633007;R-HSA-6804757;R-HSA-6806003;R-HSA-453279;R-HSA-69206;R-HSA-174048;R-HSA-176412;R-HSA-69473;R-HSA-75035;R-HSA-6804114;R-HSA-69273;R-HSA-5689896;R-HSA-2465910;R-HSA-113507;R-HSA-113510;R-HSA-110056;R-HSA-112409;R-HSA-162658;R-HSA-2299718;R-HSA-69205;R-HSA-2514853;R-HSA-2980767;R-HSA-69478;R-HSA-4419969;R-HSA-1538133;R-HSA-1362300;R-HSA-170145;R-HSA-176417	Organelle biogenesis and maintenance;Cilium Assembly;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;M Phase;G2/M Transition;Cell Cycle, Mitotic;G2/M Checkpoints;Cell Cycle Checkpoints;The role of GTSE1 in G2/M progression after G2 checkpoint;Transcriptional regulation by RUNX2;Resolution of Sister Chromatid Cohesion;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Nuclear Envelope Breakdown;Nuclear Pore Complex (NPC) Disassembly;Mitotic Prophase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2;Regulation of TP53 Activity;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;Mitotic G1 phase and G1/S transition;G1/S Transition;APC/C:Cdc20 mediated degradation of Cyclin B;Phosphorylation of the APC/C;G2/M DNA damage checkpoint;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Cyclin A/B1/B2 associated events during G2/M transition;Ovarian tumor domain proteases;MASTL Facilitates Mitotic Progression;E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;MAPK3 (ERK1) activation;RAF-independent MAPK1/3 activation;Golgi Cisternae Pericentriolar Stack Reorganization;Condensation of Prophase Chromosomes;G1/S-Specific Transcription;Condensation of Prometaphase Chromosomes;Activation of NIMA Kinases NEK9, NEK6, NEK7;G2/M DNA replication checkpoint;Depolymerisation of the Nuclear Lamina;G0 and Early G1;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes;Phosphorylation of Emi1
PDSS1	positive	SPAG5	ENSG00000076382	PDSS1	1	PDSS1	1	0.00178954534005593					GO:0005737;GO:0051301;GO:0005694;GO:0005856;GO:0005515;GO:0007049;GO:0005874;GO:0008017;GO:0000922;GO:0005815;GO:0005819;GO:0030496;GO:0007059;GO:0000775;GO:0000776;GO:0000777;GO:0034451;GO:0051988;GO:0072686;GO:0097431;GO:0007051;GO:0000070;GO:0035371;GO:1905832;GO:0032388;GO:0090235;GO:0071539	cell division;regulation of attachment of spindle microtubules to kinetochore;cytoplasm;cytoskeleton;chromosome;protein binding;cell cycle;microtubule;microtubule binding;spindle pole;microtubule organizing center;spindle;midbody;chromosome segregation;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;centriolar satellite;mitotic spindle;mitotic spindle pole;spindle organization;mitotic sister chromatid segregation;microtubule plus-end;positive regulation of spindle assembly;positive regulation of intracellular transport;regulation of metaphase plate congression;protein localization to centrosome	Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;Kinetochore;Microtubule;Mitosis;Phosphoprotein;Reference proteome		
PDSS1	positive	TBRG4	ENSG00000136270	PDSS1	1	PDSS1	1	0.00178954534005593		WBGene00007207(0)			GO:0003723;GO:0004672;GO:0005739;GO:0006468;GO:0005759;GO:0005515;GO:0007050;GO:0008284;GO:0016071;GO:0044528;GO:0090615	protein kinase activity;RNA binding;mitochondrion;protein phosphorylation;mitochondrial matrix;protein binding;cell cycle arrest;positive regulation of cell population proliferation;mRNA metabolic process;regulation of mitochondrial mRNA stability;mitochondrial mRNA processing	Alternative splicing;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide		
PDSS1	positive	FANCI	ENSG00000140525	PDSS1	1	PDSS1	1	0.00178954534005593		WBGene00020935(0)		Fanconi anemia;FANCI-Related Fanconi Anemia;Fanconi anemia;Fanconi anemia complementation group I	GO:0005634;GO:0016020;GO:0005829;GO:0005654;GO:0003677;GO:0006281;GO:0005515;GO:0006974;GO:0007049;GO:0036297;GO:0070182;GO:0031398	DNA repair;nucleus;membrane;nucleoplasm;cytosol;DNA binding;protein binding;cellular response to DNA damage stimulus;cell cycle;interstrand cross-link repair;DNA polymerase binding;positive regulation of protein ubiquitination	Alternative splicing;Cell cycle;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Disease mutation;Fanconi anemia;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-6783310;R-HSA-73894;R-HSA-6796648	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Fanconi Anemia Pathway;DNA Repair;TP53 Regulates Transcription of DNA Repair Genes
PDSS1	positive	RFC4	ENSG00000163918	PDSS1	1	PDSS1	1	0.00178954534005593	WBGene00004340	WBGene00004340(1)			GO:0005524;GO:0005654;GO:0003677;GO:0006260;GO:0005634;GO:0000166;GO:0005515;GO:0032508;GO:0006261;GO:1901796;GO:0019985;GO:0006283;GO:0042276;GO:0017116;GO:0003689;GO:0042769;GO:0006296;GO:0033683;GO:0032201;GO:1900264;GO:0031390;GO:0006297;GO:0070987;GO:0006271;GO:0005663;GO:0031391;GO:0019899	DNA binding;ATP binding;DNA replication;nucleoplasm;nucleus;nucleotide binding;protein binding;DNA duplex unwinding;DNA-dependent DNA replication;DNA repair;regulation of signal transduction by p53 class mediator;translesion synthesis;transcription-coupled nucleotide-excision repair;error-prone translesion synthesis;single-stranded DNA helicase activity;DNA damage response, detection of DNA damage;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;telomere maintenance via semi-conservative replication;DNA clamp loader activity;positive regulation of DNA-directed DNA polymerase activity;Ctf18 RFC-like complex;nucleotide-excision repair, DNA gap filling;error-free translesion synthesis;DNA strand elongation involved in DNA replication;DNA replication factor C complex;Elg1 RFC-like complex;enzyme binding	ATP-binding;Acetylation;Alternative splicing;DNA replication;Direct protein sequencing;Nucleotide-binding;Nucleus;Polymorphism;Reference proteome	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-73886;R-HSA-5633007;R-HSA-6804756;R-HSA-176187;R-HSA-157579;R-HSA-180786;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-5685938;R-HSA-110312;R-HSA-5655862;R-HSA-5656121;R-HSA-69190;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174411;R-HSA-174417;R-HSA-69091;R-HSA-69109;R-HSA-69186;R-HSA-110320;R-HSA-5696397	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Chromosome Maintenance;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Activation of ATR in response to replication stress;Telomere Maintenance;Extension of Telomeres;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through Single Strand Annealing (SSA);Translesion synthesis by REV1;Translesion synthesis by POLK;Translesion synthesis by POLI;DNA strand elongation;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Polymerase switching;Leading Strand Synthesis;Lagging Strand Synthesis;Translesion Synthesis by POLH;Gap-filling DNA repair synthesis and ligation in GG-NER
PDSS1	positive	HMGB3	ENSG00000029993	PDSS1	1	PDSS1	1	0.00190449254609071	WBGene00001972;WBGene00001971	WBGene00001972(1)		Colobomatous microphthalmia microcephaly intellectual disability and short stature;Microphthalmia syndromic 13	GO:0005634;GO:0003677;GO:0003723;GO:0005737;GO:0005694;GO:0005515;GO:0006310;GO:0002376;GO:0045087;GO:0000400;GO:0008301;GO:0032392;GO:0000790;GO:0006357;GO:0045944;GO:0008134;GO:0003690;GO:0007275;GO:0045089;GO:0045578;GO:0045638	DNA binding;nucleus;RNA binding;cytoplasm;chromosome;protein binding;DNA recombination;immune system process;innate immune response;four-way junction DNA binding;DNA binding, bending;DNA geometric change;regulation of transcription, DNA-templated;chromatin remodeling;nuclear chromatin;regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;transcription factor binding;double-stranded DNA binding;multicellular organism development;positive regulation of innate immune response;negative regulation of B cell differentiation;negative regulation of myeloid cell differentiation	3D-structure;Acetylation;Chromosome;Cytoplasm;DNA-binding;Disulfide bond;Immunity;Innate immunity;Microphthalmia;Nucleus;Oxidation;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation		
PDSS1	positive	GINS1	ENSG00000101003	PDSS1	1	PDSS1	1	0.00190449254609071	WBGene00011275	WBGene00011275(1)		Combined immunodeficiency due to GINS1 deficiency;IMMUNODEFICIENCY 55	GO:0005634;GO:0005737;GO:0032508;GO:0006260;GO:0005654;GO:0043138;GO:0001833;GO:0006271;GO:1902983;GO:0000811	DNA replication;GINS complex;nucleus;cytoplasm;nucleoplasm;inner cell mass cell proliferation;DNA strand elongation involved in DNA replication;DNA strand elongation involved in mitotic DNA replication	3D-structure;DNA replication;Disease mutation;Nucleus;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-176974;R-HSA-69190	Cell Cycle;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Unwinding of DNA;DNA strand elongation
PDSS1	positive	FBXO5	ENSG00000112029	PDSS1	1	PDSS1	1	0.00190449254609071					GO:0005634;GO:0005737;GO:0046872;GO:0005654;GO:0016567;GO:0051301;GO:0005856;GO:0005515;GO:0007049;GO:0005819;GO:0005829;GO:0019901;GO:0031145;GO:1901990;GO:0007346;GO:0008284;GO:0010971;GO:0006275;GO:0000083;GO:0045669;GO:0010997;GO:0072687;GO:2000773;GO:1904667;GO:0070169;GO:0045835;GO:0051444;GO:1990948;GO:0001556;GO:0007057;GO:0016050;GO:0032876;GO:0040020;GO:0045841;GO:0046785;GO:0051225;GO:1905322;GO:2001021	protein binding;nucleus;cytoplasm;metal ion binding;nucleoplasm;protein ubiquitination;cytoskeleton;cell division;cell cycle;spindle;cytosol;protein kinase binding;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;regulation of mitotic cell cycle;positive regulation of cell population proliferation;positive regulation of G2/M transition of mitotic cell cycle;regulation of DNA replication;regulation of transcription involved in G1/S transition of mitotic cell cycle;positive regulation of osteoblast differentiation;anaphase-promoting complex binding;meiotic spindle;negative regulation of cellular senescence;negative regulation of ubiquitin protein ligase activity;positive regulation of biomineral tissue development;regulation of mitotic nuclear division;negative regulation of meiotic nuclear division;negative regulation of ubiquitin-protein transferase activity;ubiquitin ligase inhibitor activity;oocyte maturation;spindle assembly involved in female meiosis I;vesicle organization;negative regulation of DNA endoreduplication;regulation of meiotic nuclear division;negative regulation of mitotic metaphase/anaphase transition;microtubule polymerization;spindle assembly;positive regulation of mesenchymal stem cell migration;negative regulation of response to DNA damage stimulus	3D-structure;Alternative splicing;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Metal-binding;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1640170;R-HSA-174113;R-HSA-174143;R-HSA-176408;R-HSA-2555396;R-HSA-453276;R-HSA-68886;R-HSA-69278;R-HSA-453279;R-HSA-69206;R-HSA-69205;R-HSA-176417;R-HSA-68881	Cell Cycle;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;Regulation of APC/C activators between G1/S and early anaphase;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;M Phase;Cell Cycle, Mitotic;Mitotic G1 phase and G1/S transition;G1/S Transition;G1/S-Specific Transcription;Phosphorylation of Emi1;Mitotic Metaphase/Anaphase Transition
PDSS1	positive	TTK	ENSG00000112742	PDSS1	1	PDSS1	1	0.00190449254609071					GO:0005737;GO:0016020;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0004713;GO:0004712;GO:0005634;GO:0007093;GO:0005515;GO:0005819;GO:0051304;GO:0018105;GO:0007094;GO:0000776;GO:0007059;GO:0008284;GO:0010862;GO:0007051;GO:0007052;GO:0033316;GO:0034501;GO:0042803;GO:0043515;GO:0016321;GO:0018107;GO:0018108;GO:0034502;GO:0046777;GO:1903096	ATP binding;protein binding;protein phosphorylation;protein kinase activity;mitotic cell cycle checkpoint;protein serine/threonine/tyrosine kinase activity;chromosome separation;cytoplasm;membrane;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;protein tyrosine kinase activity;nucleus;spindle;peptidyl-serine phosphorylation;mitotic spindle assembly checkpoint;kinetochore;chromosome segregation;positive regulation of cell population proliferation;positive regulation of pathway-restricted SMAD protein phosphorylation;spindle organization;mitotic spindle organization;meiotic spindle assembly checkpoint;protein localization to kinetochore;kinetochore binding;female meiosis chromosome segregation;peptidyl-threonine phosphorylation;peptidyl-tyrosine phosphorylation;protein localization to chromosome;protein autophosphorylation;protein localization to meiotic spindle midzone	3D-structure;ATP-binding;Acetylation;Alternative splicing;Kinase;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Tyrosine-protein kinase		
PDSS1	positive	CCT5	ENSG00000150753	PDSS1	1	PDSS1	1	0.00190449254609071	WBGene00000380	WBGene00000380(0)		Mutilating hereditary sensory neuropathy with spastic paraplegia;NEUROPATHY HEREDITARY SENSORY WITH SPASTIC PARAPLEGIA AUTOSOMAL RECESSIVE	GO:0050821;GO:0005737;GO:0000166;GO:0005524;GO:0005730;GO:0005829;GO:0006457;GO:0005856;GO:0005515;GO:0005874;GO:0051082;GO:0005815;GO:0070062;GO:0009615;GO:0032212;GO:0048487;GO:0005813;GO:1904851;GO:1904871;GO:1904874;GO:0003730;GO:0048027;GO:0031681;GO:0005832;GO:0007339;GO:1901998;GO:0044297	ATP binding;protein folding;unfolded protein binding;protein stabilization;cytoplasm;nucleotide binding;cytoskeleton;protein binding;microtubule;microtubule organizing center;cytosol;extracellular exosome;response to virus;positive regulation of telomere maintenance via telomerase;beta-tubulin binding;centrosome;positive regulation of establishment of protein localization to telomere;positive regulation of protein localization to Cajal body;positive regulation of telomerase RNA localization to Cajal body;mRNA 3'-UTR binding;mRNA 5'-UTR binding;G-protein beta-subunit binding;chaperonin-containing T-complex;binding of sperm to zona pellucida;toxin transport;cell body	3D-structure;ATP-binding;Acetylation;Alternative splicing;Chaperone;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Isopeptide bond;Neuropathy;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-1852241;R-HSA-5617833;R-HSA-392499;R-HSA-389958;R-HSA-389960;R-HSA-390466;R-HSA-391251;R-HSA-5620920;R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-389957;R-HSA-390450	Organelle biogenesis and maintenance;Cilium Assembly;Metabolism of proteins;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Chaperonin-mediated protein folding;Protein folding;Cargo trafficking to the periciliary membrane;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;BBSome-mediated cargo-targeting to cilium;Association of TriC/CCT with target proteins during biosynthesis;Prefoldin mediated transfer of substrate  to CCT/TriC;Folding of actin by CCT/TriC
PDSS1	positive	MRPL17	ENSG00000158042	PDSS1	1	PDSS1	1	0.00190449254609071	WBGene00021829	WBGene00021829(1)			GO:0005739;GO:0003735;GO:0006412;GO:0005840;GO:0005762;GO:0019904;GO:0005743;GO:0070125;GO:0070126;GO:0005622	structural constituent of ribosome;translation;ribosome;mitochondrion;mitochondrial large ribosomal subunit;protein domain specific binding;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;large ribosomal subunit	3D-structure;Mitochondrion;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
PDSS1	positive	AIMP2	ENSG00000106305	PDSS1	1	PDSS1	1	0.00202610997446995				LEUKODYSTROPHY HYPOMYELINATING 17	GO:0005634;GO:0005737;GO:0016020;GO:0006412;GO:0005829;GO:0060090;GO:0008285;GO:0031398;GO:0060510;GO:0065003;GO:1901216;GO:1903632;GO:0017101;GO:0005515;GO:0006915;GO:0007275;GO:0030154;GO:0006418	aminoacyl-tRNA synthetase multienzyme complex;nucleus;cytoplasm;membrane;translation;cytosol;molecular adaptor activity;negative regulation of cell population proliferation;positive regulation of protein ubiquitination;type II pneumocyte differentiation;protein-containing complex assembly;positive regulation of neuron death;positive regulation of aminoacyl-tRNA ligase activity;protein binding;apoptotic process;multicellular organism development;cell differentiation;tRNA aminoacylation for protein translation	3D-structure;Alternative splicing;Apoptosis;Cytoplasm;Developmental protein;Differentiation;Direct protein sequencing;Disease mutation;Leukodystrophy;Nucleus;Phosphoprotein;Polymorphism;Protein biosynthesis;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-1430728;R-HSA-71291;R-HSA-72766;R-HSA-2408522;R-HSA-379716;R-HSA-379724	Metabolism of proteins;Metabolism;Metabolism of amino acids and derivatives;Translation;Selenoamino acid metabolism;Cytosolic tRNA aminoacylation;tRNA Aminoacylation
PDSS1	positive	CCT7	ENSG00000135624	PDSS1	1	PDSS1	1	0.00202610997446995	WBGene00020391	WBGene00020391(0)			GO:0050821;GO:0005737;GO:0000166;GO:0005524;GO:0006457;GO:0005515;GO:0005874;GO:0051082;GO:0005829;GO:0070062;GO:0032212;GO:1904851;GO:1904871;GO:1904874;GO:0005832;GO:0042802;GO:0007339;GO:1901998;GO:0044297;GO:0042026	ATP binding;protein folding;unfolded protein binding;protein stabilization;cytoplasm;nucleotide binding;protein binding;microtubule;cytosol;extracellular exosome;positive regulation of telomere maintenance via telomerase;positive regulation of establishment of protein localization to telomere;positive regulation of protein localization to Cajal body;positive regulation of telomerase RNA localization to Cajal body;chaperonin-containing T-complex;identical protein binding;binding of sperm to zona pellucida;toxin transport;cell body;protein refolding	3D-structure;ATP-binding;Acetylation;Alternative splicing;Chaperone;Cytoplasm;Direct protein sequencing;Isopeptide bond;Methylation;Nucleotide-binding;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-389958;R-HSA-389960;R-HSA-390466;R-HSA-391251;R-HSA-6814122;R-HSA-390471;R-HSA-389957;R-HSA-390450	Metabolism of proteins;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Chaperonin-mediated protein folding;Protein folding;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;Association of TriC/CCT with target proteins during biosynthesis;Prefoldin mediated transfer of substrate  to CCT/TriC;Folding of actin by CCT/TriC
PDSS1	positive	KIF15	ENSG00000163808	PDSS1	1	PDSS1	1	0.00202610997446995	WBGene00002228	WBGene00002228(0)		21q22.11q22.12 microdeletion syndrome	GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0003777;GO:0005856;GO:0005515;GO:0008017;GO:0005874;GO:0007018;GO:0005819;GO:0016887;GO:0005829;GO:0006890;GO:0003774;GO:0019886;GO:0005871;GO:0000278;GO:0005873;GO:0005813	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;cytoplasm;membrane;nucleotide binding;cytoskeleton;protein binding;microtubule;spindle;ATPase activity;cytosol;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;motor activity;antigen processing and presentation of exogenous peptide antigen via MHC class II;kinesin complex;mitotic cell cycle;plus-end kinesin complex;centrosome	3D-structure;ATP-binding;Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Microtubule;Motor protein;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-2132295;R-HSA-983189;R-HSA-983231	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;MHC class II antigen presentation;Kinesins;Factors involved in megakaryocyte development and platelet production
PDSS1	positive	MCMBP	ENSG00000197771	PDSS1	1	PDSS1	1	0.00202610997446995					GO:0005634;GO:0005829;GO:0005654;GO:0005886;GO:0051301;GO:0005515;GO:0007049;GO:0006260;GO:0006261;GO:0000790;GO:0003682;GO:0007062;GO:0042555	nucleus;nucleoplasm;cytosol;cell division;cell junction;protein binding;cell cycle;DNA replication;DNA-dependent DNA replication;nuclear chromatin;chromatin binding;sister chromatid cohesion;MCM complex	3D-structure;Alternative splicing;Cell cycle;Cell division;DNA replication;Mitosis;Nucleus;Phosphoprotein;Reference proteome		
PDSS1	positive	TRIP13	ENSG00000071539	PDSS1	1	PDSS1	1	0.00215473579756165	WBGene00008641			Mosaic variegated aneuploidy syndrome;Nephroblastoma;Mosaic Variegated Aneuploidy and Wilms Tumour;Mosaic variegated aneuploidy syndrome 3	GO:0000166;GO:0005524;GO:0005515;GO:0006302;GO:0051321;GO:0030154;GO:0007283;GO:1903506;GO:0042802;GO:0007130;GO:0007131;GO:0048477;GO:0005634;GO:0006366;GO:0003712;GO:0007094;GO:0005694;GO:0001556;GO:0007141;GO:0007144;GO:0007286;GO:0051598;GO:0001673	ATP binding;nucleotide binding;protein binding;double-strand break repair;meiotic cell cycle;cell differentiation;spermatogenesis;regulation of nucleic acid-templated transcription;nucleus;identical protein binding;synaptonemal complex assembly;reciprocal meiotic recombination;oogenesis;transcription by RNA polymerase II;transcription coregulator activity;mitotic spindle assembly checkpoint;chromosome;oocyte maturation;male meiosis I;female meiosis I;spermatid development;meiotic recombination checkpoint;male germ cell nucleus	3D-structure;ATP-binding;Acetylation;Alternative splicing;Differentiation;Disease mutation;Meiosis;Nucleotide-binding;Oogenesis;Reference proteome;Spermatogenesis		
PDSS1	positive	C1QBP	ENSG00000108561	PDSS1	1	PDSS1	1	0.00215473579756165	WBGene00010303	WBGene00010303(0)		Severe Neonatal- Childhood- or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33	GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0016020;GO:0005739;GO:0005759;GO:0005886;GO:0005829;GO:0005515;GO:0005576;GO:0006915;GO:0009986;GO:0002376;GO:0045087;GO:0042254;GO:0005730;GO:0002250;GO:0003729;GO:0000122;GO:0008134;GO:0003714;GO:0043065;GO:0016032;GO:0008494;GO:0070131;GO:0006955;GO:0032689;GO:2000510;GO:0006958;GO:0045785;GO:0014065;GO:0048025;GO:0042256;GO:0005540;GO:0051897;GO:0039534;GO:0050687;GO:1900026;GO:0007597;GO:0001849;GO:1901165;GO:0090023;GO:0005080;GO:0030984;GO:0031690;GO:0097177;GO:0030449;GO:0032695;GO:0039536;GO:0005615;GO:0048786;GO:0098793;GO:0098978;GO:0098982	mitochondrial matrix;mRNA processing;RNA splicing;nucleus;cytoplasm;membrane;plasma membrane;mitochondrion;cytosol;protein binding;extracellular region;apoptotic process;mRNA binding;cell surface;immune system process;innate immune response;ribosome biogenesis;nucleolus;adaptive immune response;negative regulation of transcription by RNA polymerase II;transcription factor binding;transcription corepressor activity;positive regulation of apoptotic process;viral process;translation activator activity;positive regulation of mitochondrial translation;immune response;negative regulation of interferon-gamma production;positive regulation of dendritic cell chemotaxis;complement activation, classical pathway;positive regulation of cell adhesion;phosphatidylinositol 3-kinase signaling;negative regulation of mRNA splicing, via spliceosome;mature ribosome assembly;hyaluronic acid binding;positive regulation of protein kinase B signaling;negative regulation of MDA-5 signaling pathway;negative regulation of defense response to virus;positive regulation of substrate adhesion-dependent cell spreading;blood coagulation, intrinsic pathway;complement component C1q complex binding;positive regulation of trophoblast cell migration;regulation of complement activation;positive regulation of neutrophil chemotaxis;protein kinase C binding;kininogen binding;adrenergic receptor binding;mitochondrial ribosome binding;negative regulation of interleukin-12 production;negative regulation of RIG-I signaling pathway;extracellular space;presynaptic active zone;presynapse;glutamatergic synapse;GABA-ergic synapse	3D-structure;Acetylation;Adaptive immunity;Apoptosis;Cell membrane;Complement pathway;Cytoplasm;Direct protein sequencing;Disease mutation;Host-virus interaction;Immunity;Innate immunity;Membrane;Mitochondrion;Nucleus;Phosphoprotein;Primary mitochondrial disease;Reference proteome;Ribosome biogenesis;Secreted;Transcription;Transcription regulation;Transit peptide;mRNA processing;mRNA splicing	R-HSA-109582;R-HSA-140837;R-HSA-140877	Hemostasis;Intrinsic Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade)
PDSS1	positive	NCAPG	ENSG00000109805	PDSS1	1	PDSS1	1	0.00215473579756165					GO:0005634;GO:0005737;GO:0016020;GO:0051301;GO:0005694;GO:0005515;GO:0007049;GO:0005829;GO:0007076;GO:0000796;GO:0030261;GO:0000793;GO:0000779	mitotic chromosome condensation;condensin complex;nucleus;cytoplasm;membrane;cell division;chromosome;protein binding;cell cycle;cytosol;chromosome condensation;condensed chromosome;condensed chromosome, centromeric region	3D-structure;Cell cycle;Cell division;Chromosome;Cytoplasm;DNA condensation;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat	R-HSA-1640170;R-HSA-68886;R-HSA-69278;R-HSA-68877;R-HSA-2514853	Cell Cycle;M Phase;Cell Cycle, Mitotic;Mitotic Prometaphase;Condensation of Prometaphase Chromosomes
PDSS1	positive	POLR3K	ENSG00000161980	PDSS1	1	PDSS1	1	0.00215473579756165	WBGene00022309	WBGene00022309(1)			GO:0003676;GO:0005634;GO:0008270;GO:0046872;GO:0006351;GO:0002376;GO:0045087;GO:0005730;GO:0003899;GO:0051607;GO:0005666;GO:0005654;GO:0005829;GO:0042779;GO:0001056;GO:0032481;GO:0006383;GO:0006386	zinc ion binding;transcription, DNA-templated;nucleic acid binding;tRNA 3'-trailer cleavage;nucleus;metal ion binding;immune system process;innate immune response;nucleolus;DNA-directed 5'-3' RNA polymerase activity;defense response to virus;RNA polymerase III complex;nucleoplasm;cytosol;positive regulation of type I interferon production;transcription by RNA polymerase III;termination of RNA polymerase III transcription	Antiviral defense;DNA-directed RNA polymerase;Immunity;Innate immunity;Metal-binding;Nucleus;Polymorphism;Reference proteome;Transcription;Zinc;Zinc-finger	R-HSA-168249;R-HSA-168256;R-HSA-74160;R-HSA-74158;R-HSA-749476;R-HSA-76046;R-HSA-76061;R-HSA-76066;R-HSA-76071;R-HSA-73980;R-HSA-1834949;R-HSA-73780	Innate Immune System;Immune System;Gene expression (Transcription);RNA Polymerase III Transcription;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase III Transcription Termination;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation
PDSS1	positive	NUP155	ENSG00000113569	PDSS1	1	PDSS1	1	0.00229072219618676	WBGene00003794	WBGene00003794(0)		Familial atrial fibrillation;Atrial fibrillation familial 15	GO:0051028;GO:0005634;GO:0016020;GO:0015031;GO:0017056;GO:0005643;GO:0031965;GO:0006406;GO:0006606;GO:0006913;GO:0086014;GO:0005515;GO:0075733;GO:0043657;GO:0006110;GO:0006409;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0044611;GO:0000972;GO:0006998;GO:0036228	nucleocytoplasmic transport;structural constituent of nuclear pore;nuclear pore;mRNA transport;nucleus;membrane;protein transport;nuclear membrane;mRNA export from nucleus;protein import into nucleus;atrial cardiac muscle cell action potential;protein binding;intracellular transport of virus;host cell;regulation of glycolytic process;RNA export from nucleus;tRNA export from nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;nuclear pore inner ring;transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery;nuclear envelope organization;protein localization to nuclear inner membrane	3D-structure;Alternative splicing;Atrial fibrillation;Disease mutation;Disulfide bond;Glycoprotein;Isopeptide bond;Membrane;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Translocation;Transport;Ubl conjugation;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-5619115;R-HSA-68886;R-HSA-69278;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Disorders of transmembrane transporters;M Phase;Cell Cycle, Mitotic;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling
PDSS1	positive	AUNIP	ENSG00000127423	PDSS1	1	PDSS1	1	0.00229072219618676					GO:0005634;GO:0005737;GO:0005813;GO:0003677;GO:0005694;GO:0005856;GO:0006281;GO:0006974;GO:0000922;GO:0005815;GO:0005515;GO:0000724;GO:0007051;GO:0003684;GO:0090734;GO:2001033	nucleus;cytoplasm;DNA binding;cytoskeleton;chromosome;centrosome;DNA repair;cellular response to DNA damage stimulus;spindle pole;microtubule organizing center;protein binding;double-strand break repair via homologous recombination;spindle organization;damaged DNA binding;site of DNA damage;negative regulation of double-strand break repair via nonhomologous end joining	Alternative splicing;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	positive	GINS2	ENSG00000131153	PDSS1	1	PDSS1	1	0.00229072219618676	WBGene00009287	WBGene00009287(1)			GO:0005634;GO:0006260;GO:0005515;GO:0032508;GO:0005654;GO:0000727;GO:0043138;GO:0031298;GO:0006271;GO:0000811	nucleus;DNA replication;protein binding;DNA duplex unwinding;nucleoplasm;double-strand break repair via break-induced replication;replication fork protection complex;3'-5' DNA helicase activity;DNA strand elongation involved in DNA replication;GINS complex	3D-structure;Acetylation;DNA replication;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-1640170;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-176974;R-HSA-69190	Cell Cycle;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Unwinding of DNA;DNA strand elongation
PDSS1	positive	KIF23	ENSG00000137807	PDSS1	1	PDSS1	1	0.00229072219618676	WBGene00006974	WBGene00006974(1)		Congenital dyserythropoietic anemia type III	GO:0005634;GO:0005737;GO:0000166;GO:0005524;GO:0005654;GO:0051301;GO:0003777;GO:0005856;GO:0005515;GO:0007049;GO:0008017;GO:0005874;GO:0007018;GO:0005925;GO:0005819;GO:0030496;GO:0016887;GO:0072383;GO:0000915;GO:0005829;GO:0006890;GO:0072686;GO:0090543;GO:0019886;GO:0005871;GO:0000281;GO:0032467;GO:0005813;GO:0000022;GO:0051256;GO:0045171;GO:0097149;GO:0003774	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;plus-end-directed vesicle transport along microtubule;actomyosin contractile ring assembly;cell;nucleus;cytoplasm;nucleotide binding;nucleoplasm;cytoskeleton;focal adhesion;cell division;protein binding;cell cycle;mitotic spindle;microtubule;Flemming body;spindle;midbody;ATPase activity;cytosol;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;antigen processing and presentation of exogenous peptide antigen via MHC class II;kinesin complex;mitotic cytokinesis;positive regulation of cytokinesis;centrosome;mitotic spindle elongation;mitotic spindle midzone assembly;intercellular bridge;centralspindlin complex;motor activity	3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Coiled coil;Cytoplasm;Cytoskeleton;Isopeptide bond;Microtubule;Mitosis;Motor protein;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-1640170;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-68886;R-HSA-69278;R-HSA-2132295;R-HSA-983189;R-HSA-983231;R-HSA-68884	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Cell Cycle;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;M Phase;Cell Cycle, Mitotic;MHC class II antigen presentation;Kinesins;Factors involved in megakaryocyte development and platelet production;Mitotic Telophase/Cytokinesis
PDSS1	positive	SNRPD1	ENSG00000167088	PDSS1	1	PDSS1	1	0.00229072219618676	WBGene00004916	WBGene00004916(0)			GO:0003723;GO:0006396;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0005829;GO:0005515;GO:0005681;GO:0000387;GO:0000398;GO:0071013;GO:0005685;GO:0005654;GO:0046540;GO:0005686;GO:0005687;GO:0005682;GO:0034709;GO:0000245;GO:0051170;GO:0034719;GO:0071005;GO:0071007;GO:0005689;GO:0030532;GO:0000243;GO:0034715;GO:1990446	RNA processing;spliceosomal snRNP assembly;RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;cytosol;protein binding;spliceosomal complex;mRNA splicing, via spliceosome;catalytic step 2 spliceosome;U1 snRNP;nucleoplasm;U4/U6 x U5 tri-snRNP complex;U2 snRNP;U4 snRNP;U5 snRNP;methylosome;spliceosomal complex assembly;import into nucleus;SMN-Sm protein complex;U2-type precatalytic spliceosome;U2-type catalytic step 2 spliceosome;U12-type spliceosomal complex;precatalytic spliceosome;small nuclear ribonucleoprotein complex;commitment complex;pICln-Sm protein complex;spliceosomal tri-snRNP complex;U1 snRNP binding	3D-structure;Cytoplasm;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Reference proteome;Repeat;Ribonucleoprotein;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-191859;R-HSA-194441;R-HSA-72203;R-HSA-72163;R-HSA-72172;R-HSA-72165	Metabolism of RNA;snRNP Assembly;Metabolism of non-coding RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA Splicing - Minor Pathway
PDSS1	positive	EXO1	ENSG00000174371	PDSS1	1	PDSS1	1	0.00229072219618676	WBGene00009731	WBGene00009731(0)			GO:0005634;GO:0046872;GO:0005654;GO:0016787;GO:0003677;GO:0003824;GO:0005886;GO:0006281;GO:0090305;GO:0005515;GO:0006310;GO:0006974;GO:0016604;GO:0016788;GO:0004518;GO:0004519;GO:0090502;GO:0004527;GO:0051321;GO:0002376;GO:0006298;GO:0035312;GO:1901796;GO:0006260;GO:0090656;GO:0008409;GO:0017108;GO:0048256;GO:0045145;GO:0003682;GO:0004523;GO:0051908;GO:0002455;GO:0016446;GO:0045190	DNA binding;catalytic activity;DNA repair;hydrolase activity, acting on ester bonds;nuclease activity;5'-3' exodeoxyribonuclease activity;nucleus;metal ion binding;nucleoplasm;plasma membrane;hydrolase activity;nucleic acid phosphodiester bond hydrolysis;protein binding;DNA recombination;cellular response to DNA damage stimulus;nuclear body;exonuclease activity;endonuclease activity;meiotic cell cycle;RNA phosphodiester bond hydrolysis, endonucleolytic;immune system process;mismatch repair;regulation of signal transduction by p53 class mediator;DNA replication;t-circle formation;5'-3' exonuclease activity;5'-flap endonuclease activity;flap endonuclease activity;single-stranded DNA 5'-3' exodeoxyribonuclease activity;chromatin binding;RNA-DNA hybrid ribonuclease activity;double-stranded DNA 5'-3' exodeoxyribonuclease activity;humoral immune response mediated by circulating immunoglobulin;somatic hypermutation of immunoglobulin genes;isotype switching	3D-structure;Acetylation;Alternative splicing;DNA damage;DNA excision;DNA repair;DNA-binding;Direct protein sequencing;Endonuclease;Excision nuclease;Exonuclease;Hydrolase;Immunity;Magnesium;Meiosis;Metal-binding;Nuclease;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-69481;R-HSA-69620;R-HSA-5633007;R-HSA-6804756;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5693554;R-HSA-5685938;R-HSA-5358508;R-HSA-5358565;R-HSA-5358606	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;G2/M Checkpoints;Cell Cycle Checkpoints;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);HDR through Single Strand Annealing (SSA);Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
PDSS1	positive	KIFC1	ENSG00000237649	PDSS1	1	PDSS1	1	0.00229072219618676	WBGene00002227;WBGene00002216;WBGene00002225;WBGene00002226				GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0003774;GO:0051301;GO:0003777;GO:0005856;GO:0007049;GO:0008017;GO:0005874;GO:0007018;GO:0007283;GO:0005815;GO:0005819;GO:0005768;GO:0005769;GO:0016887;GO:0072686;GO:0090307;GO:0005871;GO:0007080;GO:0000070;GO:0008569	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;cell;nucleus;cytoplasm;membrane;nucleotide binding;endosome;motor activity;cytoskeleton;cell division;cell cycle;microtubule;spermatogenesis;microtubule organizing center;spindle;early endosome;ATPase activity;mitotic spindle;mitotic spindle assembly;kinesin complex;mitotic metaphase plate congression;mitotic sister chromatid segregation;ATP-dependent microtubule motor activity, minus-end-directed	3D-structure;ATP-binding;Cell cycle;Cell division;Coiled coil;Cytoplasm;Cytoskeleton;Endosome;Microtubule;Mitosis;Motor protein;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-109582;R-HSA-5653656;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-983189;R-HSA-983231	Hemostasis;Vesicle-mediated transport;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
PDSS1	positive	SRPK1	ENSG00000096063	PDSS1	1	PDSS1	1	0.00243443575113622	WBGene00004980	WBGene00002187(0);WBGene00002188(0);WBGene00008200(0);WBGene00013091(0);WBGene00007977(0);WBGene00013705(0);WBGene00004055(0);WBGene00004056(0)			GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005829;GO:0005783;GO:0043231;GO:0005886;GO:0005515;GO:0000287;GO:0030154;GO:0007059;GO:0035556;GO:0010468;GO:0016032;GO:0045087;GO:0016363;GO:0045070;GO:0048024;GO:0000245;GO:0045071;GO:0050684;GO:0035092	ATP binding;protein phosphorylation;protein kinase activity;RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;nuclear speck;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleoplasm;cytosol;plasma membrane;endoplasmic reticulum;intracellular membrane-bounded organelle;protein binding;magnesium ion binding;cell differentiation;chromosome segregation;intracellular signal transduction;regulation of gene expression;viral process;innate immune response;chromatin;nuclear matrix;positive regulation of viral genome replication;regulation of mRNA splicing, via spliceosome;spliceosomal complex assembly;negative regulation of viral genome replication;regulation of mRNA processing;sperm chromatin condensation	3D-structure;ATP-binding;Alternative splicing;Chromosome partition;Cytoplasm;Differentiation;Direct protein sequencing;Endoplasmic reticulum;Host-virus interaction;Kinase;Microsome;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;mRNA processing;mRNA splicing		
PDSS1	positive	MCM3	ENSG00000112118	PDSS1	1	PDSS1	1	0.00243443575113622	WBGene00003155	WBGene00003155(0)			GO:0048471;GO:0005634;GO:0016020;GO:0005813;GO:0000166;GO:0005524;GO:0005654;GO:0016787;GO:0003677;GO:0005515;GO:0032508;GO:0006270;GO:0007049;GO:0006260;GO:0003678;GO:0004386;GO:0042555;GO:0000784;GO:0003697;GO:0000082;GO:0000727;GO:0003688;GO:1902975;GO:0006267;GO:0006271;GO:0005658;GO:0005737	DNA binding;ATP binding;DNA replication;DNA replication initiation;MCM complex;perinuclear region of cytoplasm;nucleus;membrane;nucleotide binding;nucleoplasm;hydrolase activity;centrosome;protein binding;DNA duplex unwinding;cell cycle;DNA helicase activity;helicase activity;nuclear chromosome, telomeric region;G1/S transition of mitotic cell cycle;double-strand break repair via break-induced replication;single-stranded DNA binding;DNA replication origin binding;mitotic DNA replication initiation;pre-replicative complex assembly involved in nuclear cell cycle DNA replication;DNA strand elongation involved in DNA replication;alpha DNA polymerase:primase complex;cytoplasm	ATP-binding;Acetylation;Alternative splicing;Cell cycle;DNA replication;DNA-binding;Direct protein sequencing;Glycoprotein;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-68867;R-HSA-68949;R-HSA-69002;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-453279;R-HSA-69206;R-HSA-176187;R-HSA-68962;R-HSA-176974;R-HSA-69190	Cell Cycle;Assembly of the pre-replicative complex;Orc1 removal from chromatin;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;Unwinding of DNA;DNA strand elongation
PDSS1	positive	DDX39A	ENSG00000123136	PDSS1	1	PDSS1	1	0.00243443575113622	WBGene00001840	WBGene00001840(1)			GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0016607;GO:0016020;GO:0000166;GO:0005524;GO:0016787;GO:0005515;GO:0004386;GO:0006406;GO:0000398;GO:0003724;GO:0042802;GO:0005654;GO:0016887;GO:0006405;GO:0031124;GO:0000346	nucleic acid binding;RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;nuclear speck;membrane;nucleotide binding;ATP binding;hydrolase activity;protein binding;helicase activity;mRNA export from nucleus;mRNA splicing, via spliceosome;RNA helicase activity;identical protein binding;nucleoplasm;ATPase activity;RNA export from nucleus;mRNA 3'-end processing;transcription export complex	ATP-binding;Acetylation;Alternative splicing;Cytoplasm;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Ubl conjugation;mRNA processing;mRNA splicing	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-159236;R-HSA-72202;R-HSA-72203;R-HSA-72187;R-HSA-73856	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination
PDSS1	positive	CSE1L	ENSG00000124207	PDSS1	1	PDSS1	1	0.00243443575113622	WBGene00002079	WBGene00002079(0)			GO:0005634;GO:0005737;GO:0016020;GO:0006886;GO:0015031;GO:0005829;GO:0005654;GO:0005515;GO:0008536;GO:0070062;GO:0005635;GO:0006606;GO:0005049;GO:0006611	protein binding;intracellular protein transport;Ran GTPase binding;nucleus;cytoplasm;membrane;protein transport;nucleoplasm;cytosol;extracellular exosome;nuclear envelope;protein import into nucleus;nuclear export signal receptor activity;protein export from nucleus	Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport		
PDSS1	positive	DLGAP5	ENSG00000126787	PDSS1	1	PDSS1	1	0.00243443575113622	WBGene00020970				GO:0005634;GO:0005737;GO:0005829;GO:0005739;GO:0004721;GO:0005856;GO:0005515;GO:0007049;GO:0005815;GO:0006470;GO:0005819;GO:0023052;GO:0008283;GO:0031616;GO:0007221;GO:0007079;GO:0045842	signaling;cell;nucleus;cytoplasm;cytosol;mitochondrion;cytoskeleton;protein binding;cell cycle;centriolar satellite;spindle;spindle pole centrosome;positive regulation of transcription of Notch receptor target;mitotic chromosome movement towards spindle pole;positive regulation of mitotic metaphase/anaphase transition	Alternative splicing;Cell cycle;Coiled coil;Cytoplasm;Cytoskeleton;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-162582;R-HSA-157118;R-HSA-9012852;R-HSA-9013508	Signal Transduction;Signaling by NOTCH;Signaling by NOTCH3;NOTCH3 Intracellular Domain Regulates Transcription
PDSS1	positive	MIS18A	ENSG00000159055	PDSS1	1	PDSS1	1	0.00243443575113622					GO:0005634;GO:0046872;GO:0005829;GO:0051301;GO:0005694;GO:0005515;GO:0007049;GO:0000775;GO:0005654;GO:0034080;GO:0000785;GO:0007059;GO:0044030	nucleus;metal ion binding;nucleoplasm;cytosol;cell division;chromosome;protein binding;cell cycle;chromosome, centromeric region;CENP-A containing nucleosome assembly;chromatin;chromosome segregation;regulation of DNA methylation	Cell cycle;Cell division;Centromere;Chromosome;Isopeptide bond;Metal-binding;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Zinc	R-HSA-1640170;R-HSA-606279;R-HSA-73886;R-HSA-774815	Cell Cycle;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly
PDSS1	positive	CENPS	ENSG00000175279	PDSS1	1	PDSS1	1	0.00243443575113622					GO:0005634;GO:0003677;GO:0051301;GO:0046982;GO:0005694;GO:0006281;GO:0005515;GO:0006974;GO:0007049;GO:0043240;GO:0000776;GO:0051382;GO:0071821;GO:0000775;GO:0000777;GO:0005654;GO:0005829;GO:0000712;GO:0031297;GO:0003682;GO:0003690;GO:0031398;GO:0034080;GO:0036297	DNA repair;kinetochore;kinetochore assembly;protein heterodimerization activity;FANCM-MHF complex;nucleus;DNA binding;cell division;chromosome;protein binding;cellular response to DNA damage stimulus;cell cycle;Fanconi anaemia nuclear complex;chromosome, centromeric region;condensed chromosome kinetochore;nucleoplasm;cytosol;resolution of meiotic recombination intermediates;replication fork processing;chromatin binding;double-stranded DNA binding;positive regulation of protein ubiquitination;CENP-A containing nucleosome assembly;interstrand cross-link repair	3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;DNA damage;DNA repair;DNA-binding;Kinetochore;Mitosis;Nucleus;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-6783310;R-HSA-73894;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-606279;R-HSA-73886;R-HSA-774815;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Fanconi Anemia Pathway;DNA Repair;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	POLD3	ENSG00000077514	PDSS1	1	PDSS1	1	0.00258625783458721	WBGene00011016				GO:0005634;GO:0006260;GO:0003887;GO:0071897;GO:0043625;GO:0005737;GO:0005515;GO:0006281;GO:0006974;GO:0006298;GO:0005654;GO:0019985;GO:0006283;GO:0016035;GO:0042769;GO:0006296;GO:0033683;GO:0000731;GO:0032201;GO:0006297;GO:0000723;GO:0006271;GO:1904161	nucleus;DNA replication;DNA-directed DNA polymerase activity;delta DNA polymerase complex;DNA biosynthetic process;cytoplasm;nucleoplasm;protein binding;DNA repair;cellular response to DNA damage stimulus;mismatch repair;protein binding, bridging;translesion synthesis;transcription-coupled nucleotide-excision repair;zeta DNA polymerase complex;DNA damage response, detection of DNA damage;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;DNA synthesis involved in DNA repair;telomere maintenance via semi-conservative replication;nucleotide-excision repair, DNA gap filling;telomere maintenance;DNA strand elongation involved in DNA replication;DNA synthesis involved in UV-damage excision repair	3D-structure;Acetylation;Alternative splicing;Cytoplasm;DNA damage;DNA excision;DNA repair;DNA replication;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-73886;R-HSA-157579;R-HSA-180786;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-69190;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174411;R-HSA-174417;R-HSA-69091;R-HSA-69109;R-HSA-69166;R-HSA-69183;R-HSA-69186;R-HSA-5696397;R-HSA-174414;R-HSA-174437;R-HSA-5358508;R-HSA-5358565;R-HSA-5358606	Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Chromosome Maintenance;Telomere Maintenance;Extension of Telomeres;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);DNA strand elongation;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;Gap-filling DNA repair synthesis and ligation in GG-NER;Processive synthesis on the C-strand of the telomere;Removal of the Flap Intermediate from the C-strand;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
PDSS1	positive	UTP20	ENSG00000120800	PDSS1	1	PDSS1	1	0.00258625783458721	WBGene00007050	WBGene00007050(0)			GO:0003723;GO:0005634;GO:0005737;GO:0005730;GO:0005886;GO:0005515;GO:0005654;GO:0006364;GO:0032040;GO:0008285;GO:0030688;GO:0000447;GO:0000472;GO:0000480;GO:0030686	RNA binding;nucleus;cytoplasm;nucleolus;plasma membrane;protein binding;nucleoplasm;rRNA processing;small-subunit processome;negative regulation of cell population proliferation;preribosome, small subunit precursor;endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA);endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);90S preribosome	Coiled coil;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;rRNA processing	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
PDSS1	positive	HAT1	ENSG00000128708	PDSS1	1	PDSS1	1	0.00258625783458721	WBGene00044069	WBGene00044069(1)			GO:0006325;GO:0005634;GO:0005737;GO:0043231;GO:0016740;GO:0005654;GO:0016746;GO:0000790;GO:0005515;GO:0042393;GO:0004402;GO:0016573;GO:0032991;GO:0000784;GO:0043967;GO:0016363;GO:0010485;GO:0006323;GO:0006335;GO:0006336;GO:0006348;GO:0006475;GO:0007584	chromatin organization;nucleus;histone acetyltransferase activity;histone acetylation;histone binding;chromatin silencing at telomere;cytoplasm;transferase activity;nucleoplasm;transferase activity, transferring acyl groups;nuclear chromatin;protein binding;protein-containing complex;nuclear chromosome, telomeric region;histone H4 acetylation;nuclear matrix;H4 histone acetyltransferase activity;DNA packaging;DNA replication-dependent nucleosome assembly;DNA replication-independent nucleosome assembly;internal protein amino acid acetylation;response to nutrient	3D-structure;Acetylation;Acyltransferase;Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transferase	R-HSA-3247509;R-HSA-4839726;R-HSA-3214847	Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones
PDSS1	positive	CENPN	ENSG00000166451	PDSS1	1	PDSS1	1	0.00258625783458721					GO:0005634;GO:0005694;GO:0007059;GO:0051382;GO:0000775;GO:0000776;GO:0000777;GO:0005654;GO:0005829;GO:0034080	chromosome segregation;kinetochore assembly;nucleus;nucleoplasm;chromosome;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cytosol;CENP-A containing nucleosome assembly	3D-structure;Alternative splicing;Centromere;Chromosome;Kinetochore;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-606279;R-HSA-73886;R-HSA-774815;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	PBK	ENSG00000168078	PDSS1	1	PDSS1	1	0.00258625783458721	WBGene00017098;WBGene00022634				GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005515;GO:0000278;GO:0005634;GO:0001933;GO:0032435;GO:0032873;GO:0034644;GO:0050728	ATP binding;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;mitotic cell cycle;nucleotide binding;kinase activity;transferase activity;phosphorylation;MAPK cascade;protein binding;activation of MAPK activity;nucleus;MAP kinase kinase activity;negative regulation of protein phosphorylation;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of stress-activated MAPK cascade;cellular response to UV;negative regulation of inflammatory response	3D-structure;ATP-binding;Acetylation;Alternative splicing;Isopeptide bond;Kinase;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation		
PDSS1	positive	MRPL13	ENSG00000172172	PDSS1	1	PDSS1	1	0.00258625783458721	WBGene00008769	WBGene00008769(1)			GO:0003735;GO:0006412;GO:0005840;GO:0003723;GO:0005739;GO:0005515;GO:0003729;GO:0017148;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:0005761	structural constituent of ribosome;translation;ribosome;RNA binding;mitochondrion;protein binding;mRNA binding;negative regulation of translation;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;mitochondrial ribosome	3D-structure;Acetylation;Mitochondrion;Reference proteome;Ribonucleoprotein;Ribosomal protein	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
PDSS1	positive	FKBP4	ENSG00000004478	PDSS1	1	PDSS1	1	0.00274658500064506	WBGene00001431;WBGene00001427;WBGene00001433	WBGene00001429(0);WBGene00001430(0)			GO:0003723;GO:0005634;GO:0005737;GO:0016853;GO:0005829;GO:0005654;GO:0005739;GO:0003755;GO:0000413;GO:0005856;GO:0042995;GO:0005515;GO:0005874;GO:0031072;GO:0030424;GO:0044295;GO:0070062;GO:1900034;GO:0005528;GO:0061077;GO:0010977;GO:0006457;GO:0030674;GO:0005524;GO:0005525;GO:0032767;GO:0035259;GO:0048156;GO:0051219;GO:0006463;GO:0006825;GO:0007566;GO:0030521;GO:0030850;GO:0031111;GO:0031115;GO:0031503;GO:0046661;GO:0048608;GO:0032991;GO:0043005;GO:0043025;GO:0048471	protein binding;peptidyl-prolyl cis-trans isomerase activity;heat shock protein binding;protein peptidyl-prolyl isomerization;FK506 binding;RNA binding;nucleus;cytoplasm;isomerase activity;nucleoplasm;cytosol;mitochondrion;cytoskeleton;cell projection;microtubule;axon;axonal growth cone;extracellular exosome;regulation of cellular response to heat;chaperone-mediated protein folding;negative regulation of neuron projection development;protein folding;protein binding, bridging;ATP binding;GTP binding;copper-dependent protein binding;glucocorticoid receptor binding;tau protein binding;phosphoprotein binding;steroid hormone receptor complex assembly;copper ion transport;embryo implantation;androgen receptor signaling pathway;prostate gland development;negative regulation of microtubule polymerization or depolymerization;negative regulation of microtubule polymerization;protein-containing complex localization;male sex differentiation;reproductive structure development;protein-containing complex;neuron projection;neuronal cell body;perinuclear region of cytoplasm	3D-structure;Acetylation;Cell projection;Chaperone;Cytoplasm;Cytoskeleton;Direct protein sequencing;Isomerase;Isopeptide bond;Methylation;Microtubule;Mitochondrion;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Rotamase;TPR repeat;Ubl conjugation	R-HSA-162582;R-HSA-2262752;R-HSA-8953897;R-HSA-3371497;R-HSA-3371556;R-HSA-8939211;R-HSA-9006931;R-HSA-9018519;R-HSA-3371568;R-HSA-3371571	Signal Transduction;Cellular responses to stress;Cellular responses to external stimuli;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular response to heat stress;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Attenuation phase;HSF1-dependent transactivation
PDSS1	positive	NDC1	ENSG00000058804	PDSS1	1	PDSS1	1	0.00274658500064506	WBGene00007118	WBGene00007118(0)			GO:0051028;GO:0005634;GO:0016020;GO:0016021;GO:0015031;GO:0005886;GO:0031965;GO:0015629;GO:0005643;GO:0075733;GO:0043657;GO:0017056;GO:0006110;GO:0006406;GO:0006409;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0051292;GO:0006999;GO:0007129;GO:0007283;GO:0031081;GO:0005737;GO:0070762	mRNA transport;nucleus;membrane;integral component of membrane;protein transport;plasma membrane;nuclear membrane;actin cytoskeleton;nuclear pore;intracellular transport of virus;host cell;structural constituent of nuclear pore;regulation of glycolytic process;mRNA export from nucleus;tRNA export from nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;nuclear pore complex assembly;nuclear pore organization;synapsis;spermatogenesis;nuclear pore distribution;cytoplasm;nuclear pore transmembrane ring	Alternative splicing;Membrane;Nuclear pore complex;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Translocation;Transmembrane;Transmembrane helix;Transport;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-5619115;R-HSA-68886;R-HSA-69278;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Disorders of transmembrane transporters;M Phase;Cell Cycle, Mitotic;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling
PDSS1	positive	CDC45	ENSG00000093009	PDSS1	1	PDSS1	1	0.00274658500064506	WBGene00009372;WBGene00045484	WBGene00009372(1)		Ear-patella-short stature syndrome;Meier-Gorlin Syndrome and Craniosynostosis;MEIER-GORLIN SYNDROME 7	GO:0005634;GO:0005737;GO:0005813;GO:0005515;GO:0032508;GO:0006270;GO:0007049;GO:0006260;GO:0005654;GO:0003697;GO:0003682;GO:0000082;GO:0000727;GO:0003688;GO:0043138;GO:0000076;GO:0000083;GO:0031938;GO:1900087;GO:1902977;GO:0005656;GO:0031261;GO:0031298	DNA replication initiation;nucleus;cytoplasm;nucleoplasm;centrosome;protein binding;cell cycle;DNA replication;chromatin binding;G1/S transition of mitotic cell cycle;double-strand break repair via break-induced replication;single-stranded DNA binding;DNA replication origin binding;DNA replication checkpoint;regulation of transcription involved in G1/S transition of mitotic cell cycle;regulation of chromatin silencing at telomere;positive regulation of G1/S transition of mitotic cell cycle;mitotic DNA replication preinitiation complex assembly;nuclear pre-replicative complex;DNA replication preinitiation complex;replication fork protection complex	3D-structure;Alternative splicing;Cell cycle;Cytoplasm;DNA replication;Disease mutation;Dwarfism;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-69002;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-453279;R-HSA-69206;R-HSA-176187;R-HSA-68962;R-HSA-176974;R-HSA-69190;R-HSA-69205	Cell Cycle;DNA Replication Pre-Initiation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;Unwinding of DNA;DNA strand elongation;G1/S-Specific Transcription
PDSS1	positive	TOMM22	ENSG00000100216	PDSS1	1	PDSS1	1	0.00274658500064506	WBGene00021133	WBGene00021133(1)			GO:0016020;GO:0016021;GO:0006886;GO:0015031;GO:0071806;GO:0005739;GO:0005741;GO:0005515;GO:0006626;GO:0016236;GO:0008320;GO:0005742;GO:0045040;GO:0043065;GO:0051204	intracellular protein transport;mitochondrial outer membrane;membrane;integral component of membrane;protein transport;protein transmembrane transport;mitochondrion;protein binding;protein targeting to mitochondrion;macroautophagy;protein transmembrane transporter activity;mitochondrial outer membrane translocase complex;protein insertion into mitochondrial outer membrane;positive regulation of apoptotic process;protein insertion into mitochondrial membrane	Acetylation;Direct protein sequencing;Membrane;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;Protein transport;Receptor;Reference proteome;Translocation;Transmembrane;Transmembrane helix;Transport	R-HSA-9612973;R-HSA-8953897;R-HSA-9609507;R-HSA-1268020;R-HSA-1632852;R-HSA-5205647;R-HSA-5205685	Autophagy;Cellular responses to external stimuli;Protein localization;Mitochondrial protein import;Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy
PDSS1	positive	PPM1G	ENSG00000115241	PDSS1	1	PDSS1	1	0.00274658500064506	WBGene00018362;WBGene00006460;WBGene00011953				GO:0005737;GO:0016020;GO:0046872;GO:0005654;GO:0016787;GO:0003824;GO:0004721;GO:0006470;GO:0005515;GO:0004722;GO:0043169;GO:0005634;GO:0004724;GO:0035970;GO:0007050	catalytic activity;cation binding;protein dephosphorylation;protein serine/threonine phosphatase activity;cytoplasm;membrane;metal ion binding;nucleoplasm;hydrolase activity;phosphoprotein phosphatase activity;protein binding;nucleus;magnesium-dependent protein serine/threonine phosphatase activity;peptidyl-threonine dephosphorylation;cell cycle arrest	Acetylation;Cytoplasm;Hydrolase;Lipoprotein;Magnesium;Manganese;Membrane;Metal-binding;Methylation;Myristate;Phosphoprotein;Protein phosphatase;Reference proteome;Repeat		
PDSS1	positive	MRPS12	ENSG00000128626	PDSS1	1	PDSS1	1	0.00274658500064506	WBGene00011391	WBGene00011391(1)			GO:0003723;GO:0005739;GO:0003735;GO:0006412;GO:0005840;GO:0015935;GO:0005515;GO:0032543;GO:0005743;GO:0070125;GO:0070126;GO:0005761;GO:0005763	structural constituent of ribosome;translation;ribosome;small ribosomal subunit;RNA binding;mitochondrion;protein binding;mitochondrial translation;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;mitochondrial ribosome;mitochondrial small ribosomal subunit	3D-structure;Mitochondrion;Polymorphism;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
PDSS1	positive	PSMA5	ENSG00000143106	PDSS1	1	PDSS1	1	0.00274658500064506	WBGene00003926	WBGene00003926(1)			GO:0005634;GO:0005737;GO:0005829;GO:0016787;GO:0005515;GO:0008233;GO:0006508;GO:0000502;GO:0006511;GO:0043161;GO:0004175;GO:0004298;GO:0051603;GO:0005839;GO:0019773;GO:0038095;GO:0005576;GO:0050852;GO:0005654;GO:0070062;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010498;GO:0010499;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0043312;GO:0034774;GO:1904813	endopeptidase activity;proteolysis involved in cellular protein catabolic process;proteasome core complex;ubiquitin-dependent protein catabolic process;proteasome core complex, alpha-subunit complex;threonine-type endopeptidase activity;proteasome-mediated ubiquitin-dependent protein catabolic process;nucleus;cytoplasm;cytosol;hydrolase activity;protein binding;peptidase activity;proteolysis;proteasome complex;Fc-epsilon receptor signaling pathway;extracellular region;T cell receptor signaling pathway;nucleoplasm;extracellular exosome;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;proteasomal protein catabolic process;proteasomal ubiquitin-independent protein catabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;neutrophil degranulation;secretory granule lumen;ficolin-1-rich granule lumen	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Glycoprotein;Hydrolase;Nucleus;Phosphoprotein;Protease;Proteasome;Reference proteome;Threonine protease	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-6798695;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Neutrophil degranulation;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
PDSS1	positive	CCNA2	ENSG00000145386	PDSS1	1	PDSS1	1	0.00274658500064506	WBGene00000863;WBGene00000865;WBGene00000866;WBGene00000867	WBGene00000867(0);WBGene00000866(0);WBGene00000865(0);WBGene00000871(0);WBGene00000870(0)		Autosomal Recessive Mental Retardation	GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0051301;GO:0005515;GO:0007049;GO:0019901;GO:0016579;GO:0016032;GO:0019904;GO:0004672;GO:0000086;GO:0006275;GO:0016538;GO:0000079;GO:0044772;GO:0000307;GO:0007265;GO:0097472;GO:0016572;GO:0044843;GO:0097124;GO:0031100;GO:0032355;GO:0033762;GO:0036120;GO:0044320;GO:0045893;GO:0048146;GO:0071314;GO:0071373;GO:0071392;GO:0071407;GO:0071456;GO:0071732;GO:0090102;GO:1990314;GO:0001939;GO:0001940	nucleus;cytoplasm;nucleoplasm;cytosol;cell division;protein binding;cell cycle;protein kinase binding;protein deubiquitination;viral process;protein domain specific binding;protein kinase activity;G2/M transition of mitotic cell cycle;regulation of DNA replication;cyclin-dependent protein serine/threonine kinase regulator activity;regulation of cyclin-dependent protein serine/threonine kinase activity;mitotic cell cycle phase transition;cyclin-dependent protein kinase holoenzyme complex;Ras protein signal transduction;histone phosphorylation;cell cycle G1/S phase transition;cyclin A2-CDK2 complex;animal organ regeneration;response to estradiol;response to glucagon;cellular response to platelet-derived growth factor stimulus;cellular response to leptin stimulus;positive regulation of transcription, DNA-templated;positive regulation of fibroblast proliferation;cellular response to cocaine;cellular response to luteinizing hormone stimulus;cellular response to estradiol stimulus;cellular response to organic cyclic compound;cellular response to hypoxia;cellular response to nitric oxide;cochlea development;cellular response to insulin-like growth factor stimulus;female pronucleus;male pronucleus	3D-structure;Acetylation;Cell cycle;Cell division;Cyclin;Cytoplasm;Host-virus interaction;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-6804116;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-174143;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-2262752;R-HSA-453274;R-HSA-453276;R-HSA-5688426;R-HSA-5689880;R-HSA-68949;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69563;R-HSA-69580;R-HSA-69615;R-HSA-69620;R-HSA-8953897;R-HSA-5633007;R-HSA-6804757;R-HSA-6806003;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-2559583;R-HSA-6804756;R-HSA-68911;R-HSA-2559582;R-HSA-5693607;R-HSA-69273;R-HSA-2559586;R-HSA-1538133;R-HSA-1362300;R-HSA-170145	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;APC/C-mediated degradation of cell cycle proteins;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Cellular responses to stress;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Deubiquitination;Ub-specific processing proteases;Orc1 removal from chromatin;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cellular responses to external stimuli;Regulation of TP53 Activity;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Cellular Senescence;Regulation of TP53 Activity through Phosphorylation;G2 Phase;Senescence-Associated Secretory Phenotype (SASP);Processing of DNA double-strand break ends;Cyclin A/B1/B2 associated events during G2/M transition;DNA Damage/Telomere Stress Induced Senescence;G0 and Early G1;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1;Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes
PDSS1	positive	GINS4	ENSG00000147536	PDSS1	1	PDSS1	1	0.00274658500064506	WBGene00013768	WBGene00013768(1)			GO:0006261;GO:0005634;GO:0005737;GO:0005515;GO:0032508;GO:0006260;GO:0005654;GO:0000727;GO:0043138;GO:0031298;GO:0006271;GO:0000811;GO:0001833	DNA-dependent DNA replication;nucleus;cytoplasm;protein binding;DNA duplex unwinding;DNA replication;nucleoplasm;double-strand break repair via break-induced replication;replication fork protection complex;3'-5' DNA helicase activity;DNA strand elongation involved in DNA replication;GINS complex;inner cell mass cell proliferation	3D-structure;Acetylation;Alternative splicing;Cytoplasm;DNA replication;Nucleus;Phosphoprotein;Reference proteome	R-HSA-1640170;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-176974;R-HSA-69190	Cell Cycle;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Unwinding of DNA;DNA strand elongation
PDSS1	positive	BUB1	ENSG00000169679	PDSS1	1	PDSS1	1	0.00274658500064506	WBGene00000275	WBGene00004721(0);WBGene00000275(0)		Mosaic variegated aneuploidy syndrome	GO:0005634;GO:0016020;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005829;GO:0005654;GO:0051301;GO:0005694;GO:0005515;GO:0007049;GO:0006915;GO:0007059;GO:0051754;GO:0000775;GO:0000776;GO:0000777;GO:0016032;GO:0007094;GO:0000778;GO:0051983;GO:0007063;GO:0007093;GO:0008283;GO:0000942	ATP binding;protein phosphorylation;protein kinase activity;mitotic spindle assembly checkpoint;nucleus;membrane;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleoplasm;cytosol;cell division;chromosome;protein binding;cell cycle;apoptotic process;chromosome segregation;meiotic sister chromatid cohesion, centromeric;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;viral process;condensed nuclear chromosome kinetochore;regulation of chromosome segregation;regulation of sister chromatid cohesion;mitotic cell cycle checkpoint;cell population proliferation;condensed nuclear chromosome outer kinetochore	3D-structure;ATP-binding;Alternative splicing;Apoptosis;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Host-virus interaction;Kinase;Kinetochore;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	AURKB	ENSG00000178999	PDSS1	1	PDSS1	1	0.00274658500064506	WBGene00000099;WBGene00000098	WBGene00000099(1)			GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005654;GO:0051301;GO:0005694;GO:0005856;GO:0005515;GO:0007049;GO:0030496;GO:0005819;GO:0000775;GO:0000780;GO:0032133;GO:0032467;GO:0000122;GO:0032466;GO:0005829;GO:0031145;GO:0007094;GO:0000779;GO:0043988;GO:1901796;GO:0046777;GO:0032465;GO:0006511;GO:0032091;GO:0032212;GO:0051973;GO:1904355;GO:0008608;GO:0004712;GO:0035174;GO:0007051;GO:0007052;GO:0005876;GO:0031616;GO:0051233;GO:0034644;GO:0019900;GO:0034501;GO:0051983;GO:0051256;GO:0016570;GO:0002903;GO:0009838;GO:0036089;GO:0044878;GO:0007568;GO:0008283;GO:0000776;GO:0010369;GO:1990023	ATP binding;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;mitotic spindle assembly checkpoint;positive regulation of cytokinesis;histone H3-S28 phosphorylation;chromosome passenger complex;nucleus;cytoplasm;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;nucleoplasm;cytoskeleton;cell division;chromosome;protein binding;cell cycle;midbody;spindle;chromosome, centromeric region;condensed nuclear chromosome, centromeric region;negative regulation of transcription by RNA polymerase II;negative regulation of cytokinesis;cytosol;anaphase-promoting complex-dependent catabolic process;condensed chromosome, centromeric region;regulation of signal transduction by p53 class mediator;protein autophosphorylation;regulation of cytokinesis;ubiquitin-dependent protein catabolic process;negative regulation of protein binding;positive regulation of telomere maintenance via telomerase;positive regulation of telomerase activity;positive regulation of telomere capping;attachment of spindle microtubules to kinetochore;protein serine/threonine/tyrosine kinase activity;histone serine kinase activity;spindle organization;mitotic spindle organization;spindle pole centrosome;spindle midzone;cellular response to UV;spindle microtubule;kinase binding;protein localization to kinetochore;regulation of chromosome segregation;mitotic spindle midzone assembly;histone modification;negative regulation of B cell apoptotic process;abscission;cleavage furrow formation;mitotic cytokinesis checkpoint;aging;cell population proliferation;positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore;kinetochore;chromocenter;mitotic spindle midzone	3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Kinase;Magnesium;Metal-binding;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-174143;R-HSA-174178;R-HSA-2467813;R-HSA-2555396;R-HSA-453276;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-2990846;R-HSA-3108232;R-HSA-4615885;R-HSA-141424;R-HSA-141444;R-HSA-69618;R-HSA-5633007;R-HSA-8986944;R-HSA-6804756;R-HSA-9022692	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Signaling by Rho GTPases;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of DNA replication proteins;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint;Regulation of TP53 Activity;Transcriptional Regulation by MECP2;Regulation of TP53 Activity through Phosphorylation;Regulation of MECP2 expression and activity
PDSS1	positive	RCC1	ENSG00000180198	PDSS1	1	PDSS1	1	0.00274658500064506	WBGene00004304	WBGene00004304(0)			GO:0005634;GO:0005737;GO:0005654;GO:0003677;GO:0031965;GO:0051301;GO:0000790;GO:0005694;GO:0005515;GO:0007049;GO:0005085;GO:0007059;GO:0003682;GO:0016032;GO:0007052;GO:0042393;GO:0000785;GO:0032991;GO:0000794;GO:0046982;GO:0051225;GO:0007088;GO:0031492;GO:0051290;GO:0000082;GO:0043199;GO:0005087;GO:0008536;GO:0031491	nucleus;cytoplasm;nucleoplasm;DNA binding;nuclear membrane;cell division;nuclear chromatin;chromosome;protein binding;cell cycle;guanyl-nucleotide exchange factor activity;chromosome segregation;chromatin binding;viral process;mitotic spindle organization;histone binding;chromatin;protein-containing complex;G1/S transition of mitotic cell cycle;condensed nuclear chromosome;protein heterodimerization activity;spindle assembly;regulation of mitotic nuclear division;nucleosomal DNA binding;sulfate binding;regulation of mitotic spindle assembly;Ran guanyl-nucleotide exchange factor activity;Ran GTPase binding;nucleosome binding;Ran protein signal transduction	3D-structure;Alternative splicing;Cell cycle;Cell division;Chromosome;Cytoplasm;DNA-binding;Direct protein sequencing;Guanine-nucleotide releasing factor;Methylation;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat	R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-162909;R-HSA-165054;R-HSA-177243;R-HSA-180746	Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Host Interactions of HIV factors;Rev-mediated nuclear export of HIV RNA;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein
PDSS1	positive	GINS3	ENSG00000181938	PDSS1	1	PDSS1	1	0.00274658500064506	WBGene00022043	WBGene00022043(0)			GO:0005634;GO:0005654;GO:0005515;GO:0006260;GO:0006271	nucleus;nucleoplasm;protein binding;DNA replication;DNA strand elongation involved in DNA replication	3D-structure;Alternative splicing;DNA replication;Nucleus;Reference proteome	R-HSA-1640170;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-176974;R-HSA-69190	Cell Cycle;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Unwinding of DNA;DNA strand elongation
PDSS1	positive	RAD51	ENSG00000051180	PDSS1	1	PDSS1	1	0.00291582937420198	WBGene00004297	WBGene00004297(1)	SP1	Familial congenital mirror movements;Fanconi anemia;Hereditary breast and ovarian cancer syndrome;MIRROR MOVEMENTS 2;Breast Cancer;FANCONI ANEMIA COMPLEMENTATION GROUP R;MIRROR MOVEMENTS 2	GO:0005524;GO:0005730;GO:0005829;GO:0003677;GO:0008094;GO:0006281;GO:0000166;GO:0005634;GO:0005737;GO:0006259;GO:0005739;GO:0005759;GO:0005694;GO:0005856;GO:0005515;GO:0006310;GO:0006974;GO:0048471;GO:0051321;GO:0003697;GO:0000724;GO:0003690;GO:0005815;GO:0042802;GO:0005654;GO:0007131;GO:0003682;GO:0032991;GO:0051260;GO:0000784;GO:0031297;GO:0008022;GO:0010569;GO:0016605;GO:0019899;GO:0000785;GO:0000790;GO:0070317;GO:0070182;GO:0000794;GO:0000228;GO:0071479;GO:0000722;GO:0042148;GO:0000793;GO:0017116;GO:0036297;GO:0006312;GO:0051106;GO:0035861;GO:0006268;GO:0000800;GO:0072757;GO:0000150;GO:0000730;GO:0010833;GO:0070192;GO:1990426	DNA binding;ATP binding;DNA repair;nucleotide binding;DNA-dependent ATPase activity;nucleus;cytoplasm;DNA metabolic process;mitochondrion;mitochondrial matrix;cytoskeleton;chromosome;protein binding;DNA recombination;cellular response to DNA damage stimulus;perinuclear region of cytoplasm;meiotic cell cycle;double-strand break repair via homologous recombination;double-stranded DNA binding;microtubule organizing center;identical protein binding;single-stranded DNA binding;PML body;nucleoplasm;reciprocal meiotic recombination;chromatin binding;protein-containing complex;nuclear chromosome, telomeric region;replication fork processing;protein C-terminus binding;regulation of double-strand break repair via homologous recombination;enzyme binding;chromatin;nuclear chromatin;negative regulation of G0 to G1 transition;DNA polymerase binding;condensed nuclear chromosome;nuclear chromosome;cellular response to ionizing radiation;telomere maintenance via recombination;strand invasion;condensed chromosome;single-stranded DNA helicase activity;interstrand cross-link repair;mitotic recombination;positive regulation of DNA ligation;site of double-strand break;DNA unwinding involved in DNA replication;lateral element;cellular response to camptothecin;recombinase activity;DNA recombinase assembly;response to ionizing radiation;telomere maintenance via telomere lengthening;chromosome organization involved in meiotic cell cycle;mitotic recombination-dependent replication fork processing;regulation of protein phosphorylation;meiosis I;response to toxic substance;response to X-ray;response to organic cyclic compound;telomere organization;response to drug;cellular response to alkaloid;cellular response to gamma radiation;cellular response to hydroxyurea;cellular response to cisplatin;response to glucoside;replication-born double-strand break repair via sister chromatid exchange	3D-structure;ATP-binding;Acetylation;Alternative splicing;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA recombination;DNA repair;DNA-binding;Disease mutation;Fanconi anemia;Isopeptide bond;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-8953750;R-HSA-5693579;R-HSA-5693616;R-HSA-5693554;R-HSA-912446;R-HSA-5685938	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;Transcriptional Regulation by E2F6;Homologous DNA Pairing and Strand Exchange;Presynaptic phase of homologous DNA pairing and strand exchange;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Meiotic recombination;HDR through Single Strand Annealing (SSA)
PDSS1	positive	STIL	ENSG00000123473	PDSS1	1	PDSS1	1	0.00291582937420198				Autosomal recessive primary microcephaly;Precursor T-cell acute lymphoblastic leukemia;microcephaly primary type 7;MICROCEPHALY 7 PRIMARY AUTOSOMAL RECESSIVE	GO:0043066;GO:0005737;GO:0005829;GO:0005856;GO:0005515;GO:0007275;GO:0005813;GO:0042802;GO:0005814;GO:0001947;GO:0007368;GO:0000578;GO:0021915;GO:0001843;GO:0007052;GO:0007224;GO:0030903;GO:0033504;GO:0046599;GO:0001701;GO:0051298;GO:0071539;GO:0030900;GO:0035264	negative regulation of apoptotic process;cytoplasm;cytoskeleton;cytosol;protein binding;multicellular organism development;centrosome;identical protein binding;centriole;heart looping;determination of left/right symmetry;embryonic axis specification;neural tube development;neural tube closure;mitotic spindle organization;smoothened signaling pathway;notochord development;floor plate development;regulation of centriole replication;in utero embryonic development;centrosome duplication;protein localization to centrosome;forebrain development;multicellular organism growth	3D-structure;Acetylation;Alternative splicing;Chromosomal rearrangement;Cytoplasm;Cytoskeleton;Developmental protein;Disease mutation;Mental retardation;Phosphoprotein;Polymorphism;Primary microcephaly;Proto-oncogene;Reference proteome;Ubl conjugation		
PDSS1	positive	TIMM17A	ENSG00000134375	PDSS1	1	PDSS1	1	0.00291582937420198	WBGene00017119;WBGene00017069	WBGene00017069(0);WBGene00017119(0)			GO:0016020;GO:0016021;GO:0006886;GO:0015031;GO:0005654;GO:0015450;GO:0005739;GO:0005743;GO:0005744;GO:0008320;GO:0006626;GO:0030150;GO:0031305;GO:0010954	intracellular protein transport;TIM23 mitochondrial import inner membrane translocase complex;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;membrane;integral component of membrane;protein transport;nucleoplasm;mitochondrion;mitochondrial inner membrane;protein targeting to mitochondrion;protein import into mitochondrial matrix;integral component of mitochondrial inner membrane;positive regulation of protein processing	Disulfide bond;Membrane;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Protein transport;Reference proteome;Translocation;Transmembrane;Transmembrane helix;Transport	R-HSA-9609507;R-HSA-1268020	Protein localization;Mitochondrial protein import
PDSS1	positive	BZW2	ENSG00000136261	PDSS1	1	PDSS1	1	0.00291582937420198					GO:0005515;GO:0005737;GO:0016020;GO:0007275;GO:0030154;GO:0007399;GO:0045296	protein binding;cytoplasm;membrane;multicellular organism development;cell differentiation;nervous system development;cadherin binding	Acetylation;Alternative splicing;Developmental protein;Differentiation;Neurogenesis;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	positive	TIMM23	ENSG00000265354	PDSS1	1	PDSS1	1	0.00291582937420198	WBGene00008857	WBGene00008857(0)			GO:0016020;GO:0016021;GO:0006886;GO:0015031;GO:0015450;GO:0005739;GO:0005743;GO:0005744;GO:0005515;GO:0008320;GO:0006626;GO:0030150;GO:0005758;GO:0031305	intracellular protein transport;TIM23 mitochondrial import inner membrane translocase complex;P-P-bond-hydrolysis-driven protein transmembrane transporter activity;membrane;integral component of membrane;protein transport;mitochondrion;mitochondrial inner membrane;protein binding;protein transmembrane transporter activity;protein targeting to mitochondrion;protein import into mitochondrial matrix;mitochondrial intermembrane space;integral component of mitochondrial inner membrane	Membrane;Mitochondrion;Mitochondrion inner membrane;Protein transport;Reference proteome;Translocation;Transmembrane;Transmembrane helix;Transport	R-HSA-9609507;R-HSA-1268020	Protein localization;Mitochondrial protein import
PDSS1	positive	TOP2A	ENSG00000131747	PDSS1	1	PDSS1	1	0.00309441903725693	WBGene00010785;WBGene00022854;WBGene00019884			Neuroblastoma	GO:0003723;GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0005524;GO:0016853;GO:0003677;GO:0006259;GO:0042803;GO:0005515;GO:0003916;GO:0006265;GO:0006974;GO:0048511;GO:0000287;GO:0005654;GO:0005730;GO:0007059;GO:0005814;GO:0000712;GO:0003682;GO:0032991;GO:0043065;GO:0008022;GO:1990904;GO:0003918;GO:0043130;GO:0019899;GO:0046982;GO:0008144;GO:0042752;GO:0008094;GO:0008301;GO:0042826;GO:0000228;GO:0005080;GO:0030263;GO:0000819;GO:0002244;GO:0006266;GO:0007143;GO:0030261;GO:0040016;GO:0044774;GO:0045870;GO:0045944;GO:1905463;GO:0000793;GO:0009330;GO:0019035	DNA binding;ATP binding;DNA topological change;DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity;DNA metabolic process;RNA binding;nucleus;cytoplasm;metal ion binding;nucleotide binding;isomerase activity;nucleoplasm;nucleolus;protein homodimerization activity;protein binding;DNA topoisomerase activity;cellular response to DNA damage stimulus;rhythmic process;magnesium ion binding;chromosome segregation;centriole;resolution of meiotic recombination intermediates;chromatin binding;protein-containing complex;positive regulation of apoptotic process;protein C-terminus binding;ribonucleoprotein complex;ubiquitin binding;enzyme binding;protein heterodimerization activity;drug binding;regulation of circadian rhythm;DNA-dependent ATPase activity;DNA binding, bending;histone deacetylase binding;nuclear chromosome;protein kinase C binding;apoptotic chromosome condensation;sister chromatid segregation;hematopoietic progenitor cell differentiation;DNA ligation;female meiotic nuclear division;chromosome condensation;embryonic cleavage;mitotic DNA integrity checkpoint;positive regulation of single stranded viral RNA replication via double stranded DNA intermediate;positive regulation of transcription by RNA polymerase II;negative regulation of DNA duplex unwinding;condensed chromosome;DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex;viral integration complex	3D-structure;ATP-binding;Acetylation;Alternative splicing;Biological rhythms;Cytoplasm;DNA-binding;Direct protein sequencing;Isomerase;Isopeptide bond;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Topoisomerase;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-1640170;R-HSA-69278;R-HSA-2990846;R-HSA-3108232;R-HSA-4615885;R-HSA-453279;R-HSA-1538133;R-HSA-1362277	Metabolism of proteins;Post-translational protein modification;Cell Cycle;Cell Cycle, Mitotic;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of DNA replication proteins;Mitotic G1 phase and G1/S transition;G0 and Early G1;Transcription of E2F targets under negative control by DREAM complex
PDSS1	positive	CDCA8	ENSG00000134690	PDSS1	1	PDSS1	1	0.00309441903725693					GO:0005634;GO:0005737;GO:0005730;GO:0051301;GO:0005694;GO:0045171;GO:0005856;GO:0005515;GO:0007049;GO:0005819;GO:0000775;GO:0005654;GO:0005829;GO:0032991;GO:0032133;GO:0051233;GO:0007080;GO:0000070;GO:0051276;GO:0010369;GO:0030496	cell;nucleus;cytoplasm;nucleoplasm;nucleolus;intercellular bridge;cytoskeleton;cell division;chromosome;protein binding;cell cycle;spindle;chromosome, centromeric region;cytosol;protein-containing complex;chromosome passenger complex;spindle midzone;mitotic metaphase plate congression;mitotic sister chromatid segregation;chromosome organization;chromocenter;midbody	3D-structure;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Isopeptide bond;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-2990846;R-HSA-3108232;R-HSA-4615885;R-HSA-141424;R-HSA-141444;R-HSA-69618	Metabolism of proteins;Post-translational protein modification;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of DNA replication proteins;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	NOLC1	ENSG00000166197	PDSS1	1	PDSS1	1	0.00309441903725693	WBGene00000931	WBGene00000931(0)			GO:0003723;GO:0005634;GO:0005737;GO:0000166;GO:0005524;GO:0005730;GO:0001650;GO:0005525;GO:0005515;GO:0006417;GO:0005654;GO:0046982;GO:0006364;GO:0000278;GO:0014029;GO:0014032;GO:0001042;GO:0003677;GO:0003700;GO:0008134;GO:0008139;GO:0019904;GO:0034512;GO:0034513;GO:0062064;GO:0062065;GO:0006970;GO:0007000;GO:0008284;GO:0033979;GO:0042306;GO:0045893;GO:0015030;GO:0031428;GO:0031429	protein binding;nucleolus;RNA binding;nucleus;cytoplasm;nucleotide binding;ATP binding;fibrillar center;GTP binding;nucleoplasm;regulation of translation;protein heterodimerization activity;rRNA processing;mitotic cell cycle;neural crest formation;neural crest cell development;RNA polymerase I core binding;DNA binding;DNA-binding transcription factor activity;transcription factor binding;nuclear localization sequence binding;protein domain specific binding;box C/D snoRNA binding;box H/ACA snoRNA binding;box C/D snoRNP complex binding;box H/ACA snoRNP complex binding;response to osmotic stress;nucleolus organization;positive regulation of cell population proliferation;box H/ACA snoRNA metabolic process;regulation of protein import into nucleus;positive regulation of transcription, DNA-templated;Cajal body;box C/D snoRNP complex;box H/ACA snoRNP complex	ATP-binding;Acetylation;Alternative splicing;Cytoplasm;GTP-binding;Isopeptide bond;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation		
PDSS1	positive	PHB	ENSG00000167085	PDSS1	1	PDSS1	1	0.00309441903725693	WBGene00004014	WBGene00004014(1)		Breast Cancer	GO:0008285;GO:0005737;GO:0005634;GO:0044212;GO:0016020;GO:0005743;GO:0005739;GO:0005886;GO:0005515;GO:0007165;GO:0009986;GO:0045893;GO:0005654;GO:0005769;GO:0071897;GO:0007005;GO:0070062;GO:0050821;GO:0070374;GO:0008022;GO:0042981;GO:0006355;GO:0000122;GO:0045892;GO:0042177;GO:0019899;GO:0070373;GO:0010944;GO:0042826;GO:0005887;GO:0030308;GO:0010942;GO:0001649;GO:0060766;GO:0010628;GO:0006851;GO:0045745;GO:0050847;GO:0001851;GO:0071354;GO:0001850;GO:0031871;GO:0016575;GO:0045917;GO:2000323	membrane;negative regulation of cell population proliferation;cytoplasm;nucleus;transcription regulatory region DNA binding;mitochondrial inner membrane;mitochondrion;plasma membrane;protein binding;signal transduction;cell surface;positive regulation of transcription, DNA-templated;nucleoplasm;early endosome;DNA biosynthetic process;mitochondrion organization;extracellular exosome;protein stabilization;positive regulation of ERK1 and ERK2 cascade;protein C-terminus binding;regulation of transcription, DNA-templated;regulation of apoptotic process;negative regulation of transcription by RNA polymerase II;negative regulation of transcription, DNA-templated;negative regulation of protein catabolic process;enzyme binding;negative regulation of ERK1 and ERK2 cascade;negative regulation of transcription by competitive promoter binding;histone deacetylase binding;integral component of plasma membrane;negative regulation of cell growth;positive regulation of cell death;osteoblast differentiation;negative regulation of androgen receptor signaling pathway;positive regulation of gene expression;mitochondrial calcium ion transmembrane transport;positive regulation of G protein-coupled receptor signaling pathway;progesterone receptor signaling pathway;complement component C3b binding;cellular response to interleukin-6;complement component C3a binding;proteinase activated receptor binding;histone deacetylation;positive regulation of complement activation;negative regulation of glucocorticoid receptor signaling pathway	3D-structure;Acetylation;Alternative splicing;Coiled coil;DNA synthesis;Direct protein sequencing;Membrane;Mitochondrion;Mitochondrion inner membrane;Nucleus;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome	R-HSA-168256;R-HSA-382551;R-HSA-162582;R-HSA-1643685;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-6802957;R-HSA-6802949;R-HSA-5673000;R-HSA-6802946;R-HSA-6802955;R-HSA-8949215;R-HSA-8949664	Immune System;Transport of small molecules;Signal Transduction;Disease;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Oncogenic MAPK signaling;Signaling by RAS mutants;RAF activation;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;Mitochondrial calcium ion transport;Processing of SMDT1
PDSS1	positive	UBE2C	ENSG00000175063	PDSS1	1	PDSS1	1	0.00309441903725693					GO:0000166;GO:0005524;GO:0016740;GO:0005829;GO:0016567;GO:0005886;GO:0051301;GO:0005515;GO:0004842;GO:0007049;GO:0006511;GO:0005634;GO:0061631;GO:0070936;GO:0005654;GO:0031145;GO:1901990;GO:0044389;GO:0010458;GO:0010994;GO:0031536;GO:0070979;GO:1904668;GO:0000151;GO:0005680	cell;nucleotide binding;ATP binding;transferase activity;cytosol;plasma membrane;protein ubiquitination;cell division;protein binding;ubiquitin-protein transferase activity;cell cycle;ubiquitin-dependent protein catabolic process;nucleus;ubiquitin conjugating enzyme activity;protein K48-linked ubiquitination;nucleoplasm;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;protein polyubiquitination;ubiquitin-like protein ligase binding;exit from mitosis;free ubiquitin chain polymerization;regulation of mitotic metaphase/anaphase transition;positive regulation of exit from mitosis;protein K11-linked ubiquitination;positive regulation of ubiquitin protein ligase activity;ubiquitin ligase complex;anaphase-promoting complex	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Mitosis;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866652;R-HSA-983168;R-HSA-983169;R-HSA-1640170;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-453276;R-HSA-68882;R-HSA-68886;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69620;R-HSA-8953897;R-HSA-69618;R-HSA-174084;R-HSA-2559583;R-HSA-141405;R-HSA-141430;R-HSA-174048;R-HSA-176407;R-HSA-176412;R-HSA-179409;R-HSA-2559582	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Cell Cycle Checkpoints;Cellular responses to external stimuli;Mitotic Spindle Checkpoint;Autodegradation of Cdh1 by Cdh1:APC/C;Cellular Senescence;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;APC/C:Cdc20 mediated degradation of Cyclin B;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;Phosphorylation of the APC/C;APC-Cdc20 mediated degradation of Nek2A;Senescence-Associated Secretory Phenotype (SASP)
PDSS1	positive	FARSA	ENSG00000179115	PDSS1	1	PDSS1	1	0.00309441903725693	WBGene00001497	WBGene00001497(0)			GO:0005737;GO:0005524;GO:0000166;GO:0004826;GO:0004812;GO:0000049;GO:0043039;GO:0006432;GO:0003723;GO:0016020;GO:0006412;GO:0016874;GO:0005515;GO:0005829;GO:0006418;GO:0051290;GO:0009328	ATP binding;cytoplasm;tRNA binding;aminoacyl-tRNA ligase activity;nucleotide binding;tRNA aminoacylation;phenylalanine-tRNA ligase activity;phenylalanyl-tRNA aminoacylation;RNA binding;membrane;translation;ligase activity;protein binding;cytosol;tRNA aminoacylation for protein translation;protein heterotetramerization;phenylalanine-tRNA ligase complex	3D-structure;ATP-binding;Acetylation;Alternative splicing;Aminoacyl-tRNA synthetase;Cytoplasm;Direct protein sequencing;Ligase;Nucleotide-binding;Phosphoprotein;Polymorphism;Protein biosynthesis;Reference proteome	R-HSA-392499;R-HSA-72766;R-HSA-379716;R-HSA-379724	Metabolism of proteins;Translation;Cytosolic tRNA aminoacylation;tRNA Aminoacylation
PDSS1	positive	DCTPP1	ENSG00000179958	PDSS1	1	PDSS1	1	0.00309441903725693					GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0016787;GO:0005739;GO:0005829;GO:0005515;GO:0000287;GO:0042802;GO:0047429;GO:0009143;GO:0042262;GO:0016462;GO:0032556;GO:0047840;GO:0006253	nucleoside-triphosphate diphosphatase activity;nucleoside triphosphate catabolic process;nucleus;cytoplasm;metal ion binding;nucleotide binding;hydrolase activity;mitochondrion;cytosol;protein binding;magnesium ion binding;identical protein binding;DNA protection;pyrophosphatase activity;pyrimidine deoxyribonucleotide binding;dCTP diphosphatase activity;dCTP catabolic process	Acetylation;Cytoplasm;Hydrolase;Magnesium;Metal-binding;Mitochondrion;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome	R-HSA-1430728;R-HSA-15869;R-HSA-499943	Metabolism;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates
PDSS1	positive	H2AFX	ENSG00000188486	PDSS1	1	PDSS1	1	0.00309441903725693	WBGene00001909;WBGene00001931;WBGene00001877;WBGene00001881;WBGene00001886;WBGene00001890;WBGene00001893;WBGene00001895;WBGene00001904;WBGene00001907;WBGene00001917;WBGene00001921;WBGene00001925;WBGene00001927;WBGene00001935;WBGene00001939;WBGene00001942;WBGene00014240	WBGene00001921(1);WBGene00001893(1);WBGene00001925(1);WBGene00001917(1);WBGene00001877(1);WBGene00001886(1);WBGene00001935(1);WBGene00001890(1);WBGene00001931(1);WBGene00001927(1);WBGene00001881(1);WBGene00001939(1);WBGene00001895(1);WBGene00001907(1);WBGene00001909(1);WBGene00001942(1);WBGene00001904(1)			GO:0005634;GO:0016607;GO:0005654;GO:0003677;GO:0046982;GO:0006334;GO:0000786;GO:0005694;GO:0005515;GO:0006281;GO:0006310;GO:0006974;GO:0007049;GO:0006302;GO:0051321;GO:0005813;GO:0000790;GO:0006325;GO:0070062;GO:0045739;GO:0016032;GO:0019899;GO:0042393;GO:0000781;GO:0000077;GO:0006303;GO:0010212;GO:0090734;GO:0003684;GO:0000724;GO:0007283;GO:0021987;GO:0071480;GO:0090398;GO:0000785;GO:0000794;GO:0001673;GO:0001741;GO:0005657;GO:0035861	DNA binding;nucleosome;protein heterodimerization activity;nucleus;nuclear speck;nucleoplasm;nucleosome assembly;chromosome;protein binding;DNA repair;DNA recombination;cellular response to DNA damage stimulus;cell cycle;double-strand break repair;meiotic cell cycle;centrosome;nuclear chromatin;chromatin organization;chromatin silencing;extracellular exosome;positive regulation of DNA repair;viral process;enzyme binding;histone binding;chromosome, telomeric region;DNA damage checkpoint;double-strand break repair via nonhomologous end joining;response to ionizing radiation;site of DNA damage;damaged DNA binding;double-strand break repair via homologous recombination;spermatogenesis;cerebral cortex development;cellular response to gamma radiation;cellular senescence;chromatin;condensed nuclear chromosome;male germ cell nucleus;XY body;replication fork;site of double-strand break	3D-structure;Acetylation;Cell cycle;Chromosome;DNA damage;DNA recombination;DNA repair;DNA-binding;Host-virus interaction;Isopeptide bond;Meiosis;Nucleosome core;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-1266738;R-HSA-392499;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-194315;R-HSA-977225;R-HSA-1221632;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-195721;R-HSA-201681;R-HSA-2262752;R-HSA-68886;R-HSA-69278;R-HSA-69481;R-HSA-69620;R-HSA-8878171;R-HSA-8939236;R-HSA-8953897;R-HSA-195258;R-HSA-211000;R-HSA-5578749;R-HSA-68875;R-HSA-157118;R-HSA-606279;R-HSA-73886;R-HSA-774815;R-HSA-8939211;R-HSA-9006931;R-HSA-5693565;R-HSA-5693606;R-HSA-201722;R-HSA-2559580;R-HSA-2559583;R-HSA-212165;R-HSA-3247509;R-HSA-427413;R-HSA-4839726;R-HSA-5250941;R-HSA-5617472;R-HSA-5619507;R-HSA-9018519;R-HSA-1912422;R-HSA-1912408;R-HSA-2559582;R-HSA-3214858;R-HSA-8936459;R-HSA-157579;R-HSA-5693607;R-HSA-69473;R-HSA-5625740;R-HSA-5250913;R-HSA-5250924;R-HSA-73772;R-HSA-73854;R-HSA-73864;R-HSA-912446;R-HSA-110328;R-HSA-110329;R-HSA-110330;R-HSA-110331;R-HSA-73884;R-HSA-73927;R-HSA-73928;R-HSA-73929;R-HSA-427359;R-HSA-212300;R-HSA-5625886;R-HSA-171306;R-HSA-2299718;R-HSA-2559586;R-HSA-427389;R-HSA-5334118;R-HSA-5693571;R-HSA-73728;R-HSA-9616222	Developmental Biology;Metabolism of proteins;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Signaling by Rho GTPases;Amyloid fiber formation;Meiotic synapsis;Reproduction;Meiosis;Cell Cycle;DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Signaling by WNT;TCF dependent signaling in response to WNT;Cellular responses to stress;M Phase;Cell Cycle, Mitotic;G2/M Checkpoints;Cell Cycle Checkpoints;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;RHO GTPase Effectors;Gene Silencing by RNA;Transcriptional regulation by small RNAs;Mitotic Prophase;Signaling by NOTCH;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly;ESR-mediated signaling;Signaling by Nuclear Receptors;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Formation of the beta-catenin:TCF transactivating complex;Oxidative Stress Induced Senescence;Cellular Senescence;Epigenetic regulation of gene expression;Chromatin modifying enzymes;NoRC negatively regulates rRNA expression;Chromatin organization;Negative epigenetic regulation of rRNA expression;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Estrogen-dependent gene expression;Pre-NOTCH Expression and Processing;Pre-NOTCH Transcription and Translation;Senescence-Associated Secretory Phenotype (SASP);RMTs methylate histone arginines;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Telomere Maintenance;Processing of DNA double-strand break ends;G2/M DNA damage checkpoint;RHO GTPases activate PKNs;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription;Meiotic recombination;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Base Excision Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;SIRT1 negatively regulates rRNA expression;PRC2 methylates histones and DNA;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Packaging Of Telomere Ends;Condensation of Prophase Chromosomes;DNA Damage/Telomere Stress Induced Senescence;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;DNA methylation;Nonhomologous End-Joining (NHEJ);RNA Polymerase I Promoter Opening;Transcriptional regulation of granulopoiesis
PDSS1	positive	LYRM4	ENSG00000214113	PDSS1	1	PDSS1	1	0.00309441903725693				Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19	GO:0005634;GO:0005739;GO:0016604;GO:0005759;GO:0044281	nucleus;mitochondrion;protein binding;nuclear body;mitochondrial matrix;iron-sulfur cluster assembly;small molecule metabolic process;L-cysteine desulfurase complex	3D-structure;Direct protein sequencing;Disease mutation;Mitochondrion;Nucleus;Polymorphism;Primary mitochondrial disease;Reference proteome	R-HSA-1430728;R-HSA-1362409	Metabolism;Mitochondrial iron-sulfur cluster biogenesis
PDSS1	positive	RFC2	ENSG00000049541	PDSS1	1	PDSS1	1	0.00328279841180112	WBGene00004338	WBGene00004338(0)		Williams syndrome	GO:0005634;GO:0000166;GO:0005524;GO:0003677;GO:0005515;GO:0032508;GO:0006260;GO:0006261;GO:0005654;GO:1901796;GO:0019985;GO:0006283;GO:0042276;GO:0017116;GO:0003689;GO:0042769;GO:0006296;GO:0033683;GO:0032201;GO:1900264;GO:0031390;GO:0006297;GO:0070987;GO:0005663;GO:0019899	DNA binding;DNA replication;nucleus;nucleotide binding;ATP binding;protein binding;DNA duplex unwinding;DNA-dependent DNA replication;DNA repair;nucleoplasm;regulation of signal transduction by p53 class mediator;translesion synthesis;transcription-coupled nucleotide-excision repair;error-prone translesion synthesis;single-stranded DNA helicase activity;DNA damage response, detection of DNA damage;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;telomere maintenance via semi-conservative replication;DNA clamp loader activity;positive regulation of DNA-directed DNA polymerase activity;Ctf18 RFC-like complex;nucleotide-excision repair, DNA gap filling;error-free translesion synthesis;DNA replication factor C complex;enzyme binding	ATP-binding;Acetylation;Alternative splicing;DNA replication;Direct protein sequencing;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Williams-Beuren syndrome	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-73886;R-HSA-5633007;R-HSA-6804756;R-HSA-176187;R-HSA-157579;R-HSA-180786;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-5685938;R-HSA-110312;R-HSA-5655862;R-HSA-5656121;R-HSA-69190;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174411;R-HSA-174417;R-HSA-69091;R-HSA-69109;R-HSA-69186;R-HSA-110320;R-HSA-5696397	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Chromosome Maintenance;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Activation of ATR in response to replication stress;Telomere Maintenance;Extension of Telomeres;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through Single Strand Annealing (SSA);Translesion synthesis by REV1;Translesion synthesis by POLK;Translesion synthesis by POLI;DNA strand elongation;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Polymerase switching;Leading Strand Synthesis;Lagging Strand Synthesis;Translesion Synthesis by POLH;Gap-filling DNA repair synthesis and ligation in GG-NER
PDSS1	positive	CENPM	ENSG00000100162	PDSS1	1	PDSS1	1	0.00328279841180112					GO:0005634;GO:0005737;GO:0005829;GO:0005694;GO:0000775;GO:0000776;GO:0000777;GO:0005654;GO:0034080	nucleus;cytoplasm;cytosol;chromosome;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;nucleoplasm;CENP-A containing nucleosome assembly	3D-structure;Alternative splicing;Centromere;Chromosome;Cytoplasm;Kinetochore;Nucleus;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-606279;R-HSA-73886;R-HSA-774815;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	DARS2	ENSG00000117593	PDSS1	1	PDSS1	1	0.00328279841180112	WBGene00001095	WBGene00001095(1)		Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome;LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION;LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION	GO:0003676;GO:0005737;GO:0005524;GO:0016874;GO:0000166;GO:0004812;GO:0006418;GO:0006412;GO:0005634;GO:0005739;GO:0005759;GO:0042803;GO:0005515;GO:0000049;GO:0004815;GO:0050560;GO:0043039;GO:0070145	ATP binding;cytoplasm;nucleic acid binding;aminoacyl-tRNA ligase activity;tRNA aminoacylation for protein translation;nucleotide binding;ligase activity;translation;nucleoplasm;mitochondrion;mitochondrial matrix;protein homodimerization activity;protein binding;tRNA binding;aspartate-tRNA ligase activity;aspartate-tRNA(Asn) ligase activity;tRNA aminoacylation;mitochondrial asparaginyl-tRNA aminoacylation	3D-structure;ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Disease mutation;Ligase;Mitochondrion;Nucleotide-binding;Phosphoprotein;Polymorphism;Protein biosynthesis;Reference proteome;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-379724;R-HSA-379726	Metabolism of proteins;Translation;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation
PDSS1	positive	NIP7	ENSG00000132603	PDSS1	1	PDSS1	1	0.00328279841180112	WBGene00016607	WBGene00016607(0)			GO:0005634;GO:0003723;GO:0005730;GO:0005829;GO:0005515;GO:0042254;GO:0030687;GO:0042273;GO:0042255	nucleus;RNA binding;ribosome assembly;nucleoplasm;nucleolus;cytosol;protein binding;ribosome biogenesis;preribosome, large subunit precursor;ribosomal large subunit biogenesis	3D-structure;Alternative splicing;Nucleus;Polymorphism;RNA-binding;Reference proteome;Ribosome biogenesis	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol
PDSS1	positive	NUDT15	ENSG00000136159	PDSS1	1	PDSS1	1	0.00328279841180112				Azathioprine or 6-mercatopurine toxicity or dose selection;THIOPURINES POOR METABOLISM OF 2	GO:0046872;GO:0016787;GO:0042738;GO:0005829;GO:0005515;GO:0004551;GO:0035529;GO:0061136;GO:0000278;GO:0047429;GO:0034656;GO:0008413;GO:0035539;GO:0006195;GO:0006203;GO:0042262;GO:0017110;GO:0000302;GO:0009217;GO:1901292	hydrolase activity;metal ion binding;cytosol;protein binding;exogenous drug catabolic process;nucleotide diphosphatase activity;NADH pyrophosphatase activity;nucleoside-triphosphate diphosphatase activity;regulation of proteasomal protein catabolic process;mitotic cell cycle;nucleobase-containing small molecule catabolic process;8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity;8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity;purine nucleotide catabolic process;dGTP catabolic process;DNA protection;nucleoside-diphosphatase activity;response to reactive oxygen species;purine deoxyribonucleoside triphosphate catabolic process;nucleoside phosphate catabolic process	3D-structure;Hydrolase;Magnesium;Manganese;Metal-binding;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-15869;R-HSA-74259;R-HSA-8956319;R-HSA-2393930	Metabolism;Metabolism of nucleotides;Purine catabolism;Nucleobase catabolism;Phosphate bond hydrolysis by NUDT proteins
PDSS1	positive	PRPF4	ENSG00000136875	PDSS1	1	PDSS1	1	0.00328279841180112	WBGene00007972	WBGene00007972(1)		Retinitis pigmentosa;RETINITIS PIGMENTOSA 70	GO:0006397;GO:0008380;GO:0005634;GO:0016607;GO:0005515;GO:0005681;GO:0000398;GO:0005654;GO:0046540;GO:0000375;GO:0071005;GO:0017070;GO:0030621;GO:0006396;GO:0015030;GO:0071001;GO:0097525	protein binding;mRNA processing;RNA splicing;nucleus;nuclear speck;spliceosomal complex;mRNA splicing, via spliceosome;nucleoplasm;U4/U6 x U5 tri-snRNP complex;RNA splicing, via transesterification reactions;U2-type precatalytic spliceosome;U6 snRNA binding;U4 snRNA binding;RNA processing;Cajal body;U4/U6 snRNP;spliceosomal snRNP complex	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Disease mutation;Nucleus;Reference proteome;Repeat;Retinitis pigmentosa;Spliceosome;WD repeat;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-72203;R-HSA-72163;R-HSA-72172	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing
PDSS1	positive	BRCA2	ENSG00000139618	PDSS1	1	PDSS1	1	0.00328279841180112				Familial pancreatic carcinoma;Familial prostate cancer;Fanconi anemia;Hereditary breast and ovarian cancer syndrome;Hereditary breast cancer;Hereditary site-specific ovarian cancer syndrome;Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations;Nephroblastoma;FANCONI ANEMIA COMPLEMENTATION GROUP D TYPE 1;Breast Cancer;BREAST-OVARIAN CANCER FAMILIAL SUSCEPTIBILITY TO 2;FANCONI ANEMIA COMPLEMENTATION GROUP D1;GLIOMA SUSCEPTIBILITY 3;Medulloblastoma;PANCREATIC CANCER SUSCEPTIBILITY TO 2;Prostate Cancer;WILMS TUMOR 1	GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0003677;GO:0006281;GO:0005856;GO:0005515;GO:0006310;GO:0006974;GO:0007049;GO:0006302;GO:0045893;GO:0000724;GO:0005813;GO:0005815;GO:0042802;GO:0032991;GO:0000784;GO:0043967;GO:0002020;GO:0000281;GO:0030141;GO:0070200;GO:0010485;GO:0003697;GO:0043966;GO:0051298;GO:0010484;GO:0043015;GO:0008022;GO:0006289;GO:0033600;GO:0000800;GO:0000722;GO:0001556;GO:0001833;GO:0006978;GO:0007141;GO:0007283;GO:0007420;GO:0007569;GO:0008283;GO:0008585;GO:0008630;GO:0010165;GO:0010225;GO:0010332;GO:0030097;GO:0032465;GO:0042771;GO:0043009;GO:0045931;GO:0048478;GO:0051276;GO:1990426;GO:0033593	DNA repair;double-strand break repair via homologous recombination;nucleus;cytoplasm;nucleoplasm;cytosol;DNA binding;cytoskeleton;protein binding;DNA recombination;cellular response to DNA damage stimulus;cell cycle;double-strand break repair;positive regulation of transcription, DNA-templated;centrosome;microtubule organizing center;identical protein binding;regulation of transcription, DNA-templated;protein-containing complex;nuclear chromosome, telomeric region;single-stranded DNA binding;histone H4 acetylation;protease binding;gamma-tubulin binding;secretory granule;establishment of protein localization to telomere;H4 histone acetyltransferase activity;histone H3 acetylation;centrosome duplication;H3 histone acetyltransferase activity;protein C-terminus binding;nucleotide-excision repair;negative regulation of mammary gland epithelial cell proliferation;lateral element;telomere maintenance via recombination;oocyte maturation;inner cell mass cell proliferation;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;male meiosis I;spermatogenesis;brain development;cell aging;cell population proliferation;female gonad development;intrinsic apoptotic signaling pathway in response to DNA damage;response to X-ray;response to UV-C;response to gamma radiation;hemopoiesis;regulation of cytokinesis;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;chordate embryonic development;positive regulation of mitotic cell cycle;replication fork protection;chromosome organization;mitotic recombination-dependent replication fork processing;BRCA2-MAGE-D1 complex	3D-structure;Cell cycle;Cytoplasm;Cytoskeleton;DNA damage;DNA recombination;DNA repair;DNA-binding;Disease mutation;Fanconi anemia;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Tumor suppressor;Ubl conjugation	R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-5693579;R-HSA-5693616;R-HSA-5693554;R-HSA-912446	Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;Homologous DNA Pairing and Strand Exchange;Presynaptic phase of homologous DNA pairing and strand exchange;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Meiotic recombination
PDSS1	positive	UCK2	ENSG00000143179	PDSS1	1	PDSS1	1	0.00328279841180112	WBGene00007089;WBGene00008131;WBGene00008948	WBGene00007089(1)			GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0019206;GO:0004849;GO:0044206;GO:0044211;GO:0005829;GO:0005575;GO:0043097;GO:0006238;GO:0009165	ATP binding;kinase activity;nucleoside kinase activity;nucleotide binding;transferase activity;phosphorylation;cytosol;UMP salvage;cellular_component;pyrimidine nucleoside salvage;uridine kinase activity;CTP salvage;nucleotide biosynthetic process	3D-structure;ATP-binding;Acetylation;Alternative splicing;Kinase;Nucleotide-binding;Phosphoprotein;Reference proteome;Transferase	R-HSA-1430728;R-HSA-15869;R-HSA-73614;R-HSA-8956321	Metabolism;Metabolism of nucleotides;Pyrimidine salvage;Nucleotide salvage
PDSS1	positive	ILF2	ENSG00000143621	PDSS1	1	PDSS1	1	0.00328279841180112	WBGene00011253	WBGene00011253(1)	ACRV1		GO:0003723;GO:0005634;GO:0005737;GO:0016020;GO:0005524;GO:0005730;GO:0003677;GO:0005515;GO:0006955;GO:0016740;GO:0045893;GO:0006351;GO:0005576;GO:0043312;GO:1990904;GO:1904813;GO:0035580;GO:1904724;GO:0003725	ATP binding;RNA binding;immune response;transferase activity;nucleus;cytoplasm;membrane;nucleoplasm;DNA binding;protein binding;positive regulation of transcription, DNA-templated;nucleolus;transcription, DNA-templated;extracellular region;neutrophil degranulation;ribonucleoprotein complex;ficolin-1-rich granule lumen;specific granule lumen;tertiary granule lumen;double-stranded RNA binding	Activator;Cytoplasm;DNA-binding;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
PDSS1	positive	NUP205	ENSG00000155561	PDSS1	1	PDSS1	1	0.00328279841180112	WBGene00003789	WBGene00003789(0)		Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;NEPHROTIC SYNDROME TYPE 13	GO:0051028;GO:0005634;GO:0016020;GO:0015031;GO:0005643;GO:0005515;GO:0075733;GO:0043657;GO:0006110;GO:0006406;GO:0006409;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0031965;GO:0017056;GO:0006913;GO:0034399;GO:0051292	nuclear pore;mRNA transport;nucleus;membrane;protein transport;protein binding;intracellular transport of virus;host cell;regulation of glycolytic process;mRNA export from nucleus;tRNA export from nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;nuclear membrane;structural constituent of nuclear pore;nucleocytoplasmic transport;nuclear periphery;nuclear pore complex assembly	3D-structure;Acetylation;Direct protein sequencing;Disease mutation;Membrane;Nuclear pore complex;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Translocation;Transport;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-5619115;R-HSA-68886;R-HSA-69278;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Disorders of transmembrane transporters;M Phase;Cell Cycle, Mitotic;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling
PDSS1	positive	BUB1B	ENSG00000156970	PDSS1	1	PDSS1	1	0.00328279841180112	WBGene00000275	WBGene00004721(0);WBGene00000275(0)		Mosaic variegated aneuploidy syndrome;MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1;Colorectal Cancer;MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1;PREMATURE CHROMATID SEPARATION TRAIT	GO:0048471;GO:0005634;GO:0005737;GO:0000166;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005829;GO:0006468;GO:0051301;GO:0005694;GO:0005856;GO:0005515;GO:0007049;GO:0006915;GO:0005815;GO:0005819;GO:0051754;GO:0000775;GO:0000776;GO:0000777;GO:0031145;GO:1901990;GO:0007094;GO:0004672;GO:0006511;GO:0000278;GO:0000778;GO:0007093;GO:0000940;GO:0005680	mitotic spindle assembly checkpoint;perinuclear region of cytoplasm;nucleus;cytoplasm;nucleotide binding;protein serine/threonine kinase activity;ATP binding;kinase activity;transferase activity;phosphorylation;cytosol;protein phosphorylation;cytoskeleton;cell division;chromosome;protein binding;cell cycle;apoptotic process;microtubule organizing center;spindle;meiotic sister chromatid cohesion, centromeric;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;protein kinase activity;ubiquitin-dependent protein catabolic process;mitotic cell cycle;condensed nuclear chromosome kinetochore;mitotic cell cycle checkpoint;condensed chromosome outer kinetochore;anaphase-promoting complex	3D-structure;ATP-binding;Acetylation;Alternative splicing;Apoptosis;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Disease mutation;Kinase;Kinetochore;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Tumor suppressor;Ubl conjugation	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-174143;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-2467813;R-HSA-2555396;R-HSA-453276;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618;R-HSA-141405;R-HSA-141430;R-HSA-179409	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;APC-Cdc20 mediated degradation of Nek2A
PDSS1	positive	CEP83	ENSG00000173588	PDSS1	1	PDSS1	1	0.00328279841180112				Infantile nephronophthisis;INFANTILE NEPHRONOPHTHISIS AND INTELLECTUAL DISABILITY;NEPHRONOPHTHISIS 18	GO:0060271;GO:0048278;GO:0005814;GO:0005737;GO:0005856;GO:0005515;GO:0005829;GO:0003674;GO:0030030;GO:0097711;GO:0051660;GO:0005794;GO:0071539;GO:0097539	cilium assembly;vesicle docking;centriole;cell;cytoplasm;cytoskeleton;protein binding;cytosol;molecular_function;cell projection organization;ciliary basal body-plasma membrane docking;Golgi apparatus;protein localization to centrosome;ciliary transition fiber;establishment of centrosome localization	Alternative splicing;Ciliopathy;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;Disease mutation;Nephronophthisis;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1852241;R-HSA-5617833;R-HSA-5620912	Organelle biogenesis and maintenance;Cilium Assembly;Anchoring of the basal body to the plasma membrane
PDSS1	positive	CCNE2	ENSG00000175305	PDSS1	1	PDSS1	1	0.00328279841180112	WBGene00000871	WBGene00000867(0);WBGene00000866(0);WBGene00000865(0);WBGene00000871(0);WBGene00000870(0);WBGene00014069(0);WBGene00021040(0);WBGene00000863(0);WBGene00000864(0);WBGene00017259(0)			GO:0005634;GO:0006468;GO:0051301;GO:0005515;GO:0007049;GO:0016538;GO:0019901;GO:0000079;GO:0000082;GO:0000723;GO:0006270;GO:0007129;GO:0051726;GO:0070192;GO:1903827;GO:0097135;GO:0005737;GO:0005654;GO:0005829;GO:0005813;GO:0004672;GO:0044772;GO:0000307;GO:0097134	nucleus;regulation of cell cycle;G1/S transition of mitotic cell cycle;protein phosphorylation;cell division;protein binding;cell cycle;cyclin-dependent protein serine/threonine kinase regulator activity;protein kinase binding;regulation of cyclin-dependent protein serine/threonine kinase activity;telomere maintenance;DNA replication initiation;synapsis;chromosome organization involved in meiotic cell cycle;regulation of cellular protein localization;cyclin E2-CDK2 complex;cytoplasm;nucleoplasm;cytosol;centrosome;protein kinase activity;mitotic cell cycle phase transition;cyclin-dependent protein kinase holoenzyme complex;cyclin E1-CDK2 complex	Alternative splicing;Cell cycle;Cell division;Cyclin;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-392499;R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-6804116;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-2262752;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69563;R-HSA-69580;R-HSA-69615;R-HSA-69620;R-HSA-8953897;R-HSA-390466;R-HSA-391251;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-2559583;R-HSA-390471;R-HSA-2559586;R-HSA-1538133;R-HSA-69200	Metabolism of proteins;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;Cellular responses to stress;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cellular responses to external stimuli;Chaperonin-mediated protein folding;Protein folding;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Cellular Senescence;Association of TriC/CCT with target proteins during biosynthesis;DNA Damage/Telomere Stress Induced Senescence;G0 and Early G1;Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes
PDSS1	positive	YRDC	ENSG00000196449	PDSS1	1	PDSS1	1	0.00328279841180112	WBGene00012997	WBGene00012997(1)			GO:0016020;GO:0003725;GO:0005739;GO:0005737;GO:0000049;GO:0016779;GO:0006450;GO:0051051	double-stranded RNA binding;membrane;mitochondrion;cytoplasm;tRNA binding;nucleotidyltransferase activity;regulation of translational fidelity;negative regulation of transport	Membrane;Mitochondrion;Phosphoprotein;Reference proteome;Transit peptide		
PDSS1	positive	METTL1	ENSG00000037897	PDSS1	1	PDSS1	1	0.00348142863833167	WBGene00012205	WBGene00012205(1)			GO:0003723;GO:0005634;GO:0016740;GO:0005730;GO:0005829;GO:0005654;GO:0008168;GO:0008033;GO:0032259;GO:0005515;GO:0006400;GO:0000049;GO:0008176;GO:0106004;GO:0030488;GO:0036265	tRNA modification;tRNA (guanine-N7-)-methyltransferase activity;RNA binding;nucleus;transferase activity;nucleoplasm;nucleolus;cytosol;methyltransferase activity;tRNA processing;methylation;protein binding;tRNA binding;tRNA (guanine-N7)-methylation;tRNA methylation;tRNA methyltransferase complex;RNA (guanine-N7)-methylation	3D-structure;Acetylation;Alternative splicing;Methyltransferase;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;S-adenosyl-L-methionine;Transferase;tRNA processing;tRNA-binding	R-HSA-6782315;R-HSA-72306;R-HSA-8953854	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
PDSS1	positive	FH	ENSG00000091483	PDSS1	1	PDSS1	1	0.00348142863833167	WBGene00001503	WBGene00001503(1)		Fumaric aciduria;HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER;Hereditary pheochromocytoma-paraganglioma;FUMARASE DEFICIENCY;FUMARASE DEFICIENCY;HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	GO:0005634;GO:0005737;GO:0006099;GO:0005739;GO:0003824;GO:0016829;GO:0005694;GO:0005829;GO:0005515;GO:0006281;GO:0006974;GO:0004333;GO:0006106;GO:0048873;GO:0120162;GO:0045239;GO:0070062;GO:0005759;GO:0006108	catalytic activity;lyase activity;tricarboxylic acid cycle;fumarate hydratase activity;fumarate metabolic process;tricarboxylic acid cycle enzyme complex;nucleus;cytoplasm;mitochondrion;chromosome;cytosol;protein binding;DNA repair;cellular response to DNA damage stimulus;malate metabolic process;homeostasis of number of cells within a tissue;positive regulation of cold-induced thermogenesis;extracellular exosome;mitochondrial matrix	3D-structure;Acetylation;Alternative initiation;Chromosome;Cytoplasm;DNA damage;DNA repair;Direct protein sequencing;Disease mutation;Lyase;Mitochondrion;Nucleus;Phosphoprotein;Reference proteome;Transit peptide;Tricarboxylic acid cycle;Tumor suppressor	R-HSA-1430728;R-HSA-1428517;R-HSA-71406;R-HSA-71403	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Pyruvate metabolism and Citric Acid (TCA) cycle;Citric acid cycle (TCA cycle)
PDSS1	positive	HSP90AB1	ENSG00000096384	PDSS1	1	PDSS1	1	0.00348142863833167	WBGene00000915;WBGene00011480	WBGene00000915(1)			GO:0051897;GO:1902949;GO:0043025;GO:0003723;GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0005829;GO:0005739;GO:0006457;GO:0005886;GO:0005515;GO:0005576;GO:0042470;GO:0051082;GO:0038096;GO:0042802;GO:0009986;GO:0034605;GO:0006986;GO:0005654;GO:0045296;GO:0070062;GO:0008180;GO:0071157;GO:0032991;GO:1900034;GO:0006805;GO:0043312;GO:0032435;GO:0034774;GO:1904813;GO:0045597;GO:0030511;GO:0030911;GO:0048471;GO:0048156;GO:1990226;GO:0051973;GO:0007004;GO:0042277;GO:0042826;GO:0019900;GO:0003725;GO:0042803;GO:0046983;GO:2000010;GO:0044295;GO:0033138;GO:0031072;GO:0097718;GO:0030235;GO:0051248;GO:0023026;GO:0050821;GO:0031625;GO:0042623;GO:0070182;GO:0021955;GO:0030010;GO:0031396;GO:0045429;GO:0048675;GO:1903827;GO:1905323;GO:0044294;GO:0043008;GO:0019062;GO:0032516;GO:0051131;GO:0060334;GO:0060338;GO:0097435;GO:1901389;GO:1901799;GO:1904031;GO:0034751;GO:1990565;GO:0002134;GO:0002135;GO:0005525;GO:0008144;GO:0017098;GO:0019887;GO:0019901;GO:0032564;GO:0044183;GO:0044325;GO:0001890;GO:0009651;GO:0010033;GO:0032092;GO:0035690;GO:0042220;GO:0042493;GO:0043066;GO:0043524;GO:0045793;GO:0071353;GO:0071407;GO:0071902;GO:1903660;GO:0005765;GO:0016234;GO:0016323;GO:0016324;GO:0031526;GO:1990913;GO:1990917	ATP binding;protein folding;unfolded protein binding;positive regulation of protein kinase B signaling;positive regulation of tau-protein kinase activity;neuronal cell body;RNA binding;nucleus;cytoplasm;membrane;nucleotide binding;cytosol;mitochondrion;plasma membrane;protein binding;extracellular region;melanosome;Fc-gamma receptor signaling pathway involved in phagocytosis;identical protein binding;cell surface;response to unfolded protein;cellular response to heat;nucleoplasm;cadherin binding;extracellular exosome;COP9 signalosome;negative regulation of cell cycle arrest;protein-containing complex;regulation of cellular response to heat;xenobiotic metabolic process;neutrophil degranulation;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;secretory granule lumen;ficolin-1-rich granule lumen;positive regulation of cell differentiation;positive regulation of transforming growth factor beta receptor signaling pathway;TPR domain binding;perinuclear region of cytoplasm;tau protein binding;histone methyltransferase binding;positive regulation of telomerase activity;telomere maintenance via telomerase;peptide binding;histone deacetylase binding;kinase binding;double-stranded RNA binding;protein dimerization activity;positive regulation of protein localization to cell surface;axonal growth cone;positive regulation of peptidyl-serine phosphorylation;heat shock protein binding;disordered domain specific binding;protein stabilization;nitric-oxide synthase regulator activity;negative regulation of protein metabolic process;MHC class II protein complex binding;protein homodimerization activity;ubiquitin protein ligase binding;ATPase activity, coupled;DNA polymerase binding;central nervous system neuron axonogenesis;establishment of cell polarity;regulation of protein ubiquitination;positive regulation of nitric oxide biosynthetic process;axon extension;regulation of cellular protein localization;telomerase holoenzyme complex assembly;dendritic growth cone;ATP-dependent protein binding;virion attachment to host cell;positive regulation of phosphoprotein phosphatase activity;chaperone-mediated protein complex assembly;regulation of interferon-gamma-mediated signaling pathway;regulation of type I interferon-mediated signaling pathway;supramolecular fiber organization;negative regulation of transforming growth factor beta activation;negative regulation of proteasomal protein catabolic process;positive regulation of cyclin-dependent protein kinase activity;aryl hydrocarbon receptor complex;HSP90-CDC37 chaperone complex;UTP binding;CTP binding;GTP binding;drug binding;sulfonylurea receptor binding;protein kinase regulator activity;protein kinase binding;dATP binding;protein folding chaperone;ion channel binding;placenta development;response to salt stress;response to organic substance;positive regulation of protein binding;cellular response to drug;response to cocaine;positive regulation of protein import into nucleus;response to drug;negative regulation of apoptotic process;negative regulation of neuron apoptotic process;positive regulation of cell size;cellular response to interleukin-4;cellular response to organic cyclic compound;positive regulation of protein serine/threonine kinase activity;negative regulation of complement-dependent cytotoxicity;lysosomal membrane;inclusion body;basolateral plasma membrane;apical plasma membrane;brush border membrane;sperm head plasma membrane;ooplasm	3D-structure;ATP-binding;Acetylation;Cell membrane;Chaperone;Cytoplasm;Direct protein sequencing;Glycoprotein;Membrane;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;S-nitrosylation;Secreted;Stress response;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-2029480;R-HSA-2029482;R-HSA-1266738;R-HSA-1430728;R-HSA-422475;R-HSA-162582;R-HSA-1640170;R-HSA-1643685;R-HSA-5663205;R-HSA-9612973;R-HSA-2262752;R-HSA-453274;R-HSA-69275;R-HSA-69278;R-HSA-8852276;R-HSA-8953897;R-HSA-211859;R-HSA-3371497;R-HSA-3371556;R-HSA-8939211;R-HSA-9006931;R-HSA-211945;R-HSA-8937144;R-HSA-6798695;R-HSA-9018519;R-HSA-373755;R-HSA-5339562;R-HSA-399954;R-HSA-168643;R-HSA-622312;R-HSA-844456;R-HSA-9613829;R-HSA-3371511;R-HSA-3371568;R-HSA-3371571;R-HSA-5336415	Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Developmental Biology;Metabolism;Axon guidance;Signal Transduction;Cell Cycle;Disease;Infectious disease;Autophagy;Cellular responses to stress;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Cellular responses to external stimuli;Biological oxidations;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular response to heat stress;ESR-mediated signaling;Signaling by Nuclear Receptors;Phase I - Functionalization of compounds;Aryl hydrocarbon receptor signalling;Neutrophil degranulation;Estrogen-dependent gene expression;Semaphorin interactions;Uptake and actions of bacterial toxins;Sema3A PAK dependent Axon repulsion;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Inflammasomes;The NLRP3 inflammasome;Chaperone Mediated Autophagy;HSF1 activation;Attenuation phase;HSF1-dependent transactivation;Uptake and function of diphtheria toxin
PDSS1	positive	DSCC1	ENSG00000136982	PDSS1	1	PDSS1	1	0.00348142863833167	WBGene00019595	WBGene00019595(0)			GO:0005634;GO:0003677;GO:0032508;GO:0007049;GO:0006260;GO:0005654;GO:0000775;GO:0005515;GO:0007064;GO:0031390;GO:0000785;GO:0006275;GO:0017116;GO:0003689;GO:1900264;GO:0034421;GO:0034088	mitotic sister chromatid cohesion;Ctf18 RFC-like complex;nucleus;DNA binding;DNA duplex unwinding;cell cycle;DNA replication;nucleoplasm;protein binding;chromosome, centromeric region;chromatin;regulation of DNA replication;single-stranded DNA helicase activity;DNA clamp loader activity;positive regulation of DNA-directed DNA polymerase activity;post-translational protein acetylation;maintenance of mitotic sister chromatid cohesion	Cell cycle;DNA replication;DNA-binding;Nucleus;Polymorphism;Reference proteome		
PDSS1	positive	DLAT	ENSG00000150768	PDSS1	1	PDSS1	1	0.00348142863833167	WBGene00009082	WBGene00009082(1)		PYRUVATE DEHYDROGENASE E2 DEFICIENCY;PYRUVATE DEHYDROGENASE E2 DEFICIENCY;PYRUVATE DEHYDROGENASE E2 DEFICIENCY	GO:0016740;GO:0006099;GO:0005739;GO:0005759;GO:0016746;GO:0005515;GO:0005975;GO:0006090;GO:0042802;GO:0006006;GO:0004742;GO:0030523;GO:0045254;GO:0034604;GO:0006086;GO:0030431;GO:0005967	transferase activity, transferring acyl groups;pyruvate metabolic process;dihydrolipoyllysine-residue acetyltransferase activity;pyruvate dehydrogenase complex;transferase activity;tricarboxylic acid cycle;mitochondrion;mitochondrial matrix;protein binding;carbohydrate metabolic process;identical protein binding;glucose metabolic process;dihydrolipoamide S-acyltransferase activity;pyruvate dehydrogenase (NAD+) activity;acetyl-CoA biosynthetic process from pyruvate;sleep;mitochondrial pyruvate dehydrogenase complex	3D-structure;Acetylation;Acyltransferase;Carbohydrate metabolism;Glucose metabolism;Lipoyl;Mitochondrion;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transferase;Transit peptide;Tricarboxylic acid cycle	R-HSA-1430728;R-HSA-162582;R-HSA-71291;R-HSA-389661;R-HSA-9006931;R-HSA-1428517;R-HSA-204174;R-HSA-5362517;R-HSA-70268;R-HSA-71406	Metabolism;Signal Transduction;Metabolism of amino acids and derivatives;Glyoxylate metabolism and glycine degradation;Signaling by Nuclear Receptors;The citric acid (TCA) cycle and respiratory electron transport;Regulation of pyruvate dehydrogenase (PDH) complex;Signaling by Retinoic Acid;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
PDSS1	positive	GEMIN6	ENSG00000152147	PDSS1	1	PDSS1	1	0.00348142863833167		WBGene00017002(0)			GO:0005634;GO:0000245;GO:0006397;GO:0008380;GO:0005737;GO:0005654;GO:0005829;GO:0005515;GO:0016604;GO:0000387;GO:0000398;GO:0032797;GO:0051170;GO:0034719;GO:0097504	nucleus;spliceosomal complex assembly;mRNA processing;RNA splicing;cytoplasm;nucleoplasm;cytosol;protein binding;nuclear body;spliceosomal snRNP assembly;mRNA splicing, via spliceosome;SMN complex;import into nucleus;SMN-Sm protein complex;Gemini of coiled bodies	3D-structure;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-191859;R-HSA-194441	Metabolism of RNA;snRNP Assembly;Metabolism of non-coding RNA
PDSS1	positive	SUV39H2	ENSG00000152455	PDSS1	1	PDSS1	1	0.00348142863833167	WBGene00018023	WBGene00019584(0);WBGene00018023(0);WBGene00008527(0);WBGene00019690(0);WBGene00020919(0);WBGene00016603(0);WBGene00021282(0);WBGene00022431(0);WBGene00008062(0);WBGene00008206(0);WBGene00020006(0)			GO:0005634;GO:0046872;GO:0018024;GO:0034968;GO:0005515;GO:0008270;GO:0016740;GO:0008168;GO:0032259;GO:0006325;GO:0005694;GO:0007049;GO:0048511;GO:0030154;GO:0000775;GO:0005654;GO:0045892;GO:0000785;GO:0000976;GO:0006338;GO:0042754;GO:0046974;GO:0000122;GO:0036123;GO:0036124;GO:0071456;GO:1904047;GO:0006333	nucleus;protein binding;histone-lysine N-methyltransferase activity;histone lysine methylation;metal ion binding;zinc ion binding;transferase activity;methyltransferase activity;methylation;chromatin organization;chromosome;cell cycle;rhythmic process;cell differentiation;chromosome, centromeric region;nucleoplasm;negative regulation of transcription, DNA-templated;chromatin;transcription regulatory region sequence-specific DNA binding;chromatin remodeling;negative regulation of circadian rhythm;histone methyltransferase activity (H3-K9 specific);negative regulation of transcription by RNA polymerase II;histone H3-K9 dimethylation;histone H3-K9 trimethylation;cellular response to hypoxia;S-adenosyl-L-methionine binding;chromatin assembly or disassembly	3D-structure;Alternative splicing;Biological rhythms;Cell cycle;Centromere;Chromatin regulator;Chromosome;Differentiation;Metal-binding;Methyltransferase;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Zinc	R-HSA-3247509;R-HSA-4839726;R-HSA-3214841	Chromatin modifying enzymes;Chromatin organization;PKMTs methylate histone lysines
PDSS1	positive	LRP8	ENSG00000157193	PDSS1	1	PDSS1	1	0.00348142863833167	WBGene00020481			MYOCARDIAL INFARCTION SUSCEPTIBILITY TO MYOCARDIAL INFARCTION SUSCEPTIBILITY TO 1 INCLUDED	GO:0016020;GO:0016021;GO:0005509;GO:0006629;GO:0005886;GO:0005515;GO:0006508;GO:0005576;GO:0006897;GO:0042981;GO:0050731;GO:0007165;GO:0001523;GO:0004888;GO:0019221;GO:0043235;GO:0005901;GO:1900006;GO:0034185;GO:0005041;GO:0030229;GO:0038024;GO:0045088;GO:0061098;GO:0032793;GO:0038026;GO:0050804;GO:0061003;GO:0038025;GO:0008035;GO:0019894;GO:0021541;GO:0021987;GO:0042493;GO:0071363;GO:0071397;GO:0005875;GO:0014069;GO:0030424;GO:0030425;GO:0043025	protein binding;calcium ion binding;membrane;integral component of membrane;lipid metabolic process;plasma membrane;proteolysis;extracellular region;regulation of innate immune response;endocytosis;regulation of apoptotic process;positive regulation of peptidyl-tyrosine phosphorylation;signal transduction;retinoid metabolic process;transmembrane signaling receptor activity;cytokine-mediated signaling pathway;receptor complex;caveola;positive regulation of dendrite development;apolipoprotein binding;low-density lipoprotein particle receptor activity;very-low-density lipoprotein particle receptor activity;cargo receptor activity;positive regulation of protein tyrosine kinase activity;positive regulation of CREB transcription factor activity;reelin-mediated signaling pathway;modulation of chemical synaptic transmission;positive regulation of dendritic spine morphogenesis;reelin receptor activity;high-density lipoprotein particle binding;kinesin binding;ammon gyrus development;cerebral cortex development;response to drug;cellular response to growth factor stimulus;cellular response to cholesterol;microtubule associated complex;postsynaptic density;axon;dendrite;neuronal cell body	3D-structure;Alternative splicing;Calcium;Cell membrane;Disulfide bond;EGF-like domain;Endocytosis;Glycoprotein;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix;Ubl conjugation	R-HSA-109582;R-HSA-1430728;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418594;R-HSA-418346;R-HSA-196854;R-HSA-2187338;R-HSA-6806667;R-HSA-975634;R-HSA-432142	Hemostasis;Metabolism;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Platelet homeostasis;Metabolism of vitamins and cofactors;Visual phototransduction;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport;Platelet sensitization by LDL
PDSS1	positive	CCNB2	ENSG00000157456	PDSS1	1	PDSS1	1	0.00348142863833167	WBGene00000865;WBGene00000867;WBGene00000866;WBGene00000863	WBGene00000867(0);WBGene00000866(0);WBGene00000865(0)			GO:0005634;GO:0005829;GO:0006468;GO:0051301;GO:0005515;GO:0007049;GO:0005813;GO:0005737;GO:0045296;GO:0019901;GO:0000086;GO:0004672;GO:0016538;GO:0015630;GO:0000079;GO:0001701;GO:0007077;GO:0040008;GO:0043029;GO:0044772;GO:0048538;GO:0051726;GO:0000307;GO:0016020	nucleus;cytosol;protein phosphorylation;cell division;protein binding;cell cycle;centrosome;cytoplasm;cadherin binding;protein kinase binding;G2/M transition of mitotic cell cycle;protein kinase activity;cyclin-dependent protein serine/threonine kinase regulator activity;microtubule cytoskeleton;regulation of cyclin-dependent protein serine/threonine kinase activity;in utero embryonic development;mitotic nuclear envelope disassembly;regulation of growth;T cell homeostasis;mitotic cell cycle phase transition;thymus development;regulation of cell cycle;cyclin-dependent protein kinase holoenzyme complex;membrane	Cell cycle;Cell division;Cyclin;Mitosis;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-453274;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-69481;R-HSA-69620;R-HSA-8852276;R-HSA-2500257;R-HSA-68877;R-HSA-2980766;R-HSA-3301854;R-HSA-68875;R-HSA-2565942;R-HSA-69273;R-HSA-162658;R-HSA-156711;R-HSA-2514853;R-HSA-2980767;R-HSA-69478	Cell Cycle;Mitotic G2-G2/M phases;M Phase;G2/M Transition;Cell Cycle, Mitotic;G2/M Checkpoints;Cell Cycle Checkpoints;The role of GTSE1 in G2/M progression after G2 checkpoint;Resolution of Sister Chromatid Cohesion;Mitotic Prometaphase;Nuclear Envelope Breakdown;Nuclear Pore Complex (NPC) Disassembly;Mitotic Prophase;Regulation of PLK1 Activity at G2/M Transition;Cyclin A/B1/B2 associated events during G2/M transition;Golgi Cisternae Pericentriolar Stack Reorganization;Polo-like kinase mediated events;Condensation of Prometaphase Chromosomes;Activation of NIMA Kinases NEK9, NEK6, NEK7;G2/M DNA replication checkpoint
PDSS1	positive	GART	ENSG00000159131	PDSS1	1	PDSS1	1	0.00348142863833167	WBGene00018174	WBGene00018174(0)			GO:0046872;GO:0000166;GO:0005524;GO:0016740;GO:0009058;GO:0016874;GO:0003824;GO:0008152;GO:0006164;GO:0006189;GO:0005829;GO:0016742;GO:0004644;GO:0070062;GO:0009113;GO:0004637;GO:0009168;GO:0004641;GO:0003360;GO:0006544;GO:0009156;GO:0010033;GO:0010035;GO:0021549;GO:0021987;GO:0046654	metal ion binding;'de novo' IMP biosynthetic process;ATP binding;phosphoribosylamine-glycine ligase activity;purine nucleobase biosynthetic process;biosynthetic process;hydroxymethyl-, formyl- and related transferase activity;phosphoribosylglycinamide formyltransferase activity;phosphoribosylformylglycinamidine cyclo-ligase activity;nucleotide binding;transferase activity;ligase activity;catalytic activity;metabolic process;purine nucleotide biosynthetic process;cytosol;extracellular exosome;purine ribonucleoside monophosphate biosynthetic process;adenine biosynthetic process;brainstem development;glycine metabolic process;ribonucleoside monophosphate biosynthetic process;response to organic substance;response to inorganic substance;cerebellum development;cerebral cortex development;tetrahydrofolate biosynthetic process	3D-structure;ATP-binding;Acetylation;Alternative splicing;Ligase;Manganese;Metal-binding;Multifunctional enzyme;Nucleotide-binding;Phosphoprotein;Polymorphism;Purine biosynthesis;Reference proteome;Transferase	R-HSA-1430728;R-HSA-15869;R-HSA-73817;R-HSA-8956320	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
PDSS1	positive	SRSF2	ENSG00000161547	PDSS1	1	PDSS1	1	0.00348142863833167	WBGene00004701	WBGene00004701(0)			GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0016607;GO:0005829;GO:0005515;GO:0000381;GO:1903507;GO:0005654;GO:0003714;GO:0006406;GO:0006405;GO:0031124;GO:0000398;GO:0045292;GO:0043484	RNA binding;nucleic acid binding;regulation of alternative mRNA splicing, via spliceosome;mRNA processing;RNA splicing;nucleus;nuclear speck;nucleoplasm;cytosol;protein binding;negative regulation of nucleic acid-templated transcription;cytoplasm;transcription corepressor activity;mRNA export from nucleus;RNA export from nucleus;mRNA 3'-end processing;mRNA splicing, via spliceosome;mRNA cis splicing, via spliceosome;protein kinase C binding;pre-mRNA binding;mitotic cell cycle;response to vitamin E;spliceosomal complex;interchromatin granule	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;mRNA processing;mRNA splicing	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-159236;R-HSA-72202;R-HSA-72203;R-HSA-72187;R-HSA-73856;R-HSA-72163;R-HSA-72172;R-HSA-72165	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA Splicing - Minor Pathway
PDSS1	positive	CHRNA5	ENSG00000169684	PDSS1	1	PDSS1	1	0.00348142863833167	WBGene00000042;WBGene00000043;WBGene00000045;WBGene00000047;WBGene00000051;WBGene00002974;WBGene00002975;WBGene00006765;WBGene00006774;WBGene00006797			SMOKING AS A QUANTITATIVE TRAIT LOCUS 3	GO:0016020;GO:0016021;GO:0005216;GO:0006811;GO:0005886;GO:0005515;GO:0007165;GO:0004888;GO:0030054;GO:0045202;GO:0045211;GO:0005230;GO:0034220;GO:0060079;GO:0005887;GO:0022848;GO:0060078;GO:0015464;GO:0042166;GO:0007268;GO:0007271;GO:0042391;GO:0050877;GO:0005892;GO:0043005;GO:0007274;GO:0035094;GO:0035095;GO:0015276;GO:2000300;GO:0098691	integral component of membrane;ion transport;ion channel activity;acetylcholine-gated cation-selective channel activity;postsynaptic membrane;transmembrane signaling receptor activity;ion transmembrane transport;extracellular ligand-gated ion channel activity;membrane;plasma membrane;protein binding;signal transduction;cell junction;synapse;excitatory postsynaptic potential;integral component of plasma membrane;regulation of postsynaptic membrane potential;acetylcholine binding;chemical synaptic transmission;synaptic transmission, cholinergic;regulation of membrane potential;nervous system process;acetylcholine-gated channel complex;neuron projection;neuromuscular synaptic transmission;acetylcholine receptor activity;response to nicotine;behavioral response to nicotine;ligand-gated ion channel activity;regulation of synaptic vesicle exocytosis;dopaminergic synapse	Cell junction;Cell membrane;Disulfide bond;Glycoprotein;Ion channel;Ion transport;Ligand-gated ion channel;Membrane;Polymorphism;Postsynaptic cell membrane;Receptor;Reference proteome;Signal;Synapse;Transmembrane;Transmembrane helix;Transport	R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-181431;R-HSA-622323;R-HSA-622327;R-HSA-629594;R-HSA-629597	Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Acetylcholine binding and downstream events;Presynaptic nicotinic acetylcholine receptors;Postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable postsynaptic nicotinic acetylcholine receptors;Highly calcium permeable nicotinic acetylcholine receptors
PDSS1	positive	CENPQ	ENSG00000031691	PDSS1	1	PDSS1	1	0.00369078794901478					GO:0005634;GO:0005654;GO:0005694;GO:0015629;GO:0000775;GO:0005829;GO:0034080;GO:0000776;GO:0051310;GO:1905342	cell;nucleus;nucleoplasm;chromosome;actin cytoskeleton;chromosome, centromeric region;cytosol;CENP-A containing nucleosome assembly;kinetochore;metaphase plate congression;positive regulation of protein localization to kinetochore	Centromere;Chromosome;Coiled coil;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-606279;R-HSA-73886;R-HSA-774815;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	BIRC5	ENSG00000089685	PDSS1	1	PDSS1	1	0.00369078794901478	WBGene00000249;WBGene00000250	WBGene00000250(0)			GO:0000226;GO:0007346;GO:0043066;GO:0043524;GO:0061178;GO:0061469;GO:0005737;GO:0005634;GO:0046872;GO:0051301;GO:0005694;GO:0005829;GO:0005856;GO:0005515;GO:0007049;GO:0006915;GO:0005874;GO:0008017;GO:0005819;GO:0030496;GO:0042802;GO:0007059;GO:0000775;GO:0000776;GO:0000777;GO:0030414;GO:0010466;GO:0005654;GO:0007605;GO:0008536;GO:0008284;GO:0019899;GO:0042981;GO:0045892;GO:0006468;GO:0019221;GO:0051087;GO:0005876;GO:0090307;GO:0004869;GO:0043027;GO:0031503;GO:0043154;GO:0000228;GO:0032133	microtubule cytoskeleton organization;regulation of mitotic cell cycle;negative regulation of apoptotic process;negative regulation of neuron apoptotic process;regulation of insulin secretion involved in cellular response to glucose stimulus;regulation of type B pancreatic cell proliferation;cytoplasm;nucleus;metal ion binding;cytoskeleton;cell division;chromosome;cytosol;protein binding;cell cycle;apoptotic process;microtubule;microtubule binding;spindle;midbody;identical protein binding;chromosome segregation;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;peptidase inhibitor activity;negative regulation of peptidase activity;nucleoplasm;sensory perception of sound;Ran GTPase binding;positive regulation of cell population proliferation;enzyme binding;regulation of apoptotic process;negative regulation of transcription, DNA-templated;protein phosphorylation;cytokine-mediated signaling pathway;chaperone binding;mitotic spindle assembly;cysteine-type endopeptidase inhibitor activity;cysteine-type endopeptidase inhibitor activity involved in apoptotic process;protein-containing complex localization;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;nuclear chromosome;spindle microtubule;chromosome passenger complex	3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Cytoplasm;Cytoskeleton;Kinetochore;Metal-binding;Microtubule;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Protease inhibitor;Reference proteome;Repressor;Thiol protease inhibitor;Transcription;Transcription regulation;Ubl conjugation;Zinc	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-1280215;R-HSA-2467813;R-HSA-2555396;R-HSA-449147;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-8951664;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-2990846;R-HSA-3108232;R-HSA-4615885;R-HSA-141424;R-HSA-141444;R-HSA-69618;R-HSA-5633008;R-HSA-6785807;R-HSA-6803205	Immune System;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Cytokine Signaling in Immune system;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Signaling by Interleukins;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;Neddylation;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of DNA replication proteins;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint;TP53 Regulates Transcription of Cell Death Genes;Interleukin-4 and Interleukin-13 signaling;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
PDSS1	positive	KIF4A	ENSG00000090889	PDSS1	1	PDSS1	1	0.00369078794901478	WBGene00002229			Intellectual disability;Mental retardation X-linked 100	GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0005654;GO:0003677;GO:0005694;GO:1904115;GO:0045171;GO:0003777;GO:0005856;GO:0005515;GO:0008017;GO:0005874;GO:0007018;GO:0005819;GO:0030496;GO:0016887;GO:0005829;GO:0006890;GO:0019886;GO:0005871;GO:0016363;GO:0000281;GO:0007052;GO:0008089;GO:0005876;GO:0006996;GO:0051256	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;nucleus;cytoplasm;membrane;nucleotide binding;nucleoplasm;DNA binding;cytoskeleton;chromosome;axon cytoplasm;protein binding;microtubule;spindle;midbody;ATPase activity;cytosol;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;antigen processing and presentation of exogenous peptide antigen via MHC class II;kinesin complex;nuclear matrix;mitotic cytokinesis;mitotic spindle organization;anterograde axonal transport;spindle microtubule;organelle organization;mitotic spindle midzone assembly	ATP-binding;Alternative splicing;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;DNA-binding;Isopeptide bond;Mental retardation;Microtubule;Motor protein;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-437239;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-2132295;R-HSA-983189;R-HSA-983231	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Developmental Biology;L1CAM interactions;Axon guidance;Recycling pathway of L1;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;MHC class II antigen presentation;Kinesins;Factors involved in megakaryocyte development and platelet production
PDSS1	positive	PRMT5	ENSG00000100462	PDSS1	1	PDSS1	1	0.00369078794901478	WBGene00016408	WBGene00016408(0)			GO:0005634;GO:0005737;GO:0016740;GO:0005829;GO:0008168;GO:0032259;GO:0005794;GO:0006325;GO:0005515;GO:0048511;GO:1903507;GO:0032922;GO:0044020;GO:0000387;GO:0006479;GO:0019918;GO:0042802;GO:0003714;GO:0005654;GO:0043021;GO:0035246;GO:1901796;GO:0070888;GO:0090161;GO:0002039;GO:0008327;GO:0008469;GO:0016274;GO:0035243;GO:0044877;GO:0046982;GO:0006353;GO:0007088;GO:0018216;GO:0034969;GO:0042118;GO:0043985;GO:0044030;GO:0045596;GO:0048714;GO:0070372;GO:0097421;GO:1904992;GO:0032991;GO:0034709;GO:0035097	methyltransferase activity;protein methylation;peptidyl-arginine N-methylation;nucleus;cytoplasm;transferase activity;nucleoplasm;cytosol;methylation;Golgi apparatus;chromatin organization;protein binding;rhythmic process;negative regulation of nucleic acid-templated transcription;circadian regulation of gene expression;histone methyltransferase activity (H4-R3 specific);spliceosomal snRNP assembly;peptidyl-arginine methylation, to symmetrical-dimethyl arginine;identical protein binding;regulation of transcription, DNA-templated;transcription corepressor activity;ribonucleoprotein complex binding;protein-arginine omega-N symmetric methyltransferase activity;regulation of signal transduction by p53 class mediator;E-box binding;Golgi ribbon formation;p53 binding;methyl-CpG binding;histone-arginine N-methyltransferase activity;protein-arginine N-methyltransferase activity;protein-containing complex binding;protein heterodimerization activity;DNA-templated transcription, termination;regulation of mitotic nuclear division;peptidyl-arginine methylation;histone arginine methylation;endothelial cell activation;histone H4-R3 methylation;regulation of DNA methylation;negative regulation of cell differentiation;positive regulation of oligodendrocyte differentiation;regulation of ERK1 and ERK2 cascade;liver regeneration;positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway;protein-containing complex;methylosome;histone methyltransferase complex	3D-structure;Acetylation;Alternative splicing;Biological rhythms;Chromatin regulator;Cytoplasm;Direct protein sequencing;Golgi apparatus;Methyltransferase;Nucleus;Reference proteome;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-191859;R-HSA-194441;R-HSA-5633007;R-HSA-3247509;R-HSA-4839726;R-HSA-3214858;R-HSA-6804760	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;snRNP Assembly;Metabolism of non-coding RNA;Regulation of TP53 Activity;Chromatin modifying enzymes;Chromatin organization;RMTs methylate histone arginines;Regulation of TP53 Activity through Methylation
PDSS1	positive	PSMA3	ENSG00000100567	PDSS1	1	PDSS1	1	0.00369078794901478	WBGene00003928	WBGene00003928(1)			GO:0005634;GO:0005737;GO:0016787;GO:0005515;GO:0008233;GO:0006508;GO:0000502;GO:0006511;GO:0004175;GO:0004298;GO:0051603;GO:0005839;GO:0019773;GO:0038095;GO:0050852;GO:0045202;GO:0005654;GO:0005829;GO:0070062;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010498;GO:0010499;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043161;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0016032;GO:0052548;GO:0031625	endopeptidase activity;proteolysis involved in cellular protein catabolic process;proteasome core complex;ubiquitin-dependent protein catabolic process;proteasome core complex, alpha-subunit complex;threonine-type endopeptidase activity;nucleus;cytoplasm;hydrolase activity;protein binding;peptidase activity;proteolysis;proteasome complex;Fc-epsilon receptor signaling pathway;T cell receptor signaling pathway;synapse;nucleoplasm;cytosol;extracellular exosome;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;proteasomal protein catabolic process;proteasomal ubiquitin-independent protein catabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;viral process;regulation of endopeptidase activity;ubiquitin protein ligase binding	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Host-virus interaction;Hydrolase;Nucleus;Phosphoprotein;Polymorphism;Protease;Proteasome;Reference proteome;Threonine protease	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
PDSS1	positive	NAT10	ENSG00000135372	PDSS1	1	PDSS1	1	0.00369078794901478	WBGene00018866	WBGene00018866(1)			GO:0003723;GO:0005634;GO:0016020;GO:0000166;GO:0005524;GO:0016740;GO:0005730;GO:0008033;GO:0016746;GO:0005515;GO:0030496;GO:0008080;GO:0045727;GO:0006364;GO:0000154;GO:0016072;GO:0034470;GO:0042274;GO:0051391;GO:0005654;GO:0000784;GO:0005697;GO:0070182;GO:0032211;GO:0106162;GO:1990883;GO:1904812	ATP binding;N-acetyltransferase activity;rRNA metabolic process;ncRNA processing;RNA binding;nucleus;membrane;nucleotide binding;transferase activity;nucleolus;tRNA processing;transferase activity, transferring acyl groups;protein binding;midbody;rRNA modification;rRNA processing;ribosomal small subunit biogenesis;tRNA acetylation;nucleoplasm;tRNA binding;nuclear chromosome, telomeric region;positive regulation of translation;telomerase holoenzyme complex;DNA polymerase binding;negative regulation of telomere maintenance via telomerase;mRNA N-acetyltransferase activity;rRNA cytidine N-acetyltransferase activity;rRNA acetylation involved in maturation of SSU-rRNA	ATP-binding;Acetylation;Acyltransferase;Alternative splicing;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transferase;rRNA processing;tRNA processing	R-HSA-8953854;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
PDSS1	positive	BORA	ENSG00000136122	PDSS1	1	PDSS1	1	0.00369078794901478		WBGene00010198(0)			GO:0051301;GO:0005515;GO:0007049;GO:0005634;GO:0005737;GO:0005829;GO:0019901;GO:0000086;GO:0032147;GO:0007088;GO:0032880;GO:0060236;GO:0072687	cell division;protein binding;cell cycle;nucleus;cytoplasm;cytosol;protein kinase binding;G2/M transition of mitotic cell cycle;activation of protein kinase activity;regulation of mitotic nuclear division;regulation of protein localization;regulation of mitotic spindle organization;meiotic spindle	Alternative splicing;Cell cycle;Cell division;Mitosis;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-453274;R-HSA-69275;R-HSA-69278;R-HSA-2565942	Cell Cycle;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic;Regulation of PLK1 Activity at G2/M Transition
PDSS1	positive	SPC25	ENSG00000152253	PDSS1	1	PDSS1	1	0.00369078794901478					GO:0005634;GO:0005829;GO:0051301;GO:0005694;GO:0005515;GO:0007049;GO:0007059;GO:0000775;GO:0000776;GO:0000777;GO:0007052;GO:0031262	nucleus;cytosol;cell division;chromosome;protein binding;cell cycle;chromosome segregation;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;mitotic spindle organization;Ndc80 complex	3D-structure;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	CHAF1B	ENSG00000159259	PDSS1	1	PDSS1	1	0.00369078794901478	WBGene00022141	WBGene00022141(1)			GO:0005634;GO:0005737;GO:0005654;GO:0000790;GO:0005829;GO:0005515;GO:0006281;GO:0006974;GO:0007049;GO:0006260;GO:0042393;GO:0032991;GO:0051082;GO:0006335;GO:0003682;GO:0006334;GO:0031497;GO:0033186	protein binding;nucleus;cytoplasm;nucleoplasm;nuclear chromatin;cytosol;DNA repair;cellular response to DNA damage stimulus;cell cycle;DNA replication;histone binding;protein-containing complex;unfolded protein binding;DNA replication-dependent nucleosome assembly;chromatin binding;nucleosome assembly;chromatin assembly;CAF-1 complex	Acetylation;Cell cycle;Cytoplasm;DNA damage;DNA repair;DNA replication;Direct protein sequencing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;WD repeat		
PDSS1	positive	PSMD13	ENSG00000185627	PDSS1	1	PDSS1	1	0.00369078794901478	WBGene00004465	WBGene00004465(1)			GO:0005634;GO:0016020;GO:0000502;GO:0038095;GO:0005576;GO:0022624;GO:0050852;GO:0005829;GO:0006511;GO:0005654;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043161;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0043312;GO:0005198;GO:0043248;GO:0008541;GO:0034774;GO:1904813;GO:0005838;GO:0007127	nucleus;membrane;proteasome complex;Fc-epsilon receptor signaling pathway;extracellular region;cytosol;proteasome accessory complex;T cell receptor signaling pathway;ubiquitin-dependent protein catabolic process;nucleoplasm;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;structural molecule activity;neutrophil degranulation;proteasome assembly;proteasome regulatory particle, lid subcomplex;secretory granule lumen;ficolin-1-rich granule lumen;proteasome regulatory particle;meiosis I	3D-structure;Acetylation;Alternative splicing;Polymorphism;Proteasome;Reference proteome	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-6798695;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Neutrophil degranulation;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
PDSS1	positive	HSPA14	ENSG00000187522	PDSS1	1	PDSS1	1	0.00369078794901478	WBGene00009691;WBGene00008714	WBGene00009691(0);WBGene00009692(0);WBGene00002026(0)			GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0005840;GO:0005829;GO:0002181;GO:0051082;GO:0042026;GO:0016887;GO:0005515;GO:0034605;GO:0005844;GO:0051085;GO:0031072;GO:0042623;GO:0044183;GO:0051787;GO:0006986;GO:0034620;GO:0006450;GO:0051083	cytoplasm;membrane;nucleotide binding;ATP binding;ribosome;cytosol;cytoplasmic translation;unfolded protein binding;protein refolding;protein binding;ATPase activity;polysome;chaperone cofactor-dependent protein refolding;heat shock protein binding;ATPase activity, coupled;protein folding chaperone;misfolded protein binding;response to unfolded protein;cellular response to unfolded protein;regulation of translational fidelity;'de novo' cotranslational protein folding	ATP-binding;Chaperone;Cytoplasm;Nucleotide-binding;Polymorphism;Reference proteome	R-HSA-2262752;R-HSA-8953897;R-HSA-3371453;R-HSA-3371556	Cellular responses to stress;Cellular responses to external stimuli;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress
PDSS1	positive	WDHD1	ENSG00000198554	PDSS1	1	PDSS1	1	0.00369078794901478	WBGene00008921	WBGene00008921(0)			GO:0005634;GO:0003677;GO:0005515;GO:0005654;GO:0006357;GO:0006261;GO:0000278;GO:0006281;GO:0000981;GO:0006974;GO:0003682;GO:0005737;GO:0031298;GO:0043596	protein binding;nucleus;nucleoplasm;DNA binding;DNA-dependent DNA replication;mitotic cell cycle;DNA repair;cellular response to DNA damage stimulus;chromatin binding;cytoplasm;replication fork protection complex;nuclear replication fork	3D-structure;Acetylation;Alternative splicing;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation;WD repeat		
PDSS1	positive	BYSL	ENSG00000112578	PDSS1	1	PDSS1	1	0.00391137203447745	WBGene00000276	WBGene00000276(1)			GO:0003723;GO:0005634;GO:0005737;GO:0016020;GO:0043231;GO:0005730;GO:0005515;GO:0042254;GO:0030688;GO:0005654;GO:0005829;GO:0030515;GO:1904749;GO:0006364;GO:0000462;GO:0001701;GO:0001825;GO:0001829;GO:0008283;GO:0045177	RNA binding;nucleus;cytoplasm;membrane;intracellular membrane-bounded organelle;nucleoplasm;nucleolus;protein binding;ribosome biogenesis;preribosome, small subunit precursor;cytosol;snoRNA binding;regulation of protein localization to nucleolus;rRNA processing;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);in utero embryonic development;blastocyst formation;trophectodermal cell differentiation;cell population proliferation;apical part of cell	3D-structure;Cytoplasm;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ribosome biogenesis	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol
PDSS1	positive	KIF14	ENSG00000118193	PDSS1	1	PDSS1	1	0.00391137203447745				Autosomal recessive primary microcephaly;Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome;Meckel syndrome 12;MICROCEPHALY 20 PRIMARY AUTOSOMAL RECESSIVE	GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0043066;GO:0005829;GO:0005886;GO:0003777;GO:0005856;GO:0005515;GO:0008017;GO:0005874;GO:0007018;GO:0005819;GO:0030496;GO:0016887;GO:0019901;GO:0030705;GO:0051233;GO:0021987;GO:0008284;GO:0090543;GO:0005871;GO:0001558;GO:0043524;GO:0043161;GO:0015631;GO:0021693;GO:0032467;GO:2000045;GO:0007080;GO:0043523;GO:0030155;GO:0031641;GO:0032147;GO:0021846;GO:0021766;GO:0045184;GO:0031146;GO:0010389;GO:0030165;GO:0021772;GO:0008574;GO:0021685;GO:0021695;GO:0030334;GO:0032487;GO:0033624;GO:0034446;GO:0051301;GO:1903429	ATP binding;protein binding;microtubule binding;microtubule motor activity;microtubule-based movement;cell;nucleus;cytoplasm;membrane;nucleotide binding;negative regulation of apoptotic process;cytosol;cytoskeleton;plasma membrane;microtubule;ATPase activity;Flemming body;spindle;midbody;protein kinase binding;cytoskeleton-dependent intracellular transport;spindle midzone;cerebral cortex development;positive regulation of cell population proliferation;kinesin complex;regulation of cell growth;negative regulation of neuron apoptotic process;proteasome-mediated ubiquitin-dependent protein catabolic process;tubulin binding;positive regulation of cytokinesis;regulation of G1/S transition of mitotic cell cycle;mitotic metaphase plate congression;regulation of neuron apoptotic process;regulation of cell adhesion;regulation of myelination;activation of protein kinase activity;cell proliferation in forebrain;hippocampus development;establishment of protein localization;olfactory bulb development;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;regulation of G2/M transition of mitotic cell cycle;PDZ domain binding;ATP-dependent microtubule motor activity, plus-end-directed;cerebellar granular layer structural organization;cerebellar cortex development;regulation of cell migration;regulation of Rap protein signal transduction;negative regulation of integrin activation;substrate adhesion-dependent cell spreading;cell division;regulation of cell maturation	ATP-binding;Ciliopathy;Coiled coil;Cytoplasm;Cytoskeleton;Disease mutation;Meckel syndrome;Microtubule;Motor protein;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Primary microcephaly;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-195258;R-HSA-5625900	Signal Transduction;Signaling by Rho GTPases;RHO GTPase Effectors;RHO GTPases activate CIT
PDSS1	positive	TUBG1	ENSG00000131462	PDSS1	1	PDSS1	1	0.00391137203447745	WBGene00006540	WBGene00006539(0);WBGene00000248(0);WBGene00006536(0);WBGene00006537(0)		Posteriorly predominant pachygyria and severe microcephaly;Cortical dysplasia complex with other brain malformations 4	GO:0000166;GO:0003924;GO:0005525;GO:0005874;GO:0007017;GO:0007020;GO:0031122;GO:0000930;GO:0005737;GO:0005856;GO:0005515;GO:0005813;GO:0005815;GO:0005634;GO:0042802;GO:0005200;GO:0000226;GO:0000278;GO:0005829;GO:0055037;GO:0000086;GO:0010389;GO:0097711;GO:0005819;GO:0000794;GO:0007052;GO:0000070;GO:0000212;GO:0000242;GO:0005814;GO:0005827;GO:0005876;GO:0005881;GO:0005929;GO:0031252;GO:0036064;GO:0045177;GO:0097730	GTP binding;microtubule-based process;microtubule;GTPase activity;microtubule nucleation;cytoplasmic microtubule organization;gamma-tubulin complex;cytoplasm;nucleotide binding;cytoskeleton;protein binding;centrosome;microtubule organizing center;nucleus;identical protein binding;structural constituent of cytoskeleton;microtubule cytoskeleton organization;mitotic cell cycle;cytosol;recycling endosome;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking;spindle;condensed nuclear chromosome;mitotic spindle organization;mitotic sister chromatid segregation;meiotic spindle organization;pericentriolar material;centriole;polar microtubule;spindle microtubule;cytoplasmic microtubule;cilium;cell leading edge;ciliary basal body;apical part of cell;non-motile cilium	3D-structure;Cytoplasm;Cytoskeleton;Disease mutation;GTP-binding;Lissencephaly;Microtubule;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1852241;R-HSA-5617833;R-HSA-1640170;R-HSA-453274;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-380320;R-HSA-68877;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518	Organelle biogenesis and maintenance;Cilium Assembly;Cell Cycle;Mitotic G2-G2/M phases;M Phase;G2/M Transition;Cell Cycle, Mitotic;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2
PDSS1	positive	MRPL15	ENSG00000137547	PDSS1	1	PDSS1	1	0.00391137203447745	WBGene00022373	WBGene00022373(1)			GO:0003723;GO:0005739;GO:0003735;GO:0006412;GO:0005840;GO:0005515;GO:0015934;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:1990830	structural constituent of ribosome;translation;large ribosomal subunit;RNA binding;mitochondrion;ribosome;protein binding;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;cellular response to leukemia inhibitory factor	3D-structure;Mitochondrion;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
PDSS1	positive	BUB3	ENSG00000154473	PDSS1	1	PDSS1	1	0.00391137203447745	WBGene00013209	WBGene00013209(0)		Mosaic variegated aneuploidy syndrome	GO:0005634;GO:0005654;GO:0051301;GO:0005694;GO:0005515;GO:0007049;GO:0051321;GO:0007059;GO:0000775;GO:0000776;GO:0000777;GO:0005829;GO:0031145;GO:1901990;GO:0043130;GO:0007094;GO:0033597;GO:1990298;GO:0006511;GO:0008608;GO:0034501;GO:0000070;GO:0051983	protein binding;nucleus;nucleoplasm;cell division;chromosome;cell cycle;meiotic cell cycle;chromosome segregation;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cytosol;anaphase-promoting complex-dependent catabolic process;regulation of mitotic cell cycle phase transition;ubiquitin binding;mitotic spindle assembly checkpoint;mitotic checkpoint complex;bub1-bub3 complex;ubiquitin-dependent protein catabolic process;attachment of spindle microtubules to kinetochore;protein localization to kinetochore;mitotic sister chromatid segregation;regulation of chromosome segregation	ADP-ribosylation;Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Chromosome partition;Isopeptide bond;Kinetochore;Meiosis;Mitosis;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ubl conjugation;WD repeat	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-174143;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-2467813;R-HSA-2555396;R-HSA-453276;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618;R-HSA-141405;R-HSA-141430;R-HSA-179409	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;APC/C-mediated degradation of cell cycle proteins;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Regulation of mitotic cell cycle;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components;Inactivation of APC/C via direct inhibition of the APC/C complex;APC-Cdc20 mediated degradation of Nek2A
PDSS1	positive	ORC6	ENSG00000091651	PDSS1	1	PDSS1	1	0.00414369440316797				Ear-patella-short stature syndrome;Meier-Gorlin syndrome 3;Meier-Gorlin syndrome 3	GO:0005634;GO:0016020;GO:0003677;GO:0001650;GO:0005515;GO:0006260;GO:0005664;GO:0005654;GO:0000082;GO:0003688;GO:0006270;GO:0000808;GO:0051782	DNA binding;DNA replication;nuclear origin of replication recognition complex;nucleus;membrane;nucleoplasm;fibrillar center;protein binding;G1/S transition of mitotic cell cycle;DNA replication initiation;origin recognition complex;negative regulation of cell division	3D-structure;DNA replication;DNA-binding;Disease mutation;Dwarfism;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-1640170;R-HSA-68827;R-HSA-68867;R-HSA-68949;R-HSA-69002;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-453279;R-HSA-69206;R-HSA-176187;R-HSA-68962;R-HSA-68689;R-HSA-113507;R-HSA-113510;R-HSA-68616	Cell Cycle;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Orc1 removal from chromatin;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;CDC6 association with the ORC:origin complex;E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Assembly of the ORC complex at the origin of replication
PDSS1	positive	POLD2	ENSG00000106628	PDSS1	1	PDSS1	1	0.00414369440316797	WBGene00008722	WBGene00008722(0)			GO:0005634;GO:0005654;GO:0003677;GO:0005515;GO:0006281;GO:0006974;GO:0006260;GO:0003887;GO:0043625;GO:0019985;GO:0006283;GO:0016035;GO:0042769;GO:0006296;GO:0033683;GO:0032201;GO:0006297;GO:0000723;GO:0006298;GO:0006271;GO:0071897;GO:0006261	DNA binding;DNA replication;DNA-directed DNA polymerase activity;nucleus;nucleoplasm;protein binding;DNA repair;cellular response to DNA damage stimulus;delta DNA polymerase complex;DNA biosynthetic process;translesion synthesis;transcription-coupled nucleotide-excision repair;zeta DNA polymerase complex;DNA damage response, detection of DNA damage;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;telomere maintenance via semi-conservative replication;nucleotide-excision repair, DNA gap filling;telomere maintenance;mismatch repair;DNA strand elongation involved in DNA replication;DNA polymerase complex;DNA-dependent DNA replication	3D-structure;Acetylation;DNA damage;DNA excision;DNA repair;DNA replication;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-73886;R-HSA-157579;R-HSA-180786;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-69190;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174411;R-HSA-174417;R-HSA-69091;R-HSA-69109;R-HSA-69166;R-HSA-69183;R-HSA-69186;R-HSA-5696397;R-HSA-174414;R-HSA-174437;R-HSA-5358508;R-HSA-5358565;R-HSA-5358606	Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Chromosome Maintenance;Telomere Maintenance;Extension of Telomeres;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);DNA strand elongation;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;Gap-filling DNA repair synthesis and ligation in GG-NER;Processive synthesis on the C-strand of the telomere;Removal of the Flap Intermediate from the C-strand;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
PDSS1	positive	EMG1	ENSG00000126749	PDSS1	1	PDSS1	1	0.00414369440316797	WBGene00012652	WBGene00012652(0)		BOWEN-CONRADI SYNDROME;BOWEN-CONRADI SYNDROME	GO:0003723;GO:0005634;GO:0005737;GO:0016740;GO:0005730;GO:0008168;GO:0032259;GO:0005515;GO:0019843;GO:0042254;GO:0006364;GO:0042274;GO:0032040;GO:0005654;GO:0070475;GO:0070037;GO:0001824;GO:0017126	methyltransferase activity;RNA binding;nucleus;cytoplasm;transferase activity;nucleoplasm;nucleolus;methylation;protein binding;ribosome biogenesis;rRNA processing;ribosomal small subunit biogenesis;rRNA binding;small-subunit processome;rRNA base methylation;rRNA (pseudouridine) methyltransferase activity;blastocyst development;nucleologenesis	3D-structure;Acetylation;Direct protein sequencing;Disease mutation;Methyltransferase;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Ribosome biogenesis;S-adenosyl-L-methionine;Transferase;rRNA processing;rRNA-binding	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
PDSS1	positive	WDR12	ENSG00000138442	PDSS1	1	PDSS1	1	0.00414369440316797	WBGene00018893	WBGene00018893(1)			GO:0005634;GO:0005515;GO:0042254;GO:0005654;GO:0005730;GO:0006364;GO:0030687;GO:0008283;GO:0043021;GO:0000463;GO:0000466;GO:0042273;GO:0070545;GO:0007219	protein binding;ribosome biogenesis;nucleus;nucleoplasm;nucleolus;rRNA processing;preribosome, large subunit precursor;maturation of 5.8S rRNA;maturation of LSU-rRNA;regulation of cell cycle;ribonucleoprotein complex binding;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);ribosomal large subunit biogenesis;PeBoW complex;Notch signaling pathway	3D-structure;Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ribosome biogenesis;Ubl conjugation;WD repeat;rRNA processing	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol
PDSS1	positive	DONSON	ENSG00000159147	PDSS1	1	PDSS1	1	0.00414369440316797	WBGene00016074;WBGene00016072	WBGene00016072(0);WBGene00016074(0)		MICROCEPHALY SHORT STATURE AND LIMB ABNORMALITIES;Microcephaly-micromelia syndrome	GO:0005634;GO:0007275;GO:0006260;GO:0005515;GO:0007095;GO:0000077;GO:0005657;GO:0048478;GO:0033260;GO:0030894	nucleus;multicellular organism development;DNA replication;protein binding;replication fork protection;mitotic G2 DNA damage checkpoint;DNA damage checkpoint;replication fork;nuclear DNA replication;replisome	Alternative splicing;Developmental protein;Disease mutation;Dwarfism;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	positive	CCT2	ENSG00000166226	PDSS1	1	PDSS1	1	0.00414369440316797	WBGene00000378	WBGene00000378(0)			GO:0050821;GO:0005737;GO:0000166;GO:0005524;GO:0005829;GO:0006457;GO:0005515;GO:0005874;GO:0051082;GO:0005576;GO:0070062;GO:0043312;GO:0005832;GO:0035578;GO:0032212;GO:0051973;GO:0031625;GO:0090666;GO:1904851;GO:1904871;GO:1904874;GO:0044183;GO:0007339;GO:0051086;GO:0051131;GO:1901998;GO:0002199;GO:0044297	ATP binding;protein folding;cytosol;unfolded protein binding;chaperonin-containing T-complex;protein stabilization;cytoplasm;nucleotide binding;protein binding;microtubule;extracellular region;extracellular exosome;neutrophil degranulation;azurophil granule lumen;positive regulation of telomere maintenance via telomerase;positive regulation of telomerase activity;ubiquitin protein ligase binding;scaRNA localization to Cajal body;positive regulation of establishment of protein localization to telomere;positive regulation of protein localization to Cajal body;positive regulation of telomerase RNA localization to Cajal body;protein folding chaperone;binding of sperm to zona pellucida;chaperone mediated protein folding independent of cofactor;chaperone-mediated protein complex assembly;toxin transport;zona pellucida receptor complex;cell body	3D-structure;ATP-binding;Acetylation;Alternative splicing;Chaperone;Cytoplasm;Direct protein sequencing;Isopeptide bond;Nucleotide-binding;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-1852241;R-HSA-5617833;R-HSA-392499;R-HSA-389958;R-HSA-389960;R-HSA-390466;R-HSA-391251;R-HSA-5620920;R-HSA-6814122;R-HSA-5620922;R-HSA-6798695;R-HSA-390471;R-HSA-389957;R-HSA-390450	Innate Immune System;Immune System;Organelle biogenesis and maintenance;Cilium Assembly;Metabolism of proteins;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Chaperonin-mediated protein folding;Protein folding;Cargo trafficking to the periciliary membrane;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;BBSome-mediated cargo-targeting to cilium;Neutrophil degranulation;Association of TriC/CCT with target proteins during biosynthesis;Prefoldin mediated transfer of substrate  to CCT/TriC;Folding of actin by CCT/TriC
PDSS1	positive	RANBP1	ENSG00000099901	PDSS1	1	PDSS1	1	0.00438828673218272	WBGene00003795	WBGene00003795(0)			GO:0005829;GO:0046907;GO:0005737;GO:0005634;GO:0050790;GO:0043547;GO:0007165;GO:0005096;GO:0005515;GO:0045296;GO:0005813;GO:0008536;GO:0005643;GO:0016032;GO:0005635;GO:0005092;GO:0046604;GO:0005623;GO:0007051;GO:0010976;GO:0035690;GO:0051592;GO:0072750;GO:0032838;GO:1904115	intracellular transport;cytosol;cytoplasm;nucleus;regulation of catalytic activity;positive regulation of GTPase activity;signal transduction;GTPase activator activity;protein binding;cadherin binding;centrosome;Ran GTPase binding;nuclear pore;viral process;nuclear envelope;GDP-dissociation inhibitor activity;positive regulation of mitotic centrosome separation;spindle organization;positive regulation of neuron projection development;cellular response to drug;response to calcium ion;cellular response to leptomycin B;plasma membrane bounded cell projection cytoplasm;axon cytoplasm	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;GTPase activation;Isopeptide bond;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-162909;R-HSA-165054;R-HSA-177243	Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Host Interactions of HIV factors;Rev-mediated nuclear export of HIV RNA;Interactions of Rev with host cellular proteins
PDSS1	positive	PSMB5	ENSG00000100804	PDSS1	1	PDSS1	1	0.00438828673218272	WBGene00003951				GO:0004175;GO:0004298;GO:0051603;GO:0005839;GO:0000502;GO:0005634;GO:0005737;GO:0005813;GO:0005654;GO:0016787;GO:0005515;GO:0008233;GO:0006508;GO:0043161;GO:0038095;GO:0050852;GO:0005829;GO:0070062;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010498;GO:0010499;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0019774;GO:0016032;GO:0006979	endopeptidase activity;proteolysis involved in cellular protein catabolic process;proteasome core complex;threonine-type endopeptidase activity;proteasome complex;proteasome-mediated ubiquitin-dependent protein catabolic process;nucleus;cytoplasm;nucleoplasm;hydrolase activity;centrosome;protein binding;peptidase activity;proteolysis;Fc-epsilon receptor signaling pathway;T cell receptor signaling pathway;cytosol;extracellular exosome;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;proteasomal protein catabolic process;proteasomal ubiquitin-independent protein catabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;proteasome core complex, beta-subunit complex;viral process;response to oxidative stress	3D-structure;Alternative splicing;Cytoplasm;Direct protein sequencing;Host-virus interaction;Hydrolase;Nucleus;Polymorphism;Protease;Proteasome;Reference proteome;Threonine protease;Zymogen	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
PDSS1	positive	NUP107	ENSG00000111581	PDSS1	1	PDSS1	1	0.00438828673218272		WBGene00003791(0)		46XX gonadal dysgenesis;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis;GALLOWAY-MOWAT SYNDROME;EARLY-CHILDHOOD-ONSET STEROID-RESISTANT NEPHROTIC SYNDROME;GALLOWAY-MOWAT SYNDROME 7;Nephrotic syndrome type 11;OVARIAN DYSGENESIS 6	GO:0051028;GO:0005634;GO:0016020;GO:0015031;GO:0017056;GO:0005643;GO:0005694;GO:0005515;GO:0006406;GO:0000775;GO:0000776;GO:0000777;GO:0005829;GO:0075733;GO:0043657;GO:0008585;GO:0006110;GO:0006409;GO:0006606;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0031965;GO:0031080;GO:0072006;GO:0034399;GO:0051292;GO:0000973	structural constituent of nuclear pore;nuclear pore;mRNA transport;nucleus;membrane;protein transport;chromosome;protein binding;mRNA export from nucleus;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;regulation of transcription, DNA-templated;cytosol;intracellular transport of virus;host cell;female gonad development;regulation of glycolytic process;tRNA export from nucleus;protein import into nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;nuclear membrane;nuclear pore outer ring;nephron development;nuclear periphery;nuclear pore complex assembly;posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery	3D-structure;Acetylation;Alternative splicing;Centromere;Chromosome;Disease mutation;Epilepsy;Kinetochore;Membrane;Mental retardation;Methylation;Nuclear pore complex;Nucleus;Phosphoprotein;Protein transport;Reference proteome;Translocation;Transport;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-5619115;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531;R-HSA-141424;R-HSA-141444;R-HSA-69618	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Disorders of transmembrane transporters;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	TIMELESS	ENSG00000111602	PDSS1	1	PDSS1	1	0.00438828673218272	WBGene00006571	WBGene00006571(0)			GO:0005634;GO:0051301;GO:0005694;GO:0005515;GO:0006281;GO:0006974;GO:0007049;GO:0007623;GO:0048511;GO:0007275;GO:0000790;GO:0003677;GO:0005654;GO:0035861;GO:0045892;GO:0006260;GO:0044770;GO:0042752;GO:0031298;GO:0002009;GO:1905168;GO:0009582;GO:0043111;GO:0072711;GO:2000781;GO:0072719;GO:0048478;GO:1904976;GO:0000076;GO:0042803;GO:0046982;GO:0000122;GO:0030324;GO:0048754	nucleus;nucleoplasm;cell division;chromosome;protein binding;DNA repair;cellular response to DNA damage stimulus;cell cycle;circadian rhythm;rhythmic process;multicellular organism development;nuclear chromatin;DNA binding;site of double-strand break;negative regulation of transcription, DNA-templated;DNA replication;cell cycle phase transition;regulation of circadian rhythm;nuclear chromosome;replication fork protection complex;morphogenesis of an epithelium;positive regulation of double-strand break repair via homologous recombination;detection of abiotic stimulus;replication fork arrest;cellular response to hydroxyurea;positive regulation of double-strand break repair;cellular response to cisplatin;replication fork protection;DNA replication checkpoint;cellular response to bleomycin;negative regulation of transcription by RNA polymerase II;lung development;branching morphogenesis of an epithelial tube	3D-structure;Alternative splicing;Biological rhythms;Cell cycle;Cell division;Chromosome;DNA damage;DNA repair;Developmental protein;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation	R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-5693607	DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;Processing of DNA double-strand break ends
PDSS1	positive	NASP	ENSG00000132780	PDSS1	1	PDSS1	1	0.00438828673218272	WBGene00007500;WBGene00008218	WBGene00007500(0)			GO:0005654;GO:0005515;GO:0005634;GO:0005737;GO:0015031;GO:0000790;GO:0007049;GO:0006260;GO:0042393;GO:0008283;GO:0032991;GO:0006335;GO:0006336;GO:0034080;GO:0043486;GO:0000082;GO:0001824;GO:0008584;GO:0033574	protein binding;nucleoplasm;nucleus;cytoplasm;protein transport;nuclear chromatin;cell cycle;DNA replication;histone binding;protein-containing complex;G1/S transition of mitotic cell cycle;DNA replication-dependent nucleosome assembly;DNA replication-independent nucleosome assembly;CENP-A containing nucleosome assembly;histone exchange;blastocyst development;male gonad development;response to testosterone	Acetylation;Alternative splicing;Cell cycle;Coiled coil;Cytoplasm;DNA replication;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Repeat;TPR repeat;Transport;Ubl conjugation		
PDSS1	positive	TUBB	ENSG00000196230	PDSS1	1	PDSS1	1	0.00438828673218272	WBGene00006538;WBGene00000248;WBGene00006536;WBGene00006537;WBGene00003171	WBGene00006539(0);WBGene00000248(0);WBGene00006536(0);WBGene00006537(0);WBGene00006530(0);WBGene00012489(0);WBGene00006529(0);WBGene00006528(0)		Multiple benign circumferential skin creases on limbs;Cortical dysplasia complex with other brain malformations 6;Circumferential Skin Creases Kunze Type;Cortical dysplasia complex with other brain malformations 6;SKIN CREASES CONGENITAL SYMMETRIC CIRCUMFERENTIAL 1	GO:0005634;GO:0005737;GO:0000166;GO:0003924;GO:0005525;GO:0005856;GO:0005515;GO:0005200;GO:0005874;GO:0005576;GO:0007017;GO:0000226;GO:0000278;GO:0070062;GO:0000086;GO:0010389;GO:0097711;GO:0043312;GO:0035578;GO:0036464;GO:0031625;GO:0042288;GO:0005198;GO:0019904;GO:0032794;GO:0044877;GO:0009987;GO:0030705;GO:0042267;GO:0050807;GO:0051225;GO:0051301;GO:0005641;GO:0032991;GO:0044297;GO:0045121;GO:0007010	GTP binding;microtubule-based process;microtubule;GTPase activity;structural constituent of cytoskeleton;nucleus;cytoplasm;nucleotide binding;cytoskeleton;protein binding;extracellular region;microtubule cytoskeleton organization;mitotic cell cycle;extracellular exosome;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking;neutrophil degranulation;azurophil granule lumen;cytoplasmic ribonucleoprotein granule;ubiquitin protein ligase binding;MHC class I protein binding;structural molecule activity;protein domain specific binding;GTPase activating protein binding;protein-containing complex binding;cellular process;cytoskeleton-dependent intracellular transport;natural killer cell mediated cytotoxicity;regulation of synapse organization;spindle assembly;cell division;nuclear envelope lumen;protein-containing complex;cell body;membrane raft;cytoskeleton organization	3D-structure;Acetylation;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;GTP-binding;Isopeptide bond;Methylation;Microtubule;Nucleotide-binding;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-1852241;R-HSA-5617833;R-HSA-1640170;R-HSA-453274;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-380320;R-HSA-68877;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518;R-HSA-6798695	Innate Immune System;Immune System;Organelle biogenesis and maintenance;Cilium Assembly;Cell Cycle;Mitotic G2-G2/M phases;M Phase;G2/M Transition;Cell Cycle, Mitotic;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2;Neutrophil degranulation
PDSS1	positive	NOL7	ENSG00000225921	PDSS1	1	PDSS1	1	0.00438828673218272					GO:0005634;GO:0003723;GO:0005730;GO:0005739	nucleus;RNA binding;nucleolus	Alternative splicing;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation		
PDSS1	positive	TDP1	ENSG00000042088	PDSS1	1	PDSS1	1	0.00464569920842239	WBGene00018678	WBGene00018678(1)		Spinocerebellar ataxia with axonal neuropathy type 1;SPINOCEREBELLAR ATAXIA AUTOSOMAL RECESSIVE WITH AXONAL NEUROPATHY1	GO:0005634;GO:0006281;GO:0008081;GO:0043231;GO:0005886;GO:0005737;GO:0016787;GO:0090305;GO:0006974;GO:0004527;GO:0004518;GO:0006302;GO:0005515;GO:0003690;GO:0003697;GO:0000012;GO:0017005	nucleus;DNA repair;phosphoric diester hydrolase activity;intracellular membrane-bounded organelle;nucleoplasm;plasma membrane;cytoplasm;hydrolase activity;nucleic acid phosphodiester bond hydrolysis;cellular response to DNA damage stimulus;exonuclease activity;nuclease activity;double-strand break repair;protein binding;double-stranded DNA binding;single-stranded DNA binding;single strand break repair;3'-tyrosyl-DNA phosphodiesterase activity	3D-structure;Alternative splicing;Cytoplasm;DNA damage;DNA repair;Disease mutation;Exonuclease;Hydrolase;Neurodegeneration;Nuclease;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat	R-HSA-5693532;R-HSA-73894;R-HSA-5693571	DNA Double-Strand Break Repair;DNA Repair;Nonhomologous End-Joining (NHEJ)
PDSS1	positive	PUM3	ENSG00000080608	PDSS1	1	PDSS1	1	0.00464569920842239	WBGene00014165	WBGene00014165(0)			GO:0003723;GO:0005634;GO:0005730;GO:0005783;GO:0003677;GO:0005694;GO:0005654;GO:0005515;GO:0010835	RNA binding;nucleus;nucleolus;endoplasmic reticulum;DNA binding;chromosome;nucleoplasm;protein binding;mRNA binding;regulation of translation;regulation of protein ADP-ribosylation	3D-structure;Acetylation;Chromosome;DNA-binding;Direct protein sequencing;Nucleus;Polymorphism;RNA-binding;Reference proteome;Repeat		
PDSS1	positive	RAD54L	ENSG00000085999	PDSS1	1	PDSS1	1	0.00464569920842239	WBGene00004298;WBGene00013792	WBGene00004298(1)		Hereditary breast cancer;Breast Cancer;LYMPHOMA NON-HODGKIN FAMILIAL	GO:0005524;GO:0005634;GO:0000166;GO:0005654;GO:0016787;GO:0003677;GO:0005515;GO:0006281;GO:0006974;GO:0004386;GO:0007131;GO:0032991;GO:0000733;GO:0006310;GO:0051321;GO:0045003;GO:0036310;GO:0015616;GO:0000724;GO:0006302;GO:0008340;GO:0010212;GO:0042493;GO:0051276	ATP binding;nucleus;nucleotide binding;nucleoplasm;hydrolase activity;DNA binding;protein binding;DNA repair;cellular response to DNA damage stimulus;helicase activity;reciprocal meiotic recombination;protein-containing complex;DNA strand renaturation;DNA recombination;meiotic cell cycle;double-strand break repair via synthesis-dependent strand annealing;annealing helicase activity;DNA translocase activity;double-strand break repair via homologous recombination;double-strand break repair;determination of adult lifespan;response to ionizing radiation;response to drug;chromosome organization	ATP-binding;DNA damage;DNA repair;DNA-binding;Helicase;Hydrolase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	positive	AHSA1	ENSG00000100591	PDSS1	1	PDSS1	1	0.00464569920842239	WBGene00007235				GO:0005829;GO:0032781;GO:0001671;GO:0051879;GO:0005737;GO:0005783;GO:0005515;GO:0051087;GO:0045296;GO:0070062	ATPase activator activity;Hsp90 protein binding;cytosol;positive regulation of ATPase activity;chaperone binding;cytoplasm;endoplasmic reticulum;protein binding;cadherin binding;extracellular exosome;viral process	3D-structure;Acetylation;Alternative splicing;Chaperone;Cytoplasm;Endoplasmic reticulum;Host-virus interaction;Isopeptide bond;Phosphoprotein;Reference proteome;Stress response;Ubl conjugation		
PDSS1	positive	SRSF7	ENSG00000115875	PDSS1	1	PDSS1	1	0.00464569920842239	WBGene00004703;WBGene00013293				GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0051028;GO:0005634;GO:0005737;GO:0008270;GO:0046872;GO:0005654;GO:0005515;GO:0000381;GO:0070062;GO:0006406;GO:0016607;GO:0006405;GO:0031124;GO:0019904;GO:0048025;GO:0000398;GO:0045292;GO:1990830	zinc ion binding;nucleic acid binding;RNA binding;mRNA processing;RNA splicing;mRNA transport;nucleus;cytoplasm;metal ion binding;nucleoplasm;protein binding;regulation of alternative mRNA splicing, via spliceosome;extracellular exosome;mRNA export from nucleus;nuclear speck;RNA export from nucleus;mRNA 3'-end processing;protein domain specific binding;negative regulation of mRNA splicing, via spliceosome;mRNA splicing, via spliceosome;mRNA cis splicing, via spliceosome;cellular response to leukemia inhibitory factor	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transport;Ubl conjugation;Zinc;Zinc-finger;mRNA processing;mRNA splicing;mRNA transport	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-159236;R-HSA-72202;R-HSA-72203;R-HSA-72187;R-HSA-73856;R-HSA-72163;R-HSA-72172;R-HSA-72165	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA Splicing - Minor Pathway
PDSS1	positive	PAICS	ENSG00000128050	PDSS1	1	PDSS1	1	0.00464569920842239	WBGene00015116	WBGene00015116(0)			GO:0006164;GO:0004639;GO:0006189;GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0016829;GO:0016874;GO:0005515;GO:0003824;GO:0008152;GO:0016831;GO:0042802;GO:0005829;GO:0045296;GO:0070062;GO:0009168;GO:0004638;GO:0043727;GO:0009113	'de novo' IMP biosynthetic process;purine nucleotide biosynthetic process;phosphoribosylaminoimidazolesuccinocarboxamide synthase activity;cytoplasm;membrane;nucleotide binding;ATP binding;lyase activity;ligase activity;protein binding;catalytic activity;metabolic process;carboxy-lyase activity;cytosol;identical protein binding;cadherin binding;extracellular exosome;purine ribonucleoside monophosphate biosynthetic process;phosphoribosylaminoimidazole carboxylase activity;5-amino-4-imidazole carboxylate lyase activity;purine nucleobase biosynthetic process	3D-structure;ATP-binding;Acetylation;Alternative splicing;Decarboxylase;Direct protein sequencing;Ligase;Lyase;Multifunctional enzyme;Nucleotide-binding;Phosphoprotein;Polymorphism;Purine biosynthesis;Reference proteome	R-HSA-1430728;R-HSA-15869;R-HSA-73817;R-HSA-8956320	Metabolism;Metabolism of nucleotides;Purine ribonucleoside monophosphate biosynthesis;Nucleobase biosynthesis
PDSS1	positive	GNL2	ENSG00000134697	PDSS1	1	PDSS1	1	0.00464569920842239	WBGene00003596	WBGene00003596(0)			GO:0003723;GO:0005634;GO:0016020;GO:0000166;GO:0005730;GO:0005525;GO:0003924;GO:0042254;GO:0008150;GO:0016021	GTP binding;nucleolus;RNA binding;nucleus;membrane;nucleotide binding;GTPase activity;ribosome biogenesis;biological_process;integral component of membrane	Acetylation;GTP-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ribosome biogenesis		
PDSS1	positive	WDR4	ENSG00000160193	PDSS1	1	PDSS1	1	0.00464569920842239	WBGene00022420	WBGene00022420(0)		GALLOWAY-MOWAT SYNDROME;GALLOWAY-MOWAT SYNDROME 6;MICROCEPHALY GROWTH DEFICIENCY SEIZURES AND BRAIN MALFORMATIONS	GO:0005634;GO:0005829;GO:0008033;GO:0005694;GO:0005515;GO:0006974;GO:0005654;GO:0106004;GO:0006400;GO:0008176;GO:0030488;GO:0036265;GO:0043527	protein binding;RNA (guanine-N7)-methylation;nucleus;nucleoplasm;cytosol;tRNA processing;chromosome;cellular response to DNA damage stimulus;tRNA (guanine-N7)-methylation;tRNA modification;tRNA (guanine-N7-)-methyltransferase activity;tRNA methylation;tRNA methyltransferase complex	Acetylation;Alternative splicing;Chromosome;DNA damage;Direct protein sequencing;Disease mutation;Epilepsy;Mental retardation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;WD repeat;tRNA processing	R-HSA-6782315;R-HSA-72306;R-HSA-8953854	tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
PDSS1	positive	PSMG1	ENSG00000183527	PDSS1	1	PDSS1	1	0.00464569920842239					GO:0005634;GO:0005737;GO:0005794;GO:0005829;GO:0005654;GO:0005783;GO:0043248;GO:0005515;GO:0070628;GO:0021930;GO:0080129	endoplasmic reticulum;proteasome assembly;nucleus;cytoplasm;Golgi apparatus;nucleoplasm;cytosol;protein binding;chaperone-mediated protein complex assembly;proteasome binding;molecular adaptor activity;cerebellar granule cell precursor proliferation;proteasome core complex assembly;chaperone complex	Acetylation;Alternative splicing;Chaperone;Cytoplasm;Endoplasmic reticulum;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	positive	BOP1	ENSG00000261236	PDSS1	1	PDSS1	1	0.00464569920842239	WBGene00012978	WBGene00012978(0)			GO:0003723;GO:0005634;GO:0005730;GO:0005515;GO:0042254;GO:0005654;GO:0006364;GO:0030687;GO:0008283;GO:0043021;GO:0000463;GO:0000466;GO:0042273;GO:0051726;GO:0070545;GO:1990904;GO:0000027;GO:1901796;GO:0000448	protein binding;rRNA processing;ribosome biogenesis;RNA binding;nucleus;nucleoplasm;nucleolus;preribosome, large subunit precursor;regulation of cell cycle;ribonucleoprotein complex binding;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);ribosomal large subunit biogenesis;PeBoW complex;ribonucleoprotein complex;ribosomal large subunit assembly;regulation of signal transduction by p53 class mediator;cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);cell population proliferation	Alternative splicing;Nucleus;Phosphoprotein;Reference proteome;Repeat;Ribosome biogenesis;WD repeat;rRNA processing	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol
PDSS1	positive	C1orf112	ENSG00000000460	PDSS1	1	PDSS1	1	0.00491650085889672							Acetylation;Alternative splicing;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	positive	TFRC	ENSG00000072274	PDSS1	1	PDSS1	1	0.00491650085889672				Combined immunodeficiency due to TFRC deficiency;Combined immunodeficiency;Immunodeficiency 46	GO:0005886;GO:0006879;GO:0006898;GO:0004998;GO:0033572;GO:0033570;GO:0003723;GO:0016020;GO:0016021;GO:0005615;GO:0005515;GO:0005576;GO:0042470;GO:0005905;GO:0009986;GO:0046718;GO:0009897;GO:0042802;GO:0006897;GO:0070062;GO:0072562;GO:0010008;GO:0042102;GO:0016032;GO:0055037;GO:0042803;GO:0005887;GO:1990712;GO:0061024;GO:1903561;GO:0031410;GO:0035690;GO:0030665;GO:0001618;GO:0003725;GO:0005768;GO:0031623;GO:0006826;GO:0016323;GO:0030890;GO:0045830;GO:0048471;GO:0030316;GO:0045780;GO:1990830;GO:0005769	plasma membrane;cellular iron ion homeostasis;receptor-mediated endocytosis;transferrin receptor activity;transferrin transport;cell;negative regulation of apoptotic process;positive regulation of protein phosphorylation;positive regulation of gene expression;protein binding;RNA binding;membrane;integral component of membrane;extracellular space;extracellular region;melanosome;clathrin-coated pit;cell surface;viral entry into host cell;external side of plasma membrane;identical protein binding;endocytosis;extracellular exosome;blood microparticle;endosome membrane;positive regulation of T cell proliferation;viral process;recycling endosome;protein homodimerization activity;integral component of plasma membrane;positive regulation of NF-kappaB transcription factor activity;HFE-transferrin receptor complex;membrane organization;extracellular vesicle;cytoplasmic vesicle;cellular response to drug;clathrin-coated vesicle membrane;positive regulation of I-kappaB kinase/NF-kappaB signaling;virus receptor activity;double-stranded RNA binding;positive regulation of protein localization to nucleus;protein-containing complex binding;endosome;receptor internalization;positive regulation of peptidyl-serine phosphorylation;iron ion transport;basolateral plasma membrane;protein kinase binding;positive regulation of B cell proliferation;positive regulation of protein-containing complex assembly;positive regulation of isotype switching;perinuclear region of cytoplasm;osteoclast differentiation;positive regulation of bone resorption;cellular response to leukemia inhibitory factor;early endosome	3D-structure;Cell membrane;Direct protein sequencing;Disease mutation;Disulfide bond;Endocytosis;Glycoprotein;Host cell receptor for virus entry;Host-virus interaction;Lipoprotein;Membrane;Palmitate;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Secreted;Signal-anchor;Transmembrane;Transmembrane helix	R-HSA-5653656;R-HSA-382551;R-HSA-199991;R-HSA-199992;R-HSA-432722;R-HSA-8856828;R-HSA-8856825;R-HSA-917937;R-HSA-917977	Vesicle-mediated transport;Transport of small molecules;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Golgi Associated Vesicle Biogenesis;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis;Iron uptake and transport;Transferrin endocytosis and recycling
PDSS1	positive	NOL10	ENSG00000115761	PDSS1	1	PDSS1	1	0.00491650085889672	WBGene00017989	WBGene00017989(1)			GO:0005634;GO:0003723;GO:0005730;GO:0000462;GO:0032040;GO:0005515	nucleus;protein binding;RNA binding;nucleolus;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);small-subunit processome	Acetylation;Alternative splicing;Coiled coil;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;WD repeat		
PDSS1	positive	TIMM10	ENSG00000134809	PDSS1	1	PDSS1	1	0.00491650085889672	WBGene00006573	WBGene00006573(0)			GO:0016020;GO:0015031;GO:0046872;GO:0005739;GO:0005743;GO:0008270;GO:0005744;GO:0005515;GO:0007605;GO:0042803;GO:0005758;GO:0051087;GO:0072321;GO:0006626;GO:0045039;GO:0140318;GO:0042719;GO:0008565	protein insertion into mitochondrial inner membrane;mitochondrial intermembrane space protein transporter complex;membrane;protein transport;metal ion binding;mitochondrion;mitochondrial inner membrane;zinc ion binding;TIM23 mitochondrial import inner membrane translocase complex;protein binding;sensory perception of sound;protein homodimerization activity;mitochondrial intermembrane space;chaperone binding;chaperone-mediated protein transport;protein targeting to mitochondrion;protein transporter activity	3D-structure;Chaperone;Disulfide bond;Membrane;Metal-binding;Mitochondrion;Mitochondrion inner membrane;Protein transport;Reference proteome;Translocation;Transport;Zinc	R-HSA-9609507;R-HSA-1268020	Protein localization;Mitochondrial protein import
PDSS1	positive	SHQ1	ENSG00000144736	PDSS1	1	PDSS1	1	0.00491650085889672	WBGene00021655	WBGene00021655(0)			GO:0000493;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0005515;GO:0051082;GO:1904874;GO:0043065;GO:0022618;GO:2000233	box H/ACA snoRNP assembly;nucleus;cytoplasm;nucleoplasm;cytosol;protein binding;unfolded protein binding;positive regulation of telomerase RNA localization to Cajal body;positive regulation of apoptotic process;ribonucleoprotein complex assembly;negative regulation of rRNA processing	3D-structure;Alternative splicing;Cytoplasm;Nucleus;Polymorphism;Reference proteome		
PDSS1	positive	ZNRD2	ENSG00000173465	PDSS1	1	PDSS1	1	0.00491650085889672	WBGene00012643	WBGene00012643(0)			GO:0051301;GO:0005515;GO:0007049;GO:0000278	cell division;protein binding;cell cycle;mitotic cell cycle	Acetylation;Cell cycle;Cell division;Mitosis;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	positive	GLMN	ENSG00000174842	PDSS1	1	PDSS1	1	0.00491650085889672				Glomuvenous malformation;GLOMUVENOUS MALFORMATIONS;GLOMUVENOUS MALFORMATIONS	GO:0005515;GO:0005737;GO:0042327;GO:0001570;GO:0040029;GO:0042130;GO:0032434;GO:0050715;GO:0045086;GO:0031625;GO:0042692;GO:0031464;GO:0031461;GO:0005171;GO:0055105;GO:0001843;GO:0031397;GO:0072359;GO:0031462;GO:0031463	protein binding;cytoplasm;positive regulation of phosphorylation;signaling receptor binding;vasculogenesis;regulation of gene expression, epigenetic;negative regulation of T cell proliferation;regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of cell population proliferation;cell surface receptor signaling pathway;positive regulation of cytokine secretion;positive regulation of interleukin-2 biosynthetic process;ubiquitin protein ligase binding;muscle cell differentiation;Cul4A-RING E3 ubiquitin ligase complex;cullin-RING ubiquitin ligase complex;hepatocyte growth factor receptor binding;ubiquitin-protein transferase inhibitor activity;neural tube closure;negative regulation of protein ubiquitination;circulatory system development;Cul2-RING ubiquitin ligase complex;Cul3-RING ubiquitin ligase complex	3D-structure;Acetylation;Alternative splicing;Disease mutation;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
PDSS1	positive	ERCC6L	ENSG00000186871	PDSS1	1	PDSS1	1	0.00491650085889672	WBGene00000803;WBGene00010011				GO:0005524;GO:0016020;GO:0000166;GO:0016787;GO:0003677;GO:0051301;GO:0005694;GO:0005515;GO:0032508;GO:0007049;GO:0003678;GO:0004386;GO:0000775;GO:0000776;GO:0000777;GO:0005829;GO:0015616	ATP binding;protein binding;membrane;nucleotide binding;hydrolase activity;DNA binding;cell division;chromosome;DNA duplex unwinding;cell cycle;DNA helicase activity;helicase activity;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cytosol;DNA translocase activity	3D-structure;ATP-binding;Cell cycle;Cell division;Centromere;Chromosome;DNA-binding;Helicase;Hydrolase;Kinetochore;Mitosis;Nucleotide-binding;Phosphoprotein;Reference proteome;Repeat;TPR repeat	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	TFDP1	ENSG00000198176	PDSS1	1	PDSS1	1	0.00491650085889672	WBGene00001061	WBGene00001061(0)	CCNE1;CDK1;DHFR;MYBL2;NRIP1;PCNA;RRM1;TYMS		GO:0005739;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0005515;GO:0007049;GO:0005667;GO:0051726;GO:0008544;GO:0043276;GO:0045893;GO:0045944;GO:0070345;GO:2000278;GO:0000981;GO:0000790;GO:0006977;GO:0001228;GO:0003713;GO:0019904;GO:0008134;GO:0070317;GO:0006357;GO:0000977;GO:0090575;GO:1900740;GO:0000083	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;transcription factor complex;regulation of cell cycle;mitochondrion;nucleus;cytoplasm;nucleoplasm;cytosol;DNA binding;protein binding;cell cycle;cis-regulatory region sequence-specific DNA binding;epidermis development;anoikis;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;negative regulation of fat cell proliferation;regulation of DNA biosynthetic process;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA-binding transcription activator activity, RNA polymerase II-specific;transcription coactivator activity;protein domain specific binding;transcription factor binding;negative regulation of G0 to G1 transition;positive regulation of G1/S transition of mitotic cell cycle;positive regulation of DNA-binding transcription factor activity;RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II transcription factor complex;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;regulation of transcription involved in G1/S transition of mitotic cell cycle;transcription by RNA polymerase II	3D-structure;Acetylation;Activator;Alternative splicing;Cell cycle;Cytoplasm;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-1266738;R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-73857;R-HSA-74160;R-HSA-109581;R-HSA-162582;R-HSA-5357801;R-HSA-1640170;R-HSA-2262752;R-HSA-69242;R-HSA-69278;R-HSA-8953897;R-HSA-157118;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-9006936;R-HSA-170834;R-HSA-2173793;R-HSA-2173796;R-HSA-2559580;R-HSA-2559583;R-HSA-8953750;R-HSA-1912422;R-HSA-1912408;R-HSA-2559585;R-HSA-69231;R-HSA-69236;R-HSA-109606;R-HSA-6804114;R-HSA-114452;R-HSA-139915;R-HSA-113510;R-HSA-9616222;R-HSA-69205;R-HSA-1538133;R-HSA-1362277;R-HSA-111448;R-HSA-113501;R-HSA-1362300	Developmental Biology;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Apoptosis;Signal Transduction;Programmed Cell Death;Cell Cycle;Cellular responses to stress;S Phase;Cell Cycle, Mitotic;Cellular responses to external stimuli;Signaling by NOTCH;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Oxidative Stress Induced Senescence;Cellular Senescence;Transcriptional Regulation by E2F6;Pre-NOTCH Expression and Processing;Pre-NOTCH Transcription and Translation;Oncogene Induced Senescence;Cyclin D associated events in G1;G1 Phase;Intrinsic Pathway for Apoptosis;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;Activation of BH3-only proteins;Activation of PUMA and translocation to mitochondria;E2F mediated regulation of DNA replication;Transcriptional regulation of granulopoiesis;G1/S-Specific Transcription;G0 and Early G1;Transcription of E2F targets under negative control by DREAM complex;Activation of NOXA and translocation to mitochondria;Inhibition of replication initiation of damaged DNA by RB1/E2F1;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
PDSS1	positive	CSTF2	ENSG00000101811	PDSS1	1	PDSS1	1	0.00520127986896557	WBGene00000774;WBGene00011059				GO:0003676;GO:0003723;GO:0006397;GO:0005634;GO:0005654;GO:0005515;GO:0016604;GO:0006378;GO:0005847;GO:0031124;GO:0003729;GO:0098789;GO:0000398;GO:0006369;GO:0006388;GO:0071920;GO:1990090	RNA binding;nucleic acid binding;mRNA 3'-end processing;mRNA polyadenylation;mRNA cleavage and polyadenylation specificity factor complex;mRNA processing;nucleus;nucleoplasm;protein binding;nuclear body;mRNA binding;pre-mRNA cleavage required for polyadenylation;mRNA splicing, via spliceosome;termination of RNA polymerase II transcription;tRNA splicing, via endonucleolytic cleavage and ligation;cleavage body;cellular response to nerve growth factor stimulus	3D-structure;Alternative splicing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ubl conjugation;mRNA processing	R-HSA-73857;R-HSA-74160;R-HSA-72306;R-HSA-8953854;R-HSA-6784531;R-HSA-72203;R-HSA-72187;R-HSA-73856;R-HSA-72163;R-HSA-72172;R-HSA-75067;R-HSA-77595	RNA Polymerase II Transcription;Gene expression (Transcription);tRNA processing;Metabolism of RNA;tRNA processing in the nucleus;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs
PDSS1	positive	POLR3G	ENSG00000113356	PDSS1	1	PDSS1	1	0.00520127986896557	WBGene00021638				GO:0003899;GO:0006383;GO:0005634;GO:0005737;GO:0005515;GO:0002376;GO:0045087;GO:0005666;GO:0051607;GO:0000790;GO:0005654;GO:0005829;GO:0008283;GO:0032728;GO:0045089;GO:0032481;GO:0006359	DNA-directed 5'-3' RNA polymerase activity;transcription by RNA polymerase III;nucleoplasm;cytosol;nucleus;cytoplasm;protein binding;immune system process;innate immune response;RNA polymerase III complex;defense response to virus;nuclear chromatin;cell population proliferation;positive regulation of interferon-beta production;positive regulation of innate immune response;positive regulation of type I interferon production;regulation of transcription by RNA polymerase III	Antiviral defense;Cytoplasm;DNA-directed RNA polymerase;Immunity;Innate immunity;Nucleus;Phosphoprotein;Reference proteome;Transcription	R-HSA-168249;R-HSA-168256;R-HSA-74160;R-HSA-74158;R-HSA-749476;R-HSA-76046;R-HSA-76061;R-HSA-76066;R-HSA-76071;R-HSA-73980;R-HSA-1834949;R-HSA-73780	Innate Immune System;Immune System;Gene expression (Transcription);RNA Polymerase III Transcription;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation From Type 3 Promoter;RNA Polymerase III Transcription Termination;Cytosolic sensors of pathogen-associated DNA ;RNA Polymerase III Chain Elongation
PDSS1	positive	UCHL5	ENSG00000116750	PDSS1	1	PDSS1	1	0.00520127986896557	WBGene00006724	WBGene00006724(1)			GO:0003723;GO:0005634;GO:0005737;GO:0005654;GO:0004843;GO:0016579;GO:0016787;GO:0005739;GO:0005829;GO:0010951;GO:0005515;GO:0031011;GO:0008233;GO:0008234;GO:0006508;GO:0006281;GO:0006310;GO:0006974;GO:0000502;GO:0006511;GO:0036459;GO:0070628;GO:0032435;GO:0061136;GO:0004866;GO:0005622;GO:0021670;GO:0030901;GO:0048853;GO:0031597	ubiquitin-dependent protein catabolic process;protein deubiquitination;thiol-dependent ubiquitin-specific protease activity;Ino80 complex;proteasome binding;RNA binding;nucleus;cytoplasm;nucleoplasm;hydrolase activity;mitochondrion;cytosol;negative regulation of endopeptidase activity;protein binding;peptidase activity;cysteine-type peptidase activity;proteolysis;DNA repair;DNA recombination;cellular response to DNA damage stimulus;proteasome complex;thiol-dependent ubiquitinyl hydrolase activity;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;regulation of proteasomal protein catabolic process;endopeptidase inhibitor activity;lateral ventricle development;midbrain development;forebrain morphogenesis;cytosolic proteasome complex	3D-structure;Acetylation;Alternative splicing;Cytoplasm;DNA damage;DNA recombination;DNA repair;Hydrolase;Nucleus;Polymorphism;Protease;Proteasome;Reference proteome;Thiol protease;Transcription;Transcription regulation;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-5688426;R-HSA-5689603;R-HSA-9006936;R-HSA-170834;R-HSA-2173788;R-HSA-2173789	Metabolism of proteins;Post-translational protein modification;Signal Transduction;Deubiquitination;UCH proteinases;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Downregulation of TGF-beta receptor signaling;TGF-beta receptor signaling activates SMADs
PDSS1	positive	CDK2	ENSG00000123374	PDSS1	1	PDSS1	1	0.00520127986896557	WBGene00000405;WBGene00000407;WBGene00019362				GO:0005634;GO:0005737;GO:0046872;GO:0005813;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005654;GO:0051301;GO:0005856;GO:0005515;GO:0006281;GO:0006974;GO:0007049;GO:0051321;GO:0006260;GO:0000287;GO:0004693;GO:0030332;GO:0000082;GO:0000122;GO:0006813;GO:0008284;GO:0018105;GO:0032298;GO:0045893;GO:0051726;GO:0000307;GO:0000781;GO:0000793;GO:0000805;GO:0000806;GO:0005667;GO:0097123;GO:0097124;GO:0097134;GO:0097135;GO:0005815;GO:0005768;GO:0006977;GO:0005829;GO:0031145;GO:0000086;GO:1901796;GO:0019904;GO:0007099;GO:0015030;GO:0051298;GO:0007265;GO:0035173;GO:0097472;GO:0031571;GO:0071732;GO:0016572;GO:0010389;GO:0060968	ATP binding;protein phosphorylation;protein kinase activity;nucleus;cytoplasm;metal ion binding;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;nucleoplasm;endosome;cytoskeleton;cell division;centrosome;protein binding;DNA repair;cellular response to DNA damage stimulus;cell cycle;meiotic cell cycle;DNA replication;magnesium ion binding;cyclin-dependent protein serine/threonine kinase activity;cyclin binding;G1/S transition of mitotic cell cycle;negative regulation of transcription by RNA polymerase II;potassium ion transport;positive regulation of cell population proliferation;peptidyl-serine phosphorylation;positive regulation of DNA-dependent DNA replication initiation;positive regulation of transcription, DNA-templated;regulation of cell cycle;cyclin-dependent protein kinase holoenzyme complex;chromosome, telomeric region;condensed chromosome;X chromosome;Y chromosome;transcription factor complex;cyclin A1-CDK2 complex;cyclin A2-CDK2 complex;cyclin E1-CDK2 complex;cyclin E2-CDK2 complex;microtubule organizing center;multicellular organism development;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;cytosol;anaphase-promoting complex-dependent catabolic process;regulation of gene expression;G2/M transition of mitotic cell cycle;regulation of signal transduction by p53 class mediator;protein domain specific binding;centriole replication;Cajal body;centrosome duplication;Ras protein signal transduction;histone kinase activity;cyclin-dependent protein kinase activity;mitotic G1 DNA damage checkpoint;cellular response to nitric oxide;histone phosphorylation;regulation of G2/M transition of mitotic cell cycle;regulation of gene silencing	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;Endosome;Kinase;Magnesium;Meiosis;Metal-binding;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;S-nitrosylation;Serine/threonine-protein kinase;Transferase	R-HSA-109582;R-HSA-1266738;R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-6804116;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-174143;R-HSA-176408;R-HSA-2262752;R-HSA-453274;R-HSA-453276;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69563;R-HSA-69580;R-HSA-69615;R-HSA-69620;R-HSA-8953897;R-HSA-983231;R-HSA-5633007;R-HSA-6804757;R-HSA-6806003;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-2559583;R-HSA-6804756;R-HSA-176187;R-HSA-68962;R-HSA-68911;R-HSA-2559582;R-HSA-8848021;R-HSA-9006927;R-HSA-5693607;R-HSA-69273;R-HSA-912446;R-HSA-2559586;R-HSA-9616222;R-HSA-1538133;R-HSA-69200;R-HSA-8849470	Hemostasis;Developmental Biology;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Reproduction;Meiosis;Cell Cycle;DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;APC/C-mediated degradation of cell cycle proteins;Regulation of APC/C activators between G1/S and early anaphase;Cellular responses to stress;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cellular responses to external stimuli;Factors involved in megakaryocyte development and platelet production;Regulation of TP53 Activity;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Cellular Senescence;Regulation of TP53 Activity through Phosphorylation;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;G2 Phase;Senescence-Associated Secretory Phenotype (SASP);Signaling by PTK6;Signaling by Non-Receptor Tyrosine Kinases;Processing of DNA double-strand break ends;Cyclin A/B1/B2 associated events during G2/M transition;Meiotic recombination;DNA Damage/Telomere Stress Induced Senescence;Transcriptional regulation of granulopoiesis;G0 and Early G1;Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes;PTK6 Regulates Cell Cycle
PDSS1	positive	PSME3	ENSG00000131467	PDSS1	1	PDSS1	1	0.00520127986896557	WBGene00013435	WBGene00013435(1)			GO:0000502;GO:0008537;GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0005654;GO:0005515;GO:0007049;GO:0006915;GO:0038095;GO:0042802;GO:0050852;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043161;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0061133;GO:0061136;GO:0002039;GO:2001237;GO:0097371;GO:0010950;GO:2000045	proteasome activator complex;proteasome complex;nucleus;cytoplasm;membrane;nucleoplasm;cytosol;protein binding;cell cycle;apoptotic process;Fc-epsilon receptor signaling pathway;identical protein binding;T cell receptor signaling pathway;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;viral process;endopeptidase activator activity;regulation of proteasomal protein catabolic process;p53 binding;negative regulation of extrinsic apoptotic signaling pathway;MDM2/MDM4 family protein binding;positive regulation of endopeptidase activity;regulation of G1/S transition of mitotic cell cycle	Acetylation;Alternative splicing;Apoptosis;Cell cycle;Cytoplasm;Direct protein sequencing;Host-virus interaction;Nucleus;Phosphoprotein;Proteasome;Reference proteome	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
PDSS1	positive	FDPS	ENSG00000160752	PDSS1	1	PDSS1	1	0.00520127986896557	WBGene00011058	WBGene00011058(1)		Disseminated superficial actinic porokeratosis;POROKERATOSIS 9 MULTIPLE TYPES	GO:0003723;GO:0005737;GO:0046872;GO:0016740;GO:0005829;GO:0005654;GO:0006629;GO:0006694;GO:0008202;GO:0008299;GO:0016126;GO:0008203;GO:0006695;GO:0016032;GO:0045540;GO:0004161;GO:0004337;GO:0033384;GO:0045337;GO:0016020;GO:0016021	isoprenoid biosynthetic process;RNA binding;cytoplasm;metal ion binding;transferase activity;nucleoplasm;cytosol;lipid metabolic process;steroid biosynthetic process;steroid metabolic process;sterol biosynthetic process;cholesterol metabolic process;cholesterol biosynthetic process;viral process;regulation of cholesterol biosynthetic process;dimethylallyltranstransferase activity;geranyltranstransferase activity;geranyl diphosphate biosynthetic process;farnesyl diphosphate biosynthetic process;membrane;integral component of membrane	3D-structure;Acetylation;Alternative splicing;Cholesterol biosynthesis;Cholesterol metabolism;Cytoplasm;Disease mutation;Host-virus interaction;Isoprene biosynthesis;Lipid biosynthesis;Lipid metabolism;Magnesium;Metal-binding;Polymorphism;Reference proteome;Steroid biosynthesis;Steroid metabolism;Sterol biosynthesis;Sterol metabolism;Transferase	R-HSA-1430728;R-HSA-556833;R-HSA-8957322;R-HSA-1655829;R-HSA-2426168;R-HSA-191273	Metabolism;Metabolism of lipids;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Activation of gene expression by SREBF (SREBP);Cholesterol biosynthesis
PDSS1	positive	KIF18B	ENSG00000186185	PDSS1	1	PDSS1	1	0.00520127986896557					GO:0005634;GO:0005737;GO:0000166;GO:0005524;GO:0005829;GO:0003774;GO:0051301;GO:0003777;GO:0005856;GO:0007049;GO:0016604;GO:0008017;GO:0005874;GO:0007018;GO:0016887;GO:0005515;GO:0007019;GO:0005871;GO:0051302;GO:0008574;GO:0000278;GO:0019894;GO:0000070;GO:0035371;GO:0000235;GO:1990023;GO:1990752;GO:0061673	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;nucleus;cytoplasm;nucleotide binding;nucleoplasm;cytosol;motor activity;cytoskeleton;cell division;cell cycle;nuclear body;microtubule;protein binding;ATPase activity;microtubule end;microtubule depolymerization;kinesin complex;regulation of cell division;mitotic cell cycle;kinesin binding;ATP-dependent microtubule motor activity, plus-end-directed;mitotic sister chromatid segregation;microtubule plus-end;astral microtubule;mitotic spindle midzone;mitotic spindle astral microtubule	ATP-binding;Alternative splicing;Cell cycle;Cell division;Coiled coil;Cytoplasm;Cytoskeleton;Microtubule;Mitosis;Motor protein;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-109582;R-HSA-5653656;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-983189;R-HSA-983231	Hemostasis;Vesicle-mediated transport;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Kinesins;Factors involved in megakaryocyte development and platelet production
PDSS1	positive	HMBS	ENSG00000256269	PDSS1	1	PDSS1	1	0.00520127986896557				Acute intermittent porphyria;PORPHYRIA ACUTE INTERMITTENT	GO:0033014;GO:0004418;GO:0005737;GO:0016740;GO:0006779;GO:0006782;GO:0018160;GO:0005829;GO:0006783	tetrapyrrole biosynthetic process;hydroxymethylbilane synthase activity;peptidyl-pyrromethane cofactor linkage;cytoplasm;transferase activity;porphyrin-containing compound biosynthetic process;protoporphyrinogen IX biosynthetic process;heme biosynthetic process;cytosol	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Disease mutation;Heme biosynthesis;Phosphoprotein;Porphyrin biosynthesis;Reference proteome;Transferase	R-HSA-1430728;R-HSA-189445;R-HSA-189451	Metabolism;Metabolism of porphyrins;Heme biosynthesis
PDSS1	positive	SMC1A	ENSG00000072501	PDSS1	1	PDSS1	1	0.00550064388726479	WBGene00001860	WBGene00012198(0);WBGene00019087(0)		Cornelia de Lange syndrome;Wiedemann-Steiner syndrome;CORNELIA DE LANGE SYNDROME TYPE 2;Epileptic encephalopathy;CORNELIA DE LANGE SYNDROME 2	GO:0003723;GO:0005634;GO:0000166;GO:0005524;GO:0005829;GO:0005654;GO:0051301;GO:0005694;GO:0006281;GO:0005515;GO:0051276;GO:0006974;GO:0007049;GO:0051321;GO:0003682;GO:0008278;GO:0000775;GO:0000776;GO:0000777;GO:0036033;GO:0007064;GO:0019827;GO:0030893;GO:0016363;GO:0046982;GO:0097431;GO:0000794;GO:0009314;GO:1901673;GO:0000070;GO:0007062;GO:0072423	ATP binding;protein binding;DNA repair;chromatin binding;chromosome;chromosome organization;mitotic sister chromatid cohesion;cohesin complex;RNA binding;nucleus;nucleotide binding;nucleoplasm;cytosol;cell division;cellular response to DNA damage stimulus;cell cycle;meiotic cell cycle;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;mediator complex binding;stem cell population maintenance;meiotic cohesin complex;nuclear matrix;protein heterodimerization activity;mitotic spindle pole;condensed nuclear chromosome;response to radiation;regulation of mitotic spindle assembly;mitotic sister chromatid segregation;sister chromatid cohesion;response to DNA damage checkpoint signaling	ATP-binding;Acetylation;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;DNA damage;DNA repair;Direct protein sequencing;Disease mutation;Kinetochore;Meiosis;Mental retardation;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-1221632;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69242;R-HSA-69278;R-HSA-2500257;R-HSA-68877;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-8939211;R-HSA-9006931;R-HSA-9018519;R-HSA-2468052;R-HSA-2470946;R-HSA-68884	Metabolism of proteins;Post-translational protein modification;Signal Transduction;Meiotic synapsis;Reproduction;Meiosis;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;S Phase;Cell Cycle, Mitotic;Resolution of Sister Chromatid Cohesion;Mitotic Prometaphase;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;ESR-mediated signaling;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Establishment of Sister Chromatid Cohesion;Cohesin Loading onto Chromatin;Mitotic Telophase/Cytokinesis
PDSS1	positive	NCBP1	ENSG00000136937	PDSS1	1	PDSS1	1	0.00550064388726479	WBGene00018156	WBGene00018156(0)			GO:0003723;GO:0006397;GO:0008380;GO:0051028;GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0005739;GO:0005515;GO:0000339;GO:0016070;GO:0045292;GO:0005846;GO:0006406;GO:0031047;GO:0003729;GO:0006417;GO:0005845;GO:1990904;GO:0006405;GO:0031124;GO:0006366;GO:0006368;GO:0006370;GO:0042795;GO:0030307;GO:0000398;GO:0000184;GO:0006446;GO:0008543;GO:0006369;GO:0098789;GO:0008334;GO:0000340;GO:0031442;GO:0051168;GO:0034518;GO:0050684;GO:0000245;GO:0048026;GO:1905216	protein binding;RNA binding;RNA metabolic process;mRNA transport;RNA cap binding;mRNA cis splicing, via spliceosome;nuclear cap binding complex;mRNA processing;RNA splicing;nucleus;cytoplasm;nucleoplasm;cytosol;mitochondrion;mRNA export from nucleus;gene silencing by RNA;mRNA binding;regulation of translation;mRNA splicing, via spliceosome;mRNA cap binding complex;ribonucleoprotein complex;RNA export from nucleus;mRNA 3'-end processing;transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;7-methylguanosine mRNA capping;snRNA transcription by RNA polymerase II;positive regulation of cell growth;RNA catabolic process;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation;fibroblast growth factor receptor signaling pathway;termination of RNA polymerase II transcription;pre-mRNA cleavage required for polyadenylation;histone mRNA metabolic process;RNA 7-methylguanosine cap binding;positive regulation of mRNA 3'-end processing;nuclear export;RNA cap binding complex;regulation of mRNA processing;spliceosomal complex assembly;positive regulation of mRNA splicing, via spliceosome;positive regulation of RNA binding	3D-structure;Acetylation;Coiled coil;Cytoplasm;Direct protein sequencing;Isopeptide bond;Nonsense-mediated mRNA decay;Nucleus;Phosphoprotein;RNA-mediated gene silencing;Reference proteome;Translation regulation;Transport;Ubl conjugation;mRNA capping;mRNA processing;mRNA splicing;mRNA transport	R-HSA-1266738;R-HSA-73857;R-HSA-74160;R-HSA-422475;R-HSA-162582;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-376176;R-HSA-5663202;R-HSA-9010553;R-HSA-112382;R-HSA-167152;R-HSA-167169;R-HSA-167172;R-HSA-167200;R-HSA-167246;R-HSA-674695;R-HSA-75955;R-HSA-9006934;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-191859;R-HSA-194441;R-HSA-72202;R-HSA-72203;R-HSA-72187;R-HSA-73856;R-HSA-113418;R-HSA-167158;R-HSA-167242;R-HSA-6807505;R-HSA-72086;R-HSA-72163;R-HSA-72172;R-HSA-1226099;R-HSA-927802;R-HSA-975957;R-HSA-1839126;R-HSA-190236;R-HSA-5654738;R-HSA-5655253;R-HSA-6803529;R-HSA-72165;R-HSA-8851708;R-HSA-75067;R-HSA-77595;R-HSA-975956;R-HSA-111367;R-HSA-77588	Developmental Biology;RNA Polymerase II Transcription;Gene expression (Transcription);Axon guidance;Signal Transduction;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Signaling by ROBO receptors;Diseases of signal transduction;Regulation of expression of SLITs and ROBOs;Formation of RNA Pol II elongation complex ;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Tat-mediated elongation of the HIV-1 transcript;RNA Polymerase II Pre-transcription Events;RNA Polymerase II Transcription Elongation;Signaling by Receptor Tyrosine Kinases;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;snRNP Assembly;Metabolism of non-coding RNA;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination;Formation of the Early Elongation Complex;Formation of the HIV-1 Early Elongation Complex;Abortive elongation of HIV-1 transcript in the absence of Tat;RNA polymerase II transcribes snRNA genes;mRNA Capping;mRNA Splicing - Major Pathway;mRNA Splicing;Signaling by FGFR in disease;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);FGFR2 mutant receptor activation;Signaling by FGFR;Signaling by FGFR2;Signaling by FGFR2 in disease;FGFR2 alternative splicing;mRNA Splicing - Minor Pathway;Signaling by FGFR2 IIIa TM;Processing of Capped Intronless Pre-mRNA;Processing of Intronless Pre-mRNAs;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC);SLBP independent Processing of Histone Pre-mRNAs;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
PDSS1	positive	MKI67	ENSG00000148773	PDSS1	1	PDSS1	1	0.00550064388726479					GO:0003723;GO:0005634;GO:0016020;GO:0000166;GO:0005524;GO:0005730;GO:0003677;GO:0005694;GO:0005515;GO:0007049;GO:0016604;GO:0008283;GO:0008022;GO:0007088;GO:0051983;GO:0000793;GO:1902275	protein binding;RNA binding;nucleus;membrane;nucleotide binding;ATP binding;nucleoplasm;nucleolus;DNA binding;chromosome;cell cycle;nuclear body;protein C-terminus binding;regulation of mitotic nuclear division;regulation of chromosome segregation;condensed chromosome;cell population proliferation;regulation of chromatin organization	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell cycle;Chromosome;DNA-binding;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation		
PDSS1	positive	DNAAF5	ENSG00000164818	PDSS1	1	PDSS1	1	0.00550064388726479				Primary ciliary dyskinesia;CILIARY DYSKINESIA PRIMARY 18;CILIARY DYSKINESIA PRIMARY 18	GO:0005737;GO:0045505;GO:0030030;GO:0003341;GO:0036159;GO:0036158;GO:0005515	cytoplasm;dynein intermediate chain binding;cell projection organization;cilium movement;inner dynein arm assembly;outer dynein arm assembly;protein binding	Acetylation;Alternative splicing;Ciliopathy;Cilium biogenesis/degradation;Cytoplasm;Direct protein sequencing;Disease mutation;Kartagener syndrome;Polymorphism;Primary ciliary dyskinesia;Reference proteome;Repeat		
PDSS1	positive	CDCA4	ENSG00000170779	PDSS1	1	PDSS1	1	0.00550064388726479					GO:0005634;GO:0005829;GO:0005654;GO:0005886;GO:0051301;GO:0005515	nucleus;nucleoplasm;cytosol;plasma membrane;cell division;protein binding	Nucleus;Reference proteome		
PDSS1	positive	NETO2	ENSG00000171208	PDSS1	1	PDSS1	1	0.00550064388726479	WBGene00019360;WBGene00010587				GO:0016020;GO:0016021;GO:2000312;GO:0035255;GO:0014069;GO:0045202;GO:0005515	protein binding;regulation of kainate selective glutamate receptor activity;membrane;integral component of membrane;ionotropic glutamate receptor binding;postsynaptic density;synapse	Alternative splicing;Direct protein sequencing;Disulfide bond;Glycoprotein;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix		
PDSS1	positive	RUVBL2	ENSG00000183207	PDSS1	1	PDSS1	1	0.00550064388726479	WBGene00020687	WBGene00020687(0)			GO:0005634;GO:0005737;GO:0016020;GO:0005813;GO:0000166;GO:0005524;GO:0005829;GO:0005654;GO:0016787;GO:0031490;GO:0006325;GO:0005515;GO:0031011;GO:0003678;GO:0032508;GO:0006281;GO:0006310;GO:0006974;GO:1903507;GO:0035267;GO:0004386;GO:0042802;GO:0006338;GO:0000812;GO:0006357;GO:0043139;GO:0097255;GO:0003714;GO:0045944;GO:0070062;GO:0090090;GO:0016887;GO:0040008;GO:0043967;GO:0016363;GO:0071339;GO:0000980;GO:0008013;GO:0051082;GO:0005622;GO:0034644;GO:0006457;GO:1904874;GO:0071392;GO:0000979;GO:0071169;GO:0043968;GO:0005719;GO:0017025;GO:0016573;GO:0000492;GO:0035066;GO:0071899;GO:0001094;GO:0042803;GO:0043531;GO:0051117;GO:0071733;GO:1990904	ATP binding;DNA helicase activity;Ino80 complex;NuA4 histone acetyltransferase complex;5'-3' DNA helicase activity;R2TP complex;nucleus;cytoplasm;membrane;nucleotide binding;nucleoplasm;cytosol;hydrolase activity;chromatin DNA binding;chromatin organization;centrosome;protein binding;DNA duplex unwinding;DNA repair;DNA recombination;cellular response to DNA damage stimulus;negative regulation of nucleic acid-templated transcription;identical protein binding;ATPase activity;helicase activity;chromatin remodeling;Swr1 complex;regulation of transcription by RNA polymerase II;transcription corepressor activity;positive regulation of transcription by RNA polymerase II;extracellular exosome;negative regulation of canonical Wnt signaling pathway;regulation of growth;histone H4 acetylation;nuclear matrix;MLL1 complex;RNA polymerase II cis-regulatory region sequence-specific DNA binding;beta-catenin binding;unfolded protein binding;intracellular;cellular response to UV;protein folding;positive regulation of telomerase RNA localization to Cajal body;cellular response to estradiol stimulus;RNA polymerase II core promoter sequence-specific DNA binding;establishment of protein localization to chromatin;histone H2A acetylation;nuclear euchromatin;TBP-class protein binding;histone acetylation;box C/D snoRNP assembly;positive regulation of histone acetylation;negative regulation of estrogen receptor binding;TFIID-class transcription factor complex binding;protein homodimerization activity;ADP binding;ATPase binding;transcriptional activation by promoter-enhancer looping;ribonucleoprotein complex	3D-structure;ATP-binding;Acetylation;Activator;Alternative splicing;Chromatin regulator;Cytoplasm;DNA damage;DNA recombination;DNA repair;Direct protein sequencing;Growth regulation;Helicase;Hydrolase;Isopeptide bond;Membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-1640170;R-HSA-73886;R-HSA-3247509;R-HSA-4839726;R-HSA-157579;R-HSA-171319;R-HSA-180786;R-HSA-3214847	Cell Cycle;Chromosome Maintenance;Chromatin modifying enzymes;Chromatin organization;Telomere Maintenance;Telomere Extension By Telomerase;Extension of Telomeres;HATs acetylate histones
PDSS1	positive	RBBP8	ENSG00000101773	PDSS1	1	PDSS1	1	0.0058152203160351		WBGene00008082(0)		JAWAD SYNDROME;Seckel syndrome;JAWAD SYNDROME;SECKEL SYNDROME 2	GO:0005634;GO:0004519;GO:0090305;GO:0000724;GO:0010792;GO:0043231;GO:0005654;GO:0016787;GO:0003677;GO:0051301;GO:0005694;GO:0006281;GO:0005515;GO:0006974;GO:0007049;GO:1903507;GO:0004518;GO:0051321;GO:0042802;GO:0003690;GO:0003697;GO:0000403;GO:1901796;GO:0006260;GO:0070317;GO:0006357;GO:0001103;GO:0003714;GO:0017053;GO:0003684;GO:0006289;GO:0035861;GO:0000729;GO:0000014;GO:0000406;GO:0070336;GO:0000082;GO:0001835;GO:0032355	nucleus;endonuclease activity;double-strand break repair via homologous recombination;DNA double-strand break processing involved in repair via single-strand annealing;nucleic acid phosphodiester bond hydrolysis;DNA repair;intracellular membrane-bounded organelle;nucleoplasm;hydrolase activity;DNA binding;cell division;chromosome;protein binding;cellular response to DNA damage stimulus;cell cycle;negative regulation of nucleic acid-templated transcription;nuclease activity;meiotic cell cycle;identical protein binding;Y-form DNA binding;double-stranded DNA binding;regulation of signal transduction by p53 class mediator;DNA replication;negative regulation of G0 to G1 transition;regulation of transcription by RNA polymerase II;RNA polymerase II repressing transcription factor binding;transcription corepressor activity;single-stranded DNA binding;transcriptional repressor complex;damaged DNA binding;site of double-strand break;DNA double-strand break processing;single-stranded DNA endodeoxyribonuclease activity;double-strand/single-strand DNA junction binding;flap-structured DNA binding;G1/S transition of mitotic cell cycle;blastocyst hatching;response to estradiol	3D-structure;Acetylation;Alternative splicing;Cell cycle;Cell division;Chromosome;Coiled coil;DNA damage;DNA repair;DNA-binding;Disease mutation;Dwarfism;Endonuclease;Hydrolase;Isopeptide bond;Meiosis;Mental retardation;Mitosis;Nuclease;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693537;R-HSA-5693538;R-HSA-5693567;R-HSA-5693568;R-HSA-73894;R-HSA-69481;R-HSA-69620;R-HSA-5633007;R-HSA-6804756;R-HSA-8953750;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5693554;R-HSA-912446;R-HSA-5685938;R-HSA-5685939	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Resolution of D-Loop Structures;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Resolution of D-loop Structures through Holliday Junction Intermediates;DNA Repair;G2/M Checkpoints;Cell Cycle Checkpoints;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Transcriptional Regulation by E2F6;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA);Meiotic recombination;HDR through Single Strand Annealing (SSA);HDR through MMEJ (alt-NHEJ)
PDSS1	positive	UMPS	ENSG00000114491	PDSS1	1	PDSS1	1	0.0058152203160351	WBGene00011559;WBGene00020036	WBGene00011559(0)		Hereditary orotic aciduria;OROTIC ACIDURIA TYPE 1;OROTIC ACIDURIA	GO:0005634;GO:0005737;GO:0016740;GO:0009116;GO:0003824;GO:0016829;GO:0016757;GO:0008152;GO:0016831;GO:0006207;GO:0006221;GO:0005829;GO:0004588;GO:0004590;GO:0006222;GO:0007565;GO:0007595;GO:0035690;GO:0044205;GO:0019856;GO:0046134	catalytic activity;nucleoside metabolic process;'de novo' pyrimidine nucleobase biosynthetic process;orotidine-5'-phosphate decarboxylase activity;orotate phosphoribosyltransferase activity;pyrimidine nucleotide biosynthetic process;'de novo' UMP biosynthetic process;nucleus;cytoplasm;transferase activity;lyase activity;transferase activity, transferring glycosyl groups;metabolic process;carboxy-lyase activity;cytosol;UMP biosynthetic process;female pregnancy;lactation;cellular response to drug;pyrimidine nucleobase biosynthetic process;pyrimidine nucleoside biosynthetic process	3D-structure;Acetylation;Alternative splicing;Decarboxylase;Disease mutation;Glycosyltransferase;Lyase;Multifunctional enzyme;Phosphoprotein;Polymorphism;Pyrimidine biosynthesis;Reference proteome;Transferase	R-HSA-1430728;R-HSA-15869;R-HSA-8956320;R-HSA-500753	Metabolism;Metabolism of nucleotides;Nucleobase biosynthesis;Pyrimidine biosynthesis
PDSS1	positive	SLIRP	ENSG00000119705	PDSS1	1	PDSS1	1	0.0058152203160351	WBGene00008224				GO:0003676;GO:0003723;GO:0005634;GO:0005739;GO:0005515;GO:1990904;GO:0070584;GO:0000961;GO:0007286;GO:0007338;GO:0030317;GO:0001669;GO:0005737;GO:0036126;GO:0048471	nucleic acid binding;RNA binding;nucleus;mitochondrion;protein binding;regulation of RNA metabolic process;ribonucleoprotein complex;mitochondrion morphogenesis;negative regulation of mitochondrial RNA catabolic process;spermatid development;single fertilization;flagellated sperm motility;acrosomal vesicle;cytoplasm;sperm flagellum;perinuclear region of cytoplasm	Alternative splicing;Mitochondrion;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repressor;Transcription;Transcription regulation;Transit peptide		
PDSS1	positive	EXOSC2	ENSG00000130713	PDSS1	1	PDSS1	1	0.0058152203160351	WBGene00022232	WBGene00022232(0)		Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome;SHORT STATURE HEARING LOSS RETINITIS PIGMENTOSA AND DISTINCTIVE FACIES	GO:0003723;GO:0005634;GO:0005737;GO:0005730;GO:0005515;GO:0006364;GO:0005654;GO:0005829;GO:0000178;GO:0043488;GO:0030307;GO:0043928;GO:0000176;GO:0000467;GO:0008312;GO:0071035;GO:0071038;GO:0071051;GO:0034427;GO:0034475;GO:0000177;GO:0000175;GO:0071034;GO:0071049	RNA binding;exosome (RNase complex);nucleus;cytoplasm;nucleoplasm;nucleolus;protein binding;rRNA processing;cytosol;regulation of mRNA stability;positive regulation of cell growth;exonucleolytic catabolism of deadenylated mRNA;nuclear exosome (RNase complex);exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);7S RNA binding;nuclear polyadenylation-dependent rRNA catabolic process;nuclear polyadenylation-dependent tRNA catabolic process;polyadenylation-dependent snoRNA 3'-end processing;nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5';U4 snRNA 3'-end processing;cytoplasmic exosome (RNase complex);3'-5'-exoribonuclease activity;CUT catabolic process;nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription	3D-structure;Alternative splicing;Cytoplasm;Deafness;Disease mutation;Dwarfism;Exosome;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Retinitis pigmentosa;rRNA processing	R-HSA-392499;R-HSA-8953854;R-HSA-450531;R-HSA-429914;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-381119;R-HSA-380994;R-HSA-381042;R-HSA-450604;R-HSA-450513;R-HSA-450385;R-HSA-429958	Metabolism of proteins;Metabolism of RNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Deadenylation-dependent mRNA decay;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;Unfolded Protein Response (UPR);ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression;KSRP (KHSRP) binds and destabilizes mRNA;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA;mRNA decay by 3' to 5' exoribonuclease
PDSS1	positive	PLK4	ENSG00000142731	PDSS1	1	PDSS1	1	0.0058152203160351				Autosomal recessive chorioretinopathy-microcephaly syndrome;Seckel syndrome;Microcephaly growth failure and retinopathy;Microcephaly and chorioretinopathy autosomal recessive 2	GO:0005634;GO:0005737;GO:0005813;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005829;GO:0005856;GO:0005515;GO:0005730;GO:0007099;GO:0042802;GO:0005814;GO:0000278;GO:0060707;GO:0098535;GO:0098536;GO:0000922;GO:0032154;GO:0000086;GO:0010389;GO:0097711;GO:0032465;GO:0046601;GO:0001741	ATP binding;protein binding;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;centriole replication;centriole;nucleus;cytoplasm;nucleotide binding;kinase activity;transferase activity;phosphorylation;cytosol;cytoskeleton;centrosome;nucleolus;identical protein binding;mitotic cell cycle;trophoblast giant cell differentiation;de novo centriole assembly involved in multi-ciliated epithelial cell differentiation;deuterosome;spindle pole;cleavage furrow;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking;regulation of cytokinesis;positive regulation of centriole replication;XY body	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cytoplasm;Cytoskeleton;Dwarfism;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-1852241;R-HSA-5617833;R-HSA-1640170;R-HSA-453274;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-380320;R-HSA-68877;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518	Organelle biogenesis and maintenance;Cilium Assembly;Cell Cycle;Mitotic G2-G2/M phases;M Phase;G2/M Transition;Cell Cycle, Mitotic;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2
PDSS1	positive	CCT3	ENSG00000163468	PDSS1	1	PDSS1	1	0.0058152203160351	WBGene00018782	WBGene00018782(1)			GO:0050821;GO:0003723;GO:0005737;GO:0000166;GO:0005524;GO:0005829;GO:0005886;GO:0006457;GO:0005515;GO:0005874;GO:0051082;GO:0070062;GO:0005856;GO:0032212;GO:1904851;GO:1904871;GO:1904874;GO:0005832;GO:0007339;GO:0046931;GO:1901998;GO:0002199;GO:0044297	ATP binding;protein folding;unfolded protein binding;protein stabilization;RNA binding;cytoplasm;nucleotide binding;cytosol;plasma membrane;protein binding;microtubule;extracellular exosome;cytoskeleton;positive regulation of telomere maintenance via telomerase;positive regulation of establishment of protein localization to telomere;positive regulation of protein localization to Cajal body;positive regulation of telomerase RNA localization to Cajal body;chaperonin-containing T-complex;binding of sperm to zona pellucida;pore complex assembly;toxin transport;zona pellucida receptor complex;cell body	3D-structure;ATP-binding;Acetylation;Alternative splicing;Chaperone;Cytoplasm;Direct protein sequencing;Disulfide bond;Isopeptide bond;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-1852241;R-HSA-5617833;R-HSA-392499;R-HSA-389958;R-HSA-389960;R-HSA-390466;R-HSA-391251;R-HSA-5620920;R-HSA-6814122;R-HSA-5620922;R-HSA-390471;R-HSA-389957;R-HSA-390450	Organelle biogenesis and maintenance;Cilium Assembly;Metabolism of proteins;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Chaperonin-mediated protein folding;Protein folding;Cargo trafficking to the periciliary membrane;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;BBSome-mediated cargo-targeting to cilium;Association of TriC/CCT with target proteins during biosynthesis;Prefoldin mediated transfer of substrate  to CCT/TriC;Folding of actin by CCT/TriC
PDSS1	positive	CHAF1A	ENSG00000167670	PDSS1	1	PDSS1	1	0.0058152203160351	WBGene00011532	WBGene00011532(0)			GO:0005634;GO:0000790;GO:0005515;GO:0006281;GO:0006974;GO:0007049;GO:0006260;GO:0042802;GO:0032991;GO:0051082;GO:0006335;GO:0003682;GO:0006334;GO:0031497;GO:0070087;GO:0033186	nucleus;nuclear chromatin;protein binding;DNA repair;cellular response to DNA damage stimulus;cell cycle;DNA replication;identical protein binding;protein-containing complex;unfolded protein binding;DNA replication-dependent nucleosome assembly;chromatin binding;nucleosome assembly;chromatin assembly;chromo shadow domain binding;CAF-1 complex	Alternative splicing;Cell cycle;Chaperone;DNA damage;DNA repair;DNA replication;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation		
PDSS1	positive	MRPL11	ENSG00000174547	PDSS1	1	PDSS1	1	0.0058152203160351	WBGene00015133	WBGene00015133(1)			GO:0003723;GO:0006412;GO:0005739;GO:0003735;GO:0005840;GO:0005515;GO:0000027;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:0005761;GO:0019843;GO:0070180;GO:0015934	structural constituent of ribosome;translation;ribosome;RNA binding;mitochondrion;protein binding;rRNA binding;ribosomal large subunit assembly;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;mitochondrial ribosome;large ribosomal subunit rRNA binding;large ribosomal subunit	3D-structure;Alternative splicing;Mitochondrion;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
PDSS1	positive	LSM2	ENSG00000204392	PDSS1	1	PDSS1	1	0.0058152203160351	WBGene00001808	WBGene00001808(1)			GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005515;GO:0005681;GO:0000398;GO:0071013;GO:0000932;GO:0005654;GO:0005829;GO:0046540;GO:0017160;GO:0043928;GO:1990726;GO:0071005;GO:0017070;GO:0005688;GO:0120115	mRNA processing;RNA binding;RNA splicing;nucleus;nucleoplasm;protein binding;spliceosomal complex;mRNA splicing, via spliceosome;catalytic step 2 spliceosome;P-body;cytosol;U4/U6 x U5 tri-snRNP complex;Ral GTPase binding;cytoplasm;exonucleolytic catabolism of deadenylated mRNA;Lsm1-7-Pat1 complex;U2-type precatalytic spliceosome;precatalytic spliceosome;U6 snRNA binding;U6 snRNP;Lsm2-8 complex;mRNA catabolic process;spliceosomal tri-snRNP complex assembly	3D-structure;Direct protein sequencing;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-429914;R-HSA-72203;R-HSA-72163;R-HSA-72172;R-HSA-430039;R-HSA-72165	Metabolism of RNA;Deadenylation-dependent mRNA decay;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA decay by 5' to 3' exoribonuclease;mRNA Splicing - Minor Pathway
PDSS1	positive	KDM1A	ENSG00000004487	PDSS1	1	PDSS1	1	0.00614565658553468	WBGene00005010;WBGene00011615	WBGene00011615(0);WBGene00005010(0)		Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome;Developmental delay and distinctive facial features;Cleft palate psychomotor retardation and distinctive facial features	GO:0005634;GO:0016491;GO:0050660;GO:0055114;GO:0006355;GO:0003677;GO:0006325;GO:0034720;GO:0005515;GO:0051091;GO:0043433;GO:0045944;GO:0044212;GO:0005654;GO:0007275;GO:0030374;GO:0000790;GO:0000122;GO:0008134;GO:0003682;GO:0006357;GO:0000784;GO:0032991;GO:0032454;GO:0033169;GO:0045892;GO:0120162;GO:0043426;GO:0019899;GO:0032091;GO:0007596;GO:0050681;GO:0043518;GO:0002039;GO:1902166;GO:0001085;GO:0032451;GO:0032452;GO:0032453;GO:0034648;GO:0042162;GO:0061752;GO:0002052;GO:0006482;GO:0010569;GO:0033184;GO:0034644;GO:0043392;GO:0051572;GO:0051573;GO:0055001;GO:0071480;GO:1903827;GO:2000179;GO:2000648;GO:0005667;GO:1990391;GO:0000380;GO:0010976;GO:0014070;GO:0021987;GO:0035563;GO:0042551;GO:0045793;GO:0046098;GO:0060992;GO:0071320	DNA binding;regulation of transcription, DNA-templated;nucleus;protein binding;flavin adenine dinucleotide binding;oxidation-reduction process;oxidoreductase activity;histone H3-K4 demethylation;nucleoplasm;chromatin organization;positive regulation of DNA-binding transcription factor activity;negative regulation of DNA-binding transcription factor activity;positive regulation of transcription by RNA polymerase II;multicellular organism development;nuclear receptor transcription coactivator activity;nuclear chromatin;negative regulation of transcription by RNA polymerase II;transcription factor binding;chromatin binding;regulation of transcription by RNA polymerase II;nuclear chromosome, telomeric region;protein-containing complex;histone demethylase activity (H3-K9 specific);histone H3-K9 demethylation;negative regulation of transcription, DNA-templated;positive regulation of cold-induced thermogenesis;MRF binding;enzyme binding;negative regulation of protein binding;blood coagulation;androgen receptor binding;negative regulation of DNA damage response, signal transduction by p53 class mediator;p53 binding;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;RNA polymerase II transcription factor binding;demethylase activity;histone demethylase activity;histone demethylase activity (H3-K4 specific);histone demethylase activity (H3-dimethyl-K4 specific);telomeric repeat-containing RNA binding;promoter-specific chromatin binding;positive regulation of neuroblast proliferation;protein demethylation;regulation of double-strand break repair via homologous recombination;positive regulation of histone ubiquitination;cellular response to UV;negative regulation of DNA binding;negative regulation of histone H3-K4 methylation;negative regulation of histone H3-K9 methylation;muscle cell development;cellular response to gamma radiation;regulation of cellular protein localization;positive regulation of neural precursor cell proliferation;positive regulation of stem cell proliferation;transcription factor complex;DNA repair complex;alternative mRNA splicing, via spliceosome;positive regulation of neuron projection development;response to organic cyclic compound;cerebral cortex development;positive regulation of chromatin binding;neuron maturation;positive regulation of cell size;guanine metabolic process;response to fungicide;cellular response to cAMP	3D-structure;Alternative splicing;Chromatin regulator;Coiled coil;Developmental protein;Direct protein sequencing;Disease mutation;FAD;Flavoprotein;Isopeptide bond;Nucleus;Oxidoreductase;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-109582;R-HSA-162582;R-HSA-194315;R-HSA-1257604;R-HSA-6807070;R-HSA-9006925;R-HSA-195258;R-HSA-983231;R-HSA-8939211;R-HSA-9006931;R-HSA-8943724;R-HSA-3214815;R-HSA-3247509;R-HSA-4839726;R-HSA-9018519;R-HSA-3214842;R-HSA-5625740;R-HSA-5625886	Hemostasis;Signal Transduction;Signaling by Rho GTPases;PIP3 activates AKT signaling;PTEN Regulation;Intracellular signaling by second messengers;RHO GTPase Effectors;Factors involved in megakaryocyte development and platelet production;ESR-mediated signaling;Signaling by Nuclear Receptors;Regulation of PTEN gene transcription;HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization;Estrogen-dependent gene expression;HDMs demethylate histones;RHO GTPases activate PKNs;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
PDSS1	positive	POLA2	ENSG00000014138	PDSS1	1	PDSS1	1	0.00614565658553468	WBGene00001002	WBGene00001002(0)			GO:0005634;GO:0005829;GO:0005654;GO:0003677;GO:0006260;GO:0003887;GO:0071897;GO:0003674;GO:0000082;GO:0006270;GO:0032201;GO:0005658;GO:0046982	DNA binding;DNA replication;DNA-directed DNA polymerase activity;nucleus;nucleoplasm;cytosol;DNA biosynthetic process;molecular_function;G1/S transition of mitotic cell cycle;DNA replication initiation;telomere maintenance via semi-conservative replication;alpha DNA polymerase:primase complex	3D-structure;Alternative splicing;DNA replication;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-69002;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-73886;R-HSA-453279;R-HSA-69206;R-HSA-68962;R-HSA-157579;R-HSA-180786;R-HSA-113510;R-HSA-69190;R-HSA-113501;R-HSA-174411;R-HSA-174417;R-HSA-174430;R-HSA-68952;R-HSA-69091;R-HSA-69109;R-HSA-69166;R-HSA-69183;R-HSA-69186	Cell Cycle;DNA Replication Pre-Initiation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;Chromosome Maintenance;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of the pre-replicative complex;Telomere Maintenance;Extension of Telomeres;E2F mediated regulation of DNA replication;DNA strand elongation;Inhibition of replication initiation of damaged DNA by RB1/E2F1;Polymerase switching on the C-strand of the telomere;Telomere C-strand (Lagging Strand) Synthesis;Telomere C-strand synthesis initiation;DNA replication initiation;Polymerase switching;Leading Strand Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis
PDSS1	positive	MLH1	ENSG00000076242	PDSS1	1	PDSS1	1	0.00614565658553468	WBGene00003373	WBGene00003373(0)		Constitutional mismatch repair deficiency syndrome;Lynch syndrome;Muir-Torre syndrome;COLORECTAL CANCER HEREDITARY NONPOLYPOSIS TYPE 2;MISMATCH REPAIR CANCER SYNDROME;Muir-Torre syndrome	GO:0005634;GO:0016020;GO:0000166;GO:0005524;GO:0005654;GO:0005694;GO:0005515;GO:0006281;GO:0006974;GO:0007049;GO:0016887;GO:0030983;GO:0006298;GO:0032300;GO:0003682;GO:0019899;GO:0003697;GO:0032407;GO:0032137;GO:0000289;GO:0000712;GO:0002204;GO:0006303;GO:0007060;GO:0007129;GO:0007131;GO:0007140;GO:0007283;GO:0008630;GO:0009617;GO:0016321;GO:0016446;GO:0016447;GO:0043060;GO:0045132;GO:0045141;GO:0045143;GO:0045190;GO:0045950;GO:0048298;GO:0048304;GO:0048477;GO:0051257;GO:0051321;GO:0000793;GO:0000794;GO:0000795;GO:0001673;GO:0005712;GO:0005715;GO:0032389	ATP binding;mismatched DNA binding;mismatch repair;ATPase activity;mismatch repair complex;cell;nucleus;membrane;nucleotide binding;nucleoplasm;chromosome;protein binding;DNA repair;cellular response to DNA damage stimulus;cell cycle;chromatin binding;enzyme binding;single-stranded DNA binding;MutSalpha complex binding;guanine/thymine mispair binding;nuclear-transcribed mRNA poly(A) tail shortening;resolution of meiotic recombination intermediates;somatic recombination of immunoglobulin genes involved in immune response;double-strand break repair via nonhomologous end joining;male meiosis chromosome segregation;synapsis;reciprocal meiotic recombination;male meiotic nuclear division;spermatogenesis;intrinsic apoptotic signaling pathway in response to DNA damage;response to bacterium;female meiosis chromosome segregation;somatic hypermutation of immunoglobulin genes;somatic recombination of immunoglobulin gene segments;meiotic metaphase I plate congression;meiotic chromosome segregation;meiotic telomere clustering;homologous chromosome segregation;isotype switching;negative regulation of mitotic recombination;positive regulation of isotype switching to IgA isotypes;positive regulation of isotype switching to IgG isotypes;oogenesis;meiotic spindle midzone assembly;meiotic cell cycle;condensed chromosome;condensed nuclear chromosome;synaptonemal complex;male germ cell nucleus;chiasma;late recombination nodule;MutLalpha complex	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell cycle;Chromosome;DNA damage;DNA repair;Disease mutation;Hereditary nonpolyposis colorectal cancer;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Tumor suppressor	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-1643685;R-HSA-73894;R-HSA-6796648;R-HSA-912446;R-HSA-5358508;R-HSA-5358565;R-HSA-5358606;R-HSA-5423599;R-HSA-5545483;R-HSA-5632987	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Reproduction;Meiosis;Cell Cycle;Disease;DNA Repair;TP53 Regulates Transcription of DNA Repair Genes;Meiotic recombination;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta);Diseases of Mismatch Repair (MMR);Defective Mismatch Repair Associated With MLH1;Defective Mismatch Repair Associated With PMS2
PDSS1	positive	RBL1	ENSG00000080839	PDSS1	1	PDSS1	1	0.00614565658553468	WBGene00003020	WBGene00003020(0)			GO:2000773;GO:0005634;GO:0005654;GO:0006357;GO:0006325;GO:0005515;GO:0007049;GO:0005667;GO:0051726;GO:0030154;GO:0016032;GO:0051302;GO:0008134;GO:0045944;GO:0000785;GO:0001102;GO:0001012;GO:0007346;GO:0010629;GO:0043550;GO:2000134;GO:1990841;GO:0000122	nucleus;regulation of transcription by RNA polymerase II;transcription factor complex;regulation of cell cycle;regulation of cell division;negative regulation of cellular senescence;nucleoplasm;chromatin organization;protein binding;cell cycle;cell differentiation;viral process;transcription factor binding;positive regulation of transcription by RNA polymerase II;chromatin;regulation of mitotic cell cycle;RNA polymerase II activating transcription factor binding;RNA polymerase II regulatory region DNA binding;negative regulation of gene expression;regulation of lipid kinase activity;negative regulation of G1/S transition of mitotic cell cycle;promoter-specific chromatin binding;negative regulation of transcription by RNA polymerase II	3D-structure;Alternative splicing;Cell cycle;Chromatin regulator;Direct protein sequencing;Host-virus interaction;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Tumor suppressor	R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1640170;R-HSA-69278;R-HSA-453279;R-HSA-69206;R-HSA-9006936;R-HSA-170834;R-HSA-2173793;R-HSA-2173796;R-HSA-69231;R-HSA-69236;R-HSA-6804114;R-HSA-69205;R-HSA-1538133;R-HSA-1362277;R-HSA-1362300	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Cell Cycle;Cell Cycle, Mitotic;Mitotic G1 phase and G1/S transition;G1/S Transition;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription;Cyclin D associated events in G1;G1 Phase;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;G1/S-Specific Transcription;G0 and Early G1;Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
PDSS1	positive	SLC25A17	ENSG00000100372	PDSS1	1	PDSS1	1	0.00614565658553468					GO:0016020;GO:0016021;GO:0005737;GO:0022857;GO:0055085;GO:0005515;GO:0005777;GO:0005778;GO:0005779;GO:0051087;GO:0001561;GO:0000295;GO:0005347;GO:0015217;GO:0015228;GO:0015230;GO:0044610;GO:0051724;GO:0080122;GO:0006635;GO:0015866;GO:0015867;GO:0015908;GO:0035349;GO:0035350;GO:0035352;GO:0051182;GO:0080121;GO:1901679;GO:0005743	membrane;integral component of membrane;transmembrane transporter activity;transmembrane transport;cytoplasm;protein binding;peroxisome;peroxisomal membrane;integral component of peroxisomal membrane;chaperone binding;fatty acid alpha-oxidation;adenine nucleotide transmembrane transporter activity;ATP transmembrane transporter activity;ADP transmembrane transporter activity;coenzyme A transmembrane transporter activity;FAD transmembrane transporter activity;FMN transmembrane transporter activity;NAD transmembrane transporter activity;AMP transmembrane transporter activity;fatty acid beta-oxidation;ADP transport;ATP transport;fatty acid transport;coenzyme A transmembrane transport;FAD transmembrane transport;NAD transmembrane transport;coenzyme transport;AMP transport;nucleotide transmembrane transport;mitochondrial inner membrane	Cytoplasm;Membrane;Peroxisome;Polymorphism;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-390918;R-HSA-9609507;R-HSA-9603798;R-HSA-389599	Metabolism;Metabolism of lipids;Fatty acid metabolism;Peroxisomal lipid metabolism;Protein localization;Class I peroxisomal membrane protein import;Alpha-oxidation of phytanate
PDSS1	positive	BLMH	ENSG00000108578	PDSS1	1	PDSS1	1	0.00614565658553468				Resistance to bleomycine in the treatment of testicular cancer	GO:0005634;GO:0005737;GO:0016787;GO:0005515;GO:0008233;GO:0008234;GO:0006508;GO:0004197;GO:0042802;GO:0005829;GO:0070062;GO:0000209;GO:0004177;GO:0009636;GO:0004180;GO:0042493;GO:0043418	proteolysis;cysteine-type endopeptidase activity;nucleus;cytoplasm;hydrolase activity;protein binding;peptidase activity;cysteine-type peptidase activity;identical protein binding;cytosol;extracellular exosome;protein polyubiquitination;aminopeptidase activity;response to toxic substance;carboxypeptidase activity;response to drug;homocysteine catabolic process	3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Hydrolase;Polymorphism;Protease;Reference proteome;Thiol protease	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
PDSS1	positive	NCLN	ENSG00000125912	PDSS1	1	PDSS1	1	0.00614565658553468	WBGene00011488	WBGene00011488(1)			GO:0016020;GO:0016021;GO:0009966;GO:0005783;GO:0005789;GO:0005515;GO:0043254;GO:0050821;GO:0061635;GO:0032991	membrane;regulation of signal transduction;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;protein binding;regulation of protein-containing complex assembly;protein stabilization;regulation of protein complex stability;protein-containing complex	Alternative splicing;Endoplasmic reticulum;Glycoprotein;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix		
PDSS1	positive	TROAP	ENSG00000135451	PDSS1	1	PDSS1	1	0.00614565658553468					GO:0005737;GO:0007155;GO:0005515	cytoplasm;cell adhesion;protein binding	Alternative splicing;Cell adhesion;Cytoplasm;Phosphoprotein;Reference proteome;Repeat		
PDSS1	positive	XRCC4	ENSG00000152422	PDSS1	1	PDSS1	1	0.00614565658553468				LIG4 SYNDROME;Microcephalic primordial dwarfism-insulin resistance syndrome;Primordial Dwarfism;SHORT STATURE MICROCEPHALY AND ENDOCRINE DYSFUNCTION	GO:0005634;GO:0005654;GO:0003677;GO:0005829;GO:0005515;GO:0006281;GO:0006310;GO:0006974;GO:0006302;GO:0042802;GO:0008022;GO:0006303;GO:0075713;GO:0010165;GO:0051103;GO:0070419;GO:0033152;GO:0005958;GO:0032807;GO:0051351;GO:0071285	DNA binding;nucleus;DNA recombination;double-strand break repair;nucleoplasm;cytosol;protein binding;DNA repair;cellular response to DNA damage stimulus;identical protein binding;protein C-terminus binding;double-strand break repair via nonhomologous end joining;establishment of integrated proviral latency;response to X-ray;DNA ligation involved in DNA repair;nonhomologous end joining complex;immunoglobulin V(D)J recombination;DNA-dependent protein kinase-DNA ligase 4 complex;DNA ligase IV complex;positive regulation of ligase activity;cellular response to lithium ion	3D-structure;Alternative splicing;Coiled coil;DNA damage;DNA recombination;DNA repair;Disease mutation;Dwarfism;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-1643685;R-HSA-5693532;R-HSA-73894;R-HSA-162587;R-HSA-162906;R-HSA-5663205;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-5693571;R-HSA-162592;R-HSA-162594;R-HSA-164843	Metabolism of proteins;Post-translational protein modification;Disease;DNA Double-Strand Break Repair;DNA Repair;HIV Life Cycle;HIV Infection;Infectious disease;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Nonhomologous End-Joining (NHEJ);Integration of provirus;Early Phase of HIV Life Cycle;2-LTR circle formation
PDSS1	positive	LRR1	ENSG00000165501	PDSS1	1	PDSS1	1	0.00614565658553468	WBGene00018016				GO:0016567;GO:0005515;GO:0005829;GO:0043687;GO:0016853	protein ubiquitination;protein binding;cytosol;post-translational protein modification;isomerase activity	Alternative splicing;Leucine-rich repeat;Polymorphism;Reference proteome;Repeat;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-983168;R-HSA-983169;R-HSA-8951664	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation
PDSS1	positive	PUS1	ENSG00000177192	PDSS1	1	PDSS1	1	0.00614565658553468	WBGene00004248	WBGene00004248(1)		Mitochondrial myopathy and sideroblastic anemia;MYOPATHY LACTIC ACIDOSIS AND SIDEROBLASTIC ANEMIA 1	GO:0003723;GO:0005634;GO:0016853;GO:0008033;GO:0005739;GO:0000049;GO:0009982;GO:0001522;GO:0009451;GO:0106029;GO:0005759;GO:0031119;GO:1990481;GO:0002153;GO:0070902	RNA binding;pseudouridine synthase activity;pseudouridine synthesis;RNA modification;tRNA pseudouridine synthesis;nucleus;isomerase activity;nucleoplasm;tRNA processing;mitochondrion;tRNA binding;tRNA pseudouridine synthase activity;mitochondrial matrix;mRNA pseudouridine synthesis;steroid receptor RNA activator RNA binding;mitochondrial tRNA pseudouridine synthesis	3D-structure;Alternative splicing;Disease mutation;Isomerase;Mitochondrion;Nucleus;Phosphoprotein;Polymorphism;Primary mitochondrial disease;Reference proteome;Transit peptide;tRNA processing		
PDSS1	positive	DDX11	ENSG00000013573	PDSS1	1	PDSS1	1	0.00649262041119281	WBGene00010839	WBGene00010839(1)		WARSAW BREAKAGE SYNDROME;WARSAW BREAKAGE SYNDROME;WARSAW BREAKAGE SYNDROME	GO:0003676;GO:0003723;GO:0005634;GO:0005737;GO:0046872;GO:0005813;GO:0000166;GO:0005524;GO:0016787;GO:0003677;GO:0001650;GO:0000790;GO:0005694;GO:0005856;GO:0003678;GO:0006281;GO:0006974;GO:0004386;GO:0007275;GO:0051536;GO:0051539;GO:0006260;GO:0005730;GO:0000922;GO:0005815;GO:0030496;GO:0006139;GO:0016818;GO:0005515;GO:0005654;GO:0070062;GO:0003682;GO:0016032;GO:0003690;GO:0031297;GO:0032508;GO:0036498;GO:0032091;GO:0003697;GO:0008094;GO:0007062;GO:0003688;GO:0045876;GO:0003727;GO:0031390;GO:1901838;GO:0051880;GO:0032079;GO:0008186;GO:0072711;GO:2000781;GO:0045142;GO:0044806;GO:0072719;GO:0035563;GO:0034085;GO:1904976;GO:1990700	DNA binding;ATP binding;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;DNA helicase activity;nucleic acid binding;nucleobase-containing compound metabolic process;helicase activity;RNA binding;nucleus;cytoplasm;metal ion binding;nucleotide binding;nucleoplasm;fibrillar center;hydrolase activity;cytoskeleton;nuclear chromatin;chromosome;centrosome;DNA repair;cellular response to DNA damage stimulus;multicellular organism development;iron-sulfur cluster binding;4 iron, 4 sulfur cluster binding;DNA replication;nucleolus;spindle pole;microtubule organizing center;midbody;protein binding;extracellular exosome;chromatin binding;viral process;double-stranded DNA binding;replication fork processing;single-stranded DNA binding;IRE1-mediated unfolded protein response;negative regulation of protein binding;DNA-dependent ATPase activity;sister chromatid cohesion;DNA replication origin binding;positive regulation of sister chromatid cohesion;DNA duplex unwinding;single-stranded RNA binding;Ctf18 RFC-like complex;positive regulation of transcription of nucleolar large rRNA by RNA polymerase I;G-quadruplex DNA binding;positive regulation of endodeoxyribonuclease activity;RNA-dependent ATPase activity;cellular response to hydroxyurea;positive regulation of double-strand break repair;triplex DNA binding;G-quadruplex DNA unwinding;cellular response to cisplatin;positive regulation of chromatin binding;establishment of sister chromatid cohesion;cellular response to bleomycin;nucleolar chromatin organization	4Fe-4S;ATP-binding;Activator;Alternative splicing;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;DNA replication;DNA-binding;Developmental protein;Disease mutation;Helicase;Host-virus interaction;Hydrolase;Iron;Iron-sulfur;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Transcription;Transcription regulation	R-HSA-392499;R-HSA-381038;R-HSA-381070;R-HSA-381119	Metabolism of proteins;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR)
PDSS1	positive	CAD	ENSG00000084774	PDSS1	1	PDSS1	1	0.00649262041119281	WBGene00004259	WBGene00004259(0)		CAD-CDG;Uridine-responsive epileptic encephalopathy;EPILEPTIC ENCEPHALOPATHY EARLY INFANTILE 50	GO:0005634;GO:0005737;GO:0016020;GO:0046872;GO:0000166;GO:0005524;GO:0016740;GO:0005654;GO:0016787;GO:0008270;GO:0016874;GO:0003824;GO:0008152;GO:0006807;GO:0016810;GO:0004088;GO:0006207;GO:0006541;GO:0006520;GO:0006221;GO:0042802;GO:0005829;GO:0016597;GO:0016743;GO:0070062;GO:0004070;GO:0016812;GO:0044205;GO:0019899;GO:0016363;GO:0004672;GO:0018107;GO:0042995;GO:0043025;GO:0019240;GO:0043195;GO:0046777;GO:0017144;GO:0046134;GO:0004151;GO:0070335;GO:0001889;GO:0006228;GO:0007507;GO:0007565;GO:0007595;GO:0014075;GO:0031000;GO:0031100;GO:0032868;GO:0033574;GO:0035690;GO:0042594;GO:0051414;GO:0071364;GO:0032991	metal ion binding;ATP binding;hydrolase activity;cellular amino acid metabolic process;'de novo' pyrimidine nucleobase biosynthetic process;aspartate carbamoyltransferase activity;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides;carboxyl- or carbamoyltransferase activity;nitrogen compound metabolic process;amino acid binding;carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity;glutamine metabolic process;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds;nucleus;cytoplasm;membrane;nucleotide binding;transferase activity;nucleoplasm;zinc ion binding;ligase activity;catalytic activity;metabolic process;pyrimidine nucleotide biosynthetic process;cytosol;identical protein binding;extracellular exosome;'de novo' UMP biosynthetic process;enzyme binding;nuclear matrix;protein kinase activity;peptidyl-threonine phosphorylation;cell projection;neuronal cell body;citrulline biosynthetic process;terminal bouton;protein autophosphorylation;drug metabolic process;pyrimidine nucleoside biosynthetic process;dihydroorotase activity;aspartate binding;liver development;UTP biosynthetic process;heart development;female pregnancy;lactation;response to amine;response to caffeine;animal organ regeneration;response to insulin;response to testosterone;cellular response to drug;response to starvation;response to cortisol;cellular response to epidermal growth factor stimulus;protein-containing complex	3D-structure;ATP-binding;Acetylation;Allosteric enzyme;Congenital disorder of glycosylation;Cytoplasm;Direct protein sequencing;Disease mutation;Epilepsy;Hydrolase;Ligase;Magnesium;Manganese;Metal-binding;Multifunctional enzyme;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Pyrimidine biosynthesis;Reference proteome;Repeat;Transferase;Zinc	R-HSA-1430728;R-HSA-15869;R-HSA-8956320;R-HSA-500753	Metabolism;Metabolism of nucleotides;Nucleobase biosynthesis;Pyrimidine biosynthesis
PDSS1	positive	TIMM50	ENSG00000105197	PDSS1	1	PDSS1	1	0.00649262041119281	WBGene00011897	WBGene00011897(1)		3-methylglutaconic aciduria type 9;3-@METHYLGLUTACONIC ACIDURIA TYPE IX	GO:0003723;GO:0005634;GO:0016607;GO:0016020;GO:0016021;GO:0015031;GO:0005654;GO:0005739;GO:0005743;GO:0005744;GO:0005515;GO:0035335;GO:0004725;GO:0043021;GO:0006470;GO:0004721;GO:0030150;GO:0004722;GO:0007006;GO:0005134;GO:0001836	protein transport;mitochondrial inner membrane;TIM23 mitochondrial import inner membrane translocase complex;RNA binding;nucleus;nuclear speck;membrane;integral component of membrane;nucleoplasm;mitochondrion;protein binding;peptidyl-tyrosine dephosphorylation;protein tyrosine phosphatase activity;ribonucleoprotein complex binding;protein dephosphorylation;phosphoprotein phosphatase activity;protein import into mitochondrial matrix;protein serine/threonine phosphatase activity;mitochondrial membrane organization;interleukin-2 receptor binding;release of cytochrome c from mitochondria	Alternative splicing;Direct protein sequencing;Disease mutation;Epilepsy;Membrane;Mental retardation;Mitochondrion;Mitochondrion inner membrane;Nucleus;Phosphoprotein;Polymorphism;Protein transport;RNA-binding;Reference proteome;Transit peptide;Translocation;Transmembrane;Transmembrane helix;Transport	R-HSA-9609507;R-HSA-1268020	Protein localization;Mitochondrial protein import
PDSS1	positive	SRSF3	ENSG00000112081	PDSS1	1	PDSS1	1	0.00649262041119281	WBGene00004703;WBGene00013293				GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0051028;GO:0005634;GO:0005737;GO:0016607;GO:0005515;GO:0006406;GO:0000381;GO:0005654;GO:0043274;GO:1990825;GO:1990830;GO:0006405;GO:0031124;GO:0000398;GO:0045292;GO:0048024	nucleic acid binding;RNA binding;mRNA processing;RNA splicing;mRNA transport;nucleus;cytoplasm;nuclear speck;protein binding;mRNA export from nucleus;regulation of alternative mRNA splicing, via spliceosome;nucleoplasm;phospholipase binding;sequence-specific mRNA binding;cellular response to leukemia inhibitory factor;RNA export from nucleus;mRNA 3'-end processing;mRNA splicing, via spliceosome;mRNA cis splicing, via spliceosome;regulation of mRNA splicing, via spliceosome	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Transport;mRNA processing;mRNA splicing;mRNA transport	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-159236;R-HSA-72202;R-HSA-72203;R-HSA-72187;R-HSA-73856;R-HSA-72163;R-HSA-72172	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Transport of Mature mRNA derived from an Intron-Containing Transcript;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;mRNA 3'-end processing;RNA Polymerase II Transcription Termination;mRNA Splicing - Major Pathway;mRNA Splicing
PDSS1	positive	MRPL3	ENSG00000114686	PDSS1	1	PDSS1	1	0.00649262041119281	WBGene00016142	WBGene00016142(1)		Combined oxidative phosphorylation defect type 9;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9	GO:0003723;GO:0005739;GO:0003735;GO:0006412;GO:0005840;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:0005622	structural constituent of ribosome;translation;ribosome;RNA binding;mitochondrion;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination	3D-structure;Disease mutation;Mitochondrion;Polymorphism;Primary mitochondrial disease;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
PDSS1	positive	MSH6	ENSG00000116062	PDSS1	1	PDSS1	1	0.00649262041119281	WBGene00003422	WBGene00003422(0)		Constitutional mismatch repair deficiency syndrome;Lynch syndrome;Muir-Torre syndrome;Colorectal cancer hereditary nonpolyposis type 5;Endometrial Cancer;MISMATCH REPAIR CANCER SYNDROME	GO:0000166;GO:0005524;GO:0003677;GO:0006281;GO:0006974;GO:0030983;GO:0006298;GO:0005634;GO:0005794;GO:0043231;GO:0005829;GO:0005654;GO:0005694;GO:0005515;GO:0032301;GO:0016032;GO:0045910;GO:0008630;GO:0019899;GO:0035064;GO:0000400;GO:0008094;GO:0008340;GO:0000710;GO:0032405;GO:0016887;GO:0032142;GO:0016447;GO:0043570;GO:0051096;GO:0032300;GO:0009411;GO:0032357;GO:0000287;GO:0016446;GO:0003690;GO:0032137;GO:0032143;GO:0043531;GO:0045190;GO:0003682;GO:0003684;GO:0006290;GO:0036297;GO:0097193;GO:0000790	ATP binding;mismatched DNA binding;mismatch repair;nucleotide binding;DNA binding;DNA repair;cellular response to DNA damage stimulus;nucleus;Golgi apparatus;intracellular membrane-bounded organelle;nucleoplasm;cytosol;chromosome;protein binding;MutSalpha complex;viral process;intrinsic apoptotic signaling pathway in response to DNA damage;enzyme binding;methylated histone binding;DNA-dependent ATPase activity;determination of adult lifespan;negative regulation of DNA recombination;meiotic mismatch repair;MutLalpha complex binding;ATPase activity;single guanine insertion binding;somatic recombination of immunoglobulin gene segments;positive regulation of helicase activity;mismatch repair complex;response to UV;magnesium ion binding;somatic hypermutation of immunoglobulin genes;four-way junction DNA binding;double-stranded DNA binding;guanine/thymine mispair binding;single thymine insertion binding;oxidized purine DNA binding;ADP binding;isotype switching;chromatin binding;damaged DNA binding;pyrimidine dimer repair;interstrand cross-link repair;intrinsic apoptotic signaling pathway;nuclear chromatin	3D-structure;ATP-binding;Acetylation;Alternative splicing;Chromosome;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Disease mutation;Hereditary nonpolyposis colorectal cancer;Host-virus interaction;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1643685;R-HSA-73894;R-HSA-5358508;R-HSA-5358565;R-HSA-5423599;R-HSA-5632928;R-HSA-5632968	Disease;DNA Repair;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Diseases of Mismatch Repair (MMR);Defective Mismatch Repair Associated With MSH2;Defective Mismatch Repair Associated With MSH6
PDSS1	positive	TCP1	ENSG00000120438	PDSS1	1	PDSS1	1	0.00649262041119281	WBGene00000377	WBGene00000377(0)			GO:0050821;GO:0003723;GO:0005737;GO:0000166;GO:0005524;GO:0005829;GO:0006457;GO:0005856;GO:0005515;GO:0005874;GO:0051082;GO:0005815;GO:0007021;GO:0070062;GO:0035722;GO:0032212;GO:0051973;GO:0005813;GO:0031625;GO:0090666;GO:1904851;GO:1904871;GO:1904874;GO:0007339;GO:0044053;GO:1901998;GO:2000109;GO:0000242;GO:0000792;GO:0001669;GO:0002199;GO:0005720;GO:0005794;GO:0005832;GO:0044297	ATP binding;protein folding;unfolded protein binding;protein stabilization;RNA binding;cytoplasm;nucleotide binding;cytoskeleton;cytosol;protein binding;microtubule;microtubule organizing center;tubulin complex assembly;extracellular exosome;interleukin-12-mediated signaling pathway;positive regulation of telomere maintenance via telomerase;positive regulation of telomerase activity;centrosome;ubiquitin protein ligase binding;scaRNA localization to Cajal body;positive regulation of establishment of protein localization to telomere;positive regulation of protein localization to Cajal body;positive regulation of telomerase RNA localization to Cajal body;binding of sperm to zona pellucida;translocation of peptides or proteins into host cell cytoplasm;toxin transport;regulation of macrophage apoptotic process;pericentriolar material;heterochromatin;acrosomal vesicle;zona pellucida receptor complex;nuclear heterochromatin;Golgi apparatus;chaperonin-containing T-complex;cell body	3D-structure;ATP-binding;Acetylation;Chaperone;Cytoplasm;Cytoskeleton;Direct protein sequencing;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-168256;R-HSA-1852241;R-HSA-5617833;R-HSA-392499;R-HSA-1280215;R-HSA-449147;R-HSA-389958;R-HSA-389960;R-HSA-390466;R-HSA-391251;R-HSA-5620920;R-HSA-6814122;R-HSA-5620922;R-HSA-447115;R-HSA-8950505;R-HSA-9020591;R-HSA-390471;R-HSA-389957;R-HSA-390450	Immune System;Organelle biogenesis and maintenance;Cilium Assembly;Metabolism of proteins;Cytokine Signaling in Immune system;Signaling by Interleukins;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Chaperonin-mediated protein folding;Protein folding;Cargo trafficking to the periciliary membrane;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding;BBSome-mediated cargo-targeting to cilium;Interleukin-12 family signaling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;Association of TriC/CCT with target proteins during biosynthesis;Prefoldin mediated transfer of substrate  to CCT/TriC;Folding of actin by CCT/TriC
PDSS1	positive	DHX9	ENSG00000135829	PDSS1	1	PDSS1	1	0.00649262041119281	WBGene00004355	WBGene00004355(1)			GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0051028;GO:0005634;GO:0005737;GO:0016020;GO:0046872;GO:0000166;GO:0005524;GO:0016787;GO:0003677;GO:0031490;GO:0005856;GO:0005515;GO:0048511;GO:0004386;GO:0006954;GO:0006260;GO:0003678;GO:0003713;GO:0005654;GO:0002376;GO:0045087;GO:0005730;GO:0003724;GO:0031047;GO:0005813;GO:0005815;GO:0003729;GO:0016442;GO:0045944;GO:0005829;GO:0016887;GO:0006417;GO:1990904;GO:0032991;GO:0006357;GO:0045739;GO:0050729;GO:1904469;GO:2000778;GO:2000637;GO:0071356;GO:0003690;GO:0051092;GO:0001085;GO:0000978;GO:0035613;GO:0010501;GO:1903608;GO:0003712;GO:0036464;GO:0047429;GO:0045089;GO:0006353;GO:0032481;GO:0070269;GO:0015629;GO:0045740;GO:0048146;GO:0000398;GO:2000373;GO:0003697;GO:0003725;GO:1990841;GO:0016604;GO:0001649;GO:0003688;GO:0070934;GO:0070937;GO:0070063;GO:0000380;GO:0071360;GO:0043138;GO:0032508;GO:0000993;GO:0005844;GO:0003727;GO:0035549;GO:0060760;GO:1902741;GO:0050684;GO:0070578;GO:0046833;GO:0042788;GO:0097165;GO:0035197;GO:1990825;GO:0001069;GO:0017111;GO:0033679;GO:0034458;GO:0045142;GO:0061676;GO:1905172;GO:1905538;GO:1990518;GO:0030423;GO:0032741;GO:0034622;GO:0039695;GO:0044806;GO:0050434;GO:0050691;GO:0070922;GO:1904973;GO:1905698;GO:2000765;GO:2000767;GO:0005726	ATP binding;nucleic acid binding;helicase activity;RNA binding;mRNA processing;RNA splicing;mRNA transport;nucleus;cytoplasm;membrane;metal ion binding;nucleotide binding;hydrolase activity;DNA binding;cytoskeleton;chromatin DNA binding;protein binding;rhythmic process;inflammatory response;DNA replication;mRNA binding;ATPase activity;DNA helicase activity;transcription coactivator activity;nucleoplasm;immune system process;innate immune response;nucleolus;RNA helicase activity;gene silencing by RNA;centrosome;microtubule organizing center;nucleoside-triphosphate diphosphatase activity;RISC complex;positive regulation of transcription by RNA polymerase II;cytosol;regulation of translation;ribonucleoprotein complex;protein-containing complex;regulation of transcription by RNA polymerase II;positive regulation of DNA repair;positive regulation of inflammatory response;positive regulation of tumor necrosis factor secretion;positive regulation of interleukin-6 secretion;positive regulation of gene silencing by miRNA;cellular response to tumor necrosis factor;viral process;double-stranded DNA binding;single-stranded DNA binding;positive regulation of NF-kappaB transcription factor activity;RNA polymerase II transcription factor binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;RNA stem-loop binding;RNA secondary structure unwinding;protein localization to cytoplasmic stress granule;transcription coregulator activity;cytoplasmic ribonucleoprotein granule;positive regulation of innate immune response;DNA-templated transcription, termination;positive regulation of type I interferon production;pyroptosis;actin cytoskeleton;positive regulation of DNA replication;positive regulation of fibroblast proliferation;mRNA splicing, via spliceosome;positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity;double-stranded RNA binding;promoter-specific chromatin binding;nuclear body;osteoblast differentiation;DNA replication origin binding;CRD-mediated mRNA stabilization;CRD-mediated mRNA stability complex;RNA polymerase binding;alternative mRNA splicing, via spliceosome;cellular response to exogenous dsRNA;3'-5' DNA helicase activity;DNA duplex unwinding;RNA polymerase II complex binding;polysome;single-stranded RNA binding;positive regulation of interferon-beta secretion;positive regulation of response to cytokine stimulus;positive regulation of interferon-alpha secretion;regulation of mRNA processing;RISC-loading complex;positive regulation of RNA export from nucleus;polysomal ribosome;sequence-specific mRNA binding;nuclear stress granule;siRNA binding;regulatory region RNA binding;nucleoside-triphosphatase activity;3'-5' DNA/RNA helicase activity;3'-5' RNA helicase activity;triplex DNA binding;importin-alpha family protein binding;RISC complex binding;polysome binding;single-stranded 3'-5' DNA helicase activity;targeting of mRNA for destruction involved in RNA interference;positive regulation of interleukin-18 production;cellular protein-containing complex assembly;DNA-templated viral transcription;G-quadruplex DNA unwinding;positive regulation of viral transcription;regulation of defense response to virus by host;small RNA loading onto RISC;positive regulation of viral translation;positive regulation of polysome binding;regulation of cytoplasmic translation;positive regulation of cytoplasmic translation;perichromatin fibrils	3D-structure;ATP-binding;Acetylation;Activator;Alternative splicing;Biological rhythms;Cytoplasm;Cytoskeleton;DNA replication;DNA-binding;Direct protein sequencing;Helicase;Host-virus interaction;Hydrolase;Immunity;Inflammatory response;Innate immunity;Isopeptide bond;Manganese;Metal-binding;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;RNA-mediated gene silencing;Reference proteome;Repeat;Transcription;Transcription regulation;Transcription termination;Translation regulation;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	R-HSA-168249;R-HSA-168256;R-HSA-8953854;R-HSA-72203;R-HSA-1834949;R-HSA-1606322;R-HSA-1810476;R-HSA-72163;R-HSA-72172;R-HSA-3134963	Innate Immune System;Immune System;Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;Cytosolic sensors of pathogen-associated DNA ;ZBP1(DAI) mediated induction of type I IFNs;RIP-mediated NFkB activation via ZBP1;mRNA Splicing - Major Pathway;mRNA Splicing;DEx/H-box helicases activate type I IFN and inflammatory cytokines production 
PDSS1	positive	ATP5MC1	ENSG00000159199	PDSS1	1	PDSS1	1	0.00649262041119281	WBGene00022336				GO:0016020;GO:0016021;GO:0005739;GO:1902600;GO:0006811;GO:0005515;GO:0015078;GO:0008289;GO:0015986;GO:0031966;GO:0045263;GO:0033177;GO:0005743;GO:0046933;GO:0006754;GO:0042407;GO:0042776;GO:0005753;GO:0000276	ATP synthesis coupled proton transport;proton transmembrane transporter activity;proton transmembrane transport;proton-transporting ATP synthase complex, coupling factor F(o);proton-transporting two-sector ATPase complex, proton-transporting domain;membrane;integral component of membrane;mitochondrion;ion transport;protein binding;lipid binding;mitochondrial membrane;mitochondrial inner membrane;ATP biosynthetic process;cristae formation;mitochondrial ATP synthesis coupled proton transport;mitochondrial proton-transporting ATP synthase complex;mitochondrial proton-transporting ATP synthase complex, coupling factor F(o);proton-transporting ATP synthase activity, rotational mechanism	CF(0);Hydrogen ion transport;Ion transport;Lipid-binding;Membrane;Methylation;Mitochondrion;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix;Transport	R-HSA-1852241;R-HSA-1430728;R-HSA-9609507;R-HSA-1428517;R-HSA-163200;R-HSA-1592230;R-HSA-1268020;R-HSA-8949613;R-HSA-163210	Organelle biogenesis and maintenance;Metabolism;Protein localization;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Mitochondrial biogenesis;Mitochondrial protein import;Cristae formation;Formation of ATP by chemiosmotic coupling
PDSS1	positive	DEPDC1	ENSG00000024526	PDSS1	1	PDSS1	1	0.00685680003212819		WBGene00002368(0)			GO:0005634;GO:0035556;GO:0007165;GO:0043547;GO:0005096;GO:0005515;GO:0045892;GO:0017053	signal transduction;intracellular signal transduction;nucleus;positive regulation of GTPase activity;GTPase activator activity;protein binding;negative regulation of transcription, DNA-templated;transcriptional repressor complex	3D-structure;Alternative splicing;GTPase activation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation		
PDSS1	positive	ENO1	ENSG00000074800	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00011884				GO:0005737;GO:0003723;GO:0005634;GO:0016020;GO:0046872;GO:0005829;GO:0000287;GO:0016829;GO:0006096;GO:0003677;GO:0005886;GO:0005615;GO:0005515;GO:0004634;GO:0000015;GO:0001227;GO:0000122;GO:0045296;GO:0070062;GO:0009615;GO:0031430;GO:0030308;GO:0045892;GO:0000977;GO:0006094;GO:0061621;GO:0042803;GO:0051020;GO:0010756;GO:0045933;GO:1903298;GO:2001171;GO:0009986;GO:0099738	glycolytic process;magnesium ion binding;phosphopyruvate hydratase activity;phosphopyruvate hydratase complex;cytoplasm;RNA binding;nucleus;membrane;metal ion binding;cytosol;plasma membrane;lyase activity;DNA binding;extracellular space;protein binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;cadherin binding;extracellular exosome;response to virus;M band;negative regulation of cell growth;negative regulation of transcription, DNA-templated;RNA polymerase II regulatory region sequence-specific DNA binding;gluconeogenesis;canonical glycolysis;GTPase binding;protein homodimerization activity;positive regulation of plasminogen activation;positive regulation of muscle contraction;negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway;positive regulation of ATP biosynthetic process;cell surface;cell cortex region	3D-structure;Acetylation;Alternative initiation;Cell membrane;Cytoplasm;DNA-binding;Direct protein sequencing;Glycolysis;Hydroxylation;Isopeptide bond;Lyase;Magnesium;Membrane;Metal-binding;Nucleus;Phosphoprotein;Plasminogen activation;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-1430728;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-70263	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;Gluconeogenesis
PDSS1	positive	SRRT	ENSG00000087087	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00017085	WBGene00017085(1)			GO:0003676;GO:0003723;GO:0005634;GO:0005737;GO:0005654;GO:0003677;GO:0005515;GO:0006397;GO:0031047;GO:0008283;GO:0006355;GO:0032991;GO:0042795;GO:0097150;GO:0000398;GO:0031053;GO:0046685;GO:0050769	nucleic acid binding;mRNA processing;RNA binding;nucleus;cytoplasm;nucleoplasm;DNA binding;protein binding;gene silencing by RNA;regulation of transcription, DNA-templated;protein-containing complex;snRNA transcription by RNA polymerase II;neuronal stem cell population maintenance;mRNA splicing, via spliceosome;primary miRNA processing;response to arsenic-containing substance;positive regulation of neurogenesis	3D-structure;Acetylation;Activator;Alternative splicing;Cytoplasm;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-mediated gene silencing;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-72203;R-HSA-6807505;R-HSA-72163;R-HSA-72172	RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;RNA polymerase II transcribes snRNA genes;mRNA Splicing - Major Pathway;mRNA Splicing
PDSS1	positive	GRPEL1	ENSG00000109519	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00007927	WBGene00007927(1)			GO:0005634;GO:0005739;GO:0005759;GO:0006457;GO:0050790;GO:0005515;GO:0042803;GO:0051087;GO:0051082;GO:0000774;GO:0030150;GO:0001405	adenyl-nucleotide exchange factor activity;protein homodimerization activity;chaperone binding;protein folding;nucleoplasm;mitochondrion;mitochondrial matrix;regulation of catalytic activity;protein binding;unfolded protein binding;protein import into mitochondrial matrix;PAM complex, Tim23 associated import motor	Acetylation;Chaperone;Mitochondrion;Reference proteome;Transit peptide	R-HSA-9609507;R-HSA-1268020	Protein localization;Mitochondrial protein import
PDSS1	positive	HBS1L	ENSG00000112339	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00010622	WBGene00010622(0)			GO:0016020;GO:0006412;GO:0000166;GO:0003924;GO:0005525;GO:0005515;GO:0003746;GO:0006414;GO:0005829;GO:0070062;GO:0007165;GO:0043928;GO:0016021	GTP binding;GTPase activity;membrane;translation;nucleotide binding;protein binding;translation elongation factor activity;translational elongation;cytosol;extracellular exosome;signal transduction;exonucleolytic catabolism of deadenylated mRNA;integral component of membrane	3D-structure;Acetylation;Alternative splicing;Elongation factor;GTP-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Protein biosynthesis;Reference proteome	R-HSA-8953854;R-HSA-429914;R-HSA-429958	Metabolism of RNA;Deadenylation-dependent mRNA decay;mRNA decay by 3' to 5' exoribonuclease
PDSS1	positive	RRP9	ENSG00000114767	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00020171	WBGene00020171(0)			GO:0003723;GO:0005634;GO:0005730;GO:0006364;GO:0032040;GO:0005654;GO:0034511;GO:0031428;GO:0005515	protein binding;rRNA processing;U3 snoRNA binding;RNA binding;nucleus;nucleolus;small-subunit processome;nucleoplasm;snoRNA binding;box C/D snoRNP complex	3D-structure;Acetylation;Direct protein sequencing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Ubl conjugation;WD repeat;rRNA processing	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
PDSS1	positive	E2F8	ENSG00000129173	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00009899				GO:0005634;GO:0005730;GO:0005829;GO:0006355;GO:0003677;GO:0003700;GO:0005515;GO:0007049;GO:0005667;GO:0043565;GO:0000981;GO:0000122;GO:0045944;GO:0000790;GO:0008134;GO:0000978;GO:0000987;GO:0001227;GO:0003714;GO:0001890;GO:0002040;GO:0006977;GO:0032466;GO:0032877;GO:0033301;GO:0051726;GO:0060707;GO:0060718;GO:0070365;GO:0005654;GO:0090575;GO:0042802;GO:0042803;GO:0008283	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;transcription factor complex;nucleus;nucleoplasm;nucleolus;cytosol;DNA binding;protein binding;cell cycle;sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;nuclear chromatin;transcription factor binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;transcription corepressor activity;placenta development;sprouting angiogenesis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;negative regulation of cytokinesis;positive regulation of DNA endoreduplication;cell cycle comprising mitosis without cytokinesis;regulation of cell cycle;trophoblast giant cell differentiation;chorionic trophoblast cell differentiation;hepatocyte differentiation;RNA polymerase II transcription factor complex;identical protein binding;cell population proliferation	3D-structure;Activator;Cell cycle;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation	R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-6804116;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription)
PDSS1	positive	MPDU1	ENSG00000129255	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00018181	WBGene00018181(1)		MPDU1-CDG;Congenital Disorders of Glycosylation;CONGENITAL DISORDER OF GLYCOSYLATION TYPE If	GO:0016020;GO:0016021;GO:0005789;GO:0005515;GO:0006457;GO:0009312;GO:0006488	membrane;integral component of membrane;endoplasmic reticulum membrane;protein binding;protein folding;oligosaccharide biosynthetic process;dolichol-linked oligosaccharide biosynthetic process	Acetylation;Alternative splicing;Congenital disorder of glycosylation;Disease mutation;Membrane;Polymorphism;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport	R-HSA-392499;R-HSA-597592;R-HSA-446193;R-HSA-446203;R-HSA-1643685;R-HSA-3781865;R-HSA-3781860;R-HSA-4687000	Metabolism of proteins;Post-translational protein modification;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation;Disease;Diseases of glycosylation;Diseases associated with N-glycosylation of proteins;Defective MPDU1 causes MPDU1-CDG (CDG-1f)
PDSS1	positive	EIF2S1	ENSG00000134001	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00021351	WBGene00021351(1)			GO:0003676;GO:0003723;GO:0005737;GO:0016020;GO:0003743;GO:0006412;GO:0006413;GO:0005515;GO:0043022;GO:0005829;GO:0070062;GO:0055085;GO:0006417;GO:0010494;GO:0034976;GO:0034644;GO:0034198;GO:0007568;GO:0032057;GO:0034063;GO:0034599;GO:0034605;GO:0036499;GO:0043558;GO:0046777;GO:1901216;GO:1905098;GO:1990737;GO:2000676;GO:0005634;GO:0005844;GO:0005850;GO:0005851;GO:0033290;GO:0043614;GO:0044207;GO:0045202;GO:0097451	RNA binding;translation initiation factor activity;nucleic acid binding;cytoplasm;membrane;translation;translational initiation;cytosol;protein binding;extracellular exosome;transmembrane transport;regulation of translation;ribosome binding;cytoplasmic stress granule;response to endoplasmic reticulum stress;cellular response to UV;cellular response to amino acid starvation;aging;negative regulation of translational initiation in response to stress;stress granule assembly;cellular response to oxidative stress;cellular response to heat;PERK-mediated unfolded protein response;regulation of translational initiation in response to stress;protein autophosphorylation;positive regulation of neuron death;negative regulation of guanyl-nucleotide exchange factor activity;response to manganese-induced endoplasmic reticulum stress;positive regulation of type B pancreatic cell apoptotic process;nucleus;polysome;eukaryotic translation initiation factor 2 complex;eukaryotic translation initiation factor 2B complex;eukaryotic 48S preinitiation complex;multi-eIF complex;translation initiation ternary complex;synapse;glial limiting end-foot	3D-structure;Acetylation;Cytoplasm;Initiation factor;Phosphoprotein;Protein biosynthesis;RNA-binding;Reference proteome;Translation regulation	R-HSA-392499;R-HSA-382551;R-HSA-382556;R-HSA-156827;R-HSA-72613;R-HSA-72649;R-HSA-72662;R-HSA-72695;R-HSA-72702;R-HSA-72706;R-HSA-72737;R-HSA-72766;R-HSA-381119;R-HSA-381042;R-HSA-72731	Metabolism of proteins;Transport of small molecules;ABC-family proteins mediated transport;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation;Unfolded Protein Response (UPR);PERK regulates gene expression;Recycling of eIF2:GDP
PDSS1	positive	NUP54	ENSG00000138750	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00003787	WBGene00003787(0)			GO:0051028;GO:0005634;GO:0016020;GO:0015031;GO:0005643;GO:0005515;GO:0075733;GO:0043657;GO:0006607;GO:0017056;GO:0006110;GO:0006406;GO:0006409;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0031965;GO:0036228;GO:0044613;GO:0006605;GO:0006913;GO:0006999;GO:0042306;GO:0051260;GO:0051290;GO:0051291;GO:0070208;GO:0032991	nuclear pore;mRNA transport;nucleus;membrane;protein transport;protein binding;intracellular transport of virus;host cell;NLS-bearing protein import into nucleus;structural constituent of nuclear pore;regulation of glycolytic process;mRNA export from nucleus;tRNA export from nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;nuclear membrane;protein localization to nuclear inner membrane;nuclear pore central transport channel;identical protein binding;protein-containing complex binding;protein targeting;nucleocytoplasmic transport;nuclear pore organization;regulation of protein import into nucleus;protein-containing complex	3D-structure;Alternative splicing;Glycoprotein;Membrane;Nuclear pore complex;Nucleus;Protein transport;Reference proteome;Repeat;Translocation;Transport;mRNA transport	R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-1430728;R-HSA-1640170;R-HSA-72306;R-HSA-8953854;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1280215;R-HSA-162909;R-HSA-2262752;R-HSA-5619115;R-HSA-68886;R-HSA-69278;R-HSA-8953897;R-HSA-70171;R-HSA-70326;R-HSA-71387;R-HSA-1169408;R-HSA-1169410;R-HSA-159227;R-HSA-159230;R-HSA-159231;R-HSA-159234;R-HSA-159236;R-HSA-165054;R-HSA-168253;R-HSA-168254;R-HSA-168255;R-HSA-168271;R-HSA-168273;R-HSA-168274;R-HSA-168276;R-HSA-168325;R-HSA-168333;R-HSA-170822;R-HSA-176033;R-HSA-177243;R-HSA-180746;R-HSA-180910;R-HSA-191859;R-HSA-194441;R-HSA-211000;R-HSA-2980766;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-3232142;R-HSA-3301854;R-HSA-3371453;R-HSA-3371556;R-HSA-4085377;R-HSA-4551638;R-HSA-4570464;R-HSA-4615885;R-HSA-5578749;R-HSA-5619102;R-HSA-5619107;R-HSA-6784531;R-HSA-68875;R-HSA-72202;R-HSA-72203;R-HSA-913531	Immune System;Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Metabolism;Cell Cycle;tRNA processing;Metabolism of RNA;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cytokine Signaling in Immune system;Host Interactions of HIV factors;Cellular responses to stress;Disorders of transmembrane transporters;M Phase;Cell Cycle, Mitotic;Cellular responses to external stimuli;Glycolysis;Glucose metabolism;Metabolism of carbohydrates;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Transport of the SLBP independent Mature mRNA;Transport of the SLBP Dependant Mature mRNA;Transport of Mature mRNA Derived from an Intronless Transcript;Transport of Mature mRNAs Derived from Intronless Transcripts;Transport of Mature mRNA derived from an Intron-Containing Transcript;Rev-mediated nuclear export of HIV RNA;Host Interactions with Influenza Factors;Influenza Infection;Influenza Life Cycle;Transport of Ribonucleoproteins into the Host Nucleus;Influenza Viral RNA Transcription and Replication;Export of Viral Ribonucleoproteins from Nucleus;NS1 Mediated Effects on Host Pathways;Viral Messenger RNA Synthesis;NEP/NS2 Interacts with the Cellular Export Machinery;Regulation of Glucokinase by Glucokinase Regulatory Protein;Interactions of Vpr with host cellular proteins;Interactions of Rev with host cellular proteins;Nuclear import of Rev protein;Vpr-mediated nuclear import of PICs;snRNP Assembly;Metabolism of non-coding RNA;Gene Silencing by RNA;Nuclear Envelope Breakdown;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;SUMOylation of ubiquitinylation proteins;Nuclear Pore Complex (NPC) Disassembly;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;SUMOylation of SUMOylation proteins;SUMOylation of chromatin organization proteins;SUMOylation of RNA binding proteins;SUMOylation of DNA replication proteins;Transcriptional regulation by small RNAs;SLC transporter disorders;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC);tRNA processing in the nucleus;Mitotic Prophase;Transport of Mature Transcript to Cytoplasm;Processing of Capped Intron-Containing Pre-mRNA;Interferon Signaling
PDSS1	positive	COPS3	ENSG00000141030	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00000815				GO:0005634;GO:0005737;GO:0005829;GO:0005654;GO:0005515;GO:0008180;GO:0006511;GO:0043687;GO:0007165;GO:0000338;GO:0006283;GO:0000715;GO:0009416;GO:0001701	COP9 signalosome;nucleus;cytoplasm;nucleoplasm;cytosol;protein binding;ubiquitin-dependent protein catabolic process;post-translational protein modification;protein deneddylation;signal transduction;transcription-coupled nucleotide-excision repair;nucleotide-excision repair, DNA damage recognition;response to light stimulus;in utero embryonic development	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;Reference proteome;Signalosome	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-73894;R-HSA-8951664;R-HSA-8856828;R-HSA-8856825;R-HSA-5696398;R-HSA-6781823;R-HSA-6781827;R-HSA-5696399;R-HSA-5696394	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;DNA Repair;Neddylation;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis;Nucleotide Excision Repair;Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Global Genome Nucleotide Excision Repair (GG-NER);DNA Damage Recognition in GG-NER
PDSS1	positive	SAE1	ENSG00000142230	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00000142	WBGene00000142(1)			GO:0008641;GO:0005634;GO:0016567;GO:0006464;GO:0043085;GO:0016874;GO:0005515;GO:0005737;GO:0005654;GO:0004839;GO:0032446;GO:0016925;GO:0008022;GO:0046982;GO:1903955;GO:0008047;GO:0044388;GO:0019948;GO:0043008;GO:0031510	ubiquitin-like modifier activating enzyme activity;cellular protein modification process;nucleus;protein ubiquitination;positive regulation of catalytic activity;ligase activity;protein binding;cytoplasm;nucleoplasm;ubiquitin activating enzyme activity;protein modification by small protein conjugation;protein sumoylation;protein C-terminus binding;protein heterodimerization activity;positive regulation of protein targeting to mitochondrion;enzyme activator activity;positive regulation of protein sumoylation;small protein activating enzyme binding;SUMO activating enzyme activity;ATP-dependent protein binding;SUMO activating enzyme complex	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Ligase;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-2990846;R-HSA-3065676;R-HSA-3065678;R-HSA-3215018	Metabolism of proteins;Post-translational protein modification;SUMOylation;SUMO is conjugated to E1 (UBA2:SAE1);SUMO is transferred from E1 to E2 (UBE2I, UBC9);Processing and activation of SUMO
PDSS1	positive	PARP1	ENSG00000143799	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00004049	WBGene00004049(1)	CDH1;E2F1;SERPINE1;THBD;VIM	Autosomal Recessive Mental Retardation	GO:0032869;GO:0005634;GO:0003723;GO:0016020;GO:0008270;GO:0046872;GO:0016740;GO:0003677;GO:0016757;GO:0005694;GO:0005515;GO:0051287;GO:0006281;GO:0006974;GO:0006915;GO:0003950;GO:0006471;GO:0006302;GO:0019899;GO:0030331;GO:0042826;GO:0046332;GO:0070412;GO:0007179;GO:0010332;GO:0010613;GO:0010990;GO:0016540;GO:0023019;GO:0033148;GO:0042769;GO:0044030;GO:0045944;GO:0051901;GO:0060391;GO:0070212;GO:0071294;GO:0071560;GO:1900182;GO:1901216;GO:1903376;GO:1904044;GO:1904646;GO:1904762;GO:2000679;GO:0005737;GO:0005730;GO:0042802;GO:0005654;GO:0019901;GO:0000784;GO:0035861;GO:0001228;GO:0032991;GO:0047485;GO:0005667;GO:0006366;GO:0005739;GO:0000977;GO:0005635;GO:0034644;GO:0007005;GO:0008134;GO:1903827;GO:0032993;GO:0000724;GO:0000122;GO:0000723;GO:1990404;GO:0070213;GO:1904357;GO:0030225;GO:0006293;GO:0006295;GO:0006296;GO:0033683;GO:0070911;GO:0140294;GO:0000715;GO:0000717;GO:0006294;GO:0018312;GO:0018424;GO:0030592;GO:0032042;GO:0034599;GO:0036211;GO:0043504;GO:0050790;GO:1903518;GO:1905168;GO:1990966;GO:2001170;GO:0090734	DNA binding;zinc ion binding;nucleus;protein ADP-ribosylation;NAD binding;NAD+ ADP-ribosyltransferase activity;cellular response to insulin stimulus;RNA binding;membrane;metal ion binding;transferase activity;nucleoplasm;nucleolus;transferase activity, transferring glycosyl groups;chromosome;protein binding;DNA repair;cellular response to DNA damage stimulus;nuclear body;apoptotic process;double-strand break repair;enzyme binding;estrogen receptor binding;histone deacetylase binding;SMAD binding;R-SMAD binding;transforming growth factor beta receptor signaling pathway;response to gamma radiation;positive regulation of cardiac muscle hypertrophy;regulation of SMAD protein complex assembly;protein autoprocessing;signal transduction involved in regulation of gene expression;positive regulation of intracellular estrogen receptor signaling pathway;DNA damage response, detection of DNA damage;regulation of DNA methylation;positive regulation of transcription by RNA polymerase II;positive regulation of mitochondrial depolarization;positive regulation of SMAD protein signal transduction;protein poly-ADP-ribosylation;cellular response to zinc ion;cellular response to transforming growth factor beta stimulus;positive regulation of protein localization to nucleus;positive regulation of neuron death;regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway;response to aldosterone;cellular response to amyloid-beta;positive regulation of myofibroblast differentiation;positive regulation of transcription regulatory region DNA binding;cytoplasm;identical protein binding;protein kinase binding;nuclear chromosome, telomeric region;site of double-strand break;DNA-binding transcription activator activity, RNA polymerase II-specific;protein-containing complex;protein N-terminus binding;transcription factor complex;transcription by RNA polymerase II;mitochondrion;RNA polymerase II regulatory region sequence-specific DNA binding;nuclear envelope;cellular response to UV;mitochondrion organization;transcription factor binding;regulation of cellular protein localization;protein-DNA complex;double-strand break repair via homologous recombination;negative regulation of transcription by RNA polymerase II;telomere maintenance;site of DNA damage;protein ADP-ribosylase activity;protein auto-ADP-ribosylation;negative regulation of telomere maintenance via telomere lengthening;macrophage differentiation;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;global genome nucleotide-excision repair;NAD DNA ADP-ribosyltransferase activity;nucleotide-excision repair, DNA damage recognition;nucleotide-excision repair, DNA duplex unwinding;nucleotide-excision repair, preincision complex assembly;peptidyl-serine ADP-ribosylation;peptidyl-glutamic acid poly-ADP-ribosylation;DNA ADP-ribosylation;mitochondrial DNA metabolic process;cellular response to oxidative stress;protein modification process;mitochondrial DNA repair;regulation of catalytic activity;positive regulation of single strand break repair;positive regulation of double-strand break repair via homologous recombination;ATP generation from poly-ADP-D-ribose;negative regulation of ATP biosynthetic process	3D-structure;ADP-ribosylation;Acetylation;Chromosome;DNA damage;DNA repair;DNA-binding;Direct protein sequencing;Glycosyltransferase;Isopeptide bond;Metal-binding;NAD;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Transferase;Ubl conjugation;Zinc;Zinc-finger	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-5693532;R-HSA-5693538;R-HSA-73894;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-9006936;R-HSA-170834;R-HSA-2173793;R-HSA-5696398;R-HSA-73884;R-HSA-73933;R-HSA-5685939;R-HSA-2173795;R-HSA-5696395;R-HSA-5696399;R-HSA-5696394;R-HSA-110362;R-HSA-110373;R-HSA-5696400	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;DNA Double-Strand Break Repair;Homology Directed Repair;DNA Repair;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Nucleotide Excision Repair;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through MMEJ (alt-NHEJ);Downregulation of SMAD2/3:SMAD4 transcriptional activity;Formation of Incision Complex in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);DNA Damage Recognition in GG-NER;POLB-Dependent Long Patch Base Excision Repair;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;Dual Incision in GG-NER
PDSS1	positive	UTP14A	ENSG00000156697	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00017855	WBGene00017855(0)			GO:0003723;GO:0005634;GO:0005730;GO:0005829;GO:0005515;GO:0042254;GO:0006364;GO:0032040;GO:0005654	rRNA processing;small-subunit processome;RNA binding;nucleus;nucleolus;cytosol;protein binding;ribosome biogenesis;nucleoplasm	Alternative splicing;Citrullination;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ribosome biogenesis;Ubl conjugation	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
PDSS1	positive	CLPB	ENSG00000162129	PDSS1	1	PDSS1	1	0.00685680003212819				3-methylglutaconic aciduria type 7;3-Methylglutaconic aciduria type VII with cataracts neurologic involvement and neutropenia;3-methylglutaconic aciduria with cataracts neurologic involvement and neutropenia	GO:0000166;GO:0005524;GO:0016787;GO:0005739;GO:0005515;GO:0003674;GO:0005575;GO:0016887;GO:0034605	ATP binding;protein binding;nucleotide binding;hydrolase activity;mitochondrion;ATPase activity;molecular_function;cellular_component;cellular response to heat	ANK repeat;ATP-binding;Acetylation;Alternative splicing;Cataract;Disease mutation;Epilepsy;Hydrolase;Mitochondrion;Nucleotide-binding;Polymorphism;Reference proteome;Repeat;Transit peptide		
PDSS1	positive	THOP1	ENSG00000172009	PDSS1	1	PDSS1	1	0.00685680003212819	WBGene00013997	WBGene00013997(0)			GO:0005737;GO:0046872;GO:0016787;GO:0008233;GO:0006508;GO:0004222;GO:0008237;GO:0005829;GO:0000209;GO:0006518;GO:0005758;GO:0042277	proteolysis;metalloendopeptidase activity;metallopeptidase activity;cytoplasm;metal ion binding;hydrolase activity;peptidase activity;cytosol;protein polyubiquitination;peptide metabolic process;mitochondrial intermembrane space;peptide binding	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Hydrolase;Metal-binding;Metalloprotease;Phosphoprotein;Protease;Reference proteome;Zinc	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
PDSS1	positive	PSMC4	ENSG00000013275	PDSS1	1	PDSS1	1	0.00723890442963204	WBGene00004503	WBGene00004503(1)			GO:0005634;GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0005829;GO:0016787;GO:0005515;GO:0000502;GO:0038095;GO:0030163;GO:0022624;GO:0050852;GO:0036402;GO:1901800;GO:0045202;GO:0005654;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043161;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0001824;GO:0016234;GO:0031597;GO:0008540;GO:0006508;GO:0045899;GO:0016887	ATP binding;hydrolase activity;cytoplasm;protein catabolic process;proteasome-activating ATPase activity;nucleus;membrane;nucleotide binding;nucleoplasm;cytosol;protein binding;proteasome complex;Fc-epsilon receptor signaling pathway;proteasome accessory complex;T cell receptor signaling pathway;positive regulation of proteasomal protein catabolic process;synapse;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;blastocyst development;inclusion body;cytosolic proteasome complex;proteolysis;positive regulation of RNA polymerase II transcriptional preinitiation complex assembly;proteasome regulatory particle, base subcomplex;ATPase activity	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Nucleotide-binding;Nucleus;Phosphoprotein;Proteasome;Reference proteome	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
PDSS1	positive	EBNA1BP2	ENSG00000117395	PDSS1	1	PDSS1	1	0.00723890442963204	WBGene00015941	WBGene00015941(0)			GO:0003723;GO:0005634;GO:0005730;GO:0005515;GO:0042254;GO:0030687;GO:0042273;GO:0006364;GO:0034399	RNA binding;nucleus;nucleolus;protein binding;ribosome biogenesis;preribosome, large subunit precursor;ribosomal large subunit biogenesis;rRNA processing;nuclear periphery	Acetylation;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ribosome biogenesis;Ubl conjugation	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol
PDSS1	positive	H2AFZ	ENSG00000164032	PDSS1	1	PDSS1	1	0.00723890442963204	WBGene00019947				GO:0005634;GO:0003677;GO:0046982;GO:0000786;GO:0005694;GO:0031490;GO:0005515;GO:0000790;GO:0006325;GO:0045944;GO:0070062;GO:0000980;GO:0000978;GO:0071392;GO:0000979;GO:0031492;GO:0005719;GO:0005720	DNA binding;nucleosome;protein heterodimerization activity;nucleus;chromosome;chromatin DNA binding;protein binding;nuclear chromatin;chromatin organization;chromatin silencing;positive regulation of transcription by RNA polymerase II;extracellular exosome;RNA polymerase II cis-regulatory region sequence-specific DNA binding;cellular response to estradiol stimulus;RNA polymerase II core promoter sequence-specific DNA binding;nucleosomal DNA binding;nuclear euchromatin;nuclear heterochromatin	3D-structure;Acetylation;Chromosome;DNA-binding;Isopeptide bond;Methylation;Nucleosome core;Nucleus;Reference proteome;Ubl conjugation	R-HSA-1266738;R-HSA-392499;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-194315;R-HSA-977225;R-HSA-1221632;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-73894;R-HSA-195721;R-HSA-201681;R-HSA-2262752;R-HSA-68886;R-HSA-69278;R-HSA-8878171;R-HSA-8939236;R-HSA-8953897;R-HSA-195258;R-HSA-211000;R-HSA-5578749;R-HSA-68875;R-HSA-157118;R-HSA-606279;R-HSA-73886;R-HSA-774815;R-HSA-8939211;R-HSA-9006931;R-HSA-201722;R-HSA-2559580;R-HSA-2559583;R-HSA-212165;R-HSA-3247509;R-HSA-427413;R-HSA-4839726;R-HSA-5250941;R-HSA-5617472;R-HSA-5619507;R-HSA-9018519;R-HSA-1912422;R-HSA-1912408;R-HSA-2559582;R-HSA-3214858;R-HSA-8936459;R-HSA-157579;R-HSA-5625740;R-HSA-5250913;R-HSA-5250924;R-HSA-73772;R-HSA-73854;R-HSA-73864;R-HSA-912446;R-HSA-110328;R-HSA-110329;R-HSA-110330;R-HSA-110331;R-HSA-73884;R-HSA-73927;R-HSA-73928;R-HSA-73929;R-HSA-427359;R-HSA-212300;R-HSA-5625886;R-HSA-171306;R-HSA-2299718;R-HSA-2559586;R-HSA-427389;R-HSA-5334118;R-HSA-73728;R-HSA-9616222	Developmental Biology;Metabolism of proteins;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Signaling by Rho GTPases;Amyloid fiber formation;Meiotic synapsis;Reproduction;Meiosis;Cell Cycle;DNA Repair;Signaling by WNT;TCF dependent signaling in response to WNT;Cellular responses to stress;M Phase;Cell Cycle, Mitotic;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Cellular responses to external stimuli;RHO GTPase Effectors;Gene Silencing by RNA;Transcriptional regulation by small RNAs;Mitotic Prophase;Signaling by NOTCH;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly;ESR-mediated signaling;Signaling by Nuclear Receptors;Formation of the beta-catenin:TCF transactivating complex;Oxidative Stress Induced Senescence;Cellular Senescence;Epigenetic regulation of gene expression;Chromatin modifying enzymes;NoRC negatively regulates rRNA expression;Chromatin organization;Negative epigenetic regulation of rRNA expression;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Estrogen-dependent gene expression;Pre-NOTCH Expression and Processing;Pre-NOTCH Transcription and Translation;Senescence-Associated Secretory Phenotype (SASP);RMTs methylate histone arginines;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Telomere Maintenance;RHO GTPases activate PKNs;Positive epigenetic regulation of rRNA expression;B-WICH complex positively regulates rRNA expression;RNA Polymerase I Promoter Escape;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription;Meiotic recombination;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Recognition and association of DNA glycosylase with site containing an affected purine;Cleavage of the damaged purine;Base Excision Repair;Depurination;Depyrimidination;Base-Excision Repair, AP Site Formation;SIRT1 negatively regulates rRNA expression;PRC2 methylates histones and DNA;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Packaging Of Telomere Ends;Condensation of Prophase Chromosomes;DNA Damage/Telomere Stress Induced Senescence;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;DNA methylation;RNA Polymerase I Promoter Opening;Transcriptional regulation of granulopoiesis
PDSS1	positive	PPIH	ENSG00000171960	PDSS1	1	PDSS1	1	0.00723890442963204	WBGene00000887	WBGene00000887(1)			GO:0005737;GO:0006397;GO:0008380;GO:0005634;GO:0016607;GO:0016853;GO:0003755;GO:0000413;GO:0006457;GO:0005515;GO:0005681;GO:0016018;GO:0051082;GO:0042026;GO:0005654;GO:0065003;GO:0000398;GO:0071001;GO:0043021;GO:0001525;GO:0045070;GO:0046540	peptidyl-prolyl cis-trans isomerase activity;protein folding;protein peptidyl-prolyl isomerization;cytoplasm;mRNA processing;RNA splicing;nucleus;nuclear speck;isomerase activity;protein binding;spliceosomal complex;cyclosporin A binding;unfolded protein binding;protein refolding;nucleoplasm;protein-containing complex assembly;mRNA splicing, via spliceosome;U4/U6 snRNP;ribonucleoprotein complex binding;angiogenesis;positive regulation of viral genome replication;U4/U6 x U5 tri-snRNP complex	3D-structure;Acetylation;Alternative splicing;Chaperone;Cytoplasm;Direct protein sequencing;Isomerase;Nucleus;Reference proteome;Rotamase;Spliceosome;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-72203;R-HSA-72163;R-HSA-72172	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing
PDSS1	positive	CYC1	ENSG00000179091	PDSS1	1	PDSS1	1	0.00723890442963204	WBGene00000869	WBGene00000869(1)		Isolated complex III deficiency;MITOCHONDRIAL COMPLEX III DEFICIENCY NUCLEAR TYPE 6;MITOCHONDRIAL COMPLEX III DEFICIENCY NUCLEAR TYPE 6	GO:0005634;GO:0016020;GO:0016021;GO:0046872;GO:0055114;GO:0005739;GO:0005743;GO:0070469;GO:0020037;GO:0009055;GO:0006122;GO:0005750;GO:0042776;GO:0045153;GO:0045155;GO:0033762	electron transfer activity;heme binding;nucleus;membrane;integral component of membrane;metal ion binding;nucleoplasm;cytosol;oxidation-reduction process;mitochondrion;mitochondrial inner membrane;nuclear body;respirasome;mitochondrial electron transport, ubiquinol to cytochrome c;mitochondrial respiratory chain complex III;mitochondrial ATP synthesis coupled proton transport;electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity;electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity;response to glucagon	3D-structure;Disease mutation;Electron transport;Heme;Iron;Membrane;Metal-binding;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Polymorphism;Primary mitochondrial disease;Reference proteome;Respiratory chain;Transit peptide;Translocase;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-9609507;R-HSA-1428517;R-HSA-163200;R-HSA-611105;R-HSA-1268020	Metabolism;Protein localization;The citric acid (TCA) cycle and respiratory electron transport;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.;Respiratory electron transport;Mitochondrial protein import
PDSS1	positive	CIAPIN1	ENSG00000005194	PDSS1	1	PDSS1	1	0.00763966352419432	WBGene00020604	WBGene00020604(1)			GO:0005634;GO:0005737;GO:0046872;GO:0043066;GO:0005654;GO:0008168;GO:0005739;GO:0005515;GO:0006915;GO:0032259;GO:0051536;GO:0051539;GO:0022900;GO:0005730;GO:0016226;GO:0051537;GO:0005758;GO:0030097;GO:0009055	cytoplasm;methyltransferase activity;iron-sulfur cluster binding;iron-sulfur cluster assembly;nucleus;metal ion binding;negative regulation of apoptotic process;nucleoplasm;mitochondrion;protein binding;apoptotic process;4 iron, 4 sulfur cluster binding;electron transport chain;nucleolus;2 iron, 2 sulfur cluster binding;mitochondrial intermembrane space;hemopoiesis;electron transfer activity	2Fe-2S;3D-structure;4Fe-4S;Alternative splicing;Apoptosis;Cytoplasm;Iron;Iron-sulfur;Metal-binding;Mitochondrion;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-2564830	Metabolism;Cytosolic iron-sulfur cluster assembly
PDSS1	positive	EIF2B3	ENSG00000070785	PDSS1	1	PDSS1	1	0.00763966352419432	WBGene00004090;WBGene00006605	WBGene00004090(0)		Congenital or early infantile CACH syndrome;Cree leukoencephalopathy;Juvenile or adult CACH syndrome;Late infantile CACH syndrome;OVARIOLEUKODYSTROPHY;LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER	GO:0005737;GO:0003743;GO:0006412;GO:0006413;GO:0009058;GO:0016779;GO:0005085;GO:0005515;GO:0005829;GO:0050852;GO:0009408;GO:0005851;GO:0009749;GO:0008135;GO:0043434;GO:0014003;GO:0021766	biosynthetic process;nucleotidyltransferase activity;cytoplasm;translation initiation factor activity;translation;translational initiation;guanyl-nucleotide exchange factor activity;protein binding;cytosol;T cell receptor signaling pathway;response to heat;oligodendrocyte development;eukaryotic translation initiation factor 2B complex;response to glucose;translation factor activity, RNA binding;response to peptide hormone;cytoplasmic translational initiation;guanyl-nucleotide exchange factor complex;hippocampus development	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Disease mutation;Initiation factor;Leukodystrophy;Phosphoprotein;Polymorphism;Protein biosynthesis;Reference proteome	R-HSA-392499;R-HSA-72613;R-HSA-72737;R-HSA-72766;R-HSA-72731	Metabolism of proteins;Eukaryotic Translation Initiation;Cap-dependent Translation Initiation;Translation;Recycling of eIF2:GDP
PDSS1	positive	ORC1	ENSG00000085840	PDSS1	1	PDSS1	1	0.00763966352419432	WBGene00012650;WBGene00000382	WBGene00012650(0)		Ear-patella-short stature syndrome;Meier-Gorlin syndrome 1;Meier-Gorlin syndrome 1	GO:0005634;GO:0046872;GO:0000166;GO:0005524;GO:0005730;GO:0005829;GO:0003677;GO:0005886;GO:0005515;GO:0003682;GO:0006260;GO:0000278;GO:0005654;GO:0000784;GO:0000082;GO:0003688;GO:0006270;GO:0000808;GO:0005664;GO:0033314;GO:0000083	ATP binding;chromatin binding;nucleus;metal ion binding;nucleotide binding;nucleoplasm;DNA binding;protein binding;DNA replication;mitotic cell cycle;cytosol;nuclear chromosome, telomeric region;G1/S transition of mitotic cell cycle;DNA replication origin binding;DNA replication initiation;origin recognition complex;nuclear origin of replication recognition complex;mitotic DNA replication checkpoint;regulation of transcription involved in G1/S transition of mitotic cell cycle	3D-structure;ATP-binding;Acetylation;DNA replication;DNA-binding;Disease mutation;Dwarfism;Magnesium;Metal-binding;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-68827;R-HSA-68867;R-HSA-68949;R-HSA-69002;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-453279;R-HSA-69206;R-HSA-176187;R-HSA-68962;R-HSA-68689;R-HSA-113507;R-HSA-113510;R-HSA-68616;R-HSA-69205	Cell Cycle;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Orc1 removal from chromatin;DNA Replication Pre-Initiation;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Mitotic G1 phase and G1/S transition;G1/S Transition;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;CDC6 association with the ORC:origin complex;E2F-enabled inhibition of pre-replication complex formation;E2F mediated regulation of DNA replication;Assembly of the ORC complex at the origin of replication;G1/S-Specific Transcription
PDSS1	positive	ZW10	ENSG00000086827	PDSS1	1	PDSS1	1	0.00763966352419432	WBGene00017643	WBGene00017643(0)			GO:0005634;GO:0005737;GO:0016020;GO:0015031;GO:0005783;GO:0005829;GO:0005789;GO:0051301;GO:0005694;GO:0005856;GO:0005515;GO:0007049;GO:0000775;GO:0000922;GO:0005819;GO:0016192;GO:0000776;GO:0000777;GO:0000278;GO:0006888;GO:0006890;GO:0070939;GO:0007094;GO:0000132;GO:0007030;GO:0019237;GO:0000070;GO:0007080;GO:0007093;GO:0007096;GO:0034501;GO:0051321;GO:0065003;GO:0005828;GO:1990423	nucleus;mitotic cell cycle;chromosome, centromeric region;cell;cytoplasm;membrane;protein transport;endoplasmic reticulum;cytosol;endoplasmic reticulum membrane;cytoskeleton;cell division;chromosome;protein binding;cell cycle;vesicle-mediated transport;spindle pole;spindle;kinetochore;condensed chromosome kinetochore;endoplasmic reticulum to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;Dsl1/NZR complex;mitotic spindle assembly checkpoint;lipid droplet;establishment of mitotic spindle orientation;Golgi organization;centromeric DNA binding;mitotic sister chromatid segregation;mitotic metaphase plate congression;mitotic cell cycle checkpoint;regulation of exit from mitosis;protein localization to kinetochore;meiotic cell cycle;protein-containing complex assembly;kinetochore microtubule;RZZ complex	Acetylation;Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Coiled coil;Cytoplasm;Cytoskeleton;Direct protein sequencing;ER-Golgi transport;Endoplasmic reticulum;Kinetochore;Membrane;Mitosis;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618	Vesicle-mediated transport;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	PSMA7	ENSG00000101182	PDSS1	1	PDSS1	1	0.00763966352419432	WBGene00003925				GO:0005737;GO:0016787;GO:0008233;GO:0006508;GO:0000502;GO:0004298;GO:0051603;GO:0005839;GO:0019773;GO:0005634;GO:0005515;GO:0006511;GO:0004175;GO:0038095;GO:0042802;GO:0050852;GO:0098794;GO:0005654;GO:0005829;GO:0070062;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010498;GO:0010499;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043161;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0016032	proteolysis involved in cellular protein catabolic process;proteasome core complex;threonine-type endopeptidase activity;cytoplasm;hydrolase activity;peptidase activity;proteolysis;proteasome complex;proteasome core complex, alpha-subunit complex;endopeptidase activity;ubiquitin-dependent protein catabolic process;nucleus;protein binding;Fc-epsilon receptor signaling pathway;identical protein binding;T cell receptor signaling pathway;postsynapse;nucleoplasm;cytosol;extracellular exosome;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;proteasomal protein catabolic process;proteasomal ubiquitin-independent protein catabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;viral process	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Glycoprotein;Host-virus interaction;Hydrolase;Nucleus;Phosphoprotein;Polymorphism;Protease;Proteasome;Reference proteome;Threonine protease	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
PDSS1	positive	MAPRE1	ENSG00000101367	PDSS1	1	PDSS1	1	0.00763966352419432	WBGene00013344;WBGene00007062	WBGene00012156(1);WBGene00007062(0);WBGene00013344(1)			GO:0003723;GO:0005737;GO:0005794;GO:0051301;GO:0005856;GO:0005515;GO:0007049;GO:0008017;GO:0005874;GO:0005813;GO:0005815;GO:0005819;GO:0042802;GO:0031110;GO:0051225;GO:0005829;GO:0045296;GO:0000086;GO:0010389;GO:0097711;GO:0051010;GO:0005881;GO:0035371;GO:0051233;GO:0035372;GO:0008022;GO:0005925;GO:0031115;GO:0019901;GO:0031116;GO:0016477;GO:1904825;GO:0001578;GO:0008104;GO:0030335;GO:0046785;GO:1903033;GO:0015630;GO:0030981;GO:0031253;GO:0042995;GO:1905721;GO:0070507	protein binding;regulation of microtubule polymerization or depolymerization;microtubule binding;microtubule organizing center;microtubule plus-end binding;RNA binding;cytoplasm;Golgi apparatus;cytoskeleton;cell division;cell cycle;microtubule;centrosome;spindle;identical protein binding;spindle assembly;cytosol;cadherin binding;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking;cytoplasmic microtubule;microtubule plus-end;spindle midzone;protein localization to microtubule;protein C-terminus binding;focal adhesion;negative regulation of microtubule polymerization;protein kinase binding;positive regulation of microtubule polymerization;cell migration;protein localization to microtubule plus-end;microtubule bundle formation;protein localization;positive regulation of cell migration;microtubule polymerization;positive regulation of microtubule plus-end binding;microtubule cytoskeleton;cortical microtubule cytoskeleton;cell projection membrane;cell projection;mitotic spindle astral microtubule end	3D-structure;Acetylation;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Direct protein sequencing;Golgi apparatus;Microtubule;Mitosis;Phosphoprotein;Reference proteome	R-HSA-1852241;R-HSA-5617833;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-453274;R-HSA-68882;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-69620;R-HSA-8852276;R-HSA-195258;R-HSA-2500257;R-HSA-380320;R-HSA-5663220;R-HSA-68877;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518;R-HSA-141424;R-HSA-141444;R-HSA-69618	Organelle biogenesis and maintenance;Cilium Assembly;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic G2-G2/M phases;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;Cell Cycle Checkpoints;The role of GTSE1 in G2/M progression after G2 checkpoint;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;Recruitment of NuMA to mitotic centrosomes;RHO GTPases Activate Formins;Mitotic Prometaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	CCNE1	ENSG00000105173	PDSS1	1	PDSS1	1	0.00763966352419432	WBGene00000871	WBGene00000867(0);WBGene00000866(0);WBGene00000865(0);WBGene00000871(0);WBGene00000870(0)			GO:1900087;GO:0005634;GO:0005654;GO:0051301;GO:0005515;GO:0007049;GO:0000082;GO:0051726;GO:0003713;GO:0045893;GO:0005737;GO:0005829;GO:0005813;GO:0019901;GO:0030521;GO:0006468;GO:0050681;GO:0004672;GO:0016538;GO:0000083;GO:0000079;GO:0044772;GO:0000307;GO:0097134;GO:0016301;GO:0000122;GO:0000723;GO:0006270;GO:0007129;GO:0016055;GO:0070192;GO:1903827	nucleus;regulation of cell cycle;G1/S transition of mitotic cell cycle;nucleoplasm;cell division;protein binding;cell cycle;transcription coactivator activity;positive regulation of transcription, DNA-templated;cytoplasm;cytosol;centrosome;protein kinase binding;androgen receptor signaling pathway;protein phosphorylation;androgen receptor binding;protein kinase activity;cyclin-dependent protein serine/threonine kinase regulator activity;regulation of transcription involved in G1/S transition of mitotic cell cycle;regulation of cyclin-dependent protein serine/threonine kinase activity;mitotic cell cycle phase transition;cyclin-dependent protein kinase holoenzyme complex;cyclin E1-CDK2 complex;kinase activity;negative regulation of transcription by RNA polymerase II;telomere maintenance;DNA replication initiation;synapsis;Wnt signaling pathway;chromosome organization involved in meiotic cell cycle;positive regulation of mesenchymal stem cell proliferation;regulation of cellular protein localization	3D-structure;Alternative splicing;Cell cycle;Cell division;Cyclin;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-6804116;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1640170;R-HSA-2262752;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69563;R-HSA-69580;R-HSA-69615;R-HSA-69620;R-HSA-8953897;R-HSA-390466;R-HSA-391251;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-2559583;R-HSA-390471;R-HSA-8848021;R-HSA-9006927;R-HSA-2559586;R-HSA-69205;R-HSA-1538133;R-HSA-69200;R-HSA-8849470	Metabolism of proteins;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Cell Cycle;Cellular responses to stress;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cellular responses to external stimuli;Chaperonin-mediated protein folding;Protein folding;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Cellular Senescence;Association of TriC/CCT with target proteins during biosynthesis;Signaling by PTK6;Signaling by Non-Receptor Tyrosine Kinases;DNA Damage/Telomere Stress Induced Senescence;G1/S-Specific Transcription;G0 and Early G1;Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes;PTK6 Regulates Cell Cycle
PDSS1	positive	MASTL	ENSG00000120539	PDSS1	1	PDSS1	1	0.00763966352419432				Autosomal thrombocytopenia with normal platelets	GO:0005634;GO:0005737;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005654;GO:0051301;GO:0005856;GO:0006974;GO:0007049;GO:0005813;GO:0005815;GO:0035556;GO:0032154;GO:0018105;GO:0051726;GO:0000278;GO:0051721;GO:0000086;GO:0032515;GO:0007147;GO:1904668	ATP binding;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;nucleus;cytoplasm;nucleotide binding;kinase activity;transferase activity;phosphorylation;nucleoplasm;cytoskeleton;cell division;cellular response to DNA damage stimulus;cell cycle;centrosome;microtubule organizing center;intracellular signal transduction;cleavage furrow;regulation of cell cycle;peptidyl-serine phosphorylation;mitotic cell cycle;protein phosphatase 2A binding;G2/M transition of mitotic cell cycle;negative regulation of phosphoprotein phosphatase activity;female meiosis II;positive regulation of ubiquitin protein ligase activity	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Disease mutation;Kinase;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-1640170;R-HSA-68886;R-HSA-69278;R-HSA-68875;R-HSA-2465910	Cell Cycle;M Phase;Cell Cycle, Mitotic;Mitotic Prophase;MASTL Facilitates Mitotic Progression
PDSS1	positive	COQ3	ENSG00000132423	PDSS1	1	PDSS1	1	0.00763966352419432	WBGene00000763	WBGene00000763(1)			GO:0016020;GO:0016740;GO:0008168;GO:0032259;GO:0005743;GO:0005739;GO:0006744;GO:0005515;GO:0005759;GO:0031314;GO:0008425;GO:0006071;GO:0008171;GO:0004395;GO:0008689;GO:0044595;GO:0044596;GO:1990886;GO:0010795	ubiquinone biosynthetic process;2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity;membrane;transferase activity;methyltransferase activity;methylation;mitochondrial inner membrane;mitochondrion;protein binding;mitochondrial matrix;extrinsic component of mitochondrial inner membrane;glycerol metabolic process;O-methyltransferase activity;hexaprenyldihydroxybenzoate methyltransferase activity;3-demethylubiquinone-9 3-O-methyltransferase activity;3,4-dihydroxy-5-polyprenylbenzoic acid O-methyltransferase activity;decaprenyldihydroxybenzoate methyltransferase activity;3-demethylubiquinone-10 3-O-methyltransferase activity;regulation of ubiquinone biosynthetic process	Acetylation;Membrane;Methyltransferase;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Reference proteome;S-adenosyl-L-methionine;Transferase;Transit peptide;Ubiquinone biosynthesis	R-HSA-1430728;R-HSA-196854;R-HSA-2142789;R-HSA-8978934	Metabolism;Metabolism of vitamins and cofactors;Ubiquinol biosynthesis;Metabolism of cofactors
PDSS1	positive	UBAP2L	ENSG00000143569	PDSS1	1	PDSS1	1	0.00763966352419432	WBGene00004143	WBGene00004143(0)			GO:0003723;GO:0005737;GO:0005515;GO:0007339;GO:0005671;GO:0061484;GO:0031519	protein binding;RNA binding;nucleus;cytoplasm;binding of sperm to zona pellucida;Ada2/Gcn5/Ada3 transcription activator complex;hematopoietic stem cell homeostasis;PcG protein complex	Acetylation;Alternative splicing;Methylation;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	positive	NCAPG2	ENSG00000146918	PDSS1	1	PDSS1	1	0.00763966352419432	WBGene00010093	WBGene00010093(0)		Severe Neurodevelopmental Syndrome;KAHN-KAHN-KATSANIS SYNDROME	GO:0005634;GO:0016607;GO:0016020;GO:0051301;GO:0005515;GO:0007049;GO:0005654;GO:0030261;GO:0035064;GO:0043425;GO:0098772;GO:0001833;GO:0006366;GO:0030218;GO:0045647;GO:0061098;GO:2000273;GO:0000796	nucleus;nuclear speck;membrane;nucleoplasm;cell division;protein binding;cell cycle;chromosome condensation;methylated histone binding;bHLH transcription factor binding;inner cell mass cell proliferation;transcription by RNA polymerase II;erythrocyte differentiation;negative regulation of erythrocyte differentiation;positive regulation of protein tyrosine kinase activity;positive regulation of signaling receptor activity;condensin complex	Alternative splicing;Cell cycle;Cell division;DNA condensation;Disease mutation;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1640170;R-HSA-68886;R-HSA-69278;R-HSA-68875;R-HSA-2299718	Cell Cycle;M Phase;Cell Cycle, Mitotic;Mitotic Prophase;Condensation of Prophase Chromosomes
PDSS1	positive	GNL3	ENSG00000163938	PDSS1	1	PDSS1	1	0.00763966352419432	WBGene00003821	WBGene00013001(0)			GO:0003723;GO:0005634;GO:0016020;GO:0000166;GO:0005730;GO:0005525;GO:0005615;GO:0005515;GO:0016604;GO:0042127;GO:1902895;GO:0019827;GO:0032206;GO:0048027;GO:0017145;GO:0033235;GO:0008283;GO:1904816;GO:0005654	GTP binding;RNA binding;nucleus;membrane;nucleotide binding;nucleolus;extracellular space;protein binding;nuclear body;regulation of cell population proliferation;positive regulation of pri-miRNA transcription by RNA polymerase II;stem cell population maintenance;positive regulation of telomere maintenance;mRNA 5'-UTR binding;stem cell division;positive regulation of protein sumoylation;cell population proliferation;positive regulation of protein localization to chromosome, telomeric region;nucleoplasm	Acetylation;Alternative splicing;Coiled coil;GTP-binding;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol
PDSS1	positive	KNTC1	ENSG00000184445	PDSS1	1	PDSS1	1	0.00763966352419432	WBGene00018900	WBGene00018900(0)			GO:0005829;GO:0005886;GO:0015629;GO:0005515;GO:0005634;GO:0005737;GO:0051301;GO:0005694;GO:0005856;GO:0007049;GO:0000922;GO:0005819;GO:0000775;GO:0000776;GO:0000777;GO:0065003;GO:0007093;GO:0005828;GO:1990423;GO:0007096	protein binding;cytosol;plasma membrane;actin cytoskeleton;nucleus;cytoplasm;cytoskeleton;cell division;chromosome;cell cycle;spindle pole;spindle;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;protein-containing complex assembly;mitotic cell cycle checkpoint;kinetochore microtubule;RZZ complex;regulation of exit from mitosis	Alternative splicing;Cell cycle;Cell division;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Kinetochore;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	MRPL42	ENSG00000198015	PDSS1	1	PDSS1	1	0.00763966352419432	WBGene00003066				GO:0003723;GO:0006412;GO:0005739;GO:0005840;GO:0005886;GO:0003735;GO:0005762;GO:0005743;GO:0070125;GO:0070126;GO:0005763;GO:0016020;GO:0016021	RNA binding;translation;plasma membrane;mitochondrion;ribosome;structural constituent of ribosome;mitochondrial large ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;mitochondrial small ribosomal subunit;membrane;integral component of membrane	3D-structure;Mitochondrion;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
PDSS1	positive	LARS2	ENSG00000011376	PDSS1	1	PDSS1	1	0.00805982834962771	WBGene00003074	WBGene00003074(0)		Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome;Perrault syndrome;Perrault syndrome;HYDROPS LACTIC ACIDOSIS AND SIDEROBLASTIC ANEMIA;Perrault syndrome 4	GO:0006412;GO:0000166;GO:0005524;GO:0005739;GO:0005759;GO:0016874;GO:0004812;GO:0006418;GO:0002161;GO:0106074;GO:0004823;GO:0006429;GO:0032543	ATP binding;aminoacyl-tRNA ligase activity;tRNA aminoacylation for protein translation;nucleotide binding;leucine-tRNA ligase activity;leucyl-tRNA aminoacylation;aminoacyl-tRNA editing activity;translation;mitochondrion;mitochondrial matrix;ligase activity;aminoacyl-tRNA metabolism involved in translational fidelity;mitochondrial translation	ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Deafness;Disease mutation;Ligase;Mitochondrion;Nucleotide-binding;Phosphoprotein;Polymorphism;Protein biosynthesis;Reference proteome;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-379724;R-HSA-379726	Metabolism of proteins;Translation;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation
PDSS1	positive	GEMIN2	ENSG00000092208	PDSS1	1	PDSS1	1	0.00805982834962771	WBGene00004886	WBGene00004886(0)			GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0005730;GO:0005829;GO:0005515;GO:0016604;GO:0005681;GO:0000387;GO:0000245;GO:0032797;GO:0005654;GO:0000375;GO:0051170;GO:0034719;GO:0097504	spliceosomal snRNP assembly;spliceosomal complex;spliceosomal complex assembly;mRNA processing;RNA splicing;nucleus;cytoplasm;nucleoplasm;nucleolus;cytosol;protein binding;nuclear body;SMN complex;RNA splicing, via transesterification reactions;import into nucleus;SMN-Sm protein complex;Gemini of coiled bodies	3D-structure;Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-191859;R-HSA-194441	Metabolism of RNA;snRNP Assembly;Metabolism of non-coding RNA
PDSS1	positive	RANGAP1	ENSG00000100401	PDSS1	1	PDSS1	1	0.00805982834962771	WBGene00004303	WBGene00004303(0)			GO:0005634;GO:0005737;GO:0043231;GO:0005829;GO:0007165;GO:0031965;GO:0005694;GO:0005096;GO:0043547;GO:0005856;GO:0005515;GO:0016235;GO:0005654;GO:0005819;GO:0000775;GO:0000776;GO:0000777;GO:0045296;GO:0090630;GO:0016925;GO:0005635;GO:0008536;GO:0005643;GO:0003723;GO:0046826;GO:0048471;GO:0031625;GO:0048678;GO:0071375;GO:1904117;GO:0030425;GO:0044614;GO:0072686;GO:1904115;GO:1990723	protein binding;signal transduction;GTPase activator activity;nucleus;cytoplasm;intracellular membrane-bounded organelle;cytosol;cytoskeleton;nuclear membrane;chromosome;positive regulation of GTPase activity;aggresome;nucleoplasm;spindle;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cadherin binding;activation of GTPase activity;protein sumoylation;nuclear envelope;Ran GTPase binding;nuclear pore;RNA binding;negative regulation of protein export from nucleus;perinuclear region of cytoplasm;ubiquitin protein ligase binding;response to axon injury;cellular response to peptide hormone stimulus;cellular response to vasopressin;dendrite;nuclear pore cytoplasmic filaments;mitotic spindle;axon cytoplasm;cytoplasmic periphery of the nuclear pore complex	3D-structure;Acetylation;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Direct protein sequencing;GTPase activation;Isopeptide bond;Kinetochore;Leucine-rich repeat;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-162909;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-165054;R-HSA-177243;R-HSA-2990846;R-HSA-3108232;R-HSA-4615885;R-HSA-141424;R-HSA-141444;R-HSA-69618	Metabolism of proteins;Post-translational protein modification;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Host Interactions of HIV factors;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Rev-mediated nuclear export of HIV RNA;Interactions of Rev with host cellular proteins;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of DNA replication proteins;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	EIF3B	ENSG00000106263	PDSS1	1	PDSS1	1	0.00805982834962771	WBGene00001225	WBGene00001225(0)			GO:0003723;GO:0003743;GO:0031369;GO:0006413;GO:0005852;GO:0005515;GO:0003676;GO:0005737;GO:0001732;GO:0002183;GO:0006412;GO:0016282;GO:0033290;GO:0045202;GO:0071541;GO:0005829;GO:0070062;GO:0075522;GO:0075525;GO:0006446;GO:0060090	protein binding;RNA binding;translation initiation factor activity;translational initiation;eukaryotic translation initiation factor 3 complex;translation initiation factor binding;nucleic acid binding;cytoplasm;formation of cytoplasmic translation initiation complex;cytoplasmic translational initiation;translation;eukaryotic 43S preinitiation complex;eukaryotic 48S preinitiation complex;synapse;eukaryotic translation initiation factor 3 complex, eIF3m;cytosol;extracellular exosome;IRES-dependent viral translational initiation;viral translational termination-reinitiation;regulation of translational initiation;molecular adaptor activity	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Initiation factor;Phosphoprotein;Polymorphism;Protein biosynthesis;RNA-binding;Reference proteome;Repeat;WD repeat	R-HSA-392499;R-HSA-156827;R-HSA-72613;R-HSA-72649;R-HSA-72662;R-HSA-72689;R-HSA-72695;R-HSA-72702;R-HSA-72706;R-HSA-72737;R-HSA-72766	Metabolism of proteins;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Formation of a pool of free 40S subunits;Formation of the ternary complex, and subsequently, the 43S complex;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation
PDSS1	positive	NSD2	ENSG00000109685	PDSS1	1	PDSS1	1	0.00805982834962771	WBGene00016603;WBGene00003222	WBGene00019883(0);WBGene00019584(0);WBGene00011729(0);WBGene00018023(0);WBGene00008527(0);WBGene00019690(0);WBGene00020919(0);WBGene00016603(0);WBGene00021282(0);WBGene00022431(0);WBGene00008062(0);WBGene00008206(0);WBGene00020006(0)		Wolf-Hirschhorn syndrome;Wolf-Hirschhorn syndrome	GO:0005634;GO:0005737;GO:0046872;GO:0016740;GO:0008168;GO:0032259;GO:0003677;GO:0006325;GO:0005694;GO:0005515;GO:0018024;GO:0006355;GO:0000981;GO:0005654;GO:0000785;GO:0006303;GO:0042799;GO:0046975;GO:0003682;GO:0043565;GO:0000122;GO:0003149;GO:0003289;GO:0003290;GO:0010452;GO:0034770;GO:0048298;GO:0060348;GO:0070201;GO:2001032	nucleus;protein binding;histone-lysine N-methyltransferase activity;cytoplasm;metal ion binding;transferase activity;nucleoplasm;methyltransferase activity;methylation;DNA binding;chromatin organization;chromosome;regulation of transcription, DNA-templated;DNA-binding transcription factor activity, RNA polymerase II-specific;chromatin;double-strand break repair via nonhomologous end joining;histone methyltransferase activity (H4-K20 specific);histone methyltransferase activity (H3-K36 specific);chromatin binding;sequence-specific DNA binding;negative regulation of transcription by RNA polymerase II;membranous septum morphogenesis;atrial septum primum morphogenesis;atrial septum secundum morphogenesis;histone H3-K36 methylation;histone H4-K20 methylation;positive regulation of isotype switching to IgA isotypes;bone development;regulation of establishment of protein localization;regulation of double-strand break repair via nonhomologous end joining	3D-structure;Alternative splicing;Chromatin regulator;Chromosomal rearrangement;Chromosome;Cytoplasm;DNA-binding;Metal-binding;Methyltransferase;Nucleus;Phosphoprotein;Proto-oncogene;Reference proteome;Repeat;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Zinc;Zinc-finger	R-HSA-1640170;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69481;R-HSA-69620;R-HSA-5693565;R-HSA-5693606;R-HSA-3247509;R-HSA-4839726;R-HSA-3214841;R-HSA-5693607;R-HSA-69473;R-HSA-5693571	Cell Cycle;DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;G2/M Checkpoints;Cell Cycle Checkpoints;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks;DNA Double Strand Break Response;Chromatin modifying enzymes;Chromatin organization;PKMTs methylate histone lysines;Processing of DNA double-strand break ends;G2/M DNA damage checkpoint;Nonhomologous End-Joining (NHEJ)
PDSS1	positive	CCDC86	ENSG00000110104	PDSS1	1	PDSS1	1	0.00805982834962771	WBGene00012739	WBGene00012739(0)			GO:0003723;GO:0005634;GO:0005730;GO:0005515;GO:0016032	RNA binding;nucleus;nucleoplasm;nucleolus;protein binding;viral process	Alternative splicing;Citrullination;Coiled coil;Host-virus interaction;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	positive	BRIX1	ENSG00000113460	PDSS1	1	PDSS1	1	0.00805982834962771	WBGene00019678	WBGene00019678(1)			GO:0003723;GO:0005634;GO:0005730;GO:0005515;GO:0042254;GO:0000027	RNA binding;nucleus;nucleoplasm;nucleolus;protein binding;ribosome biogenesis;ribosomal large subunit assembly	Acetylation;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ribosome biogenesis;Ubl conjugation		
PDSS1	positive	WARS2	ENSG00000116874	PDSS1	1	PDSS1	1	0.00805982834962771	WBGene00006946	WBGene00006946(1)		Autosomal recessive non-syndromic intellectual disability;NEURODEVELOPMENTAL DISORDER MITOCHONDRIAL WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS WITH OR WITHOUT SEIZURES	GO:0006412;GO:0000166;GO:0005524;GO:0005739;GO:0005759;GO:0005886;GO:0016874;GO:0004812;GO:0004830;GO:0006418;GO:0006436;GO:0005829;GO:0070183;GO:0001570	ATP binding;aminoacyl-tRNA ligase activity;tRNA aminoacylation for protein translation;nucleotide binding;tryptophan-tRNA ligase activity;tryptophanyl-tRNA aminoacylation;translation;plasma membrane;mitochondrion;mitochondrial matrix;ligase activity;cytosol;mitochondrial tryptophanyl-tRNA aminoacylation;vasculogenesis	3D-structure;ATP-binding;Alternative splicing;Aminoacyl-tRNA synthetase;Disease mutation;Ligase;Mitochondrion;Nucleotide-binding;Polymorphism;Primary mitochondrial disease;Protein biosynthesis;Reference proteome;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-379724;R-HSA-379726	Metabolism of proteins;Translation;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation
PDSS1	positive	PWP1	ENSG00000136045	PDSS1	1	PDSS1	1	0.00805982834962771	WBGene00010435	WBGene00010435(0)			GO:0005634;GO:0005794;GO:0005730;GO:0005694;GO:0042254;GO:1990889;GO:0033140;GO:0034773;GO:2000738;GO:0006351;GO:1901838;GO:0005515	protein binding;nucleus;Golgi apparatus;nucleolus;chromosome;ribosome biogenesis;H4K20me3 modified histone binding;negative regulation of peptidyl-serine phosphorylation of STAT protein;histone H4-K20 trimethylation;positive regulation of stem cell differentiation;transcription, DNA-templated;positive regulation of transcription of nucleolar large rRNA by RNA polymerase I	Alternative splicing;Chromosome;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ribosome biogenesis;Transcription;Transcription regulation;WD repeat		
PDSS1	positive	TDG	ENSG00000139372	PDSS1	1	PDSS1	1	0.00805982834962771					GO:0005634;GO:0005654;GO:0016787;GO:0003677;GO:0005886;GO:0006325;GO:0042803;GO:0006281;GO:0005515;GO:0006974;GO:0006298;GO:0019104;GO:0030983;GO:0003690;GO:0006284;GO:0003684;GO:0006285;GO:0045008;GO:0080111;GO:0000287;GO:0040029;GO:0032183;GO:0045995;GO:0005524;GO:0004844;GO:0031404;GO:0043621;GO:0003712;GO:0005080;GO:0008134;GO:0008263;GO:0019904;GO:0031402;GO:0043739;GO:0000122;GO:0032091;GO:0035511;GO:0035562;GO:1902544;GO:0016605	DNA repair;DNA N-glycosylase activity;nucleus;nucleoplasm;plasma membrane;hydrolase activity;DNA binding;chromatin organization;protein homodimerization activity;protein binding;cellular response to DNA damage stimulus;mismatch repair;mismatched DNA binding;double-stranded DNA binding;base-excision repair;damaged DNA binding;base-excision repair, AP site formation;depyrimidination;DNA demethylation;magnesium ion binding;regulation of gene expression, epigenetic;regulation of embryonic development;ATP binding;uracil DNA N-glycosylase activity;chloride ion binding;protein self-association;transcription coregulator activity;protein kinase C binding;transcription factor binding;pyrimidine-specific mismatch base pair DNA N-glycosylase activity;protein domain specific binding;sodium ion binding;SUMO binding;G/U mismatch-specific uracil-DNA glycosylase activity;negative regulation of transcription by RNA polymerase II;negative regulation of protein binding;oxidative DNA demethylation;negative regulation of chromatin binding;regulation of DNA N-glycosylase activity;PML body	3D-structure;Activator;Chromatin regulator;DNA damage;DNA repair;Direct protein sequencing;Hydrolase;Isopeptide bond;Nucleus;Polymorphism;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-73894;R-HSA-2990846;R-HSA-3108214;R-HSA-3108232;R-HSA-212165;R-HSA-110328;R-HSA-110329;R-HSA-110357;R-HSA-73884;R-HSA-73928;R-HSA-73929;R-HSA-73933;R-HSA-5221030	Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);DNA Repair;SUMOylation;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;Epigenetic regulation of gene expression;Recognition and association of DNA glycosylase with site containing an affected pyrimidine;Cleavage of the damaged pyrimidine ;Displacement of DNA glycosylase by APEX1;Base Excision Repair;Depyrimidination;Base-Excision Repair, AP Site Formation;Resolution of Abasic Sites (AP sites);TET1,2,3 and TDG demethylate DNA
PDSS1	positive	ELOC	ENSG00000154582	PDSS1	1	PDSS1	1	0.00805982834962771	WBGene00001236;WBGene00001237;WBGene00077680	WBGene00077680(0);WBGene00001236(0);WBGene00001237(0)			GO:0006511;GO:0005634;GO:0005515;GO:0003746;GO:0006414;GO:0016567;GO:0005654;GO:0005829;GO:0043687;GO:0061418;GO:0016032;GO:0006366;GO:0006368;GO:0006357;GO:0004842;GO:0032968;GO:0070449	ubiquitin-dependent protein catabolic process;nucleus;protein binding;translation elongation factor activity;translational elongation;protein ubiquitination;nucleoplasm;cytosol;post-translational protein modification;regulation of transcription from RNA polymerase II promoter in response to hypoxia;viral process;transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;regulation of transcription by RNA polymerase II;positive regulation of transcription elongation from RNA polymerase II promoter;elongin complex	3D-structure;Alternative splicing;Host-virus interaction;Nucleus;Reference proteome;Transcription;Transcription regulation;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-422475;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-1234174;R-HSA-1234176;R-HSA-162909;R-HSA-180585;R-HSA-2262752;R-HSA-376176;R-HSA-8951664;R-HSA-8953897;R-HSA-9010553;R-HSA-112382;R-HSA-167152;R-HSA-167169;R-HSA-167172;R-HSA-167200;R-HSA-167238;R-HSA-167243;R-HSA-167246;R-HSA-167287;R-HSA-167290;R-HSA-674695;R-HSA-6796648;R-HSA-75955	Adaptive Immune System;Immune System;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Axon guidance;Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Host Interactions of HIV factors;Vif-mediated degradation of APOBEC3G;Cellular responses to stress;Signaling by ROBO receptors;Neddylation;Cellular responses to external stimuli;Regulation of expression of SLITs and ROBOs;Formation of RNA Pol II elongation complex ;Formation of HIV elongation complex in the absence of HIV Tat;HIV Transcription Elongation;Transcription of the HIV genome;Formation of HIV-1 elongation complex containing HIV-1 Tat;Pausing and recovery of Tat-mediated HIV elongation;Tat-mediated HIV elongation arrest and recovery;Tat-mediated elongation of the HIV-1 transcript;HIV elongation arrest and recovery;Pausing and recovery of HIV elongation;RNA Polymerase II Pre-transcription Events;TP53 Regulates Transcription of DNA Repair Genes;RNA Polymerase II Transcription Elongation
PDSS1	positive	UTP11	ENSG00000183520	PDSS1	1	PDSS1	1	0.00805982834962771	WBGene00007623	WBGene00007623(1)			GO:0005615;GO:0043065;GO:0005737;GO:0003723;GO:0005634;GO:0005515;GO:0005730;GO:0006364;GO:0032040;GO:0005654;GO:0007399	rRNA processing;small-subunit processome;extracellular space;positive regulation of apoptotic process;cytoplasm;RNA binding;nucleus;protein binding;nucleolus;nucleoplasm;nervous system development	Alternative splicing;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;rRNA processing	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
PDSS1	positive	RBM14	ENSG00000239306	PDSS1	1	PDSS1	1	0.00805982834962771	WBGene00004384				GO:0003676;GO:0003723;GO:0005634;GO:0005737;GO:0016607;GO:0005515;GO:0030374;GO:0002376;GO:0045087;GO:0005730;GO:0060395;GO:0098534;GO:0045944;GO:0005667;GO:0005654;GO:1990904;GO:0002218;GO:0009725;GO:0016575;GO:0046600	nucleic acid binding;RNA binding;nucleus;cytoplasm;nuclear speck;protein binding;nuclear receptor transcription coactivator activity;immune system process;innate immune response;nucleolus;SMAD protein signal transduction;centriole assembly;positive regulation of transcription by RNA polymerase II;transcription factor complex;mRNA binding;nucleoplasm;ribonucleoprotein complex;activation of innate immune response;response to hormone;histone deacetylation;negative regulation of centriole replication	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Immunity;Innate immunity;Isopeptide bond;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8878166;R-HSA-8941326	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX2;RUNX2 regulates bone development
PDSS1	positive	PSMB3	ENSG00000277791	PDSS1	1	PDSS1	1	0.00805982834962771	WBGene00003949	WBGene00003949(1)			GO:0005634;GO:0005737;GO:0016787;GO:0005515;GO:0008233;GO:0006508;GO:0000502;GO:0043161;GO:0004175;GO:0004298;GO:0051603;GO:0005839;GO:0038095;GO:0019774;GO:0050852;GO:0005654;GO:0005829;GO:0070062;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010498;GO:0010499;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0016032	endopeptidase activity;proteolysis involved in cellular protein catabolic process;proteasome core complex;threonine-type endopeptidase activity;proteasome-mediated ubiquitin-dependent protein catabolic process;proteasome core complex, beta-subunit complex;nucleus;cytoplasm;hydrolase activity;protein binding;peptidase activity;proteolysis;proteasome complex;Fc-epsilon receptor signaling pathway;T cell receptor signaling pathway;nucleoplasm;cytosol;extracellular exosome;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;proteasomal protein catabolic process;proteasomal ubiquitin-independent protein catabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;viral process	3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Host-virus interaction;Hydrolase;Nucleus;Polymorphism;Protease;Proteasome;Reference proteome;Threonine protease	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
PDSS1	positive	SUV39H1	ENSG00000101945	PDSS1	1	PDSS1	1	0.0085001712028282	WBGene00018023	WBGene00018023(0);WBGene00008527(0);WBGene00019690(0);WBGene00020919(0);WBGene00016603(0);WBGene00021282(0);WBGene00022431(0);WBGene00008062(0);WBGene00008206(0);WBGene00020006(0)			GO:0005634;GO:0008270;GO:0046872;GO:0016740;GO:0008168;GO:0032259;GO:0006325;GO:0005694;GO:0005515;GO:0007049;GO:0048511;GO:0030154;GO:0005654;GO:0018024;GO:0034968;GO:0006364;GO:0000775;GO:0016032;GO:0047485;GO:0045892;GO:0000976;GO:0000794;GO:0042754;GO:0006974;GO:0008757;GO:0000183;GO:0005677;GO:0033553;GO:0003682;GO:0042054;GO:0046974;GO:0000122;GO:0036123;GO:0036124;GO:0071456;GO:0000792;GO:0005652	zinc ion binding;nucleus;protein binding;histone-lysine N-methyltransferase activity;histone lysine methylation;metal ion binding;transferase activity;methyltransferase activity;methylation;chromatin organization;chromosome;cell cycle;rhythmic process;cell differentiation;nucleoplasm;rRNA processing;chromosome, centromeric region;viral process;protein N-terminus binding;negative regulation of transcription, DNA-templated;transcription regulatory region sequence-specific DNA binding;condensed nuclear chromosome;negative regulation of circadian rhythm;cellular response to DNA damage stimulus;S-adenosylmethionine-dependent methyltransferase activity;chromatin silencing at rDNA;chromatin silencing complex;rDNA heterochromatin;chromatin binding;histone methyltransferase activity;histone methyltransferase activity (H3-K9 specific);negative regulation of transcription by RNA polymerase II;histone H3-K9 dimethylation;histone H3-K9 trimethylation;cellular response to hypoxia;heterochromatin;nuclear lamina	3D-structure;Acetylation;Alternative splicing;Biological rhythms;Cell cycle;Centromere;Chromatin regulator;Chromosome;Differentiation;Host-virus interaction;Metal-binding;Methyltransferase;Nucleus;Phosphoprotein;Reference proteome;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Zinc;rRNA processing	R-HSA-74160;R-HSA-212165;R-HSA-3247509;R-HSA-4839726;R-HSA-5250941;R-HSA-3214841;R-HSA-427359	Gene expression (Transcription);Epigenetic regulation of gene expression;Chromatin modifying enzymes;Chromatin organization;Negative epigenetic regulation of rRNA expression;PKMTs methylate histone lysines;SIRT1 negatively regulates rRNA expression
PDSS1	positive	RPA3	ENSG00000106399	PDSS1	1	PDSS1	1	0.0085001712028282					GO:0005634;GO:0003677;GO:0006281;GO:0005515;GO:0006310;GO:0006974;GO:0006260;GO:0006298;GO:0005654;GO:0007346;GO:0042127;GO:1900034;GO:0036297;GO:0003697;GO:0006284;GO:1901796;GO:0000082;GO:0000724;GO:0019985;GO:0006283;GO:0003684;GO:0005662;GO:0042276;GO:0006289;GO:0035861;GO:0000723;GO:0042769;GO:0006293;GO:0006295;GO:0006296;GO:0033683;GO:0006294;GO:0032201;GO:0006297;GO:0070987	DNA binding;nucleus;DNA repair;DNA replication;DNA recombination;protein binding;cellular response to DNA damage stimulus;mismatch repair;nucleoplasm;regulation of mitotic cell cycle;regulation of cell population proliferation;regulation of cellular response to heat;interstrand cross-link repair;base-excision repair;single-stranded DNA binding;regulation of signal transduction by p53 class mediator;G1/S transition of mitotic cell cycle;double-strand break repair via homologous recombination;translesion synthesis;transcription-coupled nucleotide-excision repair;damaged DNA binding;DNA replication factor A complex;error-prone translesion synthesis;nucleotide-excision repair;site of double-strand break;telomere maintenance;DNA damage response, detection of DNA damage;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;nucleotide-excision repair, preincision complex assembly;telomere maintenance via semi-conservative replication;nucleotide-excision repair, DNA gap filling;error-free translesion synthesis	3D-structure;Acetylation;DNA damage;DNA recombination;DNA repair;DNA replication;Isopeptide bond;Nucleus;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-6783310;R-HSA-73894;R-HSA-2262752;R-HSA-69002;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-8953897;R-HSA-3371453;R-HSA-3371556;R-HSA-73886;R-HSA-5633007;R-HSA-453279;R-HSA-69206;R-HSA-6804756;R-HSA-176187;R-HSA-68962;R-HSA-157579;R-HSA-180786;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-912446;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-5685938;R-HSA-110312;R-HSA-5655862;R-HSA-5656121;R-HSA-69190;R-HSA-3371511;R-HSA-5696395;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174417;R-HSA-69166;R-HSA-69183;R-HSA-69186;R-HSA-110320;R-HSA-5696397;R-HSA-174414;R-HSA-174437;R-HSA-5358508;R-HSA-5358565;R-HSA-5358606	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Fanconi Anemia Pathway;DNA Repair;Cellular responses to stress;DNA Replication Pre-Initiation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Cellular responses to external stimuli;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Chromosome Maintenance;Regulation of TP53 Activity;Mitotic G1 phase and G1/S transition;G1/S Transition;Regulation of TP53 Activity through Phosphorylation;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;Telomere Maintenance;Extension of Telomeres;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Meiotic recombination;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through Single Strand Annealing (SSA);Translesion synthesis by REV1;Translesion synthesis by POLK;Translesion synthesis by POLI;DNA strand elongation;HSF1 activation;Formation of Incision Complex in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;Translesion Synthesis by POLH;Gap-filling DNA repair synthesis and ligation in GG-NER;Processive synthesis on the C-strand of the telomere;Removal of the Flap Intermediate from the C-strand;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
PDSS1	positive	DHX15	ENSG00000109606	PDSS1	1	PDSS1	1	0.0085001712028282	WBGene00018967;WBGene00003389;WBGene00003392;WBGene00003393	WBGene00018967(1)			GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0016607;GO:0000166;GO:0005524;GO:0016787;GO:0005515;GO:0004386;GO:0005730;GO:0003724;GO:0005654;GO:0000398;GO:0071008;GO:0003725;GO:0009636;GO:0043279;GO:0005689	ATP binding;nucleic acid binding;helicase activity;RNA binding;mRNA processing;RNA splicing;nucleus;nuclear speck;nucleotide binding;hydrolase activity;protein binding;nucleolus;RNA helicase activity;nucleoplasm;spliceosomal complex;mRNA splicing, via spliceosome;U2-type post-mRNA release spliceosomal complex;double-stranded RNA binding;response to toxic substance;response to alkaloid;U12-type spliceosomal complex	3D-structure;ATP-binding;Acetylation;Helicase;Hydrolase;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-72203;R-HSA-72163;R-HSA-72172	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing
PDSS1	positive	HJURP	ENSG00000123485	PDSS1	1	PDSS1	1	0.0085001712028282					GO:0005634;GO:0005730;GO:0005829;GO:0005739;GO:0003677;GO:0005694;GO:0005515;GO:0007049;GO:0042393;GO:0042802;GO:0007059;GO:0000775;GO:0000777;GO:0005654;GO:0043254;GO:0034080;GO:0051101	nucleus;histone binding;nucleoplasm;nucleolus;mitochondrion;DNA binding;chromosome;protein binding;cell cycle;identical protein binding;chromosome segregation;chromosome, centromeric region;condensed chromosome kinetochore;regulation of protein-containing complex assembly;CENP-A containing nucleosome assembly;regulation of DNA binding	3D-structure;Alternative splicing;Cell cycle;Centromere;Chaperone;Chromosome;DNA-binding;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-1640170;R-HSA-606279;R-HSA-73886;R-HSA-774815	Cell Cycle;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly
PDSS1	positive	ACLY	ENSG00000131473	PDSS1	1	PDSS1	1	0.0085001712028282	WBGene00007150;WBGene00016995	WBGene00016995(1);WBGene00007150(1)			GO:0005737;GO:0016020;GO:0046872;GO:0000166;GO:0005524;GO:0016740;GO:0005829;GO:0005654;GO:0003824;GO:0016829;GO:0005886;GO:0006629;GO:0003878;GO:0046912;GO:0048037;GO:0006085;GO:0006101;GO:0005576;GO:0005515;GO:0070062;GO:0043312;GO:1904813;GO:0035578;GO:0031325;GO:0046949;GO:0006633;GO:0006695;GO:0015936;GO:0008610;GO:0006107	catalytic activity;transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer;cofactor binding;citrate metabolic process;ATP citrate synthase activity;acetyl-CoA biosynthetic process;cytoplasm;membrane;metal ion binding;nucleotide binding;ATP binding;transferase activity;nucleoplasm;cytosol;plasma membrane;lyase activity;lipid metabolic process;extracellular region;protein binding;extracellular exosome;neutrophil degranulation;ficolin-1-rich granule lumen;azurophil granule lumen;positive regulation of cellular metabolic process;fatty-acyl-CoA biosynthetic process;fatty acid biosynthetic process;cholesterol biosynthetic process;coenzyme A metabolic process;lipid biosynthetic process;oxaloacetate metabolic process	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cytoplasm;Isopeptide bond;Lipid biosynthesis;Lipid metabolism;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-556833;R-HSA-75105;R-HSA-8978868;R-HSA-6798695;R-HSA-163685;R-HSA-163765	Innate Immune System;Immune System;Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Fatty acid metabolism;Neutrophil degranulation;Integration of energy metabolism;ChREBP activates metabolic gene expression
PDSS1	positive	IMMT	ENSG00000132305	PDSS1	1	PDSS1	1	0.0085001712028282	WBGene00020511;WBGene00012315	WBGene00020511(0);WBGene00012315(0)			GO:0016020;GO:0016021;GO:0005739;GO:0005743;GO:0003723;GO:0005515;GO:0061617;GO:0042407;GO:0070584;GO:0051560	membrane;integral component of membrane;mitochondrion;mitochondrial inner membrane;RNA binding;protein binding;MICOS complex;inner mitochondrial membrane organization;SAM complex;MIB complex;cristae formation;mitochondrion morphogenesis;mitochondrial calcium ion homeostasis;mitochondrial intermembrane space	Acetylation;Alternative splicing;Direct protein sequencing;Membrane;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide;Transmembrane;Transmembrane helix	R-HSA-1852241;R-HSA-1592230;R-HSA-8949613	Organelle biogenesis and maintenance;Mitochondrial biogenesis;Cristae formation
PDSS1	positive	CNOT9	ENSG00000144580	PDSS1	1	PDSS1	1	0.0085001712028282	WBGene00016139	WBGene00016139(1)			GO:0005634;GO:0005737;GO:0016020;GO:0030014;GO:0031047;GO:0000932;GO:0005515;GO:0006402;GO:0006977;GO:0005829;GO:0033138;GO:0019904;GO:0000289;GO:0006417;GO:0017148;GO:0033147;GO:0030015;GO:0032991;GO:0042803;GO:0007548;GO:0005154;GO:0019900;GO:2000327;GO:0045742;GO:0019221	mRNA catabolic process;CCR4-NOT complex;nucleus;cytoplasm;membrane;gene silencing by RNA;protein binding;P-body;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;cytosol;positive regulation of peptidyl-serine phosphorylation;protein domain specific binding;nuclear-transcribed mRNA poly(A) tail shortening;regulation of translation;negative regulation of translation;negative regulation of intracellular estrogen receptor signaling pathway;CCR4-NOT core complex;protein-containing complex;protein homodimerization activity;sex differentiation;epidermal growth factor receptor binding;kinase binding;positive regulation of nuclear receptor transcription coactivator activity;positive regulation of epidermal growth factor receptor signaling pathway;cytokine-mediated signaling pathway	3D-structure;Acetylation;Activator;Alternative splicing;Cytoplasm;Direct protein sequencing;Nucleus;Polymorphism;RNA-mediated gene silencing;Reference proteome;Repressor;Transcription;Transcription regulation;Translation regulation	R-HSA-1266738;R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-73857;R-HSA-74160;R-HSA-8953854;R-HSA-429914;R-HSA-429947;R-HSA-6804115;R-HSA-5617472;R-HSA-5619507	Developmental Biology;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism of RNA;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation
PDSS1	positive	TAF5	ENSG00000148835	PDSS1	1	PDSS1	1	0.0085001712028282	WBGene00006386	WBGene00006386(1)			GO:0005634;GO:0005654;GO:0003700;GO:0006325;GO:0015629;GO:0004402;GO:0006355;GO:0006367;GO:0042802;GO:0005515;GO:0016032;GO:0016573;GO:0044212;GO:0006366;GO:0006352;GO:1901796;GO:0000790;GO:0005669;GO:0033276;GO:0042795;GO:0046983;GO:0016251	protein binding;nucleus;nucleoplasm;actin cytoskeleton;transcription initiation from RNA polymerase II promoter;identical protein binding;viral process;transcription regulatory region DNA binding;transcription by RNA polymerase II;RNA polymerase II general transcription initiation factor activity;DNA-templated transcription, initiation;regulation of signal transduction by p53 class mediator;nuclear chromatin;transcription factor TFIID complex;transcription factor TFTC complex;snRNA transcription by RNA polymerase II	3D-structure;Alternative splicing;Direct protein sequencing;Host-virus interaction;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;WD repeat	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-167172;R-HSA-674695;R-HSA-5633007;R-HSA-6807505;R-HSA-167161;R-HSA-167162;R-HSA-6804756;R-HSA-73776;R-HSA-73779;R-HSA-75953;R-HSA-76042	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Transcription of the HIV genome;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity;RNA polymerase II transcribes snRNA genes;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
PDSS1	positive	AIFM1	ENSG00000156709	PDSS1	1	PDSS1	1	0.0085001712028282	WBGene00006937	WBGene00006937(1)		Severe X-linked mitochondrial encephalomyopathy;Spondyloepimetaphyseal dysplasia Bieganski type;X-linked Charcot-Marie-Tooth disease type 4;X-linked hereditary sensory and autonomic neuropathy with deafness;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6;COWCHOCK SYNDROME;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6;COWCHOCK SYNDROME;Deafness X-linked 5	GO:0050660;GO:0055114;GO:0046983;GO:0016491;GO:0005634;GO:0005737;GO:0016020;GO:0005743;GO:0003677;GO:0005739;GO:0005829;GO:0005515;GO:0006915;GO:0048471;GO:0005758;GO:0043065;GO:0030261;GO:0006919;GO:0070059;GO:0016174;GO:0016651;GO:0071949;GO:0002931;GO:0009636;GO:0010942;GO:0043525;GO:0051402;GO:0070301;GO:0071392;GO:0071732;GO:0090650;GO:1902065;GO:1902510;GO:1904045	flavin adenine dinucleotide binding;oxidation-reduction process;oxidoreductase activity;protein dimerization activity;nucleus;cytoplasm;membrane;mitochondrial inner membrane;DNA binding;mitochondrion;cytosol;protein binding;apoptotic process;perinuclear region of cytoplasm;mitochondrial intermembrane space;positive regulation of apoptotic process;chromosome condensation;FAD binding;activation of cysteine-type endopeptidase activity involved in apoptotic process;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;NAD(P)H oxidase activity;oxidoreductase activity, acting on NAD(P)H;mitochondrial respiratory chain complex assembly;protein import into mitochondrial intermembrane space;response to ischemia;response to toxic substance;positive regulation of cell death;positive regulation of neuron apoptotic process;neuron apoptotic process;cellular response to hydrogen peroxide;cellular response to estradiol stimulus;cellular response to nitric oxide;cellular response to oxygen-glucose deprivation;response to L-glutamate;regulation of apoptotic DNA fragmentation;cellular response to aldosterone	3D-structure;Acetylation;Alternative splicing;Apoptosis;Charcot-Marie-Tooth disease;Cytoplasm;DNA-binding;Deafness;Direct protein sequencing;Disease mutation;FAD;Flavoprotein;Isopeptide bond;Membrane;Mental retardation;Mitochondrion;Mitochondrion inner membrane;NAD;Neurodegeneration;Neuropathy;Nucleus;Oxidoreductase;Phosphoprotein;Primary mitochondrial disease;Reference proteome;Transit peptide;Ubl conjugation		
PDSS1	positive	TOPBP1	ENSG00000163781	PDSS1	1	PDSS1	1	0.0085001712028282	WBGene00009507				GO:0005634;GO:0005737;GO:0003677;GO:0005694;GO:0015629;GO:0005856;GO:0005515;GO:0006281;GO:0006974;GO:0016604;GO:0000922;GO:0005815;GO:0042802;GO:0005654;GO:0016605;GO:0006259;GO:1901796;GO:0006260;GO:0033314;GO:0008022;GO:0010212;GO:0000794;GO:0001673	nucleus;cytoplasm;intracellular membrane-bounded organelle;nucleoplasm;plasma membrane;DNA binding;cytoskeleton;chromosome;actin cytoskeleton;protein binding;DNA repair;cellular response to DNA damage stimulus;nuclear body;spindle pole;microtubule organizing center;identical protein binding;PML body;DNA metabolic process;regulation of signal transduction by p53 class mediator;DNA replication;DNA replication initiation;mitotic DNA replication checkpoint;mitotic G2 DNA damage checkpoint;protein C-terminus binding;response to ionizing radiation;condensed nuclear chromosome;male germ cell nucleus	3D-structure;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69481;R-HSA-69620;R-HSA-5633007;R-HSA-6804756;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-5685938	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;G2/M Checkpoints;Cell Cycle Checkpoints;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;HDR through Single Strand Annealing (SSA)
PDSS1	positive	PSMD1	ENSG00000173692	PDSS1	1	PDSS1	1	0.0085001712028282	WBGene00004459	WBGene00004459(0)			GO:0016020;GO:0050790;GO:0000502;GO:0038095;GO:0005576;GO:0005634;GO:0030234;GO:0042176;GO:0022624;GO:0050852;GO:0005515;GO:0005654;GO:0005829;GO:0004175;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043161;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0043312;GO:0005838;GO:0008540;GO:0035578;GO:0031625;GO:0034515	enzyme regulator activity;regulation of protein catabolic process;proteasome complex;membrane;regulation of catalytic activity;Fc-epsilon receptor signaling pathway;extracellular region;nucleus;protein binding;proteasome accessory complex;T cell receptor signaling pathway;nucleoplasm;cytosol;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;neutrophil degranulation;proteasome regulatory particle;azurophil granule lumen;ubiquitin protein ligase binding;proteasome regulatory particle, base subcomplex;proteasome storage granule	3D-structure;Acetylation;Alternative splicing;Phosphoprotein;Proteasome;Reference proteome;Repeat	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-6798695;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Neutrophil degranulation;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling
PDSS1	positive	AURKAIP1	ENSG00000175756	PDSS1	1	PDSS1	1	0.0085001712028282					GO:0005634;GO:0043231;GO:0016301;GO:0016310;GO:0005654;GO:0005739;GO:0005840;GO:0005515;GO:0006397;GO:0005743;GO:0045839;GO:0070125;GO:0070126;GO:0045862	nucleus;intracellular membrane-bounded organelle;nucleoplasm;mitochondrion;ribosome;protein binding;mRNA processing;mitochondrial inner membrane;negative regulation of mitotic nuclear division;mitochondrial translational elongation;mitochondrial translational termination;positive regulation of proteolysis	3D-structure;Mitochondrion;Nucleus;Polymorphism;Reference proteome;Ribonucleoprotein;Ribosomal protein	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
PDSS1	positive	IPO9	ENSG00000198700	PDSS1	1	PDSS1	1	0.0085001712028282					GO:0005634;GO:0005737;GO:0016020;GO:0006886;GO:0015031;GO:0008536;GO:0005829;GO:0005515;GO:0005635;GO:0006606;GO:0042393;GO:0061608	intracellular protein transport;Ran GTPase binding;nucleus;cytoplasm;membrane;protein transport;cytosol;protein binding;nuclear envelope;protein import into nucleus;histone binding;nuclear import signal receptor activity	3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Nucleus;Protein transport;Reference proteome;Transport		
PDSS1	positive	MCTS1	ENSG00000232119	PDSS1	1	PDSS1	1	0.0085001712028282	WBGene00015703	WBGene00015703(1)			GO:0003723;GO:0005737;GO:0003743;GO:0006412;GO:0006413;GO:0005829;GO:0005886;GO:0005515;GO:0006974;GO:0007049;GO:0022627;GO:0032790;GO:0040008;GO:0075522;GO:0001731;GO:0002188;GO:0008284	RNA binding;cytoplasm;translation initiation factor activity;translation;translational initiation;cytosol;plasma membrane;protein binding;cellular response to DNA damage stimulus;cell cycle;ribosome disassembly;cytosolic small ribosomal subunit;regulation of growth;IRES-dependent viral translational initiation;formation of translation preinitiation complex;translation reinitiation;positive regulation of cell population proliferation	3D-structure;Alternative splicing;Cell cycle;Cytoplasm;DNA damage;Growth regulation;Initiation factor;Phosphoprotein;Polymorphism;Protein biosynthesis;Reference proteome;Transcription;Transcription regulation;Tumor suppressor		
PDSS1	positive	ME2	ENSG00000082212	PDSS1	1	PDSS1	1	0.00896148576769862	WBGene00012983	WBGene00012983(0)			GO:0046872;GO:0016491;GO:0055114;GO:0005739;GO:0005759;GO:0003824;GO:0008152;GO:0051287;GO:0022900;GO:0004470;GO:0004471;GO:0009055;GO:0006099;GO:0006108;GO:0006090;GO:0004473;GO:0008948;GO:1902031	oxidation-reduction process;NAD binding;malic enzyme activity;malate dehydrogenase (decarboxylating) (NAD+) activity;intracellular membrane-bounded organelle;metal ion binding;oxidoreductase activity;mitochondrion;mitochondrial matrix;catalytic activity;metabolic process;electron transport chain;electron transfer activity;tricarboxylic acid cycle;malate metabolic process;pyruvate metabolic process;malate dehydrogenase (decarboxylating) (NADP+) activity;oxaloacetate decarboxylase activity;regulation of NADP metabolic process	3D-structure;Acetylation;Allosteric enzyme;Alternative splicing;Direct protein sequencing;Metal-binding;Mitochondrion;NAD;Oxidoreductase;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-1428517;R-HSA-71406;R-HSA-71403	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Pyruvate metabolism and Citric Acid (TCA) cycle;Citric acid cycle (TCA cycle)
PDSS1	positive	PES1	ENSG00000100029	PDSS1	1	PDSS1	1	0.00896148576769862	WBGene00003063	WBGene00003063(1)			GO:0003723;GO:0005634;GO:0016020;GO:0005730;GO:0005829;GO:0005694;GO:0005515;GO:0042254;GO:0005654;GO:0006364;GO:0008283;GO:0043021;GO:0000463;GO:0000466;GO:0007000;GO:0033365;GO:0042273;GO:0000793;GO:0030687;GO:0070545;GO:0051726	ribosome biogenesis;nucleolus;RNA binding;nucleus;membrane;nucleoplasm;cytosol;chromosome;protein binding;rRNA processing;regulation of cell cycle;ribonucleoprotein complex binding;maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);nucleolus organization;protein localization to organelle;ribosomal large subunit biogenesis;condensed chromosome;preribosome, large subunit precursor;PeBoW complex;cell population proliferation	3D-structure;Acetylation;Alternative splicing;Chromosome;Isopeptide bond;Nucleus;Polymorphism;Reference proteome;Ribosome biogenesis;Ubl conjugation;rRNA processing	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol
PDSS1	positive	CEP76	ENSG00000101624	PDSS1	1	PDSS1	1	0.00896148576769862					GO:0005737;GO:0005856;GO:0005515;GO:0005813;GO:0005815;GO:0005829;GO:0005814;GO:0000086;GO:0010389;GO:0097711;GO:0032991;GO:0046599	cytoplasm;cytoskeleton;protein binding;centrosome;microtubule organizing center;cytosol;centriole;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking;protein-containing complex;regulation of centriole replication	Alternative splicing;Cytoplasm;Cytoskeleton;Phosphoprotein;Reference proteome	R-HSA-1852241;R-HSA-5617833;R-HSA-1640170;R-HSA-453274;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-380320;R-HSA-68877;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518	Organelle biogenesis and maintenance;Cilium Assembly;Cell Cycle;Mitotic G2-G2/M phases;M Phase;G2/M Transition;Cell Cycle, Mitotic;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2
PDSS1	positive	WDR77	ENSG00000116455	PDSS1	1	PDSS1	1	0.00896148576769862					GO:0005634;GO:0005737;GO:0005794;GO:0005829;GO:0005654;GO:1903508;GO:0006357;GO:0008284;GO:0008285;GO:0060528;GO:0060770;GO:0005515;GO:0008327;GO:0000387;GO:0034709;GO:0030374	protein binding;nucleus;cytoplasm;Golgi apparatus;nucleoplasm;cytosol;positive regulation of nucleic acid-templated transcription;regulation of transcription by RNA polymerase II;positive regulation of cell population proliferation;negative regulation of cell population proliferation;secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development;negative regulation of epithelial cell proliferation involved in prostate gland development;methyl-CpG binding;spliceosomal snRNP assembly;methylosome;nuclear receptor transcription coactivator activity	3D-structure;Alternative splicing;Cytoplasm;Direct protein sequencing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;WD repeat	R-HSA-8953854;R-HSA-191859;R-HSA-194441;R-HSA-3247509;R-HSA-4839726;R-HSA-3214858	Metabolism of RNA;snRNP Assembly;Metabolism of non-coding RNA;Chromatin modifying enzymes;Chromatin organization;RMTs methylate histone arginines
PDSS1	positive	FASTKD3	ENSG00000124279	PDSS1	1	PDSS1	1	0.00896148576769862					GO:0003723;GO:0005634;GO:0004672;GO:0005739;GO:0006468;GO:0005515;GO:0070131;GO:0033617;GO:0044528	protein kinase activity;RNA binding;nucleoplasm;mitochondrion;protein phosphorylation;protein binding;positive regulation of mitochondrial translation;mitochondrial respiratory chain complex IV assembly;regulation of mitochondrial mRNA stability	Mitochondrion;Polymorphism;Reference proteome;Transit peptide		
PDSS1	positive	MPHOSPH6	ENSG00000135698	PDSS1	1	PDSS1	1	0.00896148576769862	WBGene00017916	WBGene00017916(1)			GO:0003723;GO:0005634;GO:0005737;GO:0005730;GO:0005515;GO:0006364;GO:0005654;GO:0000176;GO:0000178;GO:0000460	RNA binding;nucleus;cytoplasm;nucleoplasm;nucleolus;cytosol;protein binding;rRNA processing;maturation of 5.8S rRNA;nuclear exosome (RNase complex);exosome (RNase complex)	3D-structure;Cytoplasm;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Ubl conjugation;rRNA processing	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol
PDSS1	positive	IMP4	ENSG00000136718	PDSS1	1	PDSS1	1	0.00896148576769862	WBGene00014083	WBGene00014083(1)			GO:0005634;GO:0005730;GO:0001650;GO:0005515;GO:0042254;GO:0006364;GO:0032040;GO:0005654;GO:0034457;GO:0030515;GO:0030684	nucleus;nucleolus;fibrillar center;protein binding;ribosome biogenesis;rRNA processing;small-subunit processome;nucleoplasm;Mpp10 complex;snoRNA binding;preribosome	Nucleus;Reference proteome;Ribonucleoprotein;Ribosome biogenesis;rRNA processing	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
PDSS1	positive	FASTKD1	ENSG00000138399	PDSS1	1	PDSS1	1	0.00896148576769862					GO:0003723;GO:0004672;GO:0006468;GO:0005739;GO:0044528;GO:0000959	protein kinase activity;RNA binding;protein phosphorylation;mitochondrion;regulation of mitochondrial mRNA stability;mitochondrial RNA metabolic process	Acetylation;Alternative splicing;Mitochondrion;Polymorphism;Reference proteome;Transit peptide		
PDSS1	positive	CDC123	ENSG00000151465	PDSS1	1	PDSS1	1	0.00896148576769862					GO:0005737;GO:0051301;GO:0007049;GO:0007050;GO:0008284;GO:0045948;GO:1905143	cytoplasm;cell division;cell cycle;cell cycle arrest;positive regulation of cell population proliferation;positive regulation of translational initiation;eukaryotic translation initiation factor 2 complex assembly	Cell cycle;Cell division;Cytoplasm;Phosphoprotein;Reference proteome		
PDSS1	positive	MRPS16	ENSG00000182180	PDSS1	1	PDSS1	1	0.00896148576769862	WBGene00018961	WBGene00018961(1)		Combined oxidative phosphorylation defect type 2;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2	GO:0006412;GO:0005829;GO:0005739;GO:0003735;GO:0005840;GO:0032543;GO:0005515;GO:0005763;GO:0005743;GO:0070125;GO:0070126;GO:0005622	structural constituent of ribosome;translation;ribosome;cytosol;mitochondrion;mitochondrial translation;protein binding;mitochondrial small ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination;small ribosomal subunit	3D-structure;Alternative splicing;Mitochondrion;Phosphoprotein;Polymorphism;Primary mitochondrial disease;Reference proteome;Ribonucleoprotein;Ribosomal protein;Transit peptide	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
PDSS1	positive	DCLRE1A	ENSG00000198924	PDSS1	1	PDSS1	1	0.00896148576769862	WBGene00045237				GO:0005634;GO:0005654;GO:0001650;GO:0051301;GO:0090305;GO:0006281;GO:0006974;GO:0007049;GO:0036297;GO:0003684;GO:0000784;GO:0006303;GO:0031848;GO:0035312	nucleus;metal ion binding;nucleoplasm;fibrillar center;cell division;nucleic acid phosphodiester bond hydrolysis;DNA repair;cellular response to DNA damage stimulus;cell cycle;interstrand cross-link repair;damaged DNA binding;nuclear chromosome, telomeric region;double-strand break repair via nonhomologous end joining;protection from non-homologous end joining at telomere;5'-3' exodeoxyribonuclease activity	3D-structure;Cell cycle;Cell division;DNA damage;DNA repair;Isopeptide bond;Metal-binding;Mitosis;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	R-HSA-6783310;R-HSA-73894	Fanconi Anemia Pathway;DNA Repair
PDSS1	positive	SLC25A13	ENSG00000004864	PDSS1	1	PDSS1	1	0.00944458721174535	WBGene00019326			Citrullinemia type II;Neonatal intrahepatic cholestasis due to citrin deficiency;CITRULLINEMIA TYPE II ADULT-ONSET;CITRULLINEMIA TYPE II NEONATAL-ONSET	GO:0016020;GO:0016021;GO:0022857;GO:0055085;GO:0046872;GO:0005739;GO:0005743;GO:0005509;GO:0005887;GO:0042802;GO:0006754;GO:0005313;GO:0006094;GO:0045333;GO:0051592;GO:0015813;GO:0015183;GO:0015810;GO:0043490;GO:0070778;GO:0006839	transmembrane transporter activity;transmembrane transport;calcium ion binding;membrane;integral component of membrane;metal ion binding;mitochondrion;mitochondrial inner membrane;identical protein binding;integral component of plasma membrane;ATP biosynthetic process;L-glutamate transmembrane transporter activity;gluconeogenesis;cellular respiration;response to calcium ion;L-glutamate transmembrane transport;L-aspartate transmembrane transporter activity;aspartate transmembrane transport;malate-aspartate shuttle;L-aspartate transmembrane transport;mitochondrial transport	3D-structure;Acetylation;Alternative splicing;Calcium;Disease mutation;Intrahepatic cholestasis;Membrane;Metal-binding;Methylation;Mitochondrion;Mitochondrion inner membrane;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-71291;R-HSA-70326;R-HSA-71387;R-HSA-9609507;R-HSA-70263;R-HSA-1268020;R-HSA-8963693	Metabolism;Metabolism of amino acids and derivatives;Glucose metabolism;Metabolism of carbohydrates;Protein localization;Gluconeogenesis;Mitochondrial protein import;Aspartate and asparagine metabolism
PDSS1	positive	MRPS34	ENSG00000074071	PDSS1	1	PDSS1	1	0.00944458721174535	WBGene00010905	WBGene00010905(0)		Leigh Syndrome with Instability of the Small Mitoribosomal Subunit;COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32	GO:0005739;GO:0003735;GO:0032543;GO:0005840;GO:0005763;GO:0005743;GO:0070125;GO:0070126	structural constituent of ribosome;mitochondrion;mitochondrial translation;ribosome;mitochondrial small ribosomal subunit;mitochondrial inner membrane;mitochondrial translational elongation;mitochondrial translational termination	3D-structure;Disease mutation;Mitochondrion;Polymorphism;Primary mitochondrial disease;Reference proteome;Ribonucleoprotein;Ribosomal protein	R-HSA-392499;R-HSA-72766;R-HSA-5368286;R-HSA-5368287;R-HSA-5389840;R-HSA-5419276	Metabolism of proteins;Translation;Mitochondrial translation initiation;Mitochondrial translation;Mitochondrial translation elongation;Mitochondrial translation termination
PDSS1	positive	XRCC5	ENSG00000079246	PDSS1	1	PDSS1	1	0.00944458721174535	WBGene00000520	WBGene00000520(0)			GO:0044212;GO:0005634;GO:0003723;GO:0016020;GO:0000166;GO:0005524;GO:0005654;GO:0016787;GO:0003677;GO:0005886;GO:0005694;GO:0003684;GO:0005515;GO:0003678;GO:0042162;GO:0000723;GO:0006303;GO:0032508;GO:0043564;GO:0006281;GO:0006310;GO:0006974;GO:0004386;GO:0002376;GO:0045087;GO:0005730;GO:0005576;GO:0016817;GO:0005829;GO:0000784;GO:0031625;GO:0003690;GO:0008022;GO:0043312;GO:1990904;GO:0034774;GO:0045892;GO:0032991;GO:0032212;GO:0051973;GO:0000783;GO:0032481;GO:0002218;GO:0006302;GO:0032993;GO:0051575;GO:0075713;GO:0070198;GO:0032204;GO:0043085;GO:0090734;GO:0003691;GO:0044877;GO:0045860;GO:0048660;GO:0071480;GO:0071481;GO:0070419;GO:0008047;GO:0045027;GO:0007420;GO:0008283;GO:0042493;GO:0050769;GO:0060218;GO:0071398;GO:0071475;GO:1904430;GO:1990830;GO:0005737	DNA binding;nucleus;DNA helicase activity;damaged DNA binding;DNA recombination;telomere maintenance;double-strand break repair via nonhomologous end joining;telomeric DNA binding;Ku70:Ku80 complex;hydrolase activity, acting on acid anhydrides;transcription regulatory region DNA binding;RNA binding;membrane;nucleotide binding;ATP binding;nucleoplasm;plasma membrane;hydrolase activity;chromosome;protein binding;DNA duplex unwinding;DNA repair;cellular response to DNA damage stimulus;helicase activity;immune system process;innate immune response;nucleolus;extracellular region;cytosol;nuclear chromosome, telomeric region;viral process;ubiquitin protein ligase binding;protein C-terminus binding;neutrophil degranulation;ribonucleoprotein complex;secretory granule lumen;double-stranded DNA binding;negative regulation of transcription, DNA-templated;protein-containing complex;positive regulation of telomere maintenance via telomerase;positive regulation of telomerase activity;nuclear telomere cap complex;positive regulation of type I interferon production;activation of innate immune response;double-strand break repair;protein-DNA complex;5'-deoxyribose-5-phosphate lyase activity;establishment of integrated proviral latency;site of DNA damage;protein localization to chromosome, telomeric region;regulation of telomere maintenance;positive regulation of catalytic activity;double-stranded telomeric DNA binding;protein-containing complex binding;positive regulation of protein kinase activity;regulation of smooth muscle cell proliferation;cellular response to gamma radiation;cellular response to X-ray;nonhomologous end joining complex;enzyme activator activity;DNA end binding;brain development;cell population proliferation;response to drug;positive regulation of neurogenesis;hematopoietic stem cell differentiation;cellular response to fatty acid;cellular hyperosmotic salinity response;negative regulation of t-circle formation;cellular response to leukemia inhibitory factor;cytoplasm	3D-structure;ADP-ribosylation;ATP-binding;Acetylation;Activator;Chromosome;DNA damage;DNA recombination;DNA repair;DNA-binding;Direct protein sequencing;Helicase;Host-virus interaction;Hydrolase;Immunity;Innate immunity;Isopeptide bond;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Systemic lupus erythematosus;Transcription;Transcription regulation;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-1643685;R-HSA-5693532;R-HSA-73894;R-HSA-162587;R-HSA-162906;R-HSA-5663205;R-HSA-6798695;R-HSA-1834949;R-HSA-5693571;R-HSA-162592;R-HSA-162594;R-HSA-164843;R-HSA-1834941;R-HSA-3270619	Innate Immune System;Immune System;Disease;DNA Double-Strand Break Repair;DNA Repair;HIV Life Cycle;HIV Infection;Infectious disease;Neutrophil degranulation;Cytosolic sensors of pathogen-associated DNA ;Nonhomologous End-Joining (NHEJ);Integration of provirus;Early Phase of HIV Life Cycle;2-LTR circle formation;STING mediated induction of host immune responses;IRF3-mediated induction of type I IFN
PDSS1	positive	MTCH2	ENSG00000109919	PDSS1	1	PDSS1	1	0.00944458721174535	WBGene00018395	WBGene00018395(1);WBGene00018397(0)			GO:0005634;GO:0016020;GO:0016021;GO:0005743;GO:0005739;GO:0043065;GO:0070585	nucleus;membrane;integral component of membrane;mitochondrial inner membrane;mitochondrion;positive regulation of apoptotic process;protein localization to mitochondrion	Acetylation;Direct protein sequencing;Membrane;Mitochondrion;Mitochondrion inner membrane;Polymorphism;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport		
PDSS1	positive	PSMD14	ENSG00000115233	PDSS1	1	PDSS1	1	0.00944458721174535	WBGene00004467;WBGene00018135	WBGene00004467(1)			GO:0005634;GO:0046872;GO:0016787;GO:0005515;GO:0008233;GO:0006508;GO:0006281;GO:0006974;GO:0000502;GO:0036459;GO:0006511;GO:0008237;GO:0038095;GO:0005576;GO:0022624;GO:0050852;GO:0061578;GO:0045471;GO:0070536;GO:0031597;GO:0005654;GO:0005829;GO:0000165;GO:0000209;GO:0002223;GO:0002479;GO:0006521;GO:0010972;GO:0016579;GO:0031145;GO:0031146;GO:0033209;GO:0038061;GO:0043161;GO:0043488;GO:0043687;GO:0055085;GO:0060071;GO:0061418;GO:0070498;GO:0090090;GO:0090263;GO:1901990;GO:1902036;GO:0004843;GO:0043312;GO:0008541;GO:0034774;GO:1904813;GO:0061133;GO:0070628;GO:0000724;GO:0006303;GO:0010950;GO:0061136	protein binding;metallopeptidase activity;Lys63-specific deubiquitinase activity;nucleus;metal ion binding;hydrolase activity;peptidase activity;proteolysis;DNA repair;cellular response to DNA damage stimulus;proteasome complex;thiol-dependent ubiquitinyl hydrolase activity;ubiquitin-dependent protein catabolic process;Fc-epsilon receptor signaling pathway;extracellular region;proteasome accessory complex;T cell receptor signaling pathway;response to ethanol;protein K63-linked deubiquitination;cytosolic proteasome complex;nucleoplasm;cytosol;MAPK cascade;protein polyubiquitination;stimulatory C-type lectin receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;regulation of cellular amino acid metabolic process;negative regulation of G2/M transition of mitotic cell cycle;protein deubiquitination;anaphase-promoting complex-dependent catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of mRNA stability;post-translational protein modification;transmembrane transport;Wnt signaling pathway, planar cell polarity pathway;regulation of transcription from RNA polymerase II promoter in response to hypoxia;interleukin-1-mediated signaling pathway;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of mitotic cell cycle phase transition;regulation of hematopoietic stem cell differentiation;thiol-dependent ubiquitin-specific protease activity;neutrophil degranulation;proteasome regulatory particle, lid subcomplex;secretory granule lumen;ficolin-1-rich granule lumen;endopeptidase activator activity;proteasome binding;double-strand break repair via homologous recombination;double-strand break repair via nonhomologous end joining;positive regulation of endopeptidase activity;regulation of proteasomal protein catabolic process	3D-structure;DNA damage;DNA repair;Direct protein sequencing;Hydrolase;Metal-binding;Metalloprotease;Phosphoprotein;Protease;Proteasome;Reference proteome;Ubl conjugation pathway;Zinc	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1266738;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-983168;R-HSA-983169;R-HSA-1430728;R-HSA-422475;R-HSA-382551;R-HSA-109581;R-HSA-162582;R-HSA-169911;R-HSA-5357801;R-HSA-1640170;R-HSA-71291;R-HSA-8953854;R-HSA-1643685;R-HSA-162906;R-HSA-5663205;R-HSA-1168372;R-HSA-1169091;R-HSA-1234174;R-HSA-1234176;R-HSA-1236974;R-HSA-1236975;R-HSA-1236978;R-HSA-1257604;R-HSA-1280215;R-HSA-162909;R-HSA-174113;R-HSA-174143;R-HSA-174154;R-HSA-174178;R-HSA-174184;R-HSA-176408;R-HSA-176409;R-HSA-176814;R-HSA-179419;R-HSA-180534;R-HSA-180585;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-211733;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-349425;R-HSA-350562;R-HSA-351202;R-HSA-376176;R-HSA-382556;R-HSA-3858494;R-HSA-4086400;R-HSA-446652;R-HSA-449147;R-HSA-449836;R-HSA-450408;R-HSA-450531;R-HSA-453274;R-HSA-453276;R-HSA-4608870;R-HSA-4641257;R-HSA-4641258;R-HSA-5358346;R-HSA-5358351;R-HSA-5362768;R-HSA-5387390;R-HSA-5607761;R-HSA-5607764;R-HSA-5610780;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5619084;R-HSA-5619115;R-HSA-5621481;R-HSA-5632684;R-HSA-5658442;R-HSA-5663202;R-HSA-5668541;R-HSA-5673001;R-HSA-5676590;R-HSA-5678895;R-HSA-5683057;R-HSA-5684996;R-HSA-5687128;R-HSA-5688426;R-HSA-5689603;R-HSA-5689880;R-HSA-6807070;R-HSA-68827;R-HSA-68867;R-HSA-68882;R-HSA-68886;R-HSA-68949;R-HSA-69002;R-HSA-69017;R-HSA-69052;R-HSA-69239;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69541;R-HSA-69563;R-HSA-69580;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-75815;R-HSA-8852276;R-HSA-8854050;R-HSA-8878166;R-HSA-8878171;R-HSA-8939236;R-HSA-8939902;R-HSA-8948751;R-HSA-8951664;R-HSA-8953897;R-HSA-9006925;R-HSA-9010553;R-HSA-9020702;R-HSA-9607240;R-HSA-157118;R-HSA-6798695;R-HSA-174084;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-8941858;R-HSA-9013694;R-HSA-9604323;R-HSA-5689901	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Developmental Biology;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Metabolism;Axon guidance;Transport of small molecules;Apoptosis;Signal Transduction;Regulation of Apoptosis;Programmed Cell Death;Cell Cycle;Metabolism of amino acids and derivatives;Metabolism of RNA;Disease;HIV Infection;Infectious disease;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;Cellular response to hypoxia;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;ER-Phagosome pathway;Antigen processing-Cross presentation;Cross-presentation of soluble exogenous antigens (endosomes);PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Host Interactions of HIV factors;SCF-beta-TrCP mediated degradation of Emi1;APC/C-mediated degradation of cell cycle proteins;APC/C:Cdc20 mediated degradation of Securin;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1;Cdc20:Phospho-APC/C mediated degradation of Cyclin A;Regulation of APC/C activators between G1/S and early anaphase;APC/C:Cdc20 mediated degradation of mitotic proteins;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint;Vpu mediated degradation of CD4;Vif-mediated degradation of APOBEC3G;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Regulation of activated PAK-2p34 by proteasome mediated degradation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Autodegradation of the E3 ubiquitin ligase COP1;Regulation of ornithine decarboxylase (ODC);Metabolism of polyamines;Signaling by ROBO receptors;ABC-family proteins mediated transport;Beta-catenin independent WNT signaling;PCP/CE pathway;Interleukin-1 family signaling;Signaling by Interleukins;Other interleukin signaling;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Mitotic G2-G2/M phases;Regulation of mitotic cell cycle;Asymmetric localization of PCP proteins;Degradation of AXIN;Degradation of DVL;Hedgehog ligand biogenesis;Signaling by Hedgehog;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD;Hh mutants abrogate ligand secretion;Dectin-1 mediated noncanonical NF-kB signaling;CLEC7A (Dectin-1) signaling;Degradation of GLI1 by the proteasome;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;ABC transporter disorders;Disorders of transmembrane transporters;C-type lectin receptors (CLRs);Hedgehog 'on' state;Regulation of RAS by GAPs;Diseases of signal transduction;TNFR2 non-canonical NF-kB pathway;RAF/MAP kinase cascade;NIK-->noncanonical NF-kB signaling;Defective CFTR causes cystic fibrosis;MAPK family signaling cascades;MAPK1/MAPK3 signaling;MAPK6/MAPK4 signaling;Deubiquitination;UCH proteinases;Ub-specific processing proteases;PTEN Regulation;CDT1 association with the CDC6:ORC:origin complex;Assembly of the pre-replicative complex;Mitotic Anaphase;M Phase;Orc1 removal from chromatin;DNA Replication Pre-Initiation;CDK-mediated phosphorylation and removal of Cdc6;Switching of origins to a post-replicative state;Synthesis of DNA;S Phase;G2/M Transition;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Stabilization of p53;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Ubiquitin-dependent degradation of Cyclin D;The role of GTSE1 in G2/M progression after G2 checkpoint;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis;Transcriptional regulation by RUNX2;Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in differentiation of HSCs;Regulation of RUNX2 expression and activity;Regulation of PTEN stability and activity;Neddylation;Cellular responses to external stimuli;Intracellular signaling by second messengers;Regulation of expression of SLITs and ROBOs;Interleukin-1 signaling;FLT3 Signaling;Signaling by NOTCH;Neutrophil degranulation;Autodegradation of Cdh1 by Cdh1:APC/C;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Regulation of RUNX3 expression and activity;Signaling by NOTCH4;Negative regulation of NOTCH4 signaling;Metalloprotease DUBs
PDSS1	positive	ICMT	ENSG00000116237	PDSS1	1	PDSS1	1	0.00944458721174535	WBGene00017673;WBGene00019710	WBGene00019710(1);WBGene00017673(1)			GO:0016020;GO:0016021;GO:0016740;GO:0008168;GO:0032259;GO:0005783;GO:0005789;GO:0004671;GO:0006481;GO:0043687;GO:0006464;GO:0003880;GO:0006612	integral component of membrane;endoplasmic reticulum;protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity;C-terminal protein methylation;membrane;transferase activity;methyltransferase activity;methylation;endoplasmic reticulum membrane;post-translational protein modification;cellular protein modification process;protein C-terminal carboxyl O-methyltransferase activity;protein targeting to membrane	Endoplasmic reticulum;Membrane;Methyltransferase;Reference proteome;S-adenosyl-L-methionine;Transferase;Transmembrane;Transmembrane helix	R-HSA-392499;R-HSA-597592;R-HSA-163841	Metabolism of proteins;Post-translational protein modification;Gamma carboxylation, hypusine formation and arylsulfatase activation
PDSS1	positive	HNRNPA2B1	ENSG00000122566	PDSS1	1	PDSS1	1	0.00944458721174535	WBGene00001999;WBGene00019249			Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUTFRONTOTEMPORAL DEMENTIA 2	GO:0003676;GO:0003723;GO:0006397;GO:0008380;GO:0051028;GO:0005634;GO:0005737;GO:0016020;GO:0005654;GO:0005515;GO:0005681;GO:0005576;GO:0006406;GO:0000398;GO:0071013;GO:0003729;GO:0070062;GO:1990904;GO:0035722;GO:0003730;GO:0000781;GO:0016363;GO:0016070;GO:0015030;GO:1990247;GO:0035198;GO:0098505;GO:0043047;GO:0031053;GO:0044806;GO:0050658;GO:1904358;GO:1905663;GO:1990428;GO:0097157;GO:0000122;GO:0048025	nucleic acid binding;mRNA processing;mRNA export from nucleus;RNA binding;RNA splicing;mRNA transport;nucleus;cytoplasm;membrane;nucleoplasm;protein binding;spliceosomal complex;extracellular region;mRNA splicing, via spliceosome;catalytic step 2 spliceosome;mRNA binding;extracellular exosome;regulation of RNA metabolic process;ribonucleoprotein complex;viral process;interleukin-12-mediated signaling pathway;mRNA 3'-UTR binding;chromosome, telomeric region;nuclear matrix;RNA metabolic process;Cajal body;N6-methyladenosine-containing RNA binding;miRNA binding;G-rich strand telomeric DNA binding;single-stranded telomeric DNA binding;primary miRNA processing;G-quadruplex DNA unwinding;RNA transport;positive regulation of telomere maintenance via telomere lengthening;positive regulation of telomerase RNA reverse transcriptase activity;miRNA transport;pre-mRNA intronic binding;negative regulation of transcription by RNA polymerase II;negative regulation of mRNA splicing, via spliceosome	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Disease mutation;Host-virus interaction;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;RNA-binding;Reference proteome;Repeat;Ribonucleoprotein;Secreted;Spliceosome;Transport;Ubl conjugation;mRNA processing;mRNA splicing;mRNA transport	R-HSA-168256;R-HSA-8953854;R-HSA-1280215;R-HSA-449147;R-HSA-72203;R-HSA-447115;R-HSA-8950505;R-HSA-9020591;R-HSA-72163;R-HSA-72172	Immune System;Metabolism of RNA;Cytokine Signaling in Immune system;Signaling by Interleukins;Processing of Capped Intron-Containing Pre-mRNA;Interleukin-12 family signaling;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation;Interleukin-12 signaling;mRNA Splicing - Major Pathway;mRNA Splicing
PDSS1	positive	C9orf40	ENSG00000135045	PDSS1	1	PDSS1	1	0.00944458721174535							Phosphoprotein;Reference proteome		
PDSS1	positive	PDCD11	ENSG00000148843	PDSS1	1	PDSS1	1	0.00944458721174535	WBGene00002850	WBGene00002850(0)			GO:0005634;GO:0003676;GO:0006396;GO:0006397;GO:0005515;GO:0003723;GO:0005730;GO:0006364;GO:0032040;GO:0005654;GO:0008134;GO:0005829	nucleus;protein binding;RNA processing;nucleic acid binding;mRNA processing;RNA binding;nucleolus;rRNA processing;small-subunit processome;nucleoplasm;transcription factor binding;cytosol	3D-structure;Acetylation;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation;rRNA processing	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
PDSS1	positive	LCMT2	ENSG00000168806	PDSS1	1	PDSS1	1	0.00944458721174535	WBGene00007137				GO:0016740;GO:0008168;GO:0008033;GO:0032259;GO:0005515;GO:0006400;GO:0031591;GO:0005737;GO:0008175;GO:0030488	protein binding;methyltransferase activity;methylation;transferase activity;tRNA processing;tRNA modification;wybutosine biosynthetic process;cytoplasm;tRNA methyltransferase activity;tRNA methylation	Methyltransferase;Polymorphism;Reference proteome;S-adenosyl-L-methionine;Transferase;tRNA processing	R-HSA-6782315;R-HSA-6782861;R-HSA-72306;R-HSA-8953854	tRNA modification in the nucleus and cytosol;Synthesis of wybutosine at G37 of tRNA(Phe);tRNA processing;Metabolism of RNA
PDSS1	positive	ELOVL6	ENSG00000170522	PDSS1	1	PDSS1	1	0.00944458721174535	WBGene00001241;WBGene00001247;WBGene00001242;WBGene00001239;WBGene00001240	WBGene00001244(1);WBGene00001240(1);WBGene00001243(1);WBGene00001247(1);WBGene00001239(1);WBGene00001245(1);WBGene00001241(1);WBGene00001242(1)			GO:0016020;GO:0016021;GO:0016740;GO:0005783;GO:0005789;GO:0006629;GO:0009922;GO:0102336;GO:0102337;GO:0102338;GO:0102756;GO:0006631;GO:0006633;GO:0006636;GO:0019367;GO:0042761;GO:0034625;GO:0035338;GO:0016747;GO:0030497;GO:0120162;GO:0030176;GO:0005515;GO:0030148;GO:0034626;GO:0045540;GO:0042759	integral component of membrane;endoplasmic reticulum;fatty acid elongase activity;fatty acid elongation, saturated fatty acid;very long-chain fatty acid biosynthetic process;membrane;transferase activity;endoplasmic reticulum membrane;lipid metabolic process;3-oxo-arachidoyl-CoA synthase activity;3-oxo-cerotoyl-CoA synthase activity;3-oxo-lignoceronyl-CoA synthase activity;very-long-chain 3-ketoacyl-CoA synthase activity;fatty acid metabolic process;fatty acid biosynthetic process;unsaturated fatty acid biosynthetic process;fatty acid elongation, monounsaturated fatty acid;long-chain fatty-acyl-CoA biosynthetic process;protein binding;sphingolipid biosynthetic process;fatty acid elongation, polyunsaturated fatty acid;integral component of endoplasmic reticulum membrane;positive regulation of cold-induced thermogenesis;regulation of cholesterol biosynthetic process;long-chain fatty acid biosynthetic process;transferase activity, transferring acyl groups other than amino-acyl groups;fatty acid elongation	Endoplasmic reticulum;Fatty acid biosynthesis;Fatty acid metabolism;Glycoprotein;Lipid biosynthesis;Lipid metabolism;Membrane;Reference proteome;Transferase;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-556833;R-HSA-75105;R-HSA-75876;R-HSA-8978868;R-HSA-8957322;R-HSA-1655829;R-HSA-2426168	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF);Activation of gene expression by SREBF (SREBP)
PDSS1	positive	EIF4G1	ENSG00000114867	PDSS1	1	PDSS1	1	0.00995031225385579	WBGene00002066			Hereditary late-onset Parkinson disease;PARKINSON DISEASE 18 AUTOSOMAL DOMINANT SUSCEPTIBILITY TO	GO:0003723;GO:0003729;GO:0016020;GO:0003743;GO:0006412;GO:0006413;GO:0005829;GO:0005515;GO:0008190;GO:0042802;GO:0043488;GO:0006417;GO:0016281;GO:0016032;GO:0010507;GO:0005634;GO:0005737;GO:0008135;GO:0005524;GO:0000184;GO:0006446;GO:0010942;GO:1901215;GO:0033138;GO:1905606;GO:0010801;GO:0030307;GO:0034645;GO:0031369;GO:0060090;GO:0002191;GO:0031669;GO:0032270;GO:0032502;GO:0060964;GO:0080135;GO:0097009;GO:1900087;GO:1905537;GO:1905612;GO:1905618;GO:1905696;GO:0005844;GO:0001662;GO:0045666	protein binding;RNA binding;translation initiation factor activity;mRNA binding;membrane;translation;translational initiation;cytosol;eukaryotic initiation factor 4E binding;identical protein binding;regulation of mRNA stability;regulation of translation;eukaryotic translation initiation factor 4F complex;viral process;negative regulation of autophagy;nucleus;cytoplasm;translation factor activity, RNA binding;positive regulation of translation in response to endoplasmic reticulum stress;ATP binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of translational initiation;positive regulation of cell death;negative regulation of neuron death;positive regulation of peptidyl-serine phosphorylation;regulation of presynapse assembly;negative regulation of peptidyl-threonine phosphorylation;translation initiation factor binding;molecular adaptor activity;cap-dependent translational initiation;positive regulation of cell growth;cellular response to nutrient levels;positive regulation of cellular protein metabolic process;developmental process;cellular macromolecule biosynthetic process;regulation of gene silencing by miRNA;regulation of cellular response to stress;energy homeostasis;positive regulation of G1/S transition of mitotic cell cycle;positive regulation of eukaryotic translation initiation factor 4F complex assembly;positive regulation of mRNA cap binding;positive regulation of miRNA mediated inhibition of translation;regulation of polysome binding;polysome;behavioral fear response;positive regulation of neuron differentiation	3D-structure;Acetylation;Alternative initiation;Alternative splicing;Cytoplasm;Disease mutation;Host-virus interaction;Initiation factor;Methylation;Neurodegeneration;Parkinson disease;Parkinsonism;Phosphoprotein;Polymorphism;Protein biosynthesis;RNA-binding;Reference proteome;Translation regulation;Translational shunt	R-HSA-168256;R-HSA-1266738;R-HSA-392499;R-HSA-422475;R-HSA-162582;R-HSA-8953854;R-HSA-1280215;R-HSA-376176;R-HSA-450408;R-HSA-450531;R-HSA-9010553;R-HSA-429914;R-HSA-429947;R-HSA-1169408;R-HSA-1169410;R-HSA-913531;R-HSA-156827;R-HSA-72613;R-HSA-72649;R-HSA-72662;R-HSA-72702;R-HSA-72706;R-HSA-72737;R-HSA-72766;R-HSA-165159;R-HSA-166208;R-HSA-927802;R-HSA-975957;R-HSA-975956	Immune System;Developmental Biology;Metabolism of proteins;Axon guidance;Signal Transduction;Metabolism of RNA;Cytokine Signaling in Immune system;Signaling by ROBO receptors;AUF1 (hnRNP D0) binds and destabilizes mRNA;Regulation of mRNA stability by proteins that bind AU-rich elements;Regulation of expression of SLITs and ROBOs;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation;mTOR signalling;mTORC1-mediated signalling;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
PDSS1	positive	PNO1	ENSG00000115946	PDSS1	1	PDSS1	1	0.00995031225385579	WBGene00013144	WBGene00013144(1)			GO:0003676;GO:0003723;GO:0005634;GO:0005730;GO:0005654;GO:0005829	RNA binding;nucleic acid binding;nucleus;nucleoplasm;nucleolus;protein binding;cytosol	3D-structure;Acetylation;Nucleus;Polymorphism;RNA-binding;Reference proteome	R-HSA-8953854;R-HSA-6791226;R-HSA-72312;R-HSA-8868773;R-HSA-6790901	Metabolism of RNA;Major pathway of rRNA processing in the nucleolus and cytosol;rRNA processing;rRNA processing in the nucleus and cytosol;rRNA modification in the nucleus and cytosol
PDSS1	positive	RPA2	ENSG00000117748	PDSS1	1	PDSS1	1	0.00995031225385579	WBGene00019767;WBGene00019079				GO:0005634;GO:0005654;GO:0003677;GO:0006281;GO:0005515;GO:0006310;GO:0006974;GO:0016604;GO:0006260;GO:0006298;GO:0000781;GO:0000784;GO:0035861;GO:1900034;GO:0031625;GO:0036297;GO:0003697;GO:0000723;GO:0010569;GO:0006284;GO:0016605;GO:0019899;GO:0019903;GO:1901796;GO:0000082;GO:0000724;GO:0019985;GO:0006283;GO:0003684;GO:0005662;GO:0042276;GO:0006289;GO:0042769;GO:0006293;GO:0006295;GO:0006296;GO:0033683;GO:0098505;GO:0006294;GO:0032201;GO:0006297;GO:0070987;GO:0031571;GO:0034502;GO:2000001;GO:0000785;GO:0047485	DNA binding;nucleus;DNA repair;DNA replication;DNA recombination;nucleoplasm;protein binding;cellular response to DNA damage stimulus;nuclear body;mismatch repair;chromosome, telomeric region;PML body;nuclear chromosome, telomeric region;site of double-strand break;regulation of cellular response to heat;ubiquitin protein ligase binding;interstrand cross-link repair;telomere maintenance;regulation of double-strand break repair via homologous recombination;base-excision repair;single-stranded DNA binding;enzyme binding;protein phosphatase binding;regulation of signal transduction by p53 class mediator;G1/S transition of mitotic cell cycle;double-strand break repair via homologous recombination;translesion synthesis;transcription-coupled nucleotide-excision repair;damaged DNA binding;DNA replication factor A complex;error-prone translesion synthesis;nucleotide-excision repair;DNA damage response, detection of DNA damage;nucleotide-excision repair, preincision complex stabilization;nucleotide-excision repair, DNA incision, 3'-to lesion;nucleotide-excision repair, DNA incision, 5'-to lesion;nucleotide-excision repair, DNA incision;G-rich strand telomeric DNA binding;nucleotide-excision repair, preincision complex assembly;telomere maintenance via semi-conservative replication;nucleotide-excision repair, DNA gap filling;error-free translesion synthesis;mitotic G1 DNA damage checkpoint;protein localization to chromosome;regulation of DNA damage checkpoint;chromatin;protein N-terminus binding	3D-structure;Acetylation;Alternative splicing;DNA damage;DNA recombination;DNA repair;DNA replication;DNA-binding;Direct protein sequencing;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1474165;R-HSA-1500620;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-6783310;R-HSA-73894;R-HSA-2262752;R-HSA-69002;R-HSA-69239;R-HSA-69242;R-HSA-69278;R-HSA-69306;R-HSA-69481;R-HSA-69620;R-HSA-8953897;R-HSA-3371453;R-HSA-3371556;R-HSA-73886;R-HSA-5633007;R-HSA-453279;R-HSA-69206;R-HSA-6804756;R-HSA-176187;R-HSA-68962;R-HSA-157579;R-HSA-180786;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-110313;R-HSA-5656169;R-HSA-73893;R-HSA-912446;R-HSA-5696398;R-HSA-6781827;R-HSA-6782135;R-HSA-6782210;R-HSA-73884;R-HSA-73933;R-HSA-5685938;R-HSA-110312;R-HSA-5655862;R-HSA-5656121;R-HSA-69190;R-HSA-3371511;R-HSA-5696395;R-HSA-5696399;R-HSA-110314;R-HSA-110373;R-HSA-5651801;R-HSA-5696400;R-HSA-174417;R-HSA-69166;R-HSA-69183;R-HSA-69186;R-HSA-110320;R-HSA-5696397;R-HSA-174414;R-HSA-174437;R-HSA-5358508;R-HSA-5358565;R-HSA-5358606	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Reproduction;Meiosis;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);Fanconi Anemia Pathway;DNA Repair;Cellular responses to stress;DNA Replication Pre-Initiation;Synthesis of DNA;S Phase;Cell Cycle, Mitotic;DNA Replication;G2/M Checkpoints;Cell Cycle Checkpoints;Cellular responses to external stimuli;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress;Chromosome Maintenance;Regulation of TP53 Activity;Mitotic G1 phase and G1/S transition;G1/S Transition;Regulation of TP53 Activity through Phosphorylation;Activation of ATR in response to replication stress;Activation of the pre-replicative complex;Telomere Maintenance;Extension of Telomeres;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template;Termination of translesion DNA synthesis;DNA Damage Bypass;Meiotic recombination;Nucleotide Excision Repair;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Dual incision in TC-NER;Gap-filling DNA repair synthesis and ligation in TC-NER;Base Excision Repair;Resolution of Abasic Sites (AP sites);HDR through Single Strand Annealing (SSA);Translesion synthesis by REV1;Translesion synthesis by POLK;Translesion synthesis by POLI;DNA strand elongation;HSF1 activation;Formation of Incision Complex in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Recognition of DNA damage by PCNA-containing replication complex;Resolution of AP sites via the multiple-nucleotide patch replacement pathway;PCNA-Dependent Long Patch Base Excision Repair;Dual Incision in GG-NER;Telomere C-strand (Lagging Strand) Synthesis;Removal of the Flap Intermediate;Processive synthesis on the lagging strand;Lagging Strand Synthesis;Translesion Synthesis by POLH;Gap-filling DNA repair synthesis and ligation in GG-NER;Processive synthesis on the C-strand of the telomere;Removal of the Flap Intermediate from the C-strand;Mismatch Repair;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha);Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
PDSS1	positive	DCLRE1B	ENSG00000118655	PDSS1	1	PDSS1	1	0.00995031225385579	WBGene00045237	WBGene00007065(0)			GO:0005634;GO:0005737;GO:0005654;GO:0016787;GO:0005694;GO:0090305;GO:0005856;GO:0005515;GO:0006281;GO:0006974;GO:0016604;GO:0004527;GO:0004518;GO:0005813;GO:0005815;GO:0000781;GO:0000784;GO:0000723;GO:0042803;GO:0007093;GO:0003684;GO:0008409;GO:0006303;GO:0044877;GO:0036297;GO:0016233;GO:0010833;GO:0031848;GO:0035312;GO:0031627;GO:0031860	nucleus;cytoplasm;nucleoplasm;hydrolase activity;cytoskeleton;chromosome;nucleic acid phosphodiester bond hydrolysis;protein binding;DNA repair;cellular response to DNA damage stimulus;nuclear body;exonuclease activity;nuclease activity;centrosome;microtubule organizing center;chromosome, telomeric region;nuclear chromosome, telomeric region;telomere maintenance;protein homodimerization activity;mitotic cell cycle checkpoint;damaged DNA binding;5'-3' exonuclease activity;double-strand break repair via nonhomologous end joining;protein-containing complex binding;interstrand cross-link repair;telomere capping;telomere maintenance via telomere lengthening;protection from non-homologous end joining at telomere;5'-3' exodeoxyribonuclease activity;telomeric loop formation;telomeric 3' overhang formation	3D-structure;Chromosome;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;Dyskeratosis congenita;Exonuclease;Hydrolase;Isopeptide bond;Nuclease;Nucleus;Polymorphism;Reference proteome;Telomere;Ubl conjugation	R-HSA-6783310;R-HSA-73894	Fanconi Anemia Pathway;DNA Repair
PDSS1	positive	ETF1	ENSG00000120705	PDSS1	1	PDSS1	1	0.00995031225385579	WBGene00020269	WBGene00020269(1)			GO:0003723;GO:0005737;GO:0006412;GO:0005515;GO:0043022;GO:0003747;GO:0006415;GO:0005829;GO:0000184;GO:0016149;GO:0006449;GO:1990825;GO:0006479;GO:0002184;GO:0018444;GO:0008079	translation release factor activity;translational termination;RNA binding;cytoplasm;translation;protein binding;cytosol;ribosome binding;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;translation release factor activity, codon specific;regulation of translational termination;protein methylation;cytoplasmic translational termination;translation release factor complex;translation termination factor activity;sequence-specific mRNA binding	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Direct protein sequencing;Hydroxylation;Isopeptide bond;Methylation;Nonsense-mediated mRNA decay;Phosphoprotein;Protein biosynthesis;Reference proteome;Ubl conjugation	R-HSA-1266738;R-HSA-392499;R-HSA-422475;R-HSA-8953854;R-HSA-376176;R-HSA-9010553;R-HSA-72766;R-HSA-927802;R-HSA-975957;R-HSA-72764;R-HSA-975956	Developmental Biology;Metabolism of proteins;Axon guidance;Metabolism of RNA;Signaling by ROBO receptors;Regulation of expression of SLITs and ROBOs;Translation;Nonsense-Mediated Decay (NMD);Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC);Eukaryotic Translation Termination;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
PDSS1	positive	KIF18A	ENSG00000121621	PDSS1	1	PDSS1	1	0.00995031225385579					GO:0005634;GO:0005737;GO:0015031;GO:0000166;GO:0005524;GO:0003779;GO:0003777;GO:0005856;GO:0042995;GO:0005515;GO:0008017;GO:0005901;GO:0005874;GO:0007018;GO:0005815;GO:0016887;GO:0005829;GO:0006890;GO:0007019;GO:0019886;GO:0005871;GO:0001726;GO:0008574;GO:0007080;GO:0005828;GO:0051010;GO:0015630;GO:0000070;GO:1990023;GO:0061673;GO:0070463;GO:0007140;GO:0070507;GO:0071392;GO:0072520;GO:0000776	ATP binding;microtubule binding;microtubule motor activity;microtubule-based movement;cell;nucleus;cytoplasm;protein transport;nucleotide binding;actin binding;cytoskeleton;cell projection;protein binding;microtubule;caveola;microtubule organizing center;ATPase activity;cytosol;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;microtubule depolymerization;antigen processing and presentation of exogenous peptide antigen via MHC class II;kinesin complex;ruffle;mitotic metaphase plate congression;kinetochore microtubule;ATP-dependent microtubule motor activity, plus-end-directed;microtubule plus-end binding;microtubule cytoskeleton;mitotic sister chromatid segregation;mitotic spindle midzone;mitotic spindle astral microtubule;tubulin-dependent ATPase activity;male meiotic nuclear division;regulation of microtubule cytoskeleton organization;cellular response to estradiol stimulus;seminiferous tubule development;kinetochore	3D-structure;ATP-binding;Cell projection;Coiled coil;Cytoplasm;Cytoskeleton;Glycoprotein;Isopeptide bond;Microtubule;Motor protein;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport;Ubl conjugation	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2132295;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-983189;R-HSA-983231;R-HSA-141424;R-HSA-141444;R-HSA-69618	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;MHC class II antigen presentation;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Kinesins;Factors involved in megakaryocyte development and platelet production;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
PDSS1	positive	NAA35	ENSG00000135040	PDSS1	1	PDSS1	1	0.00995031225385579	WBGene00020719	WBGene00020719(0)			GO:0005737;GO:0043066;GO:0005515;GO:0031417;GO:0005844;GO:0004596;GO:0006474;GO:0048659;GO:0017196	N-terminal peptidyl-methionine acetylation;NatC complex;cytoplasm;negative regulation of apoptotic process;protein binding;polysome;peptide alpha-N-acetyltransferase activity;N-terminal protein amino acid acetylation;smooth muscle cell proliferation	Alternative splicing;Cytoplasm;Phosphoprotein;Reference proteome	R-HSA-5653656;R-HSA-199991;R-HSA-6811442;R-HSA-6811440	Vesicle-mediated transport;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Retrograde transport at the Trans-Golgi-Network
PDSS1	positive	CHAC2	ENSG00000143942	PDSS1	1	PDSS1	1	0.00995031225385579	WBGene00017724				GO:0005737;GO:0016829;GO:0005829;GO:0003839;GO:0006751;GO:0061928;GO:0003674;GO:0008150;GO:0005575;GO:0006750	glutathione catabolic process;gamma-glutamylcyclotransferase activity;cytoplasm;lyase activity;cytosol;molecular_function;biological_process;cellular_component;glutathione biosynthetic process;glutathione specific gamma-glutamylcyclotransferase activity	Cytoplasm;Lyase;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-156580;R-HSA-156590;R-HSA-174403;R-HSA-211859	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Glutathione synthesis and recycling;Biological oxidations
PDSS1	positive	LYAR	ENSG00000145220	PDSS1	1	PDSS1	1	0.00995031225385579	WBGene00007628	WBGene00007628(0)			GO:0003723;GO:0005634;GO:0005737;GO:0046872;GO:0005730;GO:0003677;GO:0042995;GO:0005515;GO:0006364;GO:0000122;GO:0001750;GO:0050766;GO:0048821	DNA binding;RNA binding;nucleus;cytoplasm;metal ion binding;nucleoplasm;nucleolus;cell projection;protein binding;immune system process;innate immune response;rRNA processing;negative regulation of transcription by RNA polymerase II;photoreceptor outer segment;positive regulation of phagocytosis;erythrocyte development	Cell projection;Coiled coil;Cytoplasm;DNA-binding;Immunity;Innate immunity;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger;rRNA processing		
PDSS1	positive	GPATCH4	ENSG00000160818	PDSS1	1	PDSS1	1	0.00995031225385579					GO:0003676	nucleic acid binding			
PDSS1	positive	LSM6	ENSG00000164167	PDSS1	1	PDSS1	1	0.00995031225385579	WBGene00003080	WBGene00003080(1)			GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0008033;GO:0005515;GO:0005681;GO:0000398;GO:0006364;GO:0000932;GO:0005732;GO:0005730;GO:0005654;GO:0005829;GO:0046540;GO:0030490;GO:0043928;GO:0071005;GO:0005688;GO:0120115;GO:0030532	mRNA splicing, via spliceosome;small nucleolar ribonucleoprotein complex;RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;tRNA processing;protein binding;spliceosomal complex;rRNA processing;P-body;nucleolus;nucleoplasm;cytosol;U4/U6 x U5 tri-snRNP complex;maturation of SSU-rRNA;protein heterodimerization activity;exonucleolytic catabolism of deadenylated mRNA;U2-type precatalytic spliceosome;U6 snRNP;Lsm2-8 complex;mRNA catabolic process;small nuclear ribonucleoprotein complex	3D-structure;Acetylation;Cytoplasm;Direct protein sequencing;Nucleus;RNA-binding;Reference proteome;Ribonucleoprotein;Spliceosome;mRNA processing;mRNA splicing;rRNA processing;tRNA processing	R-HSA-8953854;R-HSA-429914;R-HSA-72203;R-HSA-72163;R-HSA-72172;R-HSA-430039	Metabolism of RNA;Deadenylation-dependent mRNA decay;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing;mRNA decay by 5' to 3' exoribonuclease
PDSS1	positive	IDH3A	ENSG00000166411	PDSS1	1	PDSS1	1	0.00995031225385579	WBGene00009664	WBGene00009664(1)			GO:0005634;GO:0046872;GO:0000287;GO:0016491;GO:0055114;GO:0006099;GO:0005739;GO:0016616;GO:0051287;GO:0004449;GO:0005759;GO:0005975;GO:0006102	magnesium ion binding;oxidation-reduction process;NAD binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;isocitrate dehydrogenase (NAD+) activity;tricarboxylic acid cycle;nucleus;metal ion binding;oxidoreductase activity;mitochondrion;mitochondrial matrix;carbohydrate metabolic process;isocitrate metabolic process	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Magnesium;Manganese;Metal-binding;Mitochondrion;NAD;Oxidoreductase;Phosphoprotein;Reference proteome;Transit peptide;Tricarboxylic acid cycle	R-HSA-1430728;R-HSA-1428517;R-HSA-71406;R-HSA-71403	Metabolism;The citric acid (TCA) cycle and respiratory electron transport;Pyruvate metabolism and Citric Acid (TCA) cycle;Citric acid cycle (TCA cycle)
PDSS1	positive	ATAD3A	ENSG00000197785	PDSS1	1	PDSS1	1	0.00995031225385579	WBGene00010015			Ocular anomalies-axonal neuropathy-developmental delay syndrome;ATAD3A disorder -  global developmental delay hypotonia optic atrophy axonal neuropathy and hypertrophic cardiomyopathy;HAREL-YOON SYNDROME	GO:0016020;GO:0016021;GO:0000166;GO:0005524;GO:0043066;GO:0005739;GO:0005743;GO:0007005;GO:0008270;GO:0001558;GO:0042645	ATP binding;mitochondrion;mitochondrion organization;membrane;integral component of membrane;nucleotide binding;negative regulation of apoptotic process;mitochondrial inner membrane;zinc ion binding;regulation of cell growth;mitochondrial nucleoid	ATP-binding;Acetylation;Alternative splicing;Coiled coil;Direct protein sequencing;Disease mutation;Membrane;Mitochondrion;Mitochondrion inner membrane;Mitochondrion nucleoid;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
PDSS1	positive	VDAC1	ENSG00000213585	PDSS1	1	PDSS1	1	0.00995031225385579	WBGene00019900	WBGene00019900(1)			GO:0005634;GO:0016020;GO:0016021;GO:0055085;GO:0005739;GO:0008308;GO:0015698;GO:0098656;GO:0005741;GO:0006811;GO:0005886;GO:0005515;GO:0006915;GO:0045121;GO:0006820;GO:0042802;GO:0070062;GO:0044325;GO:0016032;GO:1903146;GO:0030855;GO:0006090;GO:0042645;GO:0046930;GO:0016236;GO:0019901;GO:0015288;GO:0005757;GO:0005253;GO:0044877;GO:0001662;GO:0006851;GO:0007268;GO:0007270;GO:0007612;GO:2000378;GO:0008021;GO:0032991	integral component of membrane;transmembrane transport;anion transport;voltage-gated anion channel activity;anion transmembrane transport;mitochondrial outer membrane;nucleus;membrane;mitochondrion;inorganic anion transport;ion transport;plasma membrane;protein binding;apoptotic process;membrane raft;identical protein binding;extracellular exosome;ion channel binding;viral process;regulation of autophagy of mitochondrion;epithelial cell differentiation;pyruvate metabolic process;mitochondrial nucleoid;pore complex;macroautophagy;protein kinase binding;porin activity;mitochondrial permeability transition pore complex;anion channel activity;protein-containing complex binding;behavioral fear response;mitochondrial calcium ion transmembrane transport;chemical synaptic transmission;neuron-neuron synaptic transmission;learning;negative regulation of reactive oxygen species metabolic process;synaptic vesicle;protein-containing complex	3D-structure;Acetylation;Apoptosis;Cell membrane;Direct protein sequencing;Host-virus interaction;Ion transport;Isopeptide bond;Membrane;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;Porin;Reference proteome;Transmembrane;Transmembrane beta strand;Transport;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-1430728;R-HSA-382551;R-HSA-9612973;R-HSA-5688426;R-HSA-5689880;R-HSA-8953897;R-HSA-9609507;R-HSA-1428517;R-HSA-70268;R-HSA-71406;R-HSA-1268020;R-HSA-1632852;R-HSA-5205647;R-HSA-5205685;R-HSA-8949215	Metabolism of proteins;Post-translational protein modification;Metabolism;Transport of small molecules;Autophagy;Deubiquitination;Ub-specific processing proteases;Cellular responses to external stimuli;Protein localization;The citric acid (TCA) cycle and respiratory electron transport;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Mitochondrial protein import;Macroautophagy;Mitophagy;Pink/Parkin Mediated Mitophagy;Mitochondrial calcium ion transport
PDSS1	negative	PIK3IP1	ENSG00000100100	PDSS1	1	PDSS1	1	0.000134011144678148					GO:0016020;GO:0016021;GO:0005886;GO:0005515;GO:0006508;GO:0014067;GO:0043553;GO:0004252;GO:0036313	membrane;integral component of membrane;plasma membrane;protein binding;proteolysis;negative regulation of phosphatidylinositol 3-kinase signaling;negative regulation of phosphatidylinositol 3-kinase activity;serine-type endopeptidase activity;phosphatidylinositol 3-kinase catalytic subunit binding	Alternative splicing;Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;Kringle;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix		
PDSS1	negative	PBXIP1	ENSG00000163346	PDSS1	1	PDSS1	1	0.000172089530554476					GO:0005634;GO:0005737;GO:0005829;GO:0003714;GO:0005856;GO:0005515;GO:0030154;GO:0045892;GO:0007275;GO:0005874;GO:0016020;GO:2001106	transcription corepressor activity;negative regulation of transcription, DNA-templated;cell differentiation;nucleus;cytoplasm;cytoskeleton;cytosol;protein binding;multicellular organism development;microtubule;membrane;regulation of Rho guanyl-nucleotide exchange factor activity	Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Microtubule;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	negative	CALCOCO1	ENSG00000012822	PDSS1	1	PDSS1	1	0.000416164586440448					GO:0005634;GO:0005737;GO:0043231;GO:0005829;GO:0005515;GO:0016055;GO:0003713;GO:0045893;GO:0045944;GO:0008022;GO:0010628;GO:0044212;GO:0000980;GO:0003712;GO:0070016;GO:0008013;GO:0043565;GO:0007165;GO:0030374;GO:0030518;GO:0003682;GO:0000790	nucleus;cytoplasm;intracellular membrane-bounded organelle;metal ion binding;cytosol;protein binding;Wnt signaling pathway;transcription coactivator activity;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;protein C-terminus binding;positive regulation of gene expression;transcription regulatory region DNA binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;transcription coregulator activity;armadillo repeat domain binding;beta-catenin binding;sequence-specific DNA binding;signal transduction;nuclear receptor transcription coactivator activity;intracellular steroid hormone receptor signaling pathway;chromatin binding;nuclear chromatin	Activator;Alternative splicing;Coiled coil;Cytoplasm;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Wnt signaling pathway;Zinc;Zinc-finger		
PDSS1	negative	TXNIP	ENSG00000265972	PDSS1	1	PDSS1	1	0.000449763680435256	WBGene00011732;WBGene00018060;WBGene00009852;WBGene00011052;WBGene00011053;WBGene00011054;WBGene00011055;WBGene00012464;WBGene00012467;WBGene00013043;WBGene00014161;WBGene00015440;WBGene00015441;WBGene00018061;WBGene00020612;WBGene00009579	WBGene00011054(0);WBGene00018061(0);WBGene00011052(0);WBGene00020612(0);WBGene00018060(0);WBGene00011053(0);WBGene00013043(0);WBGene00008843(0);WBGene00014161(0);WBGene00009852(0);WBGene00009853(0);WBGene00012464(0)			GO:0005737;GO:0005515;GO:0007049;GO:0004857;GO:0000122;GO:0006606;GO:0006979;GO:0009612;GO:0009749;GO:0032355;GO:0032570;GO:0042127;GO:0042493;GO:0042542;GO:0043065;GO:0043086;GO:0048008;GO:0051592;GO:0005634;GO:0005758;GO:0005829;GO:0031625;GO:0030216;GO:0051782;GO:0071228	cytoplasm;protein binding;cell cycle;negative regulation of catalytic activity;cytosol;ubiquitin protein ligase binding;keratinocyte differentiation;negative regulation of cell division;cellular response to tumor cell;enzyme inhibitor activity;negative regulation of transcription by RNA polymerase II;protein import into nucleus;response to oxidative stress;response to mechanical stimulus;response to glucose;response to estradiol;response to progesterone;regulation of cell population proliferation;response to drug;response to hydrogen peroxide;positive regulation of apoptotic process;platelet-derived growth factor receptor signaling pathway;response to calcium ion;nucleus;mitochondrial intermembrane space	3D-structure;Alternative splicing;Cell cycle;Cytoplasm;Disulfide bond;Isopeptide bond;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation;Tumor suppressor;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9614085;R-HSA-168643;R-HSA-622312;R-HSA-844456;R-HSA-9617629	Innate Immune System;Immune System;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Inflammasomes;The NLRP3 inflammasome;Regulation of FOXO transcriptional activity by acetylation
PDSS1	negative	GABARAPL1	ENSG00000139112	PDSS1	1	PDSS1	1	0.000485862330783626	WBGene00002980	WBGene00002981(0)			GO:0005737;GO:0006914;GO:0016020;GO:0005783;GO:0005794;GO:0005856;GO:0005515;GO:0031410;GO:0005874;GO:0030659;GO:0005776;GO:0005829;GO:0031625;GO:0008017;GO:0000045;GO:0000422;GO:0006995;GO:0016236;GO:0097352;GO:0000421;GO:0050811;GO:0005739;GO:0030957;GO:0048487;GO:0005622;GO:0032590;GO:0032839;GO:0044297	cytoplasm;autophagy;membrane;endoplasmic reticulum;Golgi apparatus;cytoskeleton;protein binding;cytoplasmic vesicle;microtubule;cytoplasmic vesicle membrane;cytosol;autophagosome;ubiquitin protein ligase binding;microtubule binding;autophagosome assembly;autophagy of mitochondrion;cellular response to nitrogen starvation;macroautophagy;autophagosome maturation;autophagosome membrane;GABA receptor binding;mitochondrion;Tat protein binding;beta-tubulin binding;intracellular;dendrite membrane;dendrite cytoplasm;cell body	3D-structure;Alternative splicing;Autophagy;Cytoplasm;Cytoplasmic vesicle;Cytoskeleton;Endoplasmic reticulum;Golgi apparatus;Lipoprotein;Membrane;Microtubule;Reference proteome	R-HSA-9612973;R-HSA-8953897;R-HSA-1632852	Autophagy;Cellular responses to external stimuli;Macroautophagy
PDSS1	negative	YPEL5	ENSG00000119801	PDSS1	1	PDSS1	1	0.000524628376568859	WBGene00015250;WBGene00015251;WBGene00009503	WBGene00015250(0);WBGene00015251(1)			GO:0005634;GO:0005737;GO:0046872;GO:0005856;GO:0000922;GO:0005813;GO:0005815;GO:0030496;GO:0005576;GO:0005515;GO:0000151;GO:0008283;GO:0043312;GO:1904813;GO:1904724;GO:0097431	nucleus;cytoplasm;metal ion binding;cytoskeleton;spindle pole;centrosome;microtubule organizing center;midbody;extracellular region;protein binding;ubiquitin ligase complex;neutrophil degranulation;ficolin-1-rich granule lumen;tertiary granule lumen;mitotic spindle pole;cell population proliferation	Cytoplasm;Cytoskeleton;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Zinc	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
PDSS1	negative	ANKRA2	ENSG00000164331	PDSS1	1	PDSS1	1	0.000610883568806564					GO:0005737;GO:0016020;GO:0005829;GO:0005856;GO:0005515;GO:0042826;GO:0005634;GO:0019901;GO:0043254;GO:0032991;GO:0031625;GO:1990393;GO:0050750	protein binding;cytoplasm;membrane;cytoskeleton;cytosol;histone deacetylase binding;nucleus;regulation of transcription by RNA polymerase II;protein kinase binding;regulation of protein-containing complex assembly;protein-containing complex;ubiquitin protein ligase binding;3M complex;low-density lipoprotein particle receptor binding	3D-structure;ANK repeat;Cytoplasm;Cytoskeleton;Membrane;Reference proteome;Repeat		
PDSS1	negative	RSRP1	ENSG00000117616	PDSS1	1	PDSS1	1	0.000954385170208516					GO:0005515	protein binding	Alternative splicing;Methylation;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	negative	KLHDC2	ENSG00000165516	PDSS1	1	PDSS1	1	0.000954385170208516					GO:0005634;GO:0031965;GO:0005515;GO:0016604	protein binding;nucleus;nucleoplasm;nuclear membrane;nuclear body	3D-structure;Alternative splicing;Kelch repeat;Nucleus;Reference proteome;Repeat		
PDSS1	negative	HDAC5	ENSG00000108840	PDSS1	1	PDSS1	1	0.00102649055863369	WBGene00001837;WBGene00001838;WBGene00018319	WBGene00001837(0);WBGene00009663(0);WBGene00219378(0);WBGene00009657(0)	SLC2A1;YY1		GO:0090051;GO:0051091;GO:0010832;GO:0045944;GO:0005737;GO:0005634;GO:0044212;GO:0032869;GO:0016607;GO:0005794;GO:0046872;GO:0005829;GO:0016787;GO:0006325;GO:0006476;GO:0005515;GO:0006954;GO:0000122;GO:0004407;GO:0016575;GO:0032041;GO:0070932;GO:0005654;GO:0042113;GO:0000118;GO:0040029;GO:0045892;GO:0000978;GO:0008134;GO:0033558;GO:0042826;GO:0005080;GO:0006338;GO:0030183;GO:0043393;GO:0001085;GO:0070491;GO:0010830;GO:0003682;GO:0006342;GO:0014823;GO:0030182;GO:0042220;GO:0042493;GO:0071222;GO:0032991	nucleus;cytoplasm;histone deacetylase activity;histone deacetylation;chromatin organization;histone deacetylase complex;regulation of gene expression, epigenetic;negative regulation of cell migration involved in sprouting angiogenesis;positive regulation of DNA-binding transcription factor activity;negative regulation of myotube differentiation;positive regulation of transcription by RNA polymerase II;transcription regulatory region DNA binding;cellular response to insulin stimulus;nuclear speck;Golgi apparatus;metal ion binding;cytosol;hydrolase activity;protein deacetylation;protein binding;inflammatory response;negative regulation of transcription by RNA polymerase II;NAD-dependent histone deacetylase activity (H3-K14 specific);histone H3 deacetylation;nucleoplasm;B cell activation;negative regulation of transcription, DNA-templated;RNA polymerase II cis-regulatory region sequence-specific DNA binding;transcription factor binding;protein deacetylase activity;histone deacetylase binding;protein kinase C binding;chromatin remodeling;B cell differentiation;regulation of protein binding;RNA polymerase II transcription factor binding;repressing transcription factor binding;regulation of myotube differentiation;chromatin binding;chromatin silencing;response to activity;neuron differentiation;response to cocaine;response to drug;cellular response to lipopolysaccharide;protein-containing complex	3D-structure;Acetylation;Alternative splicing;Chromatin regulator;Cytoplasm;Hydrolase;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1643685;R-HSA-1257604;R-HSA-5663202;R-HSA-6807070;R-HSA-9006925;R-HSA-157118;R-HSA-1980143;R-HSA-2644602;R-HSA-2644603;R-HSA-2644606;R-HSA-2894858;R-HSA-2894862;R-HSA-8943724;R-HSA-2122947;R-HSA-350054	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Disease;PIP3 activates AKT signaling;Diseases of signal transduction;PTEN Regulation;Intracellular signaling by second messengers;Signaling by NOTCH;Signaling by NOTCH1;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Regulation of PTEN gene transcription;NOTCH1 Intracellular Domain Regulates Transcription;Notch-HLH transcription pathway
PDSS1	negative	ASAH1	ENSG00000104763	PDSS1	1	PDSS1	1	0.00110356309897242	WBGene00010769;WBGene00009192;WBGene00021917	WBGene00009192(1);WBGene00010769(1)		Farber disease;Spinal muscular atrophy-progressive myoclonic epilepsy syndrome;Farber lipogranulomatosis;Spinal Muscular Atrophy Associated with Progressive Myoclonic Epilepsy;Farber lipogranulomatosis;SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	GO:0005634;GO:0005737;GO:0016787;GO:0006629;GO:0005615;GO:0005764;GO:0005576;GO:0006665;GO:0017040;GO:0102121;GO:0006687;GO:0070062;GO:0071356;GO:0043312;GO:1904813;GO:1904724;GO:0043202;GO:0030216;GO:0046513;GO:0016811;GO:0016810;GO:0050810;GO:0046512;GO:0046514;GO:0062098;GO:0016020;GO:0016021	lipid metabolic process;lysosome;nucleus;cytoplasm;hydrolase activity;extracellular space;extracellular region;sphingolipid metabolic process;N-acylsphingosine amidohydrolase activity;ceramidase activity;glycosphingolipid metabolic process;extracellular exosome;cellular response to tumor necrosis factor;neutrophil degranulation;ficolin-1-rich granule lumen;tertiary granule lumen;lysosomal lumen;keratinocyte differentiation;ceramide biosynthetic process;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides;hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds;regulation of steroid biosynthetic process;sphingosine biosynthetic process;ceramide catabolic process;regulation of programmed necrotic cell death;membrane;integral component of membrane	3D-structure;Alternative splicing;Cytoplasm;Direct protein sequencing;Disease mutation;Disulfide bond;Epilepsy;Glycoprotein;Hydrolase;Lipid metabolism;Lysosome;Neurodegeneration;Nucleus;Polymorphism;Reference proteome;Secreted;Signal;Sphingolipid metabolism	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-1660662;R-HSA-428157;R-HSA-556833;R-HSA-6798695	Innate Immune System;Immune System;Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids;Neutrophil degranulation
PDSS1	negative	MARF1	ENSG00000166783	PDSS1	1	PDSS1	1	0.00110356309897242					GO:0003676;GO:0003723;GO:0016020;GO:0005794;GO:0043231;GO:0051321;GO:0030154;GO:0005777;GO:0010468;GO:0003674;GO:0010923;GO:0048477;GO:0007143;GO:0006302	nucleic acid binding;peroxisome;regulation of gene expression;RNA binding;membrane;Golgi apparatus;intracellular membrane-bounded organelle;meiotic cell cycle;cell differentiation;molecular_function;negative regulation of phosphatase activity;oogenesis;female meiotic nuclear division;double-strand break repair	3D-structure;Alternative splicing;Differentiation;Meiosis;Oogenesis;Peroxisome;Phosphoprotein;RNA-binding;Reference proteome;Repeat		
PDSS1	negative	MBNL2	ENSG00000139793	PDSS1	1	PDSS1	1	0.00118590649382289	WBGene00019347	WBGene00019347(0)			GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0046872;GO:0005654;GO:0000381;GO:0043484	metal ion binding;RNA binding;mRNA processing;RNA splicing;nucleus;cytoplasm;nucleoplasm;regulation of alternative mRNA splicing, via spliceosome;regulation of RNA splicing	3D-structure;Alternative splicing;Cytoplasm;Metal-binding;Nucleus;RNA-binding;Reference proteome;Repeat;Zinc;Zinc-finger;mRNA processing;mRNA splicing		
PDSS1	negative	LYRM9	ENSG00000232859	PDSS1	1	PDSS1	1	0.00118590649382289							Reference proteome		
PDSS1	negative	PINK1	ENSG00000158828	PDSS1	1	PDSS1	1	0.00127384012425769	WBGene00017137	WBGene00017137(0)		Young-onset Parkinson disease;PARKINSON DISEASE 6 AUTOSOMAL RECESSIVE EARLY-ONSET	GO:0005737;GO:0016020;GO:0016021;GO:0046872;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005743;GO:0016567;GO:0005739;GO:0005829;GO:0005515;GO:0000287;GO:0005741;GO:0006914;GO:0050821;GO:0000422;GO:0031625;GO:0031396;GO:0005634;GO:1903146;GO:1903214;GO:0090200;GO:0051897;GO:0007005;GO:0048471;GO:0035556;GO:2001243;GO:0043123;GO:1903955;GO:0018105;GO:0034599;GO:0000785;GO:0005856;GO:0005758;GO:0016236;GO:0044877;GO:0006511;GO:0006979;GO:0010629;GO:0010821;GO:0043524;GO:0046329;GO:0097237;GO:0098779;GO:0099074;GO:1900407;GO:1902803;GO:1903202;GO:2000378;GO:0097413;GO:0036289;GO:0031398;GO:0044297;GO:0043254;GO:0002020;GO:0055131;GO:0032148;GO:0033138;GO:0090258;GO:0030424;GO:1903204;GO:0072655;GO:0072656;GO:0016242;GO:0051881;GO:0071456;GO:0016239;GO:0010952;GO:2001171;GO:0051443;GO:1903751;GO:1902902;GO:0090141;GO:1902958;GO:1903384;GO:0010857;GO:0016504;GO:0043422;GO:1904841;GO:0001934;GO:0002082;GO:0002931;GO:0010310;GO:0022904;GO:0032226;GO:0033603;GO:0033605;GO:0035307;GO:0038203;GO:0043066;GO:0043523;GO:0045727;GO:0051091;GO:0061136;GO:1901215;GO:1901727;GO:1903147;GO:1903298;GO:1903852;GO:1904544;GO:1904783;GO:1904881;GO:1904925;GO:2000377;GO:0030426;GO:0031307;GO:0097449	ATP binding;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;autophagy of mitochondrion;cytoplasm;membrane;integral component of membrane;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;endoplasmic reticulum;mitochondrial inner membrane;protein ubiquitination;mitochondrion;cytosol;protein binding;mitochondrial outer membrane;autophagy;magnesium ion binding;protein stabilization;regulation of apoptotic process;ubiquitin protein ligase binding;regulation of protein ubiquitination;nucleus;regulation of autophagy of mitochondrion;regulation of protein targeting to mitochondrion;positive regulation of release of cytochrome c from mitochondria;positive regulation of protein kinase B signaling;mitochondrion organization;perinuclear region of cytoplasm;intracellular signal transduction;negative regulation of intrinsic apoptotic signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of protein targeting to mitochondrion;peptidyl-serine phosphorylation;cellular response to oxidative stress;chromatin;cytoskeleton;mitochondrial intermembrane space;macroautophagy;protein-containing complex binding;ubiquitin-dependent protein catabolic process;response to oxidative stress;negative regulation of gene expression;regulation of mitochondrion organization;negative regulation of neuron apoptotic process;negative regulation of JNK cascade;cellular response to toxic substance;positive regulation of mitophagy in response to mitochondrial depolarization;mitochondrion to lysosome transport;regulation of cellular response to oxidative stress;regulation of synaptic vesicle transport;negative regulation of oxidative stress-induced cell death;negative regulation of reactive oxygen species metabolic process;Lewy body;peptidyl-serine autophosphorylation;positive regulation of protein ubiquitination;cell body;regulation of protein-containing complex assembly;protease binding;C3HC4-type RING finger domain binding;activation of protein kinase B activity;positive regulation of peptidyl-serine phosphorylation;negative regulation of mitochondrial fission;axon;negative regulation of oxidative stress-induced neuron death;establishment of protein localization to mitochondrion;maintenance of protein location in mitochondrion;negative regulation of macroautophagy;regulation of mitochondrial membrane potential;cellular response to hypoxia;positive regulation of macroautophagy;positive regulation of peptidase activity;positive regulation of ATP biosynthetic process;positive regulation of ubiquitin-protein transferase activity;negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide;negative regulation of autophagosome assembly;positive regulation of mitochondrial fission;positive regulation of mitochondrial electron transport, NADH to ubiquinone;negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway;calcium-dependent protein kinase activity;peptidase activator activity;protein kinase B binding;TORC2 complex binding;positive regulation of protein phosphorylation;regulation of oxidative phosphorylation;response to ischemia;regulation of hydrogen peroxide metabolic process;respiratory electron transport chain;positive regulation of synaptic transmission, dopaminergic;positive regulation of dopamine secretion;positive regulation of catecholamine secretion;positive regulation of protein dephosphorylation;TORC2 signaling;negative regulation of apoptotic process;regulation of neuron apoptotic process;positive regulation of translation;positive regulation of DNA-binding transcription factor activity;regulation of proteasomal protein catabolic process;negative regulation of neuron death;positive regulation of histone deacetylase activity;negative regulation of autophagy of mitochondrion;negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway;positive regulation of cristae formation;positive regulation of free ubiquitin chain polymerization;positive regulation of NMDA glutamate receptor activity;cellular response to hydrogen sulfide;positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization;regulation of reactive oxygen species metabolic process;growth cone;integral component of mitochondrial outer membrane;astrocyte projection	ATP-binding;Alternative splicing;Autophagy;Cytoplasm;Disease mutation;Kinase;Magnesium;Membrane;Metal-binding;Mitochondrion;Mitochondrion inner membrane;Mitochondrion outer membrane;Neurodegeneration;Nucleotide-binding;Parkinson disease;Parkinsonism;Phosphoprotein;Polymorphism;Primary mitochondrial disease;Reference proteome;Serine/threonine-protein kinase;Transferase;Transit peptide;Transmembrane;Transmembrane helix	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9612973;R-HSA-8953897;R-HSA-9614085;R-HSA-1632852;R-HSA-9614657;R-HSA-5205647;R-HSA-5205685	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Autophagy;Cellular responses to external stimuli;FOXO-mediated transcription;Macroautophagy;FOXO-mediated transcription of cell death genes;Mitophagy;Pink/Parkin Mediated Mitophagy
PDSS1	negative	LMBRD1	ENSG00000168216	PDSS1	1	PDSS1	1	0.00136769965550598				Methylmalonic acidemia with homocystinuria type cblF;methylmalonic aciduria and homocystinuria type cblF;METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA cblF TYPE	GO:0016020;GO:0016021;GO:0005765;GO:0005764;GO:0016032;GO:0031419;GO:0009235;GO:0015420;GO:0015889;GO:0005158;GO:0005886;GO:0045334	membrane;integral component of membrane;lysosomal membrane;lysosome;viral process;cobalamin binding;cobalamin metabolic process;ATPase-coupled vitamin B12 transmembrane transporter activity;cobalamin transport;insulin receptor binding;plasma membrane;clathrin-coated endocytic vesicle	Alternative splicing;Cobalamin;Cobalt;Glycoprotein;Host-virus interaction;Lysosome;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Transport	R-HSA-1430728;R-HSA-1643685;R-HSA-196854;R-HSA-196849;R-HSA-196741;R-HSA-3296469;R-HSA-3296482;R-HSA-5668914;R-HSA-3359458	Metabolism;Disease;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Cobalamin (Cbl, vitamin B12) transport and metabolism;Defects in cobalamin (B12) metabolism;Defects in vitamin and cofactor metabolism;Diseases of metabolism;Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF
PDSS1	negative	TSC22D3	ENSG00000157514	PDSS1	1	PDSS1	1	0.00146783765231251	WBGene00011824;WBGene00012994;WBGene00016269	WBGene00011824(0);WBGene00012994(0)	CCND1		GO:0006355;GO:0003700;GO:0005634;GO:0005737;GO:0006357;GO:0000981;GO:0005829;GO:0034220;GO:0006970;GO:0070236	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleus;cytoplasm;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;cytosol;ion transmembrane transport;response to osmotic stress;negative regulation of activation-induced cell death of T cells	Alternative splicing;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome	R-HSA-382551;R-HSA-2672351;R-HSA-983712	Transport of small molecules;Stimuli-sensing channels;Ion channel transport
PDSS1	negative	CTDSP2	ENSG00000175215	PDSS1	1	PDSS1	1	0.00146783765231251	WBGene00007054	WBGene00007054(1)			GO:0005634;GO:0046872;GO:0016787;GO:0006357;GO:0016311;GO:0004721;GO:0005515;GO:0016791;GO:0008420;GO:0006470;GO:0001933;GO:2000134;GO:0005654;GO:0036498	phosphatase activity;regulation of transcription by RNA polymerase II;RNA polymerase II CTD heptapeptide repeat phosphatase activity;nucleus;metal ion binding;hydrolase activity;dephosphorylation;phosphoprotein phosphatase activity;protein binding;protein dephosphorylation;negative regulation of protein phosphorylation;negative regulation of G1/S transition of mitotic cell cycle;nucleoplasm;IRE1-mediated unfolded protein response	3D-structure;Hydrolase;Magnesium;Metal-binding;Nucleus;Phosphoprotein;Protein phosphatase;Reference proteome	R-HSA-392499;R-HSA-381038;R-HSA-381070;R-HSA-381119	Metabolism of proteins;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR)
PDSS1	negative	HECA	ENSG00000112406	PDSS1	1	PDSS1	1	0.00157462420314447	WBGene00010614;WBGene00015073	WBGene00015073(0);WBGene00010614(0)			GO:0016020;GO:0007275;GO:0003674;GO:0005634;GO:0005737;GO:0045930;GO:0030323	membrane;multicellular organism development;molecular_function;nucleus;cytoplasm;negative regulation of mitotic cell cycle;respiratory tube development	Developmental protein;Phosphoprotein;Reference proteome		
PDSS1	negative	KIAA0355	ENSG00000166398	PDSS1	1	PDSS1	1	0.00157462420314447							Phosphoprotein;Reference proteome		
PDSS1	negative	RBL2	ENSG00000103479	PDSS1	1	PDSS1	1	0.0018097147391527	WBGene00003020	WBGene00003020(0)			GO:0006357;GO:0005667;GO:0051726;GO:0051302;GO:0005634;GO:0005730;GO:0005829;GO:0003677;GO:0006325;GO:0005515;GO:0007049;GO:0030154;GO:0006977;GO:0005654;GO:0070062;GO:0000785;GO:0001102;GO:0001012;GO:0007346;GO:0010629;GO:0043550;GO:2000134;GO:1990841	regulation of transcription by RNA polymerase II;transcription factor complex;regulation of cell cycle;regulation of cell division;nucleus;nucleoplasm;nucleolus;cytosol;DNA binding;chromatin organization;protein binding;cell cycle;cell differentiation;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;extracellular exosome;chromatin;regulation of mitotic cell cycle;RNA polymerase II activating transcription factor binding;RNA polymerase II regulatory region DNA binding;negative regulation of gene expression;regulation of lipid kinase activity;negative regulation of G1/S transition of mitotic cell cycle;promoter-specific chromatin binding	3D-structure;Alternative splicing;Cell cycle;Chromatin regulator;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Tumor suppressor	R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-73857;R-HSA-74160;R-HSA-1640170;R-HSA-69242;R-HSA-69278;R-HSA-9614085;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-69231;R-HSA-69236;R-HSA-9617828;R-HSA-6804114;R-HSA-69205;R-HSA-1538133;R-HSA-1362277;R-HSA-1362300	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;RNA Polymerase II Transcription;Gene expression (Transcription);Cell Cycle;S Phase;Cell Cycle, Mitotic;FOXO-mediated transcription;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Cyclin D associated events in G1;G1 Phase;FOXO-mediated transcription of cell cycle genes;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;G1/S-Specific Transcription;G0 and Early G1;Transcription of E2F targets under negative control by DREAM complex;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
PDSS1	negative	HBP1	ENSG00000105856	PDSS1	1	PDSS1	1	0.0018097147391527					GO:0003723;GO:0005634;GO:0016607;GO:0005654;GO:0006355;GO:0003677;GO:0005515;GO:0016055;GO:0006357;GO:0000981;GO:0000790;GO:0007050	regulation of transcription, DNA-templated;protein binding;RNA binding;nucleus;nuclear speck;nucleoplasm;DNA binding;Wnt signaling pathway;RNA polymerase II cis-regulatory region sequence-specific DNA binding;negative regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;cell cycle arrest;DNA-binding transcription repressor activity, RNA polymerase II-specific	3D-structure;Alternative splicing;DNA-binding;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Wnt signaling pathway		
PDSS1	negative	YPEL3	ENSG00000090238	PDSS1	1	PDSS1	1	0.00193885224276447	WBGene00009503;WBGene00015251				GO:0005634;GO:0046872;GO:0005730;GO:2000774	nucleus;metal ion binding;nucleolus;positive regulation of cellular senescence	Alternative splicing;Metal-binding;Nucleus;Reference proteome;Ubl conjugation;Zinc		
PDSS1	negative	MOAP1	ENSG00000165943	PDSS1	1	PDSS1	1	0.00193885224276447					GO:0005515;GO:0006915;GO:0005737;GO:0043065;GO:0005829;GO:0090200;GO:0031625;GO:0005739;GO:0008625;GO:0097192;GO:0097190;GO:0008630;GO:0005741;GO:0001844	protein binding;apoptotic process;cytoplasm;regulation of apoptotic process;positive regulation of apoptotic process;cytosol;positive regulation of release of cytochrome c from mitochondria;ubiquitin protein ligase binding;mitochondrion;extrinsic apoptotic signaling pathway via death domain receptors;extrinsic apoptotic signaling pathway in absence of ligand;apoptotic signaling pathway;intrinsic apoptotic signaling pathway in response to DNA damage;mitochondrial outer membrane;protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	Apoptosis;Reference proteome;Ubl conjugation		
PDSS1	negative	CCNG2	ENSG00000138764	PDSS1	1	PDSS1	1	0.00207630663183833	WBGene00019831	WBGene00000867(0);WBGene00000866(0);WBGene00000865(0);WBGene00000871(0);WBGene00000870(0);WBGene00014069(0);WBGene00021040(0);WBGene00000863(0);WBGene00000864(0);WBGene00017259(0)			GO:0005737;GO:0006468;GO:0051301;GO:0007049;GO:0051726;GO:0005634;GO:0019901;GO:0004672;GO:0016538;GO:0000079;GO:0044772;GO:0000307	regulation of cell cycle;cytoplasm;protein phosphorylation;cell division;cell cycle;nucleus;protein kinase binding;protein kinase activity;cyclin-dependent protein serine/threonine kinase regulator activity;regulation of cyclin-dependent protein serine/threonine kinase activity;mitotic cell cycle phase transition;cyclin-dependent protein kinase holoenzyme complex	Alternative splicing;Cell cycle;Cell division;Cyclin;Cytoplasm;Mitosis;Polymorphism;Reference proteome	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-9614085;R-HSA-9617828	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);FOXO-mediated transcription;FOXO-mediated transcription of cell cycle genes
PDSS1	negative	THBS3	ENSG00000169231	PDSS1	1	PDSS1	1	0.00222254521761045					GO:0005509;GO:0007155;GO:0005576;GO:0048471;GO:0008201;GO:0062023;GO:0005201;GO:0007160;GO:0003417;GO:0043931;GO:0060346	extracellular region;calcium ion binding;cell adhesion;heparin binding;perinuclear region of cytoplasm;collagen-containing extracellular matrix;extracellular matrix structural constituent;cell-matrix adhesion;growth plate cartilage development;ossification involved in bone maturation;bone trabecula formation	Alternative splicing;Calcium;Cell adhesion;Disulfide bond;EGF-like domain;Glycoprotein;Polymorphism;Reference proteome;Repeat;Signal	R-HSA-162582;R-HSA-186797;R-HSA-9006934	Signal Transduction;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases
PDSS1	negative	SATB1	ENSG00000182568	PDSS1	1	PDSS1	1	0.00222254521761045		WBGene00022861(0)	BCL2;CDK4;GATA3;HBE1;IL4;MKI67;SPARC;SPI1		GO:0005634;GO:0005654;GO:0003677;GO:0006325;GO:0005515;GO:0016604;GO:0006338;GO:0000977;GO:0000122;GO:0000981;GO:0000790;GO:0001227;GO:0016032;GO:0016605;GO:0016363;GO:0003690;GO:0003682;GO:0003700;GO:0006355;GO:0008544;GO:0016571;GO:0042110;GO:0043367;GO:0043374;GO:0050798;GO:0060004;GO:0000785;GO:0005720	DNA binding;chromatin remodeling;nucleus;nucleoplasm;chromatin organization;protein binding;nuclear body;regulation of transcription by RNA polymerase II;negative regulation of transcription by RNA polymerase II;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;PML body;DNA-binding transcription repressor activity, RNA polymerase II-specific;viral process;nuclear matrix;double-stranded DNA binding;chromatin binding;DNA-binding transcription factor activity;regulation of transcription, DNA-templated;epidermis development;histone methylation;T cell activation;CD4-positive, alpha-beta T cell differentiation;CD8-positive, alpha-beta T cell differentiation;activated T cell proliferation;reflex;chromatin;nuclear heterochromatin	3D-structure;Acetylation;Alternative splicing;Chromatin regulator;Chromosomal rearrangement;DNA-binding;Homeobox;Host-virus interaction;Isopeptide bond;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-109581;R-HSA-5357801;R-HSA-2990846;R-HSA-3108232;R-HSA-4551638;R-HSA-75153;R-HSA-111465	Metabolism of proteins;Post-translational protein modification;Apoptosis;Programmed Cell Death;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of chromatin organization proteins;Apoptotic execution phase;Apoptotic cleavage of cellular proteins
PDSS1	negative	NISCH	ENSG00000010322	PDSS1	1	PDSS1	1	0.00237805670901292	WBGene00008750	WBGene00008750(0)			GO:0005737;GO:0016020;GO:0005886;GO:0005515;GO:0006915;GO:0035091;GO:0042802;GO:0005768;GO:0005769;GO:0005178;GO:0019901;GO:0055037;GO:0005829;GO:0006006;GO:0008217;GO:0016601;GO:0030036;GO:0030336;GO:0032228;GO:0048243	protein binding;phosphatidylinositol binding;integrin binding;cytoplasm;membrane;endosome;plasma membrane;apoptotic process;identical protein binding;early endosome;protein kinase binding;recycling endosome;cytosol;glucose metabolic process;regulation of blood pressure;Rac protein signal transduction;actin cytoskeleton organization;negative regulation of cell migration;regulation of synaptic transmission, GABAergic;norepinephrine secretion	3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell membrane;Coiled coil;Cytoplasm;Endosome;Leucine-rich repeat;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat		
PDSS1	negative	MTMR3	ENSG00000100330	PDSS1	1	PDSS1	1	0.00237805670901292	WBGene00003476	WBGene00003475(0);WBGene00021683(0);WBGene00003476(0);WBGene00003479(0);WBGene00003478(0);WBGene00003477(0)			GO:0005737;GO:0016020;GO:0046872;GO:0016787;GO:0006629;GO:0004721;GO:0005515;GO:0004725;GO:0016311;GO:0035335;GO:0005829;GO:0019898;GO:0004438;GO:0006470;GO:0046856;GO:0019903;GO:0006661;GO:0004722;GO:0016236;GO:0042149;GO:2000785;GO:0052629;GO:0060304;GO:1904562	metal ion binding;protein tyrosine phosphatase activity;dephosphorylation;cytoplasm;membrane;hydrolase activity;lipid metabolic process;phosphoprotein phosphatase activity;protein binding;peptidyl-tyrosine dephosphorylation;cytosol;extrinsic component of membrane;phosphatidylinositol-3-phosphatase activity;protein dephosphorylation;phosphatidylinositol dephosphorylation;protein phosphatase binding;phosphatidylinositol biosynthetic process;protein serine/threonine phosphatase activity;macroautophagy;cellular response to glucose starvation;regulation of autophagosome assembly;phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity;regulation of phosphatidylinositol dephosphorylation;phosphatidylinositol 5-phosphate metabolic process	Alternative splicing;Coiled coil;Cytoplasm;Hydrolase;Lipid metabolism;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Protein phosphatase;Reference proteome;Zinc;Zinc-finger	R-HSA-1430728;R-HSA-556833;R-HSA-9612973;R-HSA-8953897;R-HSA-1483255;R-HSA-1483257;R-HSA-1660499;R-HSA-1632852	Metabolism;Metabolism of lipids;Autophagy;Cellular responses to external stimuli;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Macroautophagy
PDSS1	negative	SERINC1	ENSG00000111897	PDSS1	1	PDSS1	1	0.00237805670901292	WBGene00021956;WBGene00011250	WBGene00011250(1);WBGene00021956(1)			GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0006629;GO:0006665;GO:0005515;GO:0008654;GO:0006658;GO:0005886;GO:0030674;GO:1904219;GO:1904222;GO:0019899;GO:0044091	membrane;sphingolipid metabolic process;phosphatidylserine metabolic process;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;lipid metabolic process;protein binding;phospholipid biosynthetic process;plasma membrane;protein binding, bridging;positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity;positive regulation of serine C-palmitoyltransferase activity;enzyme binding;membrane biogenesis	Endoplasmic reticulum;Glycoprotein;Lipid biosynthesis;Lipid metabolism;Lipoprotein;Membrane;Myristate;Phospholipid biosynthesis;Phospholipid metabolism;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-71291;R-HSA-977347	Metabolism;Metabolism of amino acids and derivatives;Serine biosynthesis
PDSS1	negative	CREBRF	ENSG00000164463	PDSS1	1	PDSS1	1	0.00237805670901292					GO:0005634;GO:0006355;GO:0003700;GO:0005515;GO:0006986;GO:0000981;GO:0005654;GO:0001228;GO:0045944;GO:0000977;GO:0030968;GO:0042711;GO:1900170;GO:1902213;GO:0016604	response to unfolded protein;nucleus;nucleoplasm;regulation of transcription, DNA-templated;DNA-binding transcription factor activity;protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;positive regulation of transcription by RNA polymerase II;RNA polymerase II regulatory region sequence-specific DNA binding;endoplasmic reticulum unfolded protein response;maternal behavior;negative regulation of glucocorticoid mediated signaling pathway;positive regulation of prolactin signaling pathway;nuclear body	Alternative splicing;Nucleus;Polymorphism;Reference proteome;Repressor;Stress response;Transcription;Transcription regulation;Transport;Unfolded protein response	R-HSA-392499;R-HSA-381119;R-HSA-8874211	Metabolism of proteins;Unfolded Protein Response (UPR);CREB3 factors activate genes
PDSS1	negative	MAN2B2	ENSG00000013288	PDSS1	1	PDSS1	1	0.00254335186843557					GO:0046872;GO:0030246;GO:0016787;GO:0003824;GO:0005975;GO:0008152;GO:0005576;GO:0016798;GO:0004559;GO:0006013;GO:0070062;GO:0006517;GO:0005774;GO:0009313;GO:0043202	carbohydrate metabolic process;catalytic activity;alpha-mannosidase activity;mannose metabolic process;carbohydrate binding;metal ion binding;hydrolase activity;metabolic process;extracellular region;hydrolase activity, acting on glycosyl bonds;extracellular exosome;protein deglycosylation;vacuolar membrane;oligosaccharide catabolic process;lysosomal lumen	Alternative splicing;Glycoprotein;Glycosidase;Hydrolase;Metal-binding;Polymorphism;Reference proteome;Secreted;Signal;Zinc	R-HSA-1430728;R-HSA-71387;R-HSA-8853383	Metabolism;Metabolism of carbohydrates;Lysosomal oligosaccharide catabolism
PDSS1	negative	EZH1	ENSG00000108799	PDSS1	1	PDSS1	1	0.00254335186843557	WBGene00003220	WBGene00019883(0);WBGene00019584(0);WBGene00011729(0);WBGene00018023(0);WBGene00008527(0);WBGene00019690(0);WBGene00020919(0);WBGene00016603(0);WBGene00021282(0);WBGene00022431(0);WBGene00008062(0);WBGene00008206(0);WBGene00020006(0)			GO:0005634;GO:0016740;GO:0005654;GO:0008168;GO:0032259;GO:0006325;GO:0018024;GO:0070734;GO:0000981;GO:0035098;GO:0000122;GO:0009653;GO:0003682;GO:0006348;GO:0000781;GO:0003714;GO:0031493;GO:0006338;GO:0006343;GO:0021766;GO:0045944;GO:0005515	protein binding;histone-lysine N-methyltransferase activity;histone H3-K27 methylation;nucleus;transferase activity;nucleoplasm;methyltransferase activity;methylation;chromatin organization;DNA-binding transcription factor activity, RNA polymerase II-specific;ESC/E(Z) complex;negative regulation of transcription by RNA polymerase II;anatomical structure morphogenesis;chromatin binding;chromatin silencing at telomere;chromosome, telomeric region;transcription corepressor activity;nucleosomal histone binding;chromatin remodeling;establishment of chromatin silencing;hippocampus development;positive regulation of transcription by RNA polymerase II	Alternative splicing;Chromatin regulator;Isopeptide bond;Methyltransferase;Nucleus;Reference proteome;Repressor;S-adenosyl-L-methionine;Transcription;Transcription regulation;Transferase;Ubl conjugation		
PDSS1	negative	FAM172A	ENSG00000113391	PDSS1	1	PDSS1	1	0.00254335186843557	WBGene00013561	WBGene00013561(1)			GO:0006397;GO:0008380;GO:0005634;GO:0005737;GO:0005783;GO:0000381;GO:0014032;GO:0035197;GO:0031048	regulation of alternative mRNA splicing, via spliceosome;mRNA processing;RNA splicing;nucleus;cytoplasm;endoplasmic reticulum;neural crest cell development;siRNA binding;gene silencing by RNA;chromatin silencing by small RNA	Alternative splicing;Cytoplasm;Endoplasmic reticulum;Nucleus;Polymorphism;Reference proteome;Signal;mRNA processing;mRNA splicing		
PDSS1	negative	FAM8A1	ENSG00000137414	PDSS1	1	PDSS1	1	0.00254335186843557	WBGene00018593	WBGene00018593(0)			GO:0016020;GO:0016021	membrane;integral component of membrane	Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix		
PDSS1	negative	NBR1	ENSG00000188554	PDSS1	1	PDSS1	1	0.00254335186843557					GO:0045668;GO:0005737;GO:0016020;GO:0043231;GO:0008270;GO:0046872;GO:0005654;GO:0005829;GO:0005515;GO:0043130;GO:0051019;GO:0016236;GO:0030500;GO:0032872;GO:0000407;GO:0005770;GO:0005776;GO:0016604;GO:0031410;GO:0005764;GO:0031430;GO:0051259;GO:0005739	zinc ion binding;protein binding;ubiquitin binding;phagophore assembly site;macroautophagy;negative regulation of osteoblast differentiation;cytoplasm;membrane;intracellular membrane-bounded organelle;metal ion binding;nucleoplasm;cytosol;mitogen-activated protein kinase binding;regulation of bone mineralization;regulation of stress-activated MAPK cascade;late endosome;autophagosome;nuclear body;cytoplasmic vesicle;lysosome;M band;receptor complex;mitochondrion	3D-structure;Alternative splicing;Cytoplasm;Cytoplasmic vesicle;Lysosome;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Zinc;Zinc-finger		
PDSS1	negative	CTBS	ENSG00000117151	PDSS1	1	PDSS1	1	0.00271896416658002		WBGene00010686(0)			GO:0016787;GO:0005975;GO:0005615;GO:0008152;GO:0004553;GO:0016798;GO:0008061;GO:0005764;GO:0004568;GO:0006032;GO:0009313	carbohydrate metabolic process;hydrolase activity, hydrolyzing O-glycosyl compounds;chitin binding;hydrolase activity;extracellular space;metabolic process;hydrolase activity, acting on glycosyl bonds;lysosome;chitin catabolic process;chitinase activity;oligosaccharide catabolic process	Glycoprotein;Glycosidase;Hydrolase;Lysosome;Polymorphism;Reference proteome;Signal		
PDSS1	negative	PGAP3	ENSG00000161395	PDSS1	1	PDSS1	1	0.00271896416658002	WBGene00019806	WBGene00019806(1)		Hyperphosphatasia-intellectual disability syndrome;Hyperphosphatasia with mental retardation syndrome 4;Hyperphosphatasia with mental retardation syndrome 4	GO:0016021;GO:0005794;GO:0006506;GO:0000139;GO:0016020;GO:0005783;GO:0005789;GO:0031227;GO:0016788;GO:0006505	GPI anchor biosynthetic process;integral component of membrane;Golgi apparatus;Golgi membrane;membrane;endoplasmic reticulum;endoplasmic reticulum membrane;intrinsic component of endoplasmic reticulum membrane;hydrolase activity, acting on ester bonds;GPI anchor metabolic process	Alternative splicing;Disease mutation;Endoplasmic reticulum;GPI-anchor biosynthesis;Glycoprotein;Golgi apparatus;Membrane;Mental retardation;Reference proteome;Signal;Transmembrane;Transmembrane helix		
PDSS1	negative	SOS2	ENSG00000100485	PDSS1	1	PDSS1	1	0.00290545043477231	WBGene00004947			Noonan Syndrome;NOONAN SYNDROME 9	GO:0003677;GO:0007264;GO:0046982;GO:0000786;GO:0005085;GO:0005089;GO:0035023;GO:0005515;GO:0005829;GO:0051056;GO:0007186;GO:0043065;GO:0005622;GO:0051057	DNA binding;nucleosome;guanyl-nucleotide exchange factor activity;small GTPase mediated signal transduction;protein heterodimerization activity;protein binding;cytosol;regulation of small GTPase mediated signal transduction;G protein-coupled receptor signaling pathway;positive regulation of apoptotic process;positive regulation of small GTPase mediated signal transduction	3D-structure;Alternative splicing;Disease mutation;Guanine-nucleotide releasing factor;Methylation;Polymorphism;Reference proteome	R-HSA-168256;R-HSA-1266738;R-HSA-422475;R-HSA-162582;R-HSA-194315;R-HSA-194840;R-HSA-193648;R-HSA-193704;R-HSA-204998;R-HSA-372790;R-HSA-388396;R-HSA-416482;R-HSA-73887;R-HSA-1280215;R-HSA-376176;R-HSA-449147;R-HSA-451927;R-HSA-428540;R-HSA-8983432	Immune System;Developmental Biology;Axon guidance;Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;NRAGE signals death through JNK;p75 NTR receptor-mediated signalling;Cell death signalling via NRAGE, NRIF and NADE;Signaling by GPCR;GPCR downstream signalling;G alpha (12/13) signalling events;Death Receptor Signalling;Cytokine Signaling in Immune system;Signaling by ROBO receptors;Signaling by Interleukins;Interleukin-2 family signaling;Activation of RAC1;Interleukin-15 signaling
PDSS1	negative	UBL3	ENSG00000122042	PDSS1	1	PDSS1	1	0.00290545043477231	WBGene00008121	WBGene00008121(1)			GO:0016020;GO:0005886;GO:0070062;GO:0005622;GO:0005515	protein binding;membrane;plasma membrane;extracellular exosome;intracellular	3D-structure;Cell membrane;Lipoprotein;Membrane;Methylation;Palmitate;Prenylation;Reference proteome		
PDSS1	negative	SECISBP2L	ENSG00000138593	PDSS1	1	PDSS1	1	0.00290545043477231					GO:0035368;GO:0003723;GO:0005515;GO:1990904;GO:0003730;GO:0043021;GO:0001514	selenocysteine insertion sequence binding;RNA binding;protein binding;ribonucleoprotein complex;mRNA 3'-UTR binding;ribonucleoprotein complex binding;selenocysteine incorporation	Alternative splicing;Phosphoprotein;Reference proteome		
PDSS1	negative	MARCH8	ENSG00000165406	PDSS1	1	PDSS1	1	0.00290545043477231	WBGene00008433;WBGene00077696				GO:0016020;GO:0016021;GO:0008270;GO:0046872;GO:0016740;GO:0016567;GO:0005765;GO:0004842;GO:0031410;GO:0030659;GO:0002376;GO:0005764;GO:0002250;GO:0005768;GO:0031901;GO:0000209	zinc ion binding;membrane;integral component of membrane;metal ion binding;transferase activity;protein ubiquitination;endosome;lysosomal membrane;ubiquitin-protein transferase activity;cytoplasmic vesicle;cytoplasmic vesicle membrane;immune system process;lysosome;adaptive immune response;immune response;cytoplasm;ubiquitin protein ligase activity;early endosome membrane;late endosome membrane;protein polyubiquitination;MHC protein binding;antigen processing and presentation of peptide antigen via MHC class II	3D-structure;Adaptive immunity;Alternative splicing;Cytoplasmic vesicle;Endosome;Immunity;Lysosome;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Transmembrane;Transmembrane helix;Ubl conjugation pathway;Zinc;Zinc-finger		
PDSS1	negative	KIAA1109	ENSG00000138688	PDSS1	1	PDSS1	1	0.00310339151300443	WBGene00003060	WBGene00003060(0)		Brain atrophy Dandy Walker and Contractures;ALKURAYA-KUCINSKAS SYNDROME	GO:0005634;GO:0016020;GO:0016021;GO:0098793;GO:0005515;GO:0048488;GO:0001558;GO:0030856	nucleus;membrane;integral component of membrane;protein binding;presynapse;endosomal transport;phagocytosis;synaptic vesicle endocytosis;endocytic recycling;regulation of cell growth;regulation of epithelial cell differentiation	Alternative splicing;Disease mutation;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
PDSS1	negative	R3HDM2	ENSG00000179912	PDSS1	1	PDSS1	1	0.00310339151300443	WBGene00022664				GO:0003676;GO:0003723;GO:0005634	nucleic acid binding;RNA binding;nucleus	3D-structure;Alternative splicing;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	negative	ZC3H6	ENSG00000188177	PDSS1	1	PDSS1	1	0.00310339151300443	WBGene00020827				GO:0046872;GO:0005634;GO:0006357;GO:0003700;GO:0000981;GO:0000790;GO:0003674;GO:0008150;GO:0005575;GO:0045892	metal ion binding;nucleus;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;molecular_function;biological_process;cellular_component;negative regulation of transcription, DNA-templated	Coiled coil;Metal-binding;Phosphoprotein;Reference proteome;Repeat;Zinc;Zinc-finger		
PDSS1	negative	CDKN1C	ENSG00000129757	PDSS1	1	PDSS1	1	0.00331339289188015				Beckwith-Wiedemann syndrome due to CDKN1C mutation;IMAGe syndrome;Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome;Silver-Russell syndrome due to a point mutation;BECKWITH-WIEDEMANN SYNDROME;IMAGe syndrome;BECKWITH-WIEDEMANN SYNDROME;Intrauterine growth retardation metaphyseal dysplasia adrenal hypoplasia congenita and genital anomalies	GO:0005737;GO:0050680;GO:0005634;GO:0030511;GO:0005515;GO:0007049;GO:0007050;GO:0004860;GO:0045893;GO:0004861;GO:0007346;GO:0045892;GO:0045930;GO:0045736;GO:0042326;GO:0044877;GO:0033673;GO:1904030;GO:0000122;GO:0001501;GO:0001822;GO:0001890;GO:0007096;GO:0007568;GO:0030099;GO:0030325;GO:0035264;GO:0042551;GO:0043010;GO:0055123;GO:0060065;GO:0060669;GO:0071514;GO:1902746	nucleus;cyclin-dependent protein serine/threonine kinase inhibitor activity;cell cycle arrest;regulation of mitotic cell cycle;cytoplasm;negative regulation of epithelial cell proliferation;positive regulation of transforming growth factor beta receptor signaling pathway;protein binding;cell cycle;protein kinase inhibitor activity;positive regulation of transcription, DNA-templated;negative regulation of transcription, DNA-templated;negative regulation of mitotic cell cycle;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of phosphorylation;protein-containing complex binding;negative regulation of kinase activity;negative regulation of cyclin-dependent protein kinase activity	Alternative splicing;Cell cycle;Disease mutation;Methylation;Nucleus;Phosphoprotein;Protein kinase inhibitor;Reference proteome;Repeat;Tumor suppressor	R-HSA-1640170;R-HSA-69278;R-HSA-453279;R-HSA-69231;R-HSA-69236	Cell Cycle;Cell Cycle, Mitotic;Mitotic G1 phase and G1/S transition;Cyclin D associated events in G1;G1 Phase
PDSS1	negative	UBXN6	ENSG00000167671	PDSS1	1	PDSS1	1	0.00331339289188015	WBGene00019163	WBGene00019163(1)			GO:0005515;GO:0005634;GO:0005737;GO:0016020;GO:0005765;GO:0005829;GO:0005856;GO:0005764;GO:0005815;GO:0005768;GO:0031902;GO:0070062;GO:0031901;GO:0032991;GO:0019898;GO:0032510;GO:0016236;GO:0036503	protein binding;nucleus;cytoplasm;membrane;endosome;lysosomal membrane;cytoskeleton;cytosol;lysosome;microtubule organizing center;late endosome membrane;extracellular exosome;early endosome membrane;protein-containing complex;extrinsic component of membrane;endosome to lysosome transport via multivesicular body sorting pathway;macroautophagy;ERAD pathway	3D-structure;Alternative splicing;Cytoplasm;Cytoskeleton;Endosome;Lysosome;Membrane;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation pathway		
PDSS1	negative	ACYP2	ENSG00000170634	PDSS1	1	PDSS1	1	0.00331339289188015					GO:0016787;GO:0003998;GO:0005515;GO:0042802;GO:0006796	acylphosphatase activity;hydrolase activity;protein binding;identical protein binding;phosphate-containing compound metabolic process	Acetylation;Direct protein sequencing;Hydrolase;Phosphoprotein;Reference proteome		
PDSS1	negative	PJA2	ENSG00000198961	PDSS1	1	PDSS1	1	0.00331339289188015	WBGene00021842				GO:0005737;GO:0016020;GO:0046872;GO:0016740;GO:0005783;GO:0005789;GO:0016567;GO:0005794;GO:0035329;GO:0004842;GO:0045111;GO:0005886;GO:0000139;GO:0030054;GO:0006954;GO:0045202;GO:0045211;GO:0045087;GO:0005515;GO:0010738;GO:0061630;GO:0014069;GO:0007616;GO:0046330;GO:0034236;GO:0034237;GO:0034137;GO:0043030;GO:1900745	ubiquitin-protein transferase activity;protein ubiquitination;hippo signaling;regulation of protein kinase A signaling;cytoplasm;membrane;metal ion binding;transferase activity;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;intermediate filament cytoskeleton;plasma membrane;cell junction;inflammatory response;Golgi membrane;synapse;innate immune response;protein binding;ubiquitin protein ligase activity;postsynaptic density;long-term memory;positive regulation of JNK cascade;protein kinase A catalytic subunit binding;protein kinase A regulatory subunit binding;positive regulation of toll-like receptor 2 signaling pathway;regulation of macrophage activation;positive regulation of p38MAPK cascade	Acetylation;Alternative splicing;Cell junction;Cell membrane;Cytoplasm;Direct protein sequencing;Endoplasmic reticulum;Golgi apparatus;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Synapse;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
PDSS1	negative	SPATA20	ENSG00000006282	PDSS1	1	PDSS1	1	0.00353608534654548	WBGene00015204	WBGene00015204(1)			GO:0003824;GO:0005576;GO:0007275;GO:0030154;GO:0007283	catalytic activity;extracellular region;multicellular organism development;cell differentiation;spermatogenesis	Alternative splicing;Developmental protein;Differentiation;Phosphoprotein;Polymorphism;Reference proteome;Secreted;Signal;Spermatogenesis		
PDSS1	negative	RABGAP1	ENSG00000011454	PDSS1	1	PDSS1	1	0.00353608534654548	WBGene00018075				GO:0005737;GO:0005829;GO:0005096;GO:0005856;GO:0005515;GO:0007049;GO:0043547;GO:0005815;GO:0017137;GO:0006886;GO:0090630;GO:0005875;GO:0043087;GO:0005813;GO:0015631;GO:0016020;GO:0016021;GO:0004930;GO:0007186;GO:0007165	cytoplasm;cytosol;cytoskeleton;GTPase activator activity;protein binding;cell cycle;positive regulation of GTPase activity;microtubule organizing center;Rab GTPase binding;intracellular protein transport;activation of GTPase activity;microtubule associated complex;regulation of GTPase activity;centrosome;tubulin binding;G protein-coupled receptor signaling pathway;integral component of membrane;G protein-coupled receptor activity;membrane;signal transduction	3D-structure;Alternative splicing;Cell cycle;Coiled coil;Cytoplasm;Cytoskeleton;GTPase activation;Phosphoprotein;Reference proteome	R-HSA-5653656;R-HSA-199991;R-HSA-9007101;R-HSA-8854214	Vesicle-mediated transport;Membrane Trafficking;Rab regulation of trafficking;TBC/RABGAPs
PDSS1	negative	CBX7	ENSG00000100307	PDSS1	1	PDSS1	1	0.00353608534654548		WBGene00007615(0);WBGene00001995(0)	CDH1		GO:0005634;GO:0005829;GO:0005654;GO:0006325;GO:0000790;GO:0005515;GO:0000122;GO:0031519;GO:0035102	PRC1 complex;nucleus;nucleoplasm;cytosol;chromatin organization;nuclear chromatin;protein binding;negative regulation of transcription by RNA polymerase II;PcG protein complex	3D-structure;Chromatin regulator;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation		
PDSS1	negative	MAPK8IP3	ENSG00000138834	PDSS1	1	PDSS1	1	0.00353608534654548	WBGene00006755;WBGene00019832	WBGene00006755(1)		Intellectual Disability with Variable Brain Anomalies;NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAINABNORMALITIES	GO:0005737;GO:0005794;GO:1904115;GO:0042995;GO:0005515;GO:0000139;GO:0048471;GO:0031410;GO:0030425;GO:0016192;GO:0005078;GO:0030424;GO:0030426;GO:0099641;GO:0044297;GO:0019894;GO:0007257;GO:0008432;GO:0030159;GO:0046328;GO:0061564;GO:0031103;GO:0043410;GO:0031434;GO:0031435;GO:0001701;GO:0007254;GO:0007411;GO:0007585;GO:0008104;GO:0009791;GO:0010468;GO:0030900;GO:0031175;GO:0043507;GO:0045666;GO:0048286;GO:0060425;GO:2001224;GO:0005790;GO:0005886;GO:0030673;GO:0043005	protein binding;MAP-kinase scaffold activity;cytoplasm;Golgi apparatus;axon cytoplasm;cell projection;perinuclear region of cytoplasm;cytoplasmic vesicle;Golgi membrane;vesicle-mediated transport;dendrite;axon;growth cone;anterograde axonal protein transport;cell body;kinesin binding;activation of JUN kinase activity;JUN kinase binding;receptor signaling complex adaptor activity;regulation of JNK cascade;axon development;axon regeneration;positive regulation of MAPK cascade;mitogen-activated protein kinase kinase binding;mitogen-activated protein kinase kinase kinase binding;in utero embryonic development;JNK cascade;axon guidance;respiratory gaseous exchange by respiratory system;protein localization;post-embryonic development;regulation of gene expression;forebrain development;neuron projection development;positive regulation of JUN kinase activity;positive regulation of neuron differentiation;lung alveolus development;lung morphogenesis;positive regulation of neuron migration;smooth endoplasmic reticulum;plasma membrane;axolemma;neuron projection	3D-structure;Alternative splicing;Cell projection;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Disease mutation;Golgi apparatus;Mental retardation;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	negative	SPSB3	ENSG00000162032	PDSS1	1	PDSS1	1	0.00353608534654548					GO:0016567;GO:0005515;GO:0006511;GO:0005829;GO:0043161;GO:0043687;GO:0019005	protein binding;protein ubiquitination;ubiquitin-dependent protein catabolic process;cytosol;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;SCF ubiquitin ligase complex	Polymorphism;Reference proteome	R-HSA-392499;R-HSA-597592;R-HSA-8951664	Metabolism of proteins;Post-translational protein modification;Neddylation
PDSS1	negative	DHRS3	ENSG00000162496	PDSS1	1	PDSS1	1	0.00353608534654548				DHRS3 related craniosynostosis	GO:0016020;GO:0016021;GO:0016491;GO:0055114;GO:0022900;GO:0042572;GO:0005789;GO:0004745;GO:0007601;GO:0052650;GO:0001523;GO:0009055;GO:0000166;GO:0005811;GO:0003151;GO:0030278;GO:0048385;GO:0048387;GO:0060021;GO:0060349;GO:0060411;GO:0042622	retinol metabolic process;retinol dehydrogenase activity;membrane;integral component of membrane;oxidoreductase activity;oxidation-reduction process;electron transport chain;endoplasmic reticulum membrane;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;visual perception;NADP-retinol dehydrogenase activity;retinoid metabolic process;electron transfer activity;nucleotide binding;outflow tract morphogenesis;regulation of ossification;regulation of retinoic acid receptor signaling pathway;roof of mouth development;bone morphogenesis;cardiac septum morphogenesis;lipid droplet;photoreceptor outer segment membrane	Alternative splicing;Membrane;NADP;Oxidoreductase;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418594;R-HSA-9006931;R-HSA-5362517;R-HSA-2187338;R-HSA-5365859;R-HSA-2187335	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Signaling by Nuclear Receptors;Signaling by Retinoic Acid;Visual phototransduction;RA biosynthesis pathway;The retinoid cycle in cones (daylight vision)
PDSS1	negative	TIMP2	ENSG00000035862	PDSS1	1	PDSS1	1	0.00377212556058704	WBGene00019478	WBGene00019478(0)			GO:0005576;GO:0008191;GO:0010951;GO:0005515;GO:0046872;GO:0008270;GO:0005615;GO:0005178;GO:0007417;GO:0007568;GO:0008285;GO:0032487;GO:0034097;GO:0042493;GO:0043410;GO:0045666;GO:0045762;GO:0045861;GO:0045930;GO:0046580;GO:0009986;GO:0030426;GO:0043005;GO:0043025;GO:0031012;GO:0030414;GO:0010466;GO:0062023;GO:0002020;GO:0043312;GO:1904813;GO:0035580;GO:1904724;GO:0022617;GO:0004857;GO:0010033;GO:0009725;GO:0051045;GO:1905049	protein binding;metalloendopeptidase inhibitor activity;negative regulation of endopeptidase activity;extracellular region;metal ion binding;zinc ion binding;extracellular space;integrin binding;central nervous system development;aging;negative regulation of cell population proliferation;regulation of Rap protein signal transduction;response to cytokine;response to drug;positive regulation of MAPK cascade;positive regulation of neuron differentiation;positive regulation of adenylate cyclase activity;negative regulation of proteolysis;negative regulation of mitotic cell cycle;negative regulation of Ras protein signal transduction;cell surface;growth cone;neuron projection;neuronal cell body;extracellular matrix;peptidase inhibitor activity;negative regulation of peptidase activity;collagen-containing extracellular matrix;protease binding;neutrophil degranulation;ficolin-1-rich granule lumen;specific granule lumen;tertiary granule lumen;extracellular matrix disassembly;enzyme inhibitor activity;response to organic substance;response to hormone;negative regulation of membrane protein ectodomain proteolysis;negative regulation of metallopeptidase activity	3D-structure;Direct protein sequencing;Disulfide bond;Metal-binding;Metalloenzyme inhibitor;Metalloprotease inhibitor;Protease inhibitor;Reference proteome;Secreted;Signal;Zinc	R-HSA-168249;R-HSA-168256;R-HSA-1474228;R-HSA-1474244;R-HSA-6798695;R-HSA-1592389	Innate Immune System;Immune System;Degradation of the extracellular matrix;Extracellular matrix organization;Neutrophil degranulation;Activation of Matrix Metalloproteinases
PDSS1	negative	TRIM8	ENSG00000171206	PDSS1	1	PDSS1	1	0.00377212556058704				Early infantile epileptic encephalopathy	GO:0005634;GO:0005737;GO:0046872;GO:0016740;GO:0016567;GO:0008270;GO:0042803;GO:0005515;GO:0002376;GO:0045087;GO:0042802;GO:0005829;GO:0010508;GO:0043123;GO:0016605;GO:0051092;GO:0051091;GO:0060333;GO:1902187;GO:0019827;GO:0032897;GO:0046597;GO:1900182	nucleus;cytoplasm;metal ion binding;transferase activity;protein ubiquitination;zinc ion binding;protein homodimerization activity;protein binding;immune system process;innate immune response;identical protein binding;PML body;cytosol;positive regulation of autophagy;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of NF-kappaB transcription factor activity;positive regulation of DNA-binding transcription factor activity;interferon-gamma-mediated signaling pathway;negative regulation of viral release from host cell;stem cell population maintenance;negative regulation of viral transcription;negative regulation of viral entry into host cell;positive regulation of protein localization to nucleus	Coiled coil;Cytoplasm;Disease mutation;Immunity;Innate immunity;Metal-binding;Nucleus;Reference proteome;Repeat;Transferase;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-168256;R-HSA-1280215;R-HSA-913531;R-HSA-877300	Immune System;Cytokine Signaling in Immune system;Interferon Signaling;Interferon gamma signaling
PDSS1	negative	TCEA2	ENSG00000171703	PDSS1	1	PDSS1	1	0.00377212556058704	WBGene00012000	WBGene00012000(0)			GO:0005634;GO:0003676;GO:0008270;GO:0046872;GO:0006355;GO:0003677;GO:0006351;GO:0005515;GO:0008023;GO:0032784;GO:0006354;GO:0003746;GO:0006414;GO:0045944	zinc ion binding;regulation of transcription, DNA-templated;nucleus;transcription, DNA-templated;nucleic acid binding;metal ion binding;DNA binding;protein binding;transcription elongation factor complex;regulation of DNA-templated transcription, elongation;DNA-templated transcription, elongation;translation elongation factor activity;translational elongation;positive regulation of transcription by RNA polymerase II	3D-structure;Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
PDSS1	negative	CTSF	ENSG00000174080	PDSS1	1	PDSS1	1	0.00377212556058704	WBGene00007055;WBGene00000776;WBGene00019986	WBGene00000784(0);WBGene00000785(0);WBGene00013076(0);WBGene00013072(0);WBGene00013764(0);WBGene00009158(0);WBGene00019314(0);WBGene00016306(0);WBGene00016300(0);WBGene00044760(0);WBGene00022189(0);WBGene00019986(0);WBGene00007055(0);WBGene00000782(0);WBGene00000781(0)		CLN13 disease;CEROID LIPOFUSCINOSIS NEURONAL 13	GO:0016787;GO:0008233;GO:0008234;GO:0006508;GO:0005764;GO:0005615;GO:0070062;GO:0004197;GO:0062023;GO:0019886;GO:0043202;GO:1903561;GO:0051603	proteolysis;cysteine-type peptidase activity;hydrolase activity;peptidase activity;lysosome;extracellular space;extracellular exosome;cysteine-type endopeptidase activity;collagen-containing extracellular matrix;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal lumen;extracellular vesicle;proteolysis involved in cellular protein catabolic process	3D-structure;Disease mutation;Disulfide bond;Glycoprotein;Hydrolase;Lysosome;Neurodegeneration;Neuronal ceroid lipofuscinosis;Polymorphism;Protease;Reference proteome;Signal;Thiol protease;Zymogen	R-HSA-1280218;R-HSA-168256;R-HSA-2132295	Adaptive Immune System;Immune System;MHC class II antigen presentation
PDSS1	negative	ZNF211	ENSG00000121417	PDSS1	1	PDSS1	1	0.00402219673779181	WBGene00021931;WBGene00001223	WBGene00019960(0);WBGene00001223(0);WBGene00017406(0)			GO:0003676;GO:0046872;GO:0006355;GO:0005622;GO:0005634;GO:0003677	regulation of transcription, DNA-templated;nucleic acid binding;metal ion binding;nucleus;DNA binding	Alternative splicing;DNA-binding;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
PDSS1	negative	ZER1	ENSG00000160445	PDSS1	1	PDSS1	1	0.00402219673779181	WBGene00020762	WBGene00020762(1)			GO:0031462;GO:0006515;GO:0032436;GO:0005515	protein binding;Cul2-RING ubiquitin ligase complex;protein quality control for misfolded or incompletely synthesized proteins;positive regulation of proteasomal ubiquitin-dependent protein catabolic process	Acetylation;Leucine-rich repeat;Polymorphism;Reference proteome;Repeat;Ubl conjugation pathway		
PDSS1	negative	HGSNAT	ENSG00000165102	PDSS1	1	PDSS1	1	0.00402219673779181				Retinitis pigmentosa;Sanfilippo syndrome type C;MUCOPOLYSACCHARIDOSIS TYPE 3C;MUCOPOLYSACCHARIDOSIS TYPE IIIC;RETINITIS PIGMENTOSA 73	GO:0016020;GO:0016021;GO:0016740;GO:0005765;GO:0016746;GO:0005764;GO:0005886;GO:0043312;GO:0035579;GO:0070821;GO:0015019;GO:0051259;GO:0006027;GO:0007041	lysosomal membrane;heparan-alpha-glucosaminide N-acetyltransferase activity;membrane;integral component of membrane;transferase activity;transferase activity, transferring acyl groups;lysosome;plasma membrane;neutrophil degranulation;specific granule membrane;tertiary granule membrane;protein complex oligomerization;glycosaminoglycan catabolic process;lysosomal transport	Acyltransferase;Alternative initiation;Disease mutation;Disulfide bond;Glycoprotein;Lysosome;Membrane;Mucopolysaccharidosis;Phosphoprotein;Reference proteome;Retinitis pigmentosa;Transferase;Transmembrane;Transmembrane helix	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-1643685;R-HSA-71387;R-HSA-6798695;R-HSA-1630316;R-HSA-1638091;R-HSA-2024096;R-HSA-5668914;R-HSA-5663084;R-HSA-2206281;R-HSA-2206291	Innate Immune System;Immune System;Metabolism;Disease;Metabolism of carbohydrates;Neutrophil degranulation;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;HS-GAG degradation;Diseases of metabolism;Diseases of carbohydrate metabolism;Mucopolysaccharidoses;MPS IIIC - Sanfilippo syndrome C
PDSS1	negative	PCMTD2	ENSG00000203880	PDSS1	1	PDSS1	1	0.00402219673779181	WBGene00020090	WBGene00020090(0)			GO:0005737;GO:0006464;GO:0032259;GO:0004719;GO:0006479	cellular protein modification process;protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;cytoplasm;protein methylation	Alternative splicing;Cytoplasm;Lipoprotein;Myristate;Reference proteome		
PDSS1	negative	AHNAK	ENSG00000124942	PDSS1	1	PDSS1	1	0.00428700919956582					GO:0005515;GO:0003723;GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0005765;GO:0005886;GO:0045121;GO:0005925;GO:0045296;GO:0070062;GO:0042383;GO:0043484;GO:0030315;GO:0031982;GO:1901385;GO:0051259;GO:0044548;GO:0015629;GO:0043034;GO:0044291;GO:0097493	protein binding;RNA binding;nucleus;cytoplasm;membrane;cytosol;plasma membrane;lysosomal membrane;focal adhesion;membrane raft;cadherin binding;extracellular exosome;sarcolemma;regulation of RNA splicing;T-tubule;vesicle;regulation of voltage-gated calcium channel activity;S100 protein binding;actin cytoskeleton;costamere;cell-cell contact zone;structural molecule activity conferring elasticity	3D-structure;Acetylation;Alternative splicing;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation		
PDSS1	negative	VPS13B	ENSG00000132549	PDSS1	1	PDSS1	1	0.00428700919956582	WBGene00016120			Cohen syndrome;Cohen syndrome;Cohen syndrome	GO:0015031	protein transport	Alternative splicing;Disease mutation;Obesity;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport		
PDSS1	negative	KLHL36	ENSG00000135686	PDSS1	1	PDSS1	1	0.00428700919956582					GO:0016567;GO:0005515	protein binding;protein ubiquitination;biological_process;cellular_component;cullin family protein binding	Alternative splicing;Kelch repeat;Reference proteome;Repeat;Ubl conjugation pathway		
PDSS1	negative	CDK19	ENSG00000155111	PDSS1	1	PDSS1	1	0.00428700919956582	WBGene00000409				GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0051726;GO:0005634;GO:0005829;GO:0016592;GO:0004693;GO:0008353;GO:0043065;GO:0050729;GO:0071222	ATP binding;protein phosphorylation;protein kinase activity;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;regulation of cell cycle;nucleus;cytosol;mediator complex;cyclin-dependent protein serine/threonine kinase activity;RNA polymerase II CTD heptapeptide repeat kinase activity;positive regulation of apoptotic process;positive regulation of inflammatory response;cellular response to lipopolysaccharide	ATP-binding;Acetylation;Alternative splicing;Kinase;Nucleotide-binding;Phosphoprotein;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-1266738;R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-381340;R-HSA-400206	Developmental Biology;Metabolism;Metabolism of lipids;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha
PDSS1	negative	ZBTB4	ENSG00000174282	PDSS1	1	PDSS1	1	0.00428700919956582		WBGene00011925(0);WBGene00011924(0);WBGene00005008(0);WBGene00006827(0)			GO:0003676;GO:0005634;GO:0046872;GO:0005829;GO:0005654;GO:0003677;GO:0005694;GO:0042803;GO:0006974;GO:0016604;GO:0043565;GO:0003700;GO:0006355;GO:0005515;GO:0000981;GO:0001227;GO:0000122;GO:0019901;GO:0045892;GO:0000977;GO:0008327;GO:0010428	protein binding;nucleic acid binding;nucleus;metal ion binding;nucleoplasm;cytosol;DNA binding;chromosome;protein homodimerization activity;cellular response to DNA damage stimulus;nuclear body;sequence-specific DNA binding;DNA-binding transcription factor activity;regulation of transcription, DNA-templated;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;protein kinase binding;negative regulation of transcription, DNA-templated;RNA polymerase II regulatory region sequence-specific DNA binding;methyl-CpG binding;methyl-CpNpG binding	Chromosome;Coiled coil;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
PDSS1	negative	FOXO4	ENSG00000184481	PDSS1	1	PDSS1	1	0.00456730096571911	WBGene00000912		BCL6;CREB1;SOD2;TNFSF10		GO:0005634;GO:0005737;GO:0016607;GO:0005829;GO:0006355;GO:0003677;GO:0003700;GO:0043565;GO:0005515;GO:0007049;GO:0007275;GO:0030154;GO:0042802;GO:0000981;GO:0007517;GO:0045944;GO:0000122;GO:0000790;GO:0008134;GO:0005654;GO:0008285;GO:0016579;GO:0007050;GO:0048863;GO:0001228;GO:0008286;GO:0042593;GO:0019899;GO:0006366;GO:0016525;GO:0051151;GO:0071158;GO:0008013;GO:0070317;GO:1990841;GO:0007095;GO:0007568;GO:0014911;GO:0031667;GO:0045893;GO:1990785	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;sequence-specific DNA binding;nucleus;cytoplasm;nuclear speck;cytosol;DNA binding;protein binding;cell cycle;multicellular organism development;cell differentiation;identical protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;muscle organ development;positive regulation of transcription by RNA polymerase II;negative regulation of transcription by RNA polymerase II;nuclear chromatin;transcription factor binding;nucleoplasm;negative regulation of cell population proliferation;protein deubiquitination;cell cycle arrest;stem cell differentiation;DNA-binding transcription activator activity, RNA polymerase II-specific;insulin receptor signaling pathway;glucose homeostasis;enzyme binding;transcription by RNA polymerase II;negative regulation of angiogenesis;negative regulation of smooth muscle cell differentiation;positive regulation of cell cycle arrest;beta-catenin binding;negative regulation of G0 to G1 transition;promoter-specific chromatin binding;mitotic G2 DNA damage checkpoint;aging;positive regulation of smooth muscle cell migration;response to nutrient levels;positive regulation of transcription, DNA-templated;response to water-immersion restraint stress	3D-structure;Acetylation;Activator;Alternative splicing;Cell cycle;Chromosomal rearrangement;Cytoplasm;DNA-binding;Developmental protein;Differentiation;Myogenesis;Nucleus;Pharmaceutical;Phosphoprotein;Proto-oncogene;Reference proteome;Transcription;Transcription regulation;Ubl conjugation	R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1643685;R-HSA-1257604;R-HSA-5663202;R-HSA-5688426;R-HSA-5689880;R-HSA-9006925;R-HSA-198693;R-HSA-2219528;R-HSA-5674400;R-HSA-9614085;R-HSA-9614399;R-HSA-9615017;R-HSA-9617828;R-HSA-9614657;R-HSA-9617629	Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Disease;PIP3 activates AKT signaling;Diseases of signal transduction;Deubiquitination;Ub-specific processing proteases;Intracellular signaling by second messengers;AKT phosphorylates targets in the nucleus;PI3K/AKT Signaling in Cancer;Constitutive Signaling by AKT1 E17K in Cancer;FOXO-mediated transcription;Regulation of localization of FOXO transcription factors;FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes;FOXO-mediated transcription of cell cycle genes;FOXO-mediated transcription of cell death genes;Regulation of FOXO transcriptional activity by acetylation
PDSS1	negative	OGA	ENSG00000198408	PDSS1	1	PDSS1	1	0.00456730096571911	WBGene00020596	WBGene00020596(1)			GO:0005634;GO:0005737;GO:0016020;GO:0005829;GO:0016787;GO:0008152;GO:0016798;GO:0016032;GO:0004415;GO:0016231;GO:0102166;GO:0102167;GO:0102571;GO:0006044;GO:0006493;GO:0006516;GO:0006517;GO:0009100	nucleus;cytoplasm;membrane;cytosol;hydrolase activity;metabolic process;hydrolase activity, acting on glycosyl bonds;viral process;hyalurononglucosaminidase activity;beta-N-acetylglucosaminidase activity;[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity;[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity;[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity;N-acetylglucosamine metabolic process;protein O-linked glycosylation;glycoprotein catabolic process;protein deglycosylation;glycoprotein metabolic process	3D-structure;Alternative splicing;Cytoplasm;Glycosidase;Host-virus interaction;Hydrolase;Nucleus;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	negative	CDIPT	ENSG00000103502	PDSS1	1	PDSS1	1	0.00486383831623993	WBGene00012897	WBGene00012897(1)			GO:0016020;GO:0016021;GO:0016740;GO:0005783;GO:0005789;GO:0005794;GO:0006629;GO:0016780;GO:0008654;GO:0005886;GO:0005515;GO:0000139;GO:0003881;GO:0019992;GO:0030145;GO:0030246;GO:0043178;GO:0006661;GO:0046341	membrane;phosphotransferase activity, for other substituted phosphate groups;phospholipid biosynthetic process;integral component of membrane;transferase activity;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;lipid metabolic process;plasma membrane;protein binding;Golgi membrane;CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity;diacylglycerol binding;manganese ion binding;carbohydrate binding;alcohol binding;phosphatidylinositol biosynthetic process;CDP-diacylglycerol metabolic process	Alternative splicing;Cell membrane;Endoplasmic reticulum;Golgi apparatus;Lipid biosynthesis;Lipid metabolism;Magnesium;Manganese;Membrane;Phospholipid biosynthesis;Phospholipid metabolism;Polymorphism;Reference proteome;Transferase;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-556833;R-HSA-1483257;R-HSA-1483206;R-HSA-1483226	Metabolism;Metabolism of lipids;Phospholipid metabolism;Glycerophospholipid biosynthesis;Synthesis of PI
PDSS1	negative	DNASE2	ENSG00000105612	PDSS1	1	PDSS1	1	0.00486383831623993	WBGene00007056;WBGene00000799;WBGene00003828	WBGene00007056(1);WBGene00003828(1);WBGene00000799(1)			GO:0016787;GO:0006259;GO:0006915;GO:0004519;GO:0007275;GO:0004518;GO:0004520;GO:0004531;GO:0000737;GO:0006308;GO:0030218;GO:0050776;GO:0005764;GO:0070062;GO:0003677;GO:0006309	deoxyribonuclease II activity;DNA metabolic process;hydrolase activity;apoptotic process;multicellular organism development;nuclease activity;endonuclease activity;endodeoxyribonuclease activity;DNA catabolic process, endonucleolytic;DNA catabolic process;erythrocyte differentiation;regulation of immune response;lysosome;extracellular exosome;DNA binding;apoptotic DNA fragmentation	Alternative splicing;Apoptosis;Developmental protein;Disulfide bond;Endonuclease;Glycoprotein;Hydrolase;Lysosome;Nuclease;Polymorphism;Reference proteome;Signal	R-HSA-5653656;R-HSA-199991;R-HSA-199992;R-HSA-432720	Vesicle-mediated transport;Membrane Trafficking;trans-Golgi Network Vesicle Budding;Lysosome Vesicle Biogenesis
PDSS1	negative	MXI1	ENSG00000119950	PDSS1	1	PDSS1	1	0.00486383831623993	WBGene00003163	WBGene00003163(0)		Prostate Cancer	GO:0005634;GO:0005730;GO:0005829;GO:0046983;GO:0003677;GO:0005515;GO:0000981;GO:0000790;GO:0001227;GO:0000122;GO:0042994;GO:0003714;GO:0000977;GO:0090575;GO:0008285	protein dimerization activity;nucleus;nucleoplasm;nucleolus;cytosol;DNA binding;protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;cytoplasmic sequestering of transcription factor;transcription corepressor activity;RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II transcription factor complex;negative regulation of cell population proliferation	Alternative splicing;DNA-binding;Disease mutation;Nucleus;Proto-oncogene;Reference proteome;Repressor;Transcription;Transcription regulation		
PDSS1	negative	BCAS3	ENSG00000141376	PDSS1	1	PDSS1	1	0.00486383831623993	WBGene00018953	WBGene00018953(0)			GO:0005730;GO:0005634;GO:0005737;GO:0005856;GO:0005515;GO:0043547;GO:0045944;GO:2000114;GO:0031252;GO:0003682;GO:0090630;GO:0001525;GO:0008134;GO:0042393;GO:0051491;GO:0010595;GO:0035148;GO:0051895;GO:0010698;GO:0048487;GO:0007030;GO:0090316;GO:0005881;GO:0071391;GO:0035257;GO:0042594;GO:0031023;GO:0035327;GO:0043085;GO:0035035;GO:2000251;GO:0045111;GO:0034260;GO:0071944	protein binding;nucleus;cytoplasm;cytoskeleton;positive regulation of GTPase activity;positive regulation of transcription by RNA polymerase II;regulation of establishment of cell polarity;cell leading edge;chromatin binding;activation of GTPase activity;angiogenesis;transcription factor binding;histone binding;positive regulation of filopodium assembly;positive regulation of endothelial cell migration;tube formation;negative regulation of focal adhesion assembly;acetyltransferase activator activity;beta-tubulin binding;Golgi organization;positive regulation of intracellular protein transport;cytoplasmic microtubule;cellular response to estrogen stimulus;nuclear hormone receptor binding;response to starvation;microtubule organizing center organization;transcriptionally active chromatin;positive regulation of catalytic activity;histone acetyltransferase binding;positive regulation of actin cytoskeleton reorganization;intermediate filament cytoskeleton;negative regulation of GTPase activity;cell periphery	Acetylation;Alternative splicing;Angiogenesis;Chromosomal rearrangement;Cytoplasm;Cytoskeleton;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Proto-oncogene;Reference proteome;Transcription;Transcription regulation;Ubl conjugation		
PDSS1	negative	TMEM80	ENSG00000177042	PDSS1	1	PDSS1	1	0.00486383831623993	WBGene00194710;WBGene00016247	WBGene00194710(0)			GO:0016020;GO:0016021;GO:0042995;GO:0005929;GO:0035869;GO:1905515	membrane;integral component of membrane;cell projection;cilium;ciliary transition zone;non-motile cilium assembly	Alternative initiation;Alternative splicing;Cell projection;Membrane;Reference proteome;Transmembrane;Transmembrane helix		
PDSS1	negative	ZNF688	ENSG00000229809	PDSS1	1	PDSS1	1	0.00486383831623993		WBGene00013734(0)			GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0003677;GO:0003700;GO:0043565;GO:0003674;GO:0008150;GO:0005575;GO:0005622	regulation of transcription, DNA-templated;nucleic acid binding;nucleus;metal ion binding;DNA binding;DNA-binding transcription factor activity;sequence-specific DNA binding;molecular_function;biological_process;cellular_component	Alternative splicing;DNA-binding;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
PDSS1	negative	CBFA2T2	ENSG00000078699	PDSS1	1	PDSS1	1	0.00517741633158875					GO:0005634;GO:0046872;GO:0006355;GO:0003700;GO:0003714;GO:0005515;GO:0045892;GO:0010976;GO:0010977;GO:0000122;GO:0030855;GO:0045746;GO:0060575	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;transcription corepressor activity;negative regulation of transcription, DNA-templated;nucleus;metal ion binding;protein binding;positive regulation of neuron projection development;negative regulation of neuron projection development;negative regulation of transcription by RNA polymerase II;epithelial cell differentiation;negative regulation of Notch signaling pathway;intestinal epithelial cell differentiation	Alternative splicing;Coiled coil;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
PDSS1	negative	VAMP4	ENSG00000117533	PDSS1	1	PDSS1	1	0.00517741633158875	WBGene00004897;WBGene00004898;WBGene00007200	WBGene00004899(0);WBGene00014084(0);WBGene00044062(0)			GO:0016020;GO:0016021;GO:0016192;GO:0005794;GO:0005515;GO:0005886;GO:0005764;GO:0009986;GO:0032588;GO:0061024;GO:0000226;GO:0030133;GO:0090161;GO:0030665;GO:0000139;GO:0005768;GO:0016189;GO:0035493;GO:1900242;GO:0008021;GO:0030285	integral component of membrane;vesicle-mediated transport;Golgi ribbon formation;membrane;Golgi apparatus;protein binding;plasma membrane;lysosome;cell surface;trans-Golgi network membrane;membrane organization;microtubule cytoskeleton organization;transport vesicle;clathrin-coated vesicle membrane;Golgi membrane;endosome;synaptic vesicle to endosome fusion;SNARE complex assembly;regulation of synaptic vesicle endocytosis;synaptic vesicle;integral component of synaptic vesicle membrane	Alternative splicing;Coiled coil;Golgi apparatus;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-5653656;R-HSA-199991;R-HSA-6811442;R-HSA-8856828;R-HSA-8856825;R-HSA-6811440	Vesicle-mediated transport;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Clathrin-mediated endocytosis;Cargo recognition for clathrin-mediated endocytosis;Retrograde transport at the Trans-Golgi-Network
PDSS1	negative	ATG14	ENSG00000126775	PDSS1	1	PDSS1	1	0.00517741633158875					GO:0005737;GO:0016020;GO:0005783;GO:0005789;GO:0005515;GO:0031410;GO:0006914;GO:0005776;GO:0034045;GO:0005829;GO:0000045;GO:0001934;GO:0000421;GO:0016236;GO:0005930;GO:0008333;GO:0001933;GO:0042149;GO:0000423;GO:0051020;GO:0097629;GO:0097632;GO:0016240;GO:0043552;GO:0009267;GO:0061635;GO:0098780;GO:0035032;GO:0001932;GO:0010608;GO:0090207;GO:0044233;GO:0045335	cytoplasm;membrane;endoplasmic reticulum;endoplasmic reticulum membrane;protein binding;cytoplasmic vesicle;autophagy;autophagosome;phagophore assembly site membrane;cytosol;autophagosome assembly;positive regulation of protein phosphorylation;autophagosome membrane;macroautophagy;axoneme;endosome to lysosome transport;negative regulation of protein phosphorylation;cellular response to glucose starvation;mitophagy;GTPase binding;extrinsic component of omegasome membrane;extrinsic component of phagophore assembly site membrane;autophagosome membrane docking;positive regulation of phosphatidylinositol 3-kinase activity;cellular response to starvation;regulation of protein complex stability;response to mitochondrial depolarisation;phosphatidylinositol 3-kinase complex, class III;regulation of protein phosphorylation;posttranscriptional regulation of gene expression;regulation of triglyceride metabolic process;mitochondria-associated endoplasmic reticulum membrane;phagocytic vesicle	3D-structure;Alternative splicing;Autophagy;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Endoplasmic reticulum;Membrane;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-9612973;R-HSA-8953897;R-HSA-1632852	Autophagy;Cellular responses to external stimuli;Macroautophagy
PDSS1	negative	RETREG3	ENSG00000141699	PDSS1	1	PDSS1	1	0.00517741633158875					GO:0016020;GO:0016021;GO:0010976;GO:0005515;GO:0032991	positive regulation of neuron projection development;membrane;integral component of membrane;protein binding;protein-containing complex	Acetylation;Alternative splicing;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix		
PDSS1	negative	RAB33B	ENSG00000172007	PDSS1	1	PDSS1	1	0.00517741633158875	WBGene00004283			SMITH-MCCORT DYSPLASIA;SMITH-MCCORT DYSPLASIA 2	GO:0003924;GO:0005525;GO:0032482;GO:0016020;GO:0015031;GO:0000166;GO:0005794;GO:0000139;GO:0006914;GO:0006891;GO:0006886;GO:0005515;GO:0005796;GO:0034067;GO:0048705;GO:1903358;GO:0000045;GO:1903434;GO:2000156;GO:0098793	GTP binding;GTPase activity;Rab protein signal transduction;membrane;protein transport;nucleotide binding;Golgi apparatus;autophagy;Golgi membrane;intra-Golgi vesicle-mediated transport;protein binding;intracellular protein transport;endomembrane system;Golgi lumen;protein localization to Golgi apparatus;skeletal system morphogenesis;regulation of Golgi organization;autophagosome assembly;negative regulation of constitutive secretory pathway;regulation of retrograde vesicle-mediated transport, Golgi to ER;presynapse	Autophagy;Disease mutation;Dwarfism;GTP-binding;Golgi apparatus;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Prenylation;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-6811442;R-HSA-9007101;R-HSA-8873719;R-HSA-6811438;R-HSA-8854214	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;Intra-Golgi and retrograde Golgi-to-ER traffic;Rab regulation of trafficking;RAB geranylgeranylation;Intra-Golgi traffic;TBC/RABGAPs
PDSS1	negative	ZNF75D	ENSG00000186376	PDSS1	1	PDSS1	1	0.00517741633158875	WBGene00044651				GO:0003676;GO:0005634;GO:0046872;GO:0006355;GO:0008270;GO:0003677;GO:0003700;GO:0005622	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;nucleic acid binding;nucleus;metal ion binding;zinc ion binding;DNA binding	Alternative splicing;DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
PDSS1	negative	PBLD	ENSG00000108187	PDSS1	1	PDSS1	1	0.00550885940896873	WBGene00011417;WBGene00011419;WBGene00011420;WBGene00011416;WBGene00235310	WBGene00011417(1);WBGene00011416(1);WBGene00011420(1);WBGene00235310(1);WBGene00011419(1)			GO:0003824;GO:0009058;GO:0005737;GO:0016853;GO:0005515;GO:0042802;GO:0070062;GO:0003674;GO:0050680;GO:0010719;GO:0030512;GO:0060394;GO:0030277;GO:0010633;GO:0060392	catalytic activity;biosynthetic process;cytoplasm;isomerase activity;protein binding;identical protein binding;extracellular exosome;molecular_function;negative regulation of epithelial cell proliferation;negative regulation of epithelial to mesenchymal transition;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of pathway-restricted SMAD protein phosphorylation;maintenance of gastrointestinal epithelium;negative regulation of epithelial cell migration;negative regulation of SMAD protein signal transduction	Alternative splicing;Direct protein sequencing;Isomerase;Polymorphism;Reference proteome		
PDSS1	negative	ING4	ENSG00000111653	PDSS1	1	PDSS1	1	0.00550885940896873	WBGene00013095;WBGene00021545;WBGene00020287	WBGene00020287(0)	ARL6IP5;BAX;CASP3;CDKN1A;CDKN1B;TP53		GO:0005634;GO:0046872;GO:0005829;GO:1903508;GO:0006325;GO:0045111;GO:0005515;GO:0007049;GO:0006915;GO:0006260;GO:0016573;GO:0008285;GO:0003713;GO:0035064;GO:0043065;GO:0005654;GO:0007050;GO:0045892;GO:0043981;GO:0043982;GO:0000123;GO:0045926;GO:0006473;GO:0043966;GO:0043983;GO:0006978	nucleus;histone acetylation;positive regulation of apoptotic process;negative regulation of cell population proliferation;methylated histone binding;metal ion binding;nucleoplasm;cytosol;positive regulation of nucleic acid-templated transcription;chromatin organization;intermediate filament cytoskeleton;protein binding;cell cycle;apoptotic process;DNA replication;transcription coactivator activity;cell cycle arrest;negative regulation of transcription, DNA-templated;histone H4-K5 acetylation;histone H4-K8 acetylation;histone acetyltransferase complex;negative regulation of growth;protein acetylation;histone H3 acetylation;histone H4-K12 acetylation;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	3D-structure;Acetylation;Alternative splicing;Apoptosis;Cell cycle;Chromatin regulator;Citrullination;Coiled coil;Metal-binding;Nucleus;Reference proteome;Tumor suppressor;Zinc;Zinc-finger	R-HSA-3247509;R-HSA-4839726;R-HSA-3214847	Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones
PDSS1	negative	GSN	ENSG00000148180	PDSS1	1	PDSS1	1	0.00550885940896873	WBGene00010593	WBGene00010593(0)		AGel amyloidosis;AMYLOIDOSIS FINNISH TYPE	GO:0005634;GO:0005737;GO:0046872;GO:0005509;GO:0003779;GO:0051015;GO:0005615;GO:0005829;GO:0005886;GO:0051016;GO:0051693;GO:0005856;GO:0005515;GO:0005576;GO:0045010;GO:0005925;GO:0051014;GO:0006911;GO:0006915;GO:0007568;GO:0008154;GO:0014003;GO:0016192;GO:0030041;GO:0030155;GO:0042060;GO:0042246;GO:0045471;GO:0048015;GO:0051593;GO:0071276;GO:0071346;GO:1903923;GO:0001726;GO:0015629;GO:0030027;GO:0032991;GO:0043209;GO:0045335;GO:0048471;GO:0060271;GO:0070062;GO:0031648;GO:0010628;GO:0044267;GO:0002102;GO:0030030;GO:0072562;GO:0043312;GO:2001269;GO:0034774;GO:1904813;GO:0030864;GO:0046597;GO:1990000;GO:0045159;GO:0014891;GO:0042989;GO:0051127;GO:0071801;GO:0090527;GO:0097017;GO:0097284;GO:1902174;GO:1903903;GO:1903906;GO:1903909;GO:0016528;GO:0030478	calcium ion binding;actin filament binding;actin nucleation;barbed-end actin filament capping;actin filament severing;cell;nucleus;cytoplasm;metal ion binding;actin binding;cytoskeleton;focal adhesion;extracellular space;cytosol;plasma membrane;protein binding;extracellular region;actin filament capping;cilium assembly;extracellular exosome;protein destabilization;positive regulation of gene expression;cellular protein metabolic process;podosome;cell projection organization;blood microparticle;neutrophil degranulation;actin filament polymerization;positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;secretory granule lumen;ficolin-1-rich granule lumen;actin cytoskeleton;cortical actin cytoskeleton;negative regulation of viral entry into host cell;amyloid fibril formation;myosin II binding;phagocytosis, engulfment;striated muscle atrophy;sequestering of actin monomers;positive regulation of actin nucleation;regulation of podosome assembly;actin filament reorganization;renal protein absorption;hepatocyte apoptotic process;positive regulation of keratinocyte apoptotic process;regulation of establishment of T cell polarity;regulation of plasma membrane raft polarization;regulation of receptor clustering;positive regulation of protein processing in phagocytic vesicle;sarcoplasm;actin cap;apoptotic process;aging;actin polymerization or depolymerization;oligodendrocyte development;vesicle-mediated transport;regulation of cell adhesion;wound healing;tissue regeneration;response to ethanol;phosphatidylinositol-mediated signaling;response to folic acid;cellular response to cadmium ion;cellular response to interferon-gamma;ruffle;lamellipodium;protein-containing complex;myelin sheath;phagocytic vesicle;perinuclear region of cytoplasm	3D-structure;Acetylation;Actin capping;Actin-binding;Alternative initiation;Alternative splicing;Amyloid;Amyloidosis;Calcium;Cilium biogenesis/degradation;Corneal dystrophy;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Disulfide bond;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Secreted;Signal	R-HSA-168249;R-HSA-168256;R-HSA-392499;R-HSA-109581;R-HSA-5357801;R-HSA-977225;R-HSA-6798695;R-HSA-75153;R-HSA-111465;R-HSA-264870	Innate Immune System;Immune System;Metabolism of proteins;Apoptosis;Programmed Cell Death;Amyloid fiber formation;Neutrophil degranulation;Apoptotic execution phase;Apoptotic cleavage of cellular proteins;Caspase-mediated cleavage of cytoskeletal proteins
PDSS1	negative	FAM102A	ENSG00000167106	PDSS1	1	PDSS1	1	0.00550885940896873	WBGene00006368	WBGene00006368(0)			GO:0005515	protein binding	Alternative splicing;Reference proteome		
PDSS1	negative	YPEL2	ENSG00000175155	PDSS1	1	PDSS1	1	0.00550885940896873	WBGene00009503;WBGene00015251				GO:0005634;GO:0046872;GO:0005730	nucleus;metal ion binding;nucleolus	Metal-binding;Nucleus;Reference proteome;Zinc		
PDSS1	negative	TUT7	ENSG00000083223	PDSS1	1	PDSS1	1	0.00585902175194253	WBGene00019629;WBGene00019628;WBGene00021338	WBGene00019628(0);WBGene00021338(0);WBGene00011131(0);WBGene00020345(0);WBGene00019629(0);WBGene00194706(0);WBGene00001596(0)			GO:0003676;GO:0008270;GO:0005829;GO:0005654;GO:0016779;GO:0003723;GO:0005737;GO:0046872;GO:0016740;GO:0005515;GO:0000289;GO:0001556;GO:0035198;GO:0031054;GO:0010586;GO:0050265;GO:0010526;GO:0031123;GO:0071076;GO:1990074;GO:0070569	zinc ion binding;nucleic acid binding;nucleotidyltransferase activity;nucleoplasm;cytosol;RNA binding;cytoplasm;metal ion binding;transferase activity;protein binding;nuclear-transcribed mRNA poly(A) tail shortening;oocyte maturation;miRNA binding;pre-miRNA processing;miRNA metabolic process;RNA uridylyltransferase activity;negative regulation of transposition, RNA-mediated;RNA 3'-end processing;RNA 3' uridylation;polyuridylation-dependent mRNA catabolic process;uridylyltransferase activity	3D-structure;Alternative splicing;Cytoplasm;Magnesium;Manganese;Metal-binding;Nucleotidyltransferase;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transferase;Zinc;Zinc-finger	R-HSA-8953854;R-HSA-429914;R-HSA-429947	Metabolism of RNA;Deadenylation-dependent mRNA decay;Deadenylation of mRNA
PDSS1	negative	MARCH2	ENSG00000099785	PDSS1	1	PDSS1	1	0.00585902175194253	WBGene00007643;WBGene00008433				GO:0016020;GO:0016021;GO:0008270;GO:0046872;GO:0016740;GO:0005783;GO:0005789;GO:0016567;GO:0005765;GO:0005515;GO:0004842;GO:0031410;GO:0005764;GO:0005768;GO:0006897;GO:0010008	zinc ion binding;membrane;integral component of membrane;metal ion binding;transferase activity;endoplasmic reticulum;cytosol;endoplasmic reticulum membrane;protein ubiquitination;endosome;lysosomal membrane;protein binding;cytoplasmic vesicle;ubiquitin protein ligase activity;lysosome;endocytosis;endosome membrane;ubiquitin-protein transferase activity	Alternative splicing;Endocytosis;Endoplasmic reticulum;Endosome;Lysosome;Membrane;Metal-binding;Polymorphism;Reference proteome;Transferase;Transmembrane;Transmembrane helix;Ubl conjugation pathway;Zinc;Zinc-finger		
PDSS1	negative	NMRK1	ENSG00000106733	PDSS1	1	PDSS1	1	0.00585902175194253	WBGene00020842				GO:0046872;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005515;GO:0009435;GO:0019363;GO:0005829;GO:0019674;GO:0050262;GO:0061769	metal ion binding;nucleotide binding;ATP binding;kinase activity;transferase activity;phosphorylation;protein binding;NAD biosynthetic process;pyridine nucleotide biosynthetic process;cytosol;NAD metabolic process;ribosylnicotinamide kinase activity;ribosylnicotinate kinase activity	3D-structure;ATP-binding;Alternative splicing;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Pyridine nucleotide biosynthesis;Reference proteome;Transferase	R-HSA-1430728;R-HSA-196854;R-HSA-196849;R-HSA-196807	Metabolism;Metabolism of vitamins and cofactors;Metabolism of water-soluble vitamins and cofactors;Nicotinate metabolism
PDSS1	negative	CDKN1B	ENSG00000111276	PDSS1	1	PDSS1	1	0.00585902175194253	WBGene00000517			Multiple endocrine neoplasia type 1;Multiple endocrine neoplasia type 4;MULTIPLE ENDOCRINE NEOPLASIA TYPE IV	GO:1904706;GO:0008285;GO:0005634;GO:0005737;GO:0043231;GO:0016301;GO:0016310;GO:0005515;GO:0007049;GO:0007050;GO:0004860;GO:0004861;GO:0005768;GO:0042127;GO:0006977;GO:0005654;GO:0005829;GO:0045736;GO:0045786;GO:0045892;GO:0000082;GO:0007507;GO:0019903;GO:0045930;GO:0051087;GO:0030308;GO:0010942;GO:0045732;GO:0000079;GO:0030332;GO:0045787;GO:0019901;GO:0044877;GO:0071850;GO:0033673;GO:0042326;GO:1904030;GO:1905179;GO:0005072;GO:0030544;GO:0001666;GO:0001890;GO:0006813;GO:0007096;GO:0007219;GO:0007605;GO:0008219;GO:0008284;GO:0009749;GO:0014070;GO:0031116;GO:0032355;GO:0042493;GO:0043066;GO:0043200;GO:0043434;GO:0045737;GO:0046686;GO:0048102;GO:0048839;GO:0050680;GO:0051271;GO:0060770;GO:0071236;GO:0071285;GO:0071407;GO:1902746;GO:0031464;GO:0032991	nucleus;cytoplasm;cyclin-dependent protein serine/threonine kinase inhibitor activity;cell cycle arrest;regulation of cell population proliferation;negative regulation of vascular smooth muscle cell proliferation;negative regulation of cell population proliferation;intracellular membrane-bounded organelle;kinase activity;phosphorylation;nucleoplasm;endosome;protein binding;cell cycle;protein kinase inhibitor activity;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;cytosol;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of cell cycle;negative regulation of transcription, DNA-templated;G1/S transition of mitotic cell cycle;heart development;protein phosphatase binding;negative regulation of mitotic cell cycle;chaperone binding;negative regulation of cell growth;positive regulation of cell death;positive regulation of protein catabolic process;regulation of cyclin-dependent protein serine/threonine kinase activity;cyclin binding;positive regulation of cell cycle;protein kinase binding;protein-containing complex binding;mitotic cell cycle arrest;negative regulation of kinase activity;negative regulation of phosphorylation;negative regulation of cyclin-dependent protein kinase activity;negative regulation of cardiac muscle tissue regeneration;transforming growth factor beta receptor, cytoplasmic mediator activity;Hsp70 protein binding;response to hypoxia;placenta development;potassium ion transport;regulation of exit from mitosis;Notch signaling pathway;sensory perception of sound;cell death;positive regulation of cell population proliferation;response to glucose;response to organic cyclic compound;positive regulation of microtubule polymerization;response to estradiol;response to drug;negative regulation of apoptotic process;response to amino acid;response to peptide hormone;positive regulation of cyclin-dependent protein serine/threonine kinase activity;response to cadmium ion;autophagic cell death;inner ear development;negative regulation of epithelial cell proliferation;negative regulation of cellular component movement;negative regulation of epithelial cell proliferation involved in prostate gland development;cellular response to antibiotic;cellular response to lithium ion;cellular response to organic cyclic compound;regulation of lens fiber cell differentiation;Cul4A-RING E3 ubiquitin ligase complex;protein-containing complex	3D-structure;Cell cycle;Cytoplasm;Direct protein sequencing;Endosome;Nucleus;Phosphoprotein;Polymorphism;Protein kinase inhibitor;Reference proteome;Tumor suppressor;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-6804116;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-1643685;R-HSA-1257604;R-HSA-2262752;R-HSA-5663202;R-HSA-69242;R-HSA-69278;R-HSA-69563;R-HSA-69580;R-HSA-69615;R-HSA-69620;R-HSA-8953897;R-HSA-9006925;R-HSA-195258;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-2219528;R-HSA-5674400;R-HSA-9614085;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-2559583;R-HSA-69231;R-HSA-69236;R-HSA-2559582;R-HSA-8848021;R-HSA-9006927;R-HSA-5625900;R-HSA-9617828;R-HSA-9634638;R-HSA-198323;R-HSA-2559586;R-HSA-8849470	Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Disease;PIP3 activates AKT signaling;Cellular responses to stress;Diseases of signal transduction;S Phase;Cell Cycle, Mitotic;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;Cellular responses to external stimuli;Intracellular signaling by second messengers;RHO GTPase Effectors;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;PI3K/AKT Signaling in Cancer;Constitutive Signaling by AKT1 E17K in Cancer;FOXO-mediated transcription;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Cellular Senescence;Cyclin D associated events in G1;G1 Phase;Senescence-Associated Secretory Phenotype (SASP);Signaling by PTK6;Signaling by Non-Receptor Tyrosine Kinases;RHO GTPases activate CIT;FOXO-mediated transcription of cell cycle genes;Estrogen-dependent nuclear events downstream of ESR-membrane signaling;AKT phosphorylates targets in the cytosol;DNA Damage/Telomere Stress Induced Senescence;PTK6 Regulates Cell Cycle
PDSS1	negative	CCDC92	ENSG00000119242	PDSS1	1	PDSS1	1	0.00585902175194253	WBGene00019284				GO:0005737;GO:0043231;GO:0005813;GO:0005654;GO:0005856;GO:0005515;GO:0005814	cytoplasm;intracellular membrane-bounded organelle;nucleoplasm;cytoskeleton;centrosome;protein binding;centriole	Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Polymorphism;Reference proteome		
PDSS1	negative	AKAP9	ENSG00000127914	PDSS1	1	PDSS1	1	0.00585902175194253				Brugada syndrome;Romano-Ward syndrome;LONG QT SYNDROME 11	GO:0060307;GO:0005737;GO:0005794;GO:0043231;GO:0005813;GO:0007165;GO:0003677;GO:0005856;GO:0005515;GO:0060090;GO:0005795;GO:0005815;GO:0015459;GO:0005801;GO:0005829;GO:0000086;GO:0010389;GO:0097711;GO:0033138;GO:0044325;GO:0061337;GO:0005102;GO:0007268;GO:0098978;GO:0060306;GO:0008076;GO:0034237;GO:0086091;GO:0071320;GO:0007020;GO:0098962;GO:1901018;GO:0031116;GO:0098909;GO:0051661;GO:1903358;GO:0097060;GO:0007194;GO:0051602;GO:0043025;GO:0044307;GO:0099147;GO:0016301;GO:0016310	DNA binding;signal transduction;molecular adaptor activity;regulation of ventricular cardiac muscle cell membrane repolarization;cytoplasm;Golgi apparatus;intracellular membrane-bounded organelle;cytoskeleton;centrosome;protein binding;Golgi stack;microtubule organizing center;potassium channel regulator activity;cis-Golgi network;cytosol;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking;positive regulation of peptidyl-serine phosphorylation;ion channel binding;cardiac conduction;signaling receptor binding;chemical synaptic transmission;glutamatergic synapse;synaptic membrane;regulation of membrane repolarization;voltage-gated potassium channel complex;protein kinase A regulatory subunit binding;regulation of heart rate by cardiac conduction;cellular response to cAMP;microtubule nucleation;positive regulation of potassium ion transmembrane transporter activity;positive regulation of microtubule polymerization;regulation of cardiac muscle cell action potential involved in regulation of contraction;regulation of postsynaptic neurotransmitter receptor activity;maintenance of centrosome location;regulation of Golgi organization;negative regulation of adenylate cyclase activity;response to electrical stimulus;neuronal cell body;dendritic branch;extrinsic component of postsynaptic density membrane;kinase activity;phosphorylation	Alternative splicing;Coiled coil;Cytoplasm;Cytoskeleton;Disease mutation;Golgi apparatus;Long QT syndrome;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1852241;R-HSA-5617833;R-HSA-1640170;R-HSA-1643685;R-HSA-453274;R-HSA-5663202;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-380320;R-HSA-68877;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518;R-HSA-397014;R-HSA-5576891;R-HSA-6802952;R-HSA-6802957;R-HSA-5576893;R-HSA-5576890	Organelle biogenesis and maintenance;Cilium Assembly;Cell Cycle;Disease;Mitotic G2-G2/M phases;Diseases of signal transduction;M Phase;G2/M Transition;Cell Cycle, Mitotic;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2;Muscle contraction;Cardiac conduction;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Phase 2 - plateau phase;Phase 3 - rapid repolarisation
PDSS1	negative	WWC3	ENSG00000047644	PDSS1	1	PDSS1	1	0.0062287878306998					GO:0060090;GO:0005829;GO:0000122;GO:0019900;GO:0046621;GO:0035331	molecular adaptor activity;cytosol;negative regulation of transcription by RNA polymerase II;kinase binding;negative regulation of organ growth;negative regulation of hippo signaling	Alternative splicing;Coiled coil;Polymorphism;Reference proteome		
PDSS1	negative	CARF	ENSG00000138380	PDSS1	1	PDSS1	1	0.0062287878306998					GO:0005634;GO:0003677;GO:0003700;GO:0061400;GO:0001228;GO:0071277;GO:0035865;GO:0000978;GO:0045944;GO:0051090;GO:0001652	DNA-binding transcription factor activity;positive regulation of transcription from RNA polymerase II promoter in response to calcium ion;nucleus;DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;cellular response to calcium ion;cellular response to potassium ion;RNA polymerase II cis-regulatory region sequence-specific DNA binding;positive regulation of transcription by RNA polymerase II;regulation of DNA-binding transcription factor activity;granular component	Activator;Alternative splicing;DNA-binding;Nucleus;Reference proteome;Transcription;Transcription regulation		
PDSS1	negative	RNPEPL1	ENSG00000142327	PDSS1	1	PDSS1	1	0.0062287878306998		WBGene00010999(0);WBGene00011000(0);WBGene00011587(0);WBGene00012776(0);WBGene00009865(0)			GO:0006508;GO:0070006;GO:0008270;GO:0046872;GO:0016787;GO:0008233;GO:0008237;GO:0004177	metalloaminopeptidase activity;proteolysis;zinc ion binding;metallopeptidase activity;metal ion binding;hydrolase activity;peptidase activity;aminopeptidase activity	Aminopeptidase;Hydrolase;Metal-binding;Metalloprotease;Polymorphism;Protease;Reference proteome;Zinc		
PDSS1	negative	SMIM14	ENSG00000163683	PDSS1	1	PDSS1	1	0.0062287878306998	WBGene00007923	WBGene00007923(1)			GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0005515;GO:0001835	membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;protein binding;blastocyst hatching	Endoplasmic reticulum;Membrane;Reference proteome;Transmembrane;Transmembrane helix		
PDSS1	negative	PCMTD1	ENSG00000168300	PDSS1	1	PDSS1	1	0.0062287878306998	WBGene00020090	WBGene00020090(0)			GO:0005737;GO:0016020;GO:0006464;GO:0032259;GO:0004719;GO:0006479	cellular protein modification process;protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;cytoplasm;membrane;protein methylation	Alternative splicing;Cytoplasm;Lipoprotein;Membrane;Myristate;Polymorphism;Reference proteome		
PDSS1	negative	PRKAB2	ENSG00000131791	PDSS1	1	PDSS1	1	0.00661907281020113	WBGene00010115;WBGene00012928	WBGene00007222(0);WBGene00010115(0);WBGene00012928(0)			GO:0006468;GO:0006629;GO:0006631;GO:0006633;GO:0005515;GO:0050790;GO:0005634;GO:0042802;GO:0005737;GO:0005654;GO:0005829;GO:0019901;GO:0007165;GO:1901796;GO:0120162;GO:0006853;GO:0007050;GO:0016241;GO:0004679;GO:0016236;GO:0042304;GO:0031588	protein binding;regulation of catalytic activity;protein phosphorylation;lipid metabolic process;fatty acid metabolic process;fatty acid biosynthetic process;nucleus;identical protein binding;cytoplasm;nucleoplasm;cytosol;protein kinase binding;signal transduction;regulation of signal transduction by p53 class mediator;positive regulation of cold-induced thermogenesis;carnitine shuttle;cell cycle arrest;regulation of macroautophagy;AMP-activated protein kinase activity;macroautophagy;regulation of fatty acid biosynthetic process;nucleotide-activated protein kinase complex	3D-structure;Alternative splicing;Fatty acid biosynthesis;Fatty acid metabolism;Lipid biosynthesis;Lipid metabolism;Phosphoprotein;Reference proteome	R-HSA-5653656;R-HSA-1852241;R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-556833;R-HSA-162582;R-HSA-8978868;R-HSA-199991;R-HSA-9612973;R-HSA-9615710;R-HSA-8953897;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-1445148;R-HSA-438064;R-HSA-442755;R-HSA-9619483;R-HSA-5633007;R-HSA-6804756;R-HSA-1592230;R-HSA-165159;R-HSA-163685;R-HSA-5628897;R-HSA-200425;R-HSA-1632852;R-HSA-380972;R-HSA-163680;R-HSA-2151209;R-HSA-9613354;R-HSA-9613829	Vesicle-mediated transport;Organelle biogenesis and maintenance;Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Metabolism of lipids;Signal Transduction;Fatty acid metabolism;Membrane Trafficking;Autophagy;Late endosomal microautophagy;Cellular responses to external stimuli;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Activation of AMPK downstream of NMDARs;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Mitochondrial biogenesis;mTOR signalling;Integration of energy metabolism;TP53 Regulates Metabolic Genes;Carnitine metabolism;Macroautophagy;Energy dependent regulation of mTOR by LKB1-AMPK;AMPK inhibits chREBP transcriptional activation activity;Activation of PPARGC1A (PGC-1alpha) by phosphorylation;Lipophagy;Chaperone Mediated Autophagy
PDSS1	negative	TACC1	ENSG00000147526	PDSS1	1	PDSS1	1	0.00661907281020113				Giant cell glioblastoma;Gliosarcoma	GO:0007052;GO:0005634;GO:0005737;GO:0016020;GO:0051301;GO:0005856;GO:0005515;GO:0007049;GO:0005815;GO:0030496;GO:0000226;GO:0030331;GO:0042974;GO:0008283;GO:0016922;GO:0035259;GO:0042975;GO:0046965;GO:0046966;GO:0021987;GO:2000327	mitotic spindle organization;cytosol;nucleus;cytoplasm;membrane;cytoskeleton;cell division;protein binding;cell cycle;microtubule organizing center;midbody;microtubule cytoskeleton organization;estrogen receptor binding;retinoic acid receptor binding;cell population proliferation;nuclear receptor binding;glucocorticoid receptor binding;peroxisome proliferator activated receptor binding;retinoid X receptor binding;thyroid hormone receptor binding;cerebral cortex development;positive regulation of nuclear receptor transcription coactivator activity	Acetylation;Activator;Alternative splicing;Cell cycle;Cell division;Coiled coil;Cytoplasm;Cytoskeleton;Lipoprotein;Membrane;Myristate;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat		
PDSS1	negative	JAK1	ENSG00000162434	PDSS1	1	PDSS1	1	0.00661907281020113					GO:0005737;GO:1903672;GO:0005634;GO:0016020;GO:0046872;GO:0000166;GO:0004672;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0035556;GO:0004713;GO:0018108;GO:0005856;GO:0005515;GO:0004715;GO:0005925;GO:0005829;GO:0000165;GO:0012505;GO:0031625;GO:0019221;GO:0035722;GO:0019903;GO:0060333;GO:0038111;GO:0060334;GO:0070102;GO:0060337;GO:0005131;GO:0046677;GO:0070106;GO:0070757;GO:0038110;GO:0005768;GO:0035723;GO:0038113;GO:0038114;GO:0031730	ATP binding;membrane;protein phosphorylation;cytoskeleton;intracellular signal transduction;protein kinase activity;protein tyrosine kinase activity;non-membrane spanning protein tyrosine kinase activity;cytoplasm;positive regulation of sprouting angiogenesis;nucleus;protein binding;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;peptidyl-tyrosine phosphorylation;focal adhesion;cytosol;MAPK cascade;endomembrane system;ubiquitin protein ligase binding;cytokine-mediated signaling pathway;interleukin-12-mediated signaling pathway;protein phosphatase binding;interferon-gamma-mediated signaling pathway;interleukin-7-mediated signaling pathway;regulation of interferon-gamma-mediated signaling pathway;interleukin-6-mediated signaling pathway;type I interferon signaling pathway;growth hormone receptor binding;response to antibiotic;interleukin-27-mediated signaling pathway;interleukin-35-mediated signaling pathway;interleukin-2-mediated signaling pathway;endosome;interleukin-15-mediated signaling pathway;interleukin-9-mediated signaling pathway;positive regulation of homotypic cell-cell adhesion;interleukin-21-mediated signaling pathway;protein localization to cell-cell junction;CCR5 chemokine receptor binding	3D-structure;ATP-binding;Acetylation;Kinase;Magnesium;Membrane;Metal-binding;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;SH2 domain;Transferase;Tyrosine-protein kinase;Ubl conjugation	R-HSA-168256;R-HSA-162582;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-1169408;R-HSA-1169410;R-HSA-913531;R-HSA-447115;R-HSA-9020591;R-HSA-451927;R-HSA-512988;R-HSA-912526;R-HSA-1266695;R-HSA-6783783;R-HSA-6785807;R-HSA-877300;R-HSA-1059683;R-HSA-6783589;R-HSA-877312;R-HSA-909733;R-HSA-912694;R-HSA-110056;R-HSA-112409;R-HSA-112411;R-HSA-6788467;R-HSA-8854691;R-HSA-8984722;R-HSA-9020956;R-HSA-9020558;R-HSA-8983432;R-HSA-8985947;R-HSA-9020958	Immune System;Signal Transduction;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling;Interleukin-12 family signaling;Interleukin-12 signaling;Interleukin-2 family signaling;Interleukin-3, Interleukin-5 and GM-CSF signaling;Interleukin receptor SHC signaling;Interleukin-7 signaling;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Interferon gamma signaling;Interleukin-6 signaling;Interleukin-6 family signaling;Regulation of IFNG signaling;Interferon alpha/beta signaling;Regulation of IFNA signaling;MAPK3 (ERK1) activation;RAF-independent MAPK1/3 activation;MAPK1 (ERK2) activation;IL-6-type cytokine receptor ligand interactions;Interleukin-20 family signaling;Interleukin-35 Signalling;Interleukin-27 signaling;Interleukin-2 signaling;Interleukin-15 signaling;Interleukin-9 signaling;Interleukin-21 signaling
PDSS1	negative	RGL2	ENSG00000237441	PDSS1	1	PDSS1	1	0.00661907281020113	WBGene00017891				GO:0007165;GO:0007264;GO:0005085;GO:0005515;GO:0005089;GO:0010667;GO:0014068;GO:0032485;GO:0007265;GO:0005575;GO:0005088;GO:0005622	signal transduction;guanyl-nucleotide exchange factor activity;small GTPase mediated signal transduction;protein binding;Rho guanyl-nucleotide exchange factor activity;negative regulation of cardiac muscle cell apoptotic process;positive regulation of phosphatidylinositol 3-kinase signaling;regulation of Ral protein signal transduction;Ras protein signal transduction;cellular_component;Ras guanyl-nucleotide exchange factor activity	Alternative splicing;Guanine-nucleotide releasing factor;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	negative	ABTB1	ENSG00000114626	PDSS1	1	PDSS1	1	0.0070308229433701					GO:0005737;GO:0006412;GO:0005730;GO:0005829;GO:0005886;GO:0005515;GO:0003746;GO:0006414;GO:0000151	protein binding;cytoplasm;translation;nucleolus;cytosol;plasma membrane;translation elongation factor activity;translational elongation;ubiquitin ligase complex	ANK repeat;Alternative splicing;Coiled coil;Cytoplasm;Elongation factor;Protein biosynthesis;Reference proteome;Repeat		
PDSS1	negative	ELF1	ENSG00000120690	PDSS1	1	PDSS1	1	0.0070308229433701	WBGene00016029		CD68;FLI1;MEIS1;TEK		GO:0005634;GO:0006355;GO:0003677;GO:0003700;GO:0043565;GO:0005515;GO:0045893;GO:0000978;GO:0001228;GO:0001817;GO:0045944;GO:0050860;GO:0000981;GO:0030154;GO:0006357;GO:0000790;GO:0005654;GO:0001959;GO:0050855	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;sequence-specific DNA binding;nucleus;DNA binding;protein binding;positive regulation of transcription, DNA-templated;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;regulation of cytokine production;positive regulation of transcription by RNA polymerase II;negative regulation of T cell receptor signaling pathway;DNA-binding transcription factor activity, RNA polymerase II-specific;cell differentiation;regulation of transcription by RNA polymerase II;nuclear chromatin;nucleoplasm;regulation of cytokine-mediated signaling pathway;regulation of B cell receptor signaling pathway	Activator;Alternative splicing;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Transcription;Transcription regulation	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-8878171;R-HSA-8939247;R-HSA-8939245	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transcriptional regulation by RUNX1;RUNX1 regulates transcription of genes involved in interleukin signaling;RUNX1 regulates transcription of genes involved in BCR signaling
PDSS1	negative	SIDT2	ENSG00000149577	PDSS1	1	PDSS1	1	0.0070308229433701	WBGene00006477;WBGene00004795;WBGene00012573;WBGene00015583;WBGene00016251;WBGene00016252;WBGene00016253;WBGene00018205	WBGene00015583(0);WBGene00016253(0);WBGene00004795(0);WBGene00016251(0);WBGene00006477(1);WBGene00016252(0);WBGene00018205(0)			GO:0003723;GO:0016020;GO:0016021;GO:0003677;GO:0005765;GO:0005886;GO:0005764;GO:0051033;GO:0033227;GO:0006401;GO:0003725;GO:0035612;GO:0035650;GO:0051032;GO:0000902;GO:0003323;GO:0009749;GO:0042593;GO:0044342;GO:0050658;GO:0061178	integral component of membrane;RNA transmembrane transporter activity;dsRNA transport;RNA binding;membrane;DNA binding;lysosomal membrane;plasma membrane;lysosome;RNA catabolic process;double-stranded RNA binding;RNA transport;AP-2 adaptor complex binding;AP-1 adaptor complex binding;nucleic acid transmembrane transporter activity;cell morphogenesis;type B pancreatic cell development;response to glucose;glucose homeostasis;type B pancreatic cell proliferation;regulation of insulin secretion involved in cellular response to glucose stimulus	Alternative splicing;Cell membrane;DNA-binding;Direct protein sequencing;Glycoprotein;Lysosome;Membrane;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Signal;Transmembrane;Transmembrane helix;Transport		
PDSS1	negative	ZNF266	ENSG00000174652	PDSS1	1	PDSS1	1	0.0070308229433701	WBGene00021931				GO:0003676;GO:0046872;GO:0006355;GO:0003677;GO:0005622;GO:0005634;GO:0005515;GO:0003700;GO:0043565	DNA binding;regulation of transcription, DNA-templated;nucleic acid binding;metal ion binding;nucleus;protein binding;DNA-binding transcription factor activity;sequence-specific DNA binding	DNA-binding;Metal-binding;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
PDSS1	negative	ARAP1	ENSG00000186635	PDSS1	1	PDSS1	1	0.0070308229433701	WBGene00017760				GO:0005737;GO:0016020;GO:0043231;GO:0046872;GO:0005829;GO:0005654;GO:0007165;GO:0005794;GO:0005886;GO:0005096;GO:0005515;GO:0043547;GO:0005547;GO:0032580;GO:0051056;GO:0005802;GO:0008360;GO:0031410;GO:0051491;GO:0051497;GO:0045742;GO:0030037;GO:0051270;GO:0031702;GO:0001921	protein binding;signal transduction;GTPase activator activity;positive regulation of GTPase activity;phosphatidylinositol-3,4,5-trisphosphate binding;cytoplasm;membrane;intracellular membrane-bounded organelle;metal ion binding;nucleoplasm;cytosol;plasma membrane;Golgi apparatus;Golgi cisterna membrane;regulation of small GTPase mediated signal transduction;trans-Golgi network;regulation of cell shape;cytoplasmic vesicle;positive regulation of filopodium assembly;negative regulation of stress fiber assembly;positive regulation of epidermal growth factor receptor signaling pathway;actin filament reorganization involved in cell cycle;regulation of cellular component movement;type 1 angiotensin receptor binding;positive regulation of receptor recycling	3D-structure;Alternative splicing;Cell membrane;Cytoplasm;GTPase activation;Golgi apparatus;Membrane;Metal-binding;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Zinc;Zinc-finger	R-HSA-162582;R-HSA-194315;R-HSA-194840;R-HSA-8848021;R-HSA-9006927;R-HSA-8849469	Signal Transduction;Signaling by Rho GTPases;Rho GTPase cycle;Signaling by PTK6;Signaling by Non-Receptor Tyrosine Kinases;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
PDSS1	negative	APPBP2	ENSG00000062725	PDSS1	1	PDSS1	1	0.00746501592643845					GO:0005623;GO:0005634;GO:0005737;GO:0016020;GO:0006886;GO:0015031;GO:0005856;GO:0005515;GO:0005874;GO:0005875;GO:0003777;GO:0030659;GO:0046907	protein binding;intracellular protein transport;nucleus;cytoplasm;membrane;protein transport;cytoskeleton;microtubule;microtubule associated complex;microtubule motor activity;cytoplasmic vesicle membrane;intracellular transport	Cytoplasm;Cytoskeleton;Membrane;Microtubule;Nucleus;Polymorphism;Protein transport;Reference proteome;Repeat;TPR repeat;Transport		
PDSS1	negative	SEC31B	ENSG00000075826	PDSS1	1	PDSS1	1	0.00746501592643845	WBGene00011338	WBGene00011338(0)			GO:0005737;GO:0016020;GO:0015031;GO:0005783;GO:0005789;GO:0006888;GO:0031410;GO:0006886;GO:0016192;GO:0000139;GO:0012507;GO:0070971;GO:0005198;GO:0007029;GO:0090110;GO:0090114;GO:0030120;GO:0030127;GO:0005515	protein binding;endoplasmic reticulum to Golgi vesicle-mediated transport;cytoplasm;membrane;protein transport;endoplasmic reticulum;endoplasmic reticulum membrane;cytoplasmic vesicle;vesicle-mediated transport;intracellular protein transport;Golgi membrane;ER to Golgi transport vesicle membrane;endoplasmic reticulum exit site;structural molecule activity;endoplasmic reticulum organization;COPII-coated vesicle cargo loading;COPII-coated vesicle budding;vesicle coat;COPII vesicle coat	Alternative splicing;Cytoplasm;Cytoplasmic vesicle;ER-Golgi transport;Endoplasmic reticulum;Membrane;Polymorphism;Protein transport;Reference proteome;Repeat;Transport;Ubl conjugation;WD repeat		
PDSS1	negative	BICRAL	ENSG00000112624	PDSS1	1	PDSS1	1	0.00746501592643845					GO:0016514	transcription coactivator activity;positive regulation of transcription, DNA-templated;SWI/SNF complex	Phosphoprotein;Reference proteome		
PDSS1	negative	IDUA	ENSG00000127415	PDSS1	1	PDSS1	1	0.00746501592643845				HURLER SYNDROME;HURLER-SCHEIE SYNDROME;SCHEIE SYNDROME;MUCOPOLYSACCHARIDOSIS TYPE 1H;MUCOPOLYSACCHARIDOSIS TYPE 1H/S;MUCOPOLYSACCHARIDOSIS TYPE 1S;HURLER SYNDROME;HURLER-SCHEIE SYNDROME;SCHEIE SYNDROME	GO:0016787;GO:0005975;GO:0008152;GO:0004553;GO:0016798;GO:0005764;GO:0070062;GO:0043202;GO:0006027;GO:0030207;GO:0003940;GO:0005102;GO:0005984;GO:0030209;GO:0030211;GO:0030135	carbohydrate metabolic process;hydrolase activity, hydrolyzing O-glycosyl compounds;hydrolase activity;metabolic process;hydrolase activity, acting on glycosyl bonds;lysosome;extracellular exosome;lysosomal lumen;glycosaminoglycan catabolic process;chondroitin sulfate catabolic process;L-iduronidase activity;signaling receptor binding;disaccharide metabolic process;dermatan sulfate catabolic process;heparin catabolic process;coated vesicle	3D-structure;Alternative splicing;Disease mutation;Disulfide bond;Glycoprotein;Glycosidase;Hydrolase;Lysosome;Mucopolysaccharidosis;Polymorphism;Reference proteome;Signal	R-HSA-1430728;R-HSA-1643685;R-HSA-71387;R-HSA-1630316;R-HSA-1638091;R-HSA-1793185;R-HSA-2024096;R-HSA-2024101;R-HSA-5668914;R-HSA-5663084;R-HSA-2206281;R-HSA-2206302	Metabolism;Disease;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Heparan sulfate/heparin (HS-GAG) metabolism;Chondroitin sulfate/dermatan sulfate metabolism;HS-GAG degradation;CS/DS degradation;Diseases of metabolism;Diseases of carbohydrate metabolism;Mucopolysaccharidoses;MPS I - Hurler syndrome
PDSS1	negative	ERMAP	ENSG00000164010	PDSS1	1	PDSS1	1	0.00746501592643845				BLOOD GROUP--SCIANNA SYSTEM;RADIN BLOOD GROUP ANTIGEN	GO:0005737;GO:0016020;GO:0016021;GO:0005886;GO:0009897;GO:0005102;GO:0050776;GO:0050852;GO:0005515	protein binding;cytoplasm;membrane;integral component of membrane;Golgi apparatus;cytosol;plasma membrane;external side of plasma membrane;signaling receptor binding;regulation of cytokine production;regulation of immune response;T cell receptor signaling pathway	Blood group antigen;Cell membrane;Cytoplasm;Disulfide bond;Glycoprotein;Immunoglobulin domain;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix		
PDSS1	negative	TRIM66	ENSG00000166436	PDSS1	1	PDSS1	1	0.00746501592643845	WBGene00003559;WBGene00003598				GO:0008270;GO:0046872;GO:0005654;GO:0016235;GO:0005622;GO:0005515;GO:0005634;GO:0045892;GO:0003682	zinc ion binding;protein binding;metal ion binding;nucleoplasm;aggresome;nucleus;negative regulation of transcription, DNA-templated;chromatin binding	3D-structure;Alternative splicing;Bromodomain;Coiled coil;Metal-binding;Nucleus;Reference proteome;Repeat;Zinc;Zinc-finger		
PDSS1	negative	CAMK1D	ENSG00000183049	PDSS1	1	PDSS1	1	0.00746501592643845	WBGene00000553				GO:0005634;GO:0005737;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0003824;GO:0008152;GO:0006954;GO:0005516;GO:0007399;GO:0050766;GO:0010976;GO:0032793;GO:0060267;GO:0090023;GO:0004683;GO:0050773;GO:0043065;GO:0043066;GO:0071622	ATP binding;protein phosphorylation;protein kinase activity;nucleus;cytoplasm;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;catalytic activity;metabolic process;inflammatory response;calmodulin binding;nervous system development;positive regulation of phagocytosis;positive regulation of neuron projection development;positive regulation of CREB transcription factor activity;positive regulation of respiratory burst;positive regulation of neutrophil chemotaxis;calmodulin-dependent protein kinase activity;regulation of dendrite development;positive regulation of apoptotic process;negative regulation of apoptotic process;regulation of granulocyte chemotaxis	3D-structure;ATP-binding;Allosteric enzyme;Alternative splicing;Calcium;Calmodulin-binding;Cytoplasm;Inflammatory response;Isopeptide bond;Kinase;Neurogenesis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation		
PDSS1	negative	KLHDC1	ENSG00000197776	PDSS1	1	PDSS1	1	0.00746501592643845		WBGene00001827(0)			GO:0005737;GO:0005829;GO:0005515	protein binding;cytoplasm;cytosol	Cytoplasm;Kelch repeat;Reference proteome;Repeat		
PDSS1	negative	MYLIP	ENSG00000007944	PDSS1	1	PDSS1	1	0.00792266121350427	WBGene00001491;WBGene00009932				GO:0005737;GO:0016020;GO:0046872;GO:0016740;GO:0016567;GO:0005886;GO:0005856;GO:0005515;GO:0008092;GO:0004842;GO:0007399;GO:0006511;GO:0005829;GO:0000209;GO:0010977;GO:0061630;GO:0032802;GO:0010989;GO:0031648;GO:0032803;GO:0042632;GO:0045732	cytoskeleton;cytoskeletal protein binding;cytoplasm;membrane;metal ion binding;transferase activity;protein ubiquitination;plasma membrane;protein binding;ubiquitin-protein transferase activity;nervous system development;ubiquitin-dependent protein catabolic process;cytosol;protein polyubiquitination;negative regulation of neuron projection development;ubiquitin protein ligase activity;low-density lipoprotein particle receptor catabolic process;negative regulation of low-density lipoprotein particle clearance;protein destabilization;regulation of low-density lipoprotein particle receptor catabolic process;cholesterol homeostasis;positive regulation of protein catabolic process	3D-structure;Alternative splicing;Cell membrane;Cytoplasm;Iron;Membrane;Metal-binding;Polymorphism;Reference proteome;Transferase;Ubl conjugation;Ubl conjugation pathway;Zinc;Zinc-finger	R-HSA-1280218;R-HSA-168256;R-HSA-983168;R-HSA-983169;R-HSA-382551;R-HSA-174824;R-HSA-8964043;R-HSA-8866427	Adaptive Immune System;Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Transport of small molecules;Plasma lipoprotein assembly, remodeling, and clearance;Plasma lipoprotein clearance;VLDLR internalisation and degradation
PDSS1	negative	MANBA	ENSG00000109323	PDSS1	1	PDSS1	1	0.00792266121350427	WBGene00007904	WBGene00007904(1)		BETA-MANNOSIDOSIS;LYSOSOMAL BETA-MANNOSIDOSIS;MANNOSIDOSIS BETA A LYSOSOMAL	GO:0005975;GO:0004553;GO:0043231;GO:0016787;GO:0008152;GO:0016798;GO:0005764;GO:0005886;GO:0043312;GO:0004567;GO:0005537;GO:0006464;GO:0006516;GO:0009313;GO:0035577;GO:0043202	carbohydrate metabolic process;hydrolase activity, hydrolyzing O-glycosyl compounds;intracellular membrane-bounded organelle;hydrolase activity;metabolic process;hydrolase activity, acting on glycosyl bonds;lysosome;plasma membrane;neutrophil degranulation;beta-mannosidase activity;mannose binding;cellular protein modification process;glycoprotein catabolic process;oligosaccharide catabolic process;azurophil granule membrane;lysosomal lumen	Disulfide bond;Glycoprotein;Glycosidase;Hydrolase;Lysosome;Polymorphism;Reference proteome;Signal	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-71387;R-HSA-6798695;R-HSA-8853383	Innate Immune System;Immune System;Metabolism;Metabolism of carbohydrates;Neutrophil degranulation;Lysosomal oligosaccharide catabolism
PDSS1	negative	RCOR3	ENSG00000117625	PDSS1	1	PDSS1	1	0.00792266121350427	WBGene00005006;WBGene00022278	WBGene00009224(0);WBGene00022215(0);WBGene00013632(0);WBGene00022278(0);WBGene00005006(0)			GO:0005634;GO:0003677;GO:0005515;GO:1903507;GO:0006355;GO:0006357;GO:0003700;GO:0000981;GO:0008134;GO:0003714;GO:0005667;GO:0044212;GO:0017053	DNA binding;nucleus;protein binding;negative regulation of nucleic acid-templated transcription;regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription factor binding;transcription corepressor activity;transcription regulatory region DNA binding;transcriptional repressor complex	3D-structure;Alternative splicing;Coiled coil;Isopeptide bond;Methylation;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Ubl conjugation		
PDSS1	negative	VPS39	ENSG00000166887	PDSS1	1	PDSS1	1	0.00792266121350427	WBGene00011625	WBGene00011625(1)			GO:0005623;GO:0005737;GO:0016020;GO:0006886;GO:0015031;GO:0016192;GO:0005765;GO:0006914;GO:0005764;GO:0005768;GO:0030897;GO:0031902;GO:0008333;GO:1990126;GO:0005770;GO:0034058;GO:1902774;GO:0005515;GO:0030123	protein binding;intracellular protein transport;vesicle-mediated transport;cytoplasm;membrane;protein transport;endosome;lysosomal membrane;autophagy;lysosome;HOPS complex;late endosome membrane;endosome to lysosome transport;retrograde transport, endosome to plasma membrane;late endosome;endosomal vesicle fusion;late endosome to lysosome transport;AP-3 adaptor complex	Alternative splicing;Autophagy;Cytoplasm;Endosome;Lysosome;Membrane;Protein transport;Reference proteome;Transport		
PDSS1	negative	CHD2	ENSG00000173575	PDSS1	1	PDSS1	1	0.00792266121350427	WBGene00010369			Lennox-Gastaut syndrome;Myoclonic-astastic epilepsy;Epileptic encephalopathy;Epileptic encephalopathy childhood-onset	GO:0003723;GO:0005634;GO:0043231;GO:0000166;GO:0005524;GO:0005730;GO:0005654;GO:0016787;GO:0003677;GO:0006325;GO:0005515;GO:0032508;GO:0003678;GO:0004386;GO:0007517;GO:0042393;GO:0006357;GO:0000978	ATP binding;RNA binding;nucleus;intracellular membrane-bounded organelle;nucleotide binding;nucleoplasm;nucleolus;hydrolase activity;DNA binding;chromatin organization;protein binding;DNA duplex unwinding;DNA helicase activity;helicase activity;muscle organ development;histone binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;regulation of transcription by RNA polymerase II;cellular response to DNA damage stimulus;hematopoietic stem cell differentiation	ATP-binding;Alternative splicing;Chromatin regulator;DNA-binding;Disease mutation;Epilepsy;Helicase;Hydrolase;Myogenesis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation		
PDSS1	negative	ULK1	ENSG00000177169	PDSS1	1	PDSS1	1	0.00792266121350427	WBGene00006786;WBGene00020324	WBGene00006786(0)			GO:0005737;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0007165;GO:0005829;GO:0005515;GO:0006914;GO:0042802;GO:0005776;GO:0016020;GO:0034045;GO:0005789;GO:0010508;GO:0075044;GO:0010506;GO:0000045;GO:0000407;GO:0008104;GO:0046777;GO:0005741;GO:0044877;GO:0031175;GO:0016241;GO:0042594;GO:0016236;GO:1990316;GO:0032045;GO:0017137;GO:0051020;GO:0007409;GO:0018105;GO:0018107;GO:0031102;GO:0031333;GO:0031669;GO:0048675;GO:2000786;GO:0030424;GO:0055037;GO:0097629;GO:0097632;GO:0097635	ATP binding;signal transduction;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;axonogenesis;cytoplasm;nucleotide binding;kinase activity;transferase activity;phosphorylation;cytosol;protein binding;autophagy;identical protein binding;autophagosome;membrane;phagophore assembly site membrane;endoplasmic reticulum membrane;positive regulation of autophagy;positive regulation by symbiont of host autophagy;regulation of autophagy;autophagosome assembly;phagophore assembly site;protein localization;protein autophosphorylation;mitochondrial outer membrane;protein-containing complex binding;neuron projection development;peptidyl-serine phosphorylation;regulation of macroautophagy;response to starvation;macroautophagy;Atg1/ULK1 kinase complex;guanyl-nucleotide exchange factor complex;Rab GTPase binding;GTPase binding;peptidyl-threonine phosphorylation;neuron projection regeneration;negative regulation of protein-containing complex assembly;cellular response to nutrient levels;axon extension;positive regulation of autophagosome assembly;axon;recycling endosome;extrinsic component of omegasome membrane;extrinsic component of phagophore assembly site membrane;extrinsic component of autophagosome membrane	3D-structure;ATP-binding;Acetylation;Autophagy;Cytoplasm;Kinase;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-5653656;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-9612973;R-HSA-8953897;R-HSA-1632852;R-HSA-5205647;R-HSA-8854214;R-HSA-8934903	Vesicle-mediated transport;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Autophagy;Cellular responses to external stimuli;Macroautophagy;Mitophagy;TBC/RABGAPs;Receptor Mediated Mitophagy
PDSS1	negative	CTSO	ENSG00000256043	PDSS1	1	PDSS1	1	0.00792266121350427	WBGene00008231;WBGene00008861;WBGene00011102;WBGene00012747;WBGene00013072;WBGene00013076;WBGene00013764;WBGene00016300;WBGene00016306;WBGene00019314;WBGene00019986;WBGene00022189;WBGene00044760	WBGene00000784(0);WBGene00000785(0);WBGene00013076(0);WBGene00013072(0);WBGene00013764(0);WBGene00019314(0);WBGene00016306(0);WBGene00016300(0);WBGene00044760(0);WBGene00022189(0);WBGene00019986(0);WBGene00000782(0);WBGene00000781(0)			GO:0016787;GO:0008233;GO:0008234;GO:0006508;GO:0005764;GO:0005615;GO:0004197;GO:0051603	proteolysis;cysteine-type peptidase activity;hydrolase activity;peptidase activity;lysosome;extracellular space;cysteine-type endopeptidase activity;proteolysis involved in cellular protein catabolic process	Disulfide bond;Glycoprotein;Hydrolase;Lysosome;Protease;Reference proteome;Signal;Thiol protease;Zymogen	R-HSA-1280218;R-HSA-168256;R-HSA-2132295	Adaptive Immune System;Immune System;MHC class II antigen presentation
PDSS1	negative	PDK2	ENSG00000005882	PDSS1	1	PDSS1	1	0.00840480028731461	WBGene00022719				GO:0000166;GO:0004672;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005829;GO:0005654;GO:0005739;GO:0006468;GO:0005759;GO:0042803;GO:0005975;GO:0006006;GO:0008286;GO:0006111;GO:0042593;GO:0072332;GO:0006885;GO:0010510;GO:0010906;GO:0034614;GO:0005967;GO:0031670;GO:0004740;GO:0010565;GO:0050848	protein kinase activity;nucleotide binding;ATP binding;kinase activity;transferase activity;phosphorylation;nucleoplasm;cytosol;mitochondrion;protein phosphorylation;mitochondrial matrix;protein homodimerization activity;carbohydrate metabolic process;protein serine/threonine kinase activity;glucose metabolic process;glucose homeostasis;insulin receptor signaling pathway;negative regulation of pyruvate dehydrogenase activity;regulation of gluconeogenesis;intrinsic apoptotic signaling pathway by p53 class mediator;regulation of pH;regulation of acetyl-CoA biosynthetic process from pyruvate;regulation of glucose metabolic process;cellular response to reactive oxygen species;mitochondrial pyruvate dehydrogenase complex;cellular response to nutrient;pyruvate dehydrogenase (acetyl-transferring) kinase activity;regulation of cellular ketone metabolic process;regulation of calcium-mediated signaling	3D-structure;ATP-binding;Alternative splicing;Carbohydrate metabolism;Glucose metabolism;Kinase;Mitochondrion;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transferase;Transit peptide	R-HSA-1430728;R-HSA-162582;R-HSA-9006931;R-HSA-1428517;R-HSA-204174;R-HSA-5362517;R-HSA-70268;R-HSA-71406	Metabolism;Signal Transduction;Signaling by Nuclear Receptors;The citric acid (TCA) cycle and respiratory electron transport;Regulation of pyruvate dehydrogenase (PDH) complex;Signaling by Retinoic Acid;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle
PDSS1	negative	WDR19	ENSG00000157796	PDSS1	1	PDSS1	1	0.00840480028731461	WBGene00001118	WBGene00001118(1)		Cranioectodermal dysplasia;Jeune syndrome;Juvenile nephronophthisis;Senior-Loken syndrome;Asphyxiating thoracic dystrophy 5;Cranioectodermal dysplasia 4;Cranioectodermal dysplasia 4;NEPHRONOPHTHISIS 13;SENIOR-LOKEN SYNDROME 8;SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY	GO:0005737;GO:0005654;GO:0031514;GO:0005856;GO:0042995;GO:0016604;GO:0005515;GO:0005929;GO:0035735;GO:0097542;GO:0030030;GO:0060271;GO:0001750;GO:0097730;GO:0035721;GO:0065003;GO:0032391;GO:1903441;GO:0030991;GO:0000902;GO:0001701;GO:0007224;GO:0008406;GO:0030326;GO:0031076;GO:0042471;GO:0048701;GO:0050877;GO:0055123;GO:0060830;GO:0060831;GO:0061055	protein binding;intraciliary retrograde transport;cytoplasm;motile cilium;cytoskeleton;cell projection;cilium;intraciliary transport involved in cilium assembly;ciliary tip;cell projection organization;cilium assembly;photoreceptor outer segment;non-motile cilium;protein-containing complex assembly;photoreceptor connecting cilium;protein localization to ciliary membrane;intraciliary transport particle A;cell morphogenesis;in utero embryonic development;smoothened signaling pathway;gonad development;embryonic limb morphogenesis;embryonic camera-type eye development;ear morphogenesis;embryonic cranial skeleton morphogenesis;nervous system process;digestive system development;ciliary receptor clustering involved in smoothened signaling pathway;smoothened signaling pathway involved in dorsal/ventral neural tube patterning;myotome development	Alternative splicing;Cell projection;Ciliopathy;Cilium;Cilium biogenesis/degradation;Cytoplasm;Cytoskeleton;Disease mutation;Ectodermal dysplasia;Leber congenital amaurosis;Nephronophthisis;Polymorphism;Reference proteome;Repeat;Senior-Loken syndrome;TPR repeat;WD repeat	R-HSA-1852241;R-HSA-5617833;R-HSA-5620924;R-HSA-162582;R-HSA-5358351;R-HSA-5610787	Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport;Signal Transduction;Signaling by Hedgehog;Hedgehog 'off' state
PDSS1	negative	AHCYL2	ENSG00000158467	PDSS1	1	PDSS1	1	0.00840480028731461	WBGene00019322				GO:0005737;GO:0005783;GO:0043231;GO:0016787;GO:0006730;GO:0005829;GO:0005515;GO:0033353;GO:0043005;GO:0004013	adenosylhomocysteinase activity;cytoplasm;endoplasmic reticulum;intracellular membrane-bounded organelle;hydrolase activity;one-carbon metabolic process;cytosol;protein binding;S-adenosylmethionine cycle;neuron projection	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Endoplasmic reticulum;Hydrolase;Microsome;NAD;One-carbon metabolism;Phosphoprotein;Reference proteome	R-HSA-382551;R-HSA-425407;R-HSA-425393;R-HSA-425381	Transport of small molecules;SLC-mediated transmembrane transport;Transport of inorganic cations/anions and amino acids/oligopeptides;Bicarbonate transporters
PDSS1	negative	TMUB2	ENSG00000168591	PDSS1	1	PDSS1	1	0.00840480028731461	WBGene00015126	WBGene00015126(0)			GO:0016020;GO:0016021;GO:0030433;GO:0005515	protein binding;ubiquitin-dependent ERAD pathway;membrane;integral component of membrane	Alternative splicing;Membrane;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix		
PDSS1	negative	ATP6AP2	ENSG00000182220	PDSS1	1	PDSS1	1	0.00840480028731461	WBGene00010993	WBGene00010993(0);WBGene00020500(0)		X-linked intellectual disability Hedera type;X-linked parkinsonism-spasticity syndrome;MENTAL RETARDATION X-LINKED WITH EPILEPSY;MENTAL RETARDATION X-LINKED SYNDROMIC HEDERA TYPE;PARKINSONISM WITH SPASTICITY X-LINKED	GO:0016021;GO:0038023;GO:0016020;GO:0005783;GO:0005789;GO:0005765;GO:0005886;GO:0042995;GO:0031410;GO:0030177;GO:0005764;GO:0009897;GO:0005515;GO:0030424;GO:0070062;GO:0000421;GO:0032591;GO:0043312;GO:0070821;GO:0101003;GO:0002003;GO:0021903;GO:0032914;GO:0043408;GO:0048069;GO:0060323;GO:0005615;GO:0016324;GO:0016471;GO:0043005;GO:0044297;GO:0003824	integral component of membrane;signaling receptor activity;membrane;endoplasmic reticulum;endoplasmic reticulum membrane;lysosomal membrane;plasma membrane;cell projection;cell junction;cytoplasmic vesicle;positive regulation of Wnt signaling pathway;synapse;postsynaptic membrane;lysosome;external side of plasma membrane;protein binding;axon;extracellular exosome;autophagosome membrane;dendritic spine membrane;neutrophil degranulation;tertiary granule membrane;ficolin-1-rich granule membrane;angiotensin maturation;rostrocaudal neural tube patterning;positive regulation of transforming growth factor beta1 production;regulation of MAPK cascade;eye pigmentation;head morphogenesis;extracellular space;apical plasma membrane;vacuolar proton-transporting V-type ATPase complex;neuron projection;cell body;catalytic activity	3D-structure;Alternative splicing;Cell junction;Cell membrane;Cell projection;Cleavage on pair of basic residues;Cytoplasmic vesicle;Disease mutation;Endoplasmic reticulum;Epilepsy;Lysosome;Membrane;Mental retardation;Neurodegeneration;Parkinsonism;Phosphoprotein;Polymorphism;Postsynaptic cell membrane;Receptor;Reference proteome;Signal;Synapse;Transmembrane;Transmembrane helix	R-HSA-168249;R-HSA-168256;R-HSA-392499;R-HSA-2980736;R-HSA-6798695;R-HSA-2022377	Innate Immune System;Immune System;Metabolism of proteins;Peptide hormone metabolism;Neutrophil degranulation;Metabolism of Angiotensinogen to Angiotensins
PDSS1	negative	PLEKHM1	ENSG00000225190	PDSS1	1	PDSS1	1	0.00840480028731461	WBGene00013093	WBGene00013093(0)		Intermediate osteopetrosis;OSTEOPETROSIS AUTOSOMAL DOMINANT 3;OSTEOPETROSIS AUTOSOMAL RECESSIVE 6	GO:0005737;GO:0016020;GO:0015031;GO:0043231;GO:0046872;GO:0005730;GO:0035556;GO:0005765;GO:0006914;GO:0005764;GO:0005768;GO:0010008;GO:0045780;GO:0032418;GO:1900029	intracellular signal transduction;cytoplasm;membrane;protein transport;intracellular membrane-bounded organelle;metal ion binding;nucleolus;endosome;lysosomal membrane;autophagy;lysosome;endosome membrane;positive regulation of bone resorption;lysosome localization;positive regulation of ruffle assembly	3D-structure;Autophagy;Cytoplasm;Disease mutation;Endosome;Lysosome;Membrane;Metal-binding;Osteopetrosis;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Repeat;Transport;Zinc;Zinc-finger		
PDSS1	negative	HERPUD1	ENSG00000051108	PDSS1	1	PDSS1	1	0.00891250688324985	WBGene00009112	WBGene00009112(0)			GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0016567;GO:0044325;GO:0005515;GO:0006511;GO:0006986;GO:0030970;GO:0003674;GO:0030968;GO:0034976;GO:1903071;GO:1902236;GO:0036499;GO:1990037;GO:0034704;GO:1990756;GO:0006874;GO:0031396;GO:0032469;GO:0043154;GO:1902235;GO:1903069;GO:2001243	protein binding;cell;membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;protein ubiquitination;ion channel binding;response to unfolded protein;ubiquitin-dependent protein catabolic process;retrograde protein transport, ER to cytosol;molecular_function;endoplasmic reticulum unfolded protein response;response to endoplasmic reticulum stress;positive regulation of ER-associated ubiquitin-dependent protein catabolic process;negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;PERK-mediated unfolded protein response;Lewy body core;protein binding, bridging involved in substrate recognition for ubiquitination;cellular calcium ion homeostasis;regulation of protein ubiquitination;endoplasmic reticulum calcium ion homeostasis;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;regulation of ER-associated ubiquitin-dependent protein catabolic process;negative regulation of intrinsic apoptotic signaling pathway	3D-structure;Acetylation;Alternative splicing;Endoplasmic reticulum;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix;Unfolded protein response	R-HSA-392499;R-HSA-381119;R-HSA-380994;R-HSA-381042	Metabolism of proteins;Unfolded Protein Response (UPR);ATF4 activates genes in response to endoplasmic reticulum  stress;PERK regulates gene expression
PDSS1	negative	CPQ	ENSG00000104324	PDSS1	1	PDSS1	1	0.00891250688324985					GO:0005615;GO:0005737;GO:0005794;GO:0043231;GO:0046872;GO:0005783;GO:0016787;GO:0042803;GO:0008233;GO:0006508;GO:0005576;GO:0008237;GO:0004180;GO:0070573;GO:0006590;GO:0042246;GO:0005764;GO:0070062;GO:0043171	metallodipeptidase activity;extracellular space;cytoplasm;Golgi apparatus;intracellular membrane-bounded organelle;metal ion binding;endoplasmic reticulum;hydrolase activity;protein homodimerization activity;peptidase activity;proteolysis;extracellular region;carboxypeptidase activity;metallopeptidase activity;thyroid hormone generation;tissue regeneration;lysosome;extracellular exosome;peptide catabolic process	Carboxypeptidase;Direct protein sequencing;Endoplasmic reticulum;Glycoprotein;Golgi apparatus;Hydrolase;Lysosome;Metal-binding;Metalloprotease;Polymorphism;Protease;Reference proteome;Secreted;Signal;Zinc;Zymogen		
PDSS1	negative	BBS2	ENSG00000125124	PDSS1	1	PDSS1	1	0.00891250688324985	WBGene00000242	WBGene00000242(1)		Bardet-Biedl syndrome;Retinitis pigmentosa;BARDET-BIEDL SYNDROME TYPE 2;BARDET-BIEDL SYNDROME 2;RETINITIS PIGMENTOSA 74	GO:0034464;GO:1905515;GO:0005737;GO:0016020;GO:0005886;GO:0005856;GO:0042995;GO:0005815;GO:0005929;GO:0060170;GO:0005515;GO:0015031;GO:0050896;GO:0043005;GO:0036064;GO:0005829;GO:0030030;GO:0060271;GO:0007601;GO:0031514;GO:0021987;GO:0045444;GO:0045494;GO:0008104;GO:0048854;GO:0021766;GO:0033365;GO:0030534;GO:0001103;GO:0032402;GO:0043001;GO:0021756;GO:0038108;GO:0060296;GO:0007288;GO:0010629;GO:0014824;GO:0033210;GO:0040015;GO:0040018;GO:0042311;GO:0044321;GO:0051216;GO:0005902;GO:0032420	BBSome;non-motile cilium assembly;protein binding;cytoplasm;membrane;cytoskeleton;plasma membrane;cell projection;microtubule organizing center;cilium;ciliary membrane;cell;protein transport;response to stimulus;neuron projection;ciliary basal body;cytosol;cell projection organization;cilium assembly;visual perception;motile cilium;cerebral cortex development;fat cell differentiation;photoreceptor cell maintenance;protein localization;brain morphogenesis;hippocampus development;protein localization to organelle;adult behavior;RNA polymerase II repressing transcription factor binding;melanosome transport;Golgi to plasma membrane protein transport;striatum development;negative regulation of appetite by leptin-mediated signaling pathway;regulation of cilium beat frequency involved in ciliary motility;sperm axoneme assembly;negative regulation of gene expression;artery smooth muscle contraction;leptin-mediated signaling pathway;negative regulation of multicellular organism growth;positive regulation of multicellular organism growth;vasodilation;response to leptin;cartilage development;microvillus;stereocilium	Bardet-Biedl syndrome;Cell membrane;Cell projection;Ciliopathy;Cilium;Cilium biogenesis/degradation;Coiled coil;Cytoplasm;Cytoskeleton;Disease mutation;Membrane;Mental retardation;Obesity;Polymorphism;Protein transport;Reference proteome;Retinitis pigmentosa;Sensory transduction;Transport;Vision	R-HSA-1852241;R-HSA-5617833;R-HSA-5620920;R-HSA-5620922	Organelle biogenesis and maintenance;Cilium Assembly;Cargo trafficking to the periciliary membrane;BBSome-mediated cargo-targeting to cilium
PDSS1	negative	TBC1D5	ENSG00000131374	PDSS1	1	PDSS1	1	0.00891250688324985	WBGene00007167				GO:0016020;GO:0015031;GO:0005794;GO:0005829;GO:0043231;GO:0005515;GO:0031410;GO:0006914;GO:0005096;GO:0017137;GO:0006886;GO:0090630;GO:0005768;GO:0005776;GO:0016236;GO:0010008;GO:0042147;GO:0042594;GO:0044877;GO:1990316;GO:0030122;GO:0002092;GO:1905394;GO:0035612;GO:0030904	membrane;protein transport;Golgi apparatus;cytosol;intracellular membrane-bounded organelle;endosome;protein binding;cytoplasmic vesicle;autophagy;GTPase activator activity;Rab GTPase binding;intracellular protein transport;activation of GTPase activity;autophagosome;macroautophagy;endosome membrane;retrograde transport, endosome to Golgi;response to starvation;protein-containing complex binding;Atg1/ULK1 kinase complex;AP-2 adaptor complex;positive regulation of receptor internalization;retromer complex binding;AP-2 adaptor complex binding;retromer complex	3D-structure;Alternative splicing;Autophagy;Cytoplasmic vesicle;Endosome;GTPase activation;Membrane;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Transport		
PDSS1	negative	KIDINS220	ENSG00000134313	PDSS1	1	PDSS1	1	0.00891250688324985	WBGene00006490			Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome;SPASTIC PARAPLEGIA INTELLECTUAL DISABILITY NYSTAGMUS AND OBESITY;SPASTIC PARAPLEGIA INTELLECTUAL DISABILITY NYSTAGMUS AND OBESITY	GO:0016020;GO:0016021;GO:0005515;GO:0005768;GO:0007399;GO:0005829;GO:0032991;GO:0030165;GO:0005770;GO:0038180;GO:0010976;GO:0019887;GO:0000186;GO:1990090;GO:0001701;GO:0048813	membrane;integral component of membrane;protein binding;endosome;nervous system development;cytosol;protein-containing complex;PDZ domain binding;late endosome;nerve growth factor signaling pathway;positive regulation of neuron projection development;protein kinase regulator activity;activation of MAPKK activity;cellular response to nerve growth factor stimulus;in utero embryonic development;dendrite morphogenesis	ANK repeat;Alternative splicing;Disease mutation;Endosome;Hereditary spastic paraplegia;Membrane;Mental retardation;Neurodegeneration;Neurogenesis;Obesity;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-9006934;R-HSA-166520;R-HSA-187037;R-HSA-187687;R-HSA-169893;R-HSA-170984	Signal Transduction;Signaling by Receptor Tyrosine Kinases;Signaling by NTRKs;Signaling by NTRK1 (TRKA);Signalling to ERKs;Prolonged ERK activation events;ARMS-mediated activation
PDSS1	negative	CSAD	ENSG00000139631	PDSS1	1	PDSS1	1	0.00891250688324985	WBGene00006762				GO:0005737;GO:0003824;GO:0016829;GO:0016831;GO:0030170;GO:0019752;GO:0042412;GO:0004068;GO:0004782;GO:0019449;GO:0019452	catalytic activity;pyridoxal phosphate binding;carboxylic acid metabolic process;carboxy-lyase activity;cytoplasm;lyase activity;taurine biosynthetic process;aspartate 1-decarboxylase activity;sulfinoalanine decarboxylase activity;L-cysteine catabolic process to hypotaurine;L-cysteine catabolic process to taurine	3D-structure;Alternative splicing;Decarboxylase;Lyase;Pyridoxal phosphate;Reference proteome	R-HSA-1430728;R-HSA-71291;R-HSA-1614558;R-HSA-1614635	Metabolism;Metabolism of amino acids and derivatives;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism
PDSS1	negative	ZBTB20	ENSG00000181722	PDSS1	1	PDSS1	1	0.00891250688324985	WBGene00012317			Intellectual disability-cataracts-calcified pinnae-myopathy syndrome;Primrose syndrome;Primrose syndrome	GO:0003676;GO:0005634;GO:0005737;GO:0046872;GO:0005654;GO:0003677;GO:0016604;GO:0000977;GO:0001227;GO:0044212;GO:0045821;GO:0046889;GO:0055088;GO:0071333;GO:0005515;GO:0000122;GO:0010629;GO:0032728;GO:0032755;GO:0032760;GO:0045892	protein binding;nucleic acid binding;cell;nucleus;cytoplasm;metal ion binding;nucleoplasm;DNA binding;nuclear body;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;transcription regulatory region DNA binding;lipid homeostasis;positive regulation of glycolytic process;positive regulation of lipid biosynthetic process;cellular response to glucose stimulus;negative regulation of transcription by RNA polymerase II;negative regulation of gene expression;positive regulation of interferon-beta production;positive regulation of interleukin-6 production;positive regulation of tumor necrosis factor production;negative regulation of transcription, DNA-templated	Alternative splicing;DNA-binding;Disease mutation;Isopeptide bond;Mental retardation;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
PDSS1	negative	TSPYL4	ENSG00000187189	PDSS1	1	PDSS1	1	0.00891250688324985	WBGene00005007	WBGene00005007(0)			GO:0005634;GO:0006334;GO:0005515	nucleus;nucleosome assembly;protein binding	Polymorphism;Reference proteome		
PDSS1	negative	HEXA	ENSG00000213614	PDSS1	1	PDSS1	1	0.00891250688324985	WBGene00020509	WBGene00020509(1)		Tay-Sachs disease B variant adult form;Tay-Sachs disease B variant infantile form;Tay-Sachs disease B variant juvenile form;TAY-SACHS DISEASE B1 VARIANT;GM2-GANGLIOSIDOSIS TYPE 1;TAY-SACHS DISEASE	GO:0016020;GO:0016787;GO:0005975;GO:0005515;GO:0008152;GO:0004553;GO:0016798;GO:0005764;GO:0004563;GO:0006687;GO:0070062;GO:0102148;GO:0042582;GO:0043202;GO:0030207;GO:0046982;GO:0042340;GO:0030214;GO:0006024;GO:0008375	carbohydrate metabolic process;hydrolase activity, hydrolyzing O-glycosyl compounds;beta-N-acetylhexosaminidase activity;membrane;hydrolase activity;protein binding;metabolic process;hydrolase activity, acting on glycosyl bonds;lysosome;glycosphingolipid metabolic process;extracellular exosome;N-acetyl-beta-D-galactosaminidase activity;azurophil granule;lysosomal lumen;chondroitin sulfate catabolic process;protein heterodimerization activity;keratan sulfate catabolic process;hyaluronan catabolic process;glycosaminoglycan biosynthetic process;acetylglucosaminyltransferase activity	3D-structure;Alternative splicing;Direct protein sequencing;Disease mutation;Disulfide bond;Gangliosidosis;Glycoprotein;Glycosidase;Hydrolase;Lysosome;Neurodegeneration;Polymorphism;Reference proteome;Signal;Zymogen	R-HSA-1430728;R-HSA-1660662;R-HSA-428157;R-HSA-556833;R-HSA-1643685;R-HSA-3781865;R-HSA-71387;R-HSA-1630316;R-HSA-2142845;R-HSA-1793185;R-HSA-3560782;R-HSA-2024101;R-HSA-1638074;R-HSA-2160916;R-HSA-2022857;R-HSA-3656234	Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism;Metabolism of lipids;Disease;Diseases of glycosylation;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Hyaluronan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Diseases associated with glycosaminoglycan metabolism;CS/DS degradation;Keratan sulfate/keratin metabolism;Hyaluronan uptake and degradation;Keratan sulfate degradation;Defective HEXA causes GM2G1
PDSS1	negative	SERINC3	ENSG00000132824	PDSS1	1	PDSS1	1	0.0094468871634561	WBGene00011250;WBGene00021956	WBGene00011250(1);WBGene00021956(1)			GO:0016020;GO:0016021;GO:0006665;GO:0006658;GO:0005737;GO:0005794;GO:0005886;GO:0000139;GO:0048471;GO:0002376;GO:0045087;GO:0051607;GO:0009597;GO:0006564;GO:1902237	membrane;sphingolipid metabolic process;phosphatidylserine metabolic process;integral component of membrane;cytoplasm;Golgi apparatus;plasma membrane;perinuclear region of cytoplasm;Golgi membrane;immune system process;innate immune response;defense response to virus;viral process;detection of virus;L-serine biosynthetic process;positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	Alternative splicing;Antiviral defense;Cell membrane;Cytoplasm;Glycoprotein;Golgi apparatus;Host-virus interaction;Immunity;Innate immunity;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-71291;R-HSA-977347	Metabolism;Metabolism of amino acids and derivatives;Serine biosynthesis
PDSS1	negative	AGO4	ENSG00000134698	PDSS1	1	PDSS1	1	0.0094468871634561	WBGene00000105;WBGene00000106	WBGene00004093(0);WBGene00018921(0);WBGene00006449(0);WBGene00011910(0);WBGene00020707(0);WBGene00021711(0);WBGene00007624(0);WBGene00010263(0);WBGene00004094(0);WBGene00011061(0);WBGene00022877(0)			GO:0005737;GO:0003676;GO:0003723;GO:0016020;GO:0005829;GO:0005654;GO:0005515;GO:0016604;GO:0031047;GO:0000932;GO:0016442;GO:0006417;GO:0045652;GO:0007223;GO:0003725;GO:0031054;GO:0035196;GO:0070578;GO:0006402;GO:0035198;GO:0035278;GO:0010629;GO:0010501;GO:0035280;GO:0010628;GO:0035194;GO:0003727;GO:0007130;GO:0007140;GO:0008584;GO:0010586;GO:0022604;GO:0043066;GO:0005634	protein binding;nucleic acid binding;cytoplasm;RNA binding;membrane;gene silencing by RNA;P-body;RISC complex;cytosol;regulation of translation;regulation of megakaryocyte differentiation;Wnt signaling pathway, calcium modulating pathway;double-stranded RNA binding;pre-miRNA processing;production of miRNAs involved in gene silencing by miRNA;RISC-loading complex;mRNA catabolic process;miRNA binding;miRNA mediated inhibition of translation;negative regulation of gene expression;RNA secondary structure unwinding;miRNA loading onto RISC involved in gene silencing by miRNA;positive regulation of gene expression;posttranscriptional gene silencing by RNA;single-stranded RNA binding;synaptonemal complex assembly;male meiotic nuclear division;male gonad development;miRNA metabolic process;regulation of cell morphogenesis;negative regulation of apoptotic process;nucleus	3D-structure;Cytoplasm;RNA-binding;RNA-mediated gene silencing;Reference proteome;Ribonucleoprotein;Translation regulation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1257604;R-HSA-195721;R-HSA-2262752;R-HSA-3858494;R-HSA-5683057;R-HSA-5687128;R-HSA-6807070;R-HSA-8878171;R-HSA-8953897;R-HSA-9006925;R-HSA-211000;R-HSA-157118;R-HSA-8939211;R-HSA-9006931;R-HSA-8986944;R-HSA-2559580;R-HSA-2559583;R-HSA-9018519;R-HSA-5628897;R-HSA-1912422;R-HSA-1912408;R-HSA-2559585;R-HSA-4086398;R-HSA-8936459;R-HSA-9022692;R-HSA-203927;R-HSA-426486;R-HSA-8934593;R-HSA-8943723;R-HSA-426496;R-HSA-8948700	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;PIP3 activates AKT signaling;Signaling by WNT;Cellular responses to stress;Beta-catenin independent WNT signaling;MAPK family signaling cascades;MAPK6/MAPK4 signaling;PTEN Regulation;Transcriptional regulation by RUNX1;Cellular responses to external stimuli;Intracellular signaling by second messengers;Gene Silencing by RNA;Signaling by NOTCH;ESR-mediated signaling;Signaling by Nuclear Receptors;Transcriptional Regulation by MECP2;Oxidative Stress Induced Senescence;Cellular Senescence;Estrogen-dependent gene expression;TP53 Regulates Metabolic Genes;Pre-NOTCH Expression and Processing;Pre-NOTCH Transcription and Translation;Oncogene Induced Senescence;Ca2+ pathway;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Regulation of MECP2 expression and activity;MicroRNA (miRNA) biogenesis;Small interfering RNA (siRNA) biogenesis;Regulation of RUNX1 Expression and Activity;Regulation of PTEN mRNA translation;Post-transcriptional silencing by small RNAs;Competing endogenous RNAs (ceRNAs) regulate PTEN translation
PDSS1	negative	KIAA0513	ENSG00000135709	PDSS1	1	PDSS1	1	0.0094468871634561					GO:0005737	cytoplasm	Alternative splicing;Cytoplasm;Phosphoprotein;Polymorphism;Reference proteome		
PDSS1	negative	LPP	ENSG00000145012	PDSS1	1	PDSS1	1	0.0094468871634561	WBGene00006999			LEUKEMIA ACUTE MYELOID	GO:0005829;GO:0005925;GO:0046872;GO:0005634;GO:0005737;GO:0016020;GO:0007155;GO:0005886;GO:0005515;GO:0030054;GO:0008150;GO:0001725;GO:0098609	cytosol;focal adhesion;metal ion binding;nucleus;cytoplasm;membrane;cell adhesion;plasma membrane;protein binding;cell junction;biological_process;stress fiber;cell-cell adhesion	Acetylation;Activator;Cell adhesion;Cell junction;Cell membrane;Chromosomal rearrangement;Cytoplasm;Isopeptide bond;LIM domain;Membrane;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Ubl conjugation;Zinc		
PDSS1	negative	LAMB2	ENSG00000172037	PDSS1	1	PDSS1	1	0.0094468871634561	WBGene00002247			LAMB-2-related infantile-onset nephrotic syndrome;PIERSON SYNDROME;Synaptic congenital myasthenic syndromes;Nephrotic syndrome type 5 with or without ocular abnormalities;PIERSON SYNDROME	GO:0007155;GO:0005576;GO:0009887;GO:0009888;GO:0005201;GO:0070062;GO:0044267;GO:0016477;GO:0034446;GO:0070831;GO:0005604;GO:0043256;GO:0043687;GO:0062023;GO:0005178;GO:0005788;GO:0030198;GO:0005198;GO:0043260;GO:0005608;GO:0000904;GO:0007411;GO:0007528;GO:0007601;GO:0014002;GO:0014044;GO:0031175;GO:0048677;GO:0050808;GO:0060041;GO:0072249;GO:0072274;GO:0031594;GO:0043083;GO:0045202	cell adhesion;extracellular region;animal organ morphogenesis;tissue development;extracellular matrix structural constituent;extracellular exosome;cellular protein metabolic process;cell migration;substrate adhesion-dependent cell spreading;basement membrane assembly;basement membrane;laminin complex;post-translational protein modification;collagen-containing extracellular matrix;integrin binding;endoplasmic reticulum lumen;extracellular matrix organization;structural molecule activity;laminin-11 complex;laminin-3 complex;cell morphogenesis involved in differentiation;axon guidance;neuromuscular junction development;visual perception;astrocyte development;Schwann cell development;neuron projection development;axon extension involved in regeneration;synapse organization;retina development in camera-type eye;metanephric glomerular visceral epithelial cell development;metanephric glomerular basement membrane development;neuromuscular junction;synaptic cleft;synapse	Basement membrane;Cell adhesion;Coiled coil;Disease mutation;Disulfide bond;Extracellular matrix;Glycoprotein;Laminin EGF-like domain;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Secreted;Signal	R-HSA-392499;R-HSA-597592;R-HSA-162582;R-HSA-1474244;R-HSA-3000178;R-HSA-9006934;R-HSA-381426;R-HSA-8957275;R-HSA-3000171;R-HSA-6806834;R-HSA-3000157;R-HSA-8874081;R-HSA-8875878	Metabolism of proteins;Post-translational protein modification;Signal Transduction;Extracellular matrix organization;ECM proteoglycans;Signaling by Receptor Tyrosine Kinases;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Post-translational protein phosphorylation;Non-integrin membrane-ECM interactions;Signaling by MET;Laminin interactions;MET activates PTK2 signaling;MET promotes cell motility
PDSS1	negative	RXRA	ENSG00000186350	PDSS1	1	PDSS1	1	0.0094468871634561	WBGene00006790;WBGene00003654	WBGene00017198(0);WBGene00016975(0);WBGene00007547(0);WBGene00003726(0);WBGene00011100(0);WBGene00011099(0);WBGene00011097(0);WBGene00011098(0);WBGene00003706(0);WBGene00003650(0);WBGene00008221(0);WBGene00017787(0);WBGene00003719(0);WBGene00015395(0);WBGene00015396(0);WBGene00015397(0);WBGene00020748(0);WBGene00003683(0);WBGene00015705(0);WBGene00022423(0);WBGene00003659(0);WBGene00044354(0);WBGene00003626(0);WBGene00021848(0)	ABCA1;CPT1B;CXCR5;HSD17B2;IL2RA;IL2RB;IL2RG;NOL7;SERPINC1		GO:0044212;GO:0005634;GO:0005737;GO:0008270;GO:0046872;GO:0006355;GO:0003677;GO:0003700;GO:0005739;GO:0043565;GO:0005515;GO:0003707;GO:0043401;GO:0030154;GO:0000977;GO:0006357;GO:0045944;GO:0000122;GO:0000981;GO:0000790;GO:0005654;GO:0090575;GO:0016032;GO:0048856;GO:0004879;GO:0008134;GO:0031490;GO:0001701;GO:0001890;GO:0001893;GO:0007507;GO:0007566;GO:0043010;GO:0045893;GO:0045994;GO:0048384;GO:0055010;GO:0055012;GO:0060038;GO:0060528;GO:0060687;GO:0003713;GO:0019899;GO:0046982;GO:0006367;GO:0032991;GO:0042802;GO:0043235;GO:0032526;GO:0019216;GO:0015721;GO:0035357;GO:0008203;GO:0019048;GO:0038023;GO:0044323;GO:0003690;GO:0070644;GO:0042277;GO:0001972;GO:0016922;GO:0042809;GO:0050692;GO:0050693;GO:0006766	DNA binding;steroid hormone receptor activity;zinc ion binding;regulation of transcription, DNA-templated;nucleus;DNA-binding transcription factor activity;sequence-specific DNA binding;transcription regulatory region DNA binding;cytoplasm;metal ion binding;mitochondrion;protein binding;steroid hormone mediated signaling pathway;cell differentiation;regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;negative regulation of transcription by RNA polymerase II;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;nucleoplasm;RNA polymerase II transcription factor complex;viral process;anatomical structure development;RNA polymerase II cis-regulatory region sequence-specific DNA binding;RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding;nuclear receptor activity;transcription factor binding;chromatin DNA binding;in utero embryonic development;placenta development;maternal placenta development;heart development;embryo implantation;camera-type eye development;positive regulation of transcription, DNA-templated;positive regulation of translational initiation by iron;retinoic acid receptor signaling pathway;ventricular cardiac muscle tissue morphogenesis;ventricular cardiac muscle cell differentiation;cardiac muscle cell proliferation;secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development;regulation of branching involved in prostate gland morphogenesis;transcription coactivator activity;enzyme binding;transcription initiation from RNA polymerase II promoter;protein-containing complex;identical protein binding;receptor complex;response to retinoic acid;regulation of lipid metabolic process;bile acid and bile salt transport;peroxisome proliferator activated receptor signaling pathway;cholesterol metabolic process;modulation by virus of host morphology or physiology;signaling receptor activity;retinoic acid-responsive element binding;double-stranded DNA binding;vitamin D response element binding;peptide binding;retinoic acid binding;nuclear receptor binding;vitamin D receptor binding;DNA binding domain binding;LBD domain binding;vitamin metabolic process	3D-structure;Acetylation;Alternative splicing;Cytoplasm;DNA-binding;Host-virus interaction;Isopeptide bond;Metal-binding;Mitochondrion;Nucleus;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-1266738;R-HSA-1852241;R-HSA-392499;R-HSA-597592;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-381340;R-HSA-400206;R-HSA-162582;R-HSA-8978868;R-HSA-211859;R-HSA-2990846;R-HSA-3108232;R-HSA-9006931;R-HSA-211897;R-HSA-211945;R-HSA-211976;R-HSA-8957322;R-HSA-1428517;R-HSA-1368108;R-HSA-400253;R-HSA-204174;R-HSA-5362517;R-HSA-70268;R-HSA-71406;R-HSA-1592230;R-HSA-2151201;R-HSA-5617472;R-HSA-5619507;R-HSA-1655829;R-HSA-200425;R-HSA-2426168;R-HSA-192105;R-HSA-193368;R-HSA-194068;R-HSA-159418;R-HSA-9616222;R-HSA-1368082;R-HSA-383280;R-HSA-193807;R-HSA-4090294	Developmental Biology;Organelle biogenesis and maintenance;Metabolism of proteins;Post-translational protein modification;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Metabolism;Metabolism of lipids;PPARA activates gene expression;Transcriptional regulation of white adipocyte differentiation;Regulation of lipid metabolism by PPARalpha;Signal Transduction;Fatty acid metabolism;Biological oxidations;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Signaling by Nuclear Receptors;Cytochrome P450 - arranged by substrate type;Phase I - Functionalization of compounds;Endogenous sterols;Metabolism of steroids;The citric acid (TCA) cycle and respiratory electron transport;BMAL1:CLOCK,NPAS2 activates circadian gene expression;Circadian Clock;Regulation of pyruvate dehydrogenase (PDH) complex;Signaling by Retinoic Acid;Pyruvate metabolism;Pyruvate metabolism and Citric Acid (TCA) cycle;Mitochondrial biogenesis;Transcriptional activation of mitochondrial biogenesis;Activation of anterior HOX genes in hindbrain development during early embryogenesis;Activation of HOX genes during differentiation;Regulation of cholesterol biosynthesis by SREBP (SREBF);Carnitine metabolism;Activation of gene expression by SREBF (SREBP);Synthesis of bile acids and bile salts;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;Bile acid and bile salt metabolism;Recycling of bile acids and salts;Transcriptional regulation of granulopoiesis;RORA activates gene expression;Nuclear Receptor transcription pathway;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;SUMOylation of intracellular receptors
PDSS1	negative	LRP10	ENSG00000197324	PDSS1	1	PDSS1	1	0.0094468871634561	WBGene00003075;WBGene00004374;WBGene00008609;WBGene00015083;WBGene00019756;WBGene00019811				GO:0016020;GO:0016021;GO:0005905;GO:0006897;GO:0005041;GO:0006629;GO:0006869;GO:0048839;GO:0005515	protein binding;membrane;integral component of membrane;clathrin-coated pit;endocytosis;low-density lipoprotein particle receptor activity;lipid metabolic process;lipid transport;inner ear development	Alternative splicing;Coated pit;Disulfide bond;Endocytosis;Glycoprotein;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418594;R-HSA-196854;R-HSA-2187338;R-HSA-6806667;R-HSA-975634	Metabolism;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of vitamins and cofactors;Visual phototransduction;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
